<?xml version="1.0" encoding="UTF-8"?>
<xliff version="1.2">
  <file original="PE_classes" datatype="plaintext" source-language="en-US" target-language="ja-JP">
    <body>
     <trans-unit id="PEO_1_label">
       <source>Age</source>
       <target>年齢
</target>
     </trans-unit>
     <trans-unit id="PEO_1_synonyms">
       <source>age at onset</source>
     </trans-unit>
     <trans-unit id="PEO_1_synonyms_1">
       <source>age-at-onset</source>
     </trans-unit>
     <trans-unit id="PEO_1_synonyms_2">
       <source>AAO</source>
     </trans-unit>
     <trans-unit id="PEO_2_label">
       <source>Age adjusted mortality rate</source>
       <target>年齢調整死亡率
</target>
     </trans-unit>
     <trans-unit id="PEO_2_synonyms">
       <source>Age adjusted mortality rates</source>
     </trans-unit>
     <trans-unit id="PEO_3_label">
       <source>Age period cohort analysis</source>
       <target>APCモデル
</target>
     </trans-unit>
     <trans-unit id="PEO_4_label">
       <source>Age specific mortality rate</source>
       <target>特定年齢死亡率
</target>
     </trans-unit>
     <trans-unit id="PEO_4_synonyms">
       <source>Age specific mortality rates</source>
     </trans-unit>
     <trans-unit id="PEO_5_label">
       <source>Age standardized mortality rate</source>
       <target>年齢調整死亡率 
</target>
     </trans-unit>
     <trans-unit id="PEO_5_synonyms">
       <source>Age standardized mortality rates</source>
     </trans-unit>
     <trans-unit id="PEO_6_label">
       <source>Analytical study</source>
       <target>分析的研究
</target>
     </trans-unit>
     <trans-unit id="PEO_6_synonyms">
       <source>Analytical studies</source>
     </trans-unit>
     <trans-unit id="PEO_7_label">
       <source>Anatomical entity</source>
       <target>解剖学的語彙
</target>
     </trans-unit>
     <trans-unit id="PEO_7_synonyms">
       <source>Anatomical entities</source>
     </trans-unit>
     <trans-unit id="PEO_7_synonyms_1">
       <source>Anatomical</source>
     </trans-unit>
     <trans-unit id="PEO_8_label">
       <source>Animal species</source>
       <target>動物種
</target>
     </trans-unit>
     <trans-unit id="PEO_9_label">
       <source>Annual prevalence</source>
       <target>年間有病数
</target>
     </trans-unit>
     <trans-unit id="PEO_10_label">
       <source>thing related to applied epidemiology</source>
       <target>応用疫学に関する概念
</target>
     </trans-unit>
     <trans-unit id="PEO_10_synonyms">
       <source>Applied epidemiology</source>
     </trans-unit>
     <trans-unit id="PEO_11_label">
       <source>Birth defect rate</source>
       <target>先天異常率
</target>
     </trans-unit>
     <trans-unit id="PEO_11_synonyms">
       <source>Birth defect rates</source>
     </trans-unit>
     <trans-unit id="PEO_12_label">
       <source>Case cohort study</source>
       <target>ケースコホート研究
</target>
     </trans-unit>
     <trans-unit id="PEO_12_synonyms">
       <source>Case cohort studies</source>
     </trans-unit>
     <trans-unit id="PEO_13_label">
       <source>Case study</source>
       <target>症例研究
</target>
     </trans-unit>
     <trans-unit id="PEO_13_synonyms">
       <source>Case studies</source>
     </trans-unit>
     <trans-unit id="PEO_14_label">
       <source>Cause specific mortality rate</source>
       <target>特定死因死亡率
</target>
     </trans-unit>
     <trans-unit id="PEO_14_synonyms">
       <source>Cause specific mortality rates</source>
     </trans-unit>
     <trans-unit id="PEO_15_label">
       <source>Cell cell interaction</source>
       <target>細胞間相互作用
</target>
     </trans-unit>
     <trans-unit id="PEO_15_synonyms">
       <source>Cell cell interactions</source>
     </trans-unit>
     <trans-unit id="PEO_16_label">
       <source>Cellular and sub cellular process</source>
       <target>細胞と細胞内のプロセス
</target>
     </trans-unit>
     <trans-unit id="PEO_16_synonyms">
       <source>Cellular and sub cellular processes</source>
     </trans-unit>
     <trans-unit id="PEO_16_synonyms_1">
       <source>cellular physiological process</source>
     </trans-unit>
     <trans-unit id="PEO_16_synonyms_2">
       <source>cellular physiological processes</source>
     </trans-unit>
     <trans-unit id="PEO_16_synonyms_3">
       <source>cell physiology</source>
     </trans-unit>
     <trans-unit id="PEO_17_label">
       <source>Cellular and subcellular entity</source>
       <target>細胞と細胞内の事象に関する語彙
</target>
     </trans-unit>
     <trans-unit id="PEO_17_synonyms">
       <source>subcellular entities</source>
     </trans-unit>
     <trans-unit id="PEO_17_synonyms_1">
       <source>cellular entities</source>
     </trans-unit>
     <trans-unit id="PEO_17_synonyms_2">
       <source>subcellular entity</source>
     </trans-unit>
     <trans-unit id="PEO_17_synonyms_3">
       <source>cellular entity</source>
     </trans-unit>
     <trans-unit id="PEO_18_label">
       <source>Clinical thing</source>
       <target>臨床関連概念
</target>
     </trans-unit>
     <trans-unit id="PEO_18_synonyms">
       <source>clinical</source>
     </trans-unit>
     <trans-unit id="PEO_19_label">
       <source>Clinical assesment</source>
       <target>臨床的評価
</target>
     </trans-unit>
     <trans-unit id="PEO_19_synonyms">
       <source>Clinical assesments</source>
     </trans-unit>
     <trans-unit id="PEO_19_synonyms_1">
       <source>Health Assesment</source>
     </trans-unit>
     <trans-unit id="PEO_19_synonyms_2">
       <source>Health Assesments</source>
     </trans-unit>
     <trans-unit id="PEO_20_label">
       <source>thing related to clinical treatment</source>
       <target>治療に関する概念
</target>
     </trans-unit>
     <trans-unit id="PEO_20_synonyms">
       <source>clinical treatment</source>
     </trans-unit>
     <trans-unit id="PEO_20_synonyms_1">
       <source>clinical treatments</source>
     </trans-unit>
     <trans-unit id="PEO_21_label">
       <source>thing related to clinical trial</source>
       <target>臨床試験に関する概念
</target>
     </trans-unit>
     <trans-unit id="PEO_21_synonyms">
       <source>Clinical trial</source>
     </trans-unit>
     <trans-unit id="PEO_21_synonyms_1">
       <source>Community bases clinical trials</source>
     </trans-unit>
     <trans-unit id="PEO_21_synonyms_2">
       <source>CBCT</source>
     </trans-unit>
     <trans-unit id="PEO_22_label">
       <source>Cohort study</source>
       <target>コホート研究
</target>
     </trans-unit>
     <trans-unit id="PEO_22_synonyms">
       <source>cohort study</source>
     </trans-unit>
     <trans-unit id="PEO_22_synonyms_1">
       <source>Cohort studies</source>
     </trans-unit>
     <trans-unit id="PEO_23_label">
       <source>Concurrent cohort study</source>
       <target>前向きコホート研究
</target>
     </trans-unit>
     <trans-unit id="PEO_23_synonyms">
       <source>Concurrent cohort studies</source>
     </trans-unit>
     <trans-unit id="PEO_24_label">
       <source>Correlation study</source>
       <target>相関研究
</target>
     </trans-unit>
     <trans-unit id="PEO_24_synonyms">
       <source>Correlation studies</source>
     </trans-unit>
     <trans-unit id="PEO_25_label">
       <source>Cross sectional survey</source>
       <target>横断研究
</target>
     </trans-unit>
     <trans-unit id="PEO_25_synonyms">
       <source>Cross sectional surveys</source>
     </trans-unit>
     <trans-unit id="PEO_26_label">
       <source>Crude mortality rate</source>
       <target>粗死亡率
</target>
     </trans-unit>
     <trans-unit id="PEO_26_synonyms">
       <source>Crude mortality rates</source>
     </trans-unit>
     <trans-unit id="PEO_27_label">
       <source>Cumulative death rate</source>
       <target>累積死亡率
</target>
     </trans-unit>
     <trans-unit id="PEO_27_synonyms">
       <source>Cumulative death rates</source>
     </trans-unit>
     <trans-unit id="PEO_28_label">
       <source>Death to case ratio</source>
       <target>死亡率
</target>
     </trans-unit>
     <trans-unit id="PEO_28_synonyms">
       <source>Death to case ratios</source>
     </trans-unit>
     <trans-unit id="PEO_29_label">
       <source>thing related to descriptive epidemiology</source>
       <target>記述疫学に関する概念
</target>
     </trans-unit>
     <trans-unit id="PEO_29_synonyms">
       <source>Descriptive epidemiology</source>
     </trans-unit>
     <trans-unit id="PEO_30_label">
       <source>descriptive statistics entity</source>
       <target>記述統計学に関連する語彙
</target>
     </trans-unit>
     <trans-unit id="PEO_30_synonyms">
       <source>Descriptive statistics</source>
     </trans-unit>
     <trans-unit id="PEO_31_label">
       <source>Descriptive study</source>
       <target>記述的研究
</target>
     </trans-unit>
     <trans-unit id="PEO_31_synonyms">
       <source>Descriptive studies</source>
     </trans-unit>
     <trans-unit id="PEO_32_label">
       <source>thing related to diagnosis</source>
       <target>診断に関連する概念
</target>
     </trans-unit>
     <trans-unit id="PEO_32_synonyms">
       <source>Diagnosis</source>
     </trans-unit>
     <trans-unit id="PEO_33_label">
       <source>Diagnostic Procedure</source>
       <target>診断手順
</target>
     </trans-unit>
     <trans-unit id="PEO_33_synonyms">
       <source>Diagnostic Procedures</source>
     </trans-unit>
     <trans-unit id="PEO_34_label">
       <source>Diagnostic test</source>
       <target>診断検査
</target>
     </trans-unit>
     <trans-unit id="PEO_34_synonyms">
       <source>Diagnostic tests</source>
     </trans-unit>
     <trans-unit id="PEO_35_label">
       <source>Disease rate at autopsy</source>
       <target>剖検における有病率
</target>
     </trans-unit>
     <trans-unit id="PEO_35_synonyms">
       <source>Disease rates at autopsy</source>
     </trans-unit>
     <trans-unit id="PEO_36_label">
       <source>Distribution</source>
       <target>分布
</target>
     </trans-unit>
     <trans-unit id="PEO_36_synonyms">
       <source>scattered</source>
     </trans-unit>
     <trans-unit id="PEO_36_synonyms_1">
       <source>Distributions</source>
     </trans-unit>
     <trans-unit id="PEO_36_synonyms_2">
       <source>diffuse</source>
     </trans-unit>
     <trans-unit id="PEO_37_label">
       <source>Epidemiological study</source>
       <target>疫学研究
</target>
     </trans-unit>
     <trans-unit id="PEO_37_synonyms">
       <source>Epidemiological studies</source>
     </trans-unit>
     <trans-unit id="PEO_38_label">
       <source>thing related to epidemiology</source>
       <target>疫学関連概念
</target>
     </trans-unit>
     <trans-unit id="PEO_38_synonyms">
       <source>Epidemiology</source>
     </trans-unit>
     <trans-unit id="PEO_39_label">
       <source>Etiological thing</source>
       <target>病因に関する概念
</target>
     </trans-unit>
     <trans-unit id="PEO_39_synonyms">
       <source>Etiology</source>
     </trans-unit>
     <trans-unit id="PEO_40_label">
       <source>Evaluation</source>
       <target>評価
</target>
     </trans-unit>
     <trans-unit id="PEO_41_label">
       <source>Ex vivo thing</source>
       <target>培養細胞・培養組織に関する事象
</target>
     </trans-unit>
     <trans-unit id="PEO_41_synonyms">
       <source>Ex vivo</source>
     </trans-unit>
     <trans-unit id="PEO_42_label">
       <source>Exposure</source>
       <target>曝露
</target>
     </trans-unit>
     <trans-unit id="PEO_43_label">
       <source>First generation migrant</source>
       <target>移民一世
</target>
     </trans-unit>
     <trans-unit id="PEO_44_label">
       <source>Frequency measure</source>
       <target>頻度の測定
</target>
     </trans-unit>
     <trans-unit id="PEO_44_synonyms">
       <source>Frequency measures</source>
     </trans-unit>
     <trans-unit id="PEO_45_label">
       <source>Gender</source>
       <target>性別
</target>
     </trans-unit>
     <trans-unit id="PEO_45_synonyms">
       <source>sex</source>
     </trans-unit>
     <trans-unit id="PEO_46_label">
       <source>Entity relating to genetic cause</source>
       <target>遺伝的な原因に関する語彙
</target>
     </trans-unit>
     <trans-unit id="PEO_46_synonyms">
       <source>Genetic cause</source>
     </trans-unit>
     <trans-unit id="PEO_47_label">
       <source>In silico thing</source>
       <target>インシリコの概念
</target>
     </trans-unit>
     <trans-unit id="PEO_47_synonyms">
       <source>In silico</source>
     </trans-unit>
     <trans-unit id="PEO_48_label">
       <source>In vitro thing</source>
       <target>in virtoの概念
</target>
     </trans-unit>
     <trans-unit id="PEO_48_synonyms">
       <source>In vitro</source>
     </trans-unit>
     <trans-unit id="PEO_49_label">
       <source>In vitro model</source>
       <target>in vitroのモデル
</target>
     </trans-unit>
     <trans-unit id="PEO_49_synonyms">
       <source>In vitro models</source>
     </trans-unit>
     <trans-unit id="PEO_50_label">
       <source>In vivo thing</source>
       <target>in vivoの概念
</target>
     </trans-unit>
     <trans-unit id="PEO_50_synonyms">
       <source>In vivo</source>
     </trans-unit>
     <trans-unit id="PEO_51_label">
       <source>In vivo model</source>
       <target>in vivoのモデル
</target>
     </trans-unit>
     <trans-unit id="PEO_51_synonyms">
       <source>In vivo models</source>
     </trans-unit>
     <trans-unit id="PEO_51_synonyms_1">
       <source>rat models</source>
     </trans-unit>
     <trans-unit id="PEO_51_synonyms_2">
       <source>alzheimer&apos;s disease mouse models</source>
     </trans-unit>
     <trans-unit id="PEO_51_synonyms_3">
       <source>animal models</source>
     </trans-unit>
     <trans-unit id="PEO_51_synonyms_4">
       <source>rat model</source>
     </trans-unit>
     <trans-unit id="PEO_51_synonyms_5">
       <source>alzheimer&apos;s disease mouse model</source>
     </trans-unit>
     <trans-unit id="PEO_51_synonyms_6">
       <source>mouse models</source>
     </trans-unit>
     <trans-unit id="PEO_51_synonyms_7">
       <source>mouse model</source>
     </trans-unit>
     <trans-unit id="PEO_51_synonyms_8">
       <source>animal model</source>
     </trans-unit>
     <trans-unit id="PEO_52_label">
       <source>Thing related to intervention</source>
       <target>介入に関する概念
</target>
     </trans-unit>
     <trans-unit id="PEO_52_synonyms">
       <source>treatment</source>
     </trans-unit>
     <trans-unit id="PEO_52_synonyms_1">
       <source>intervention</source>
     </trans-unit>
     <trans-unit id="PEO_53_label">
       <source>Life time prevalence</source>
       <target>生涯有病率
</target>
     </trans-unit>
     <trans-unit id="PEO_54_label">
       <source>Measure of central location</source>
       <target>中心地の測定
</target>
     </trans-unit>
     <trans-unit id="PEO_54_synonyms">
       <source>Measures of central location</source>
     </trans-unit>
     <trans-unit id="PEO_55_label">
       <source>Measure of disease occurrence entity</source>
       <target>発病の観測に関する語彙
</target>
     </trans-unit>
     <trans-unit id="PEO_55_synonyms">
       <source>Measures of disease occurrence</source>
     </trans-unit>
     <trans-unit id="PEO_55_synonyms_1">
       <source>Measure of disease occurrence</source>
     </trans-unit>
     <trans-unit id="PEO_56_label">
       <source>Measure of dispersion</source>
       <target>分散の測定
</target>
     </trans-unit>
     <trans-unit id="PEO_56_synonyms">
       <source>Measures of dispersion</source>
     </trans-unit>
     <trans-unit id="PEO_57_label">
       <source>Measurement scale</source>
       <target>測定スケール
</target>
     </trans-unit>
     <trans-unit id="PEO_57_synonyms">
       <source>Measurement scales</source>
     </trans-unit>
     <trans-unit id="PEO_58_label">
       <source>Migrant study</source>
       <target>移民研究
</target>
     </trans-unit>
     <trans-unit id="PEO_58_synonyms">
       <source>Migrant studies</source>
     </trans-unit>
     <trans-unit id="PEO_59_label">
       <source>Molecular and cellular mechanism thing</source>
       <target>分子と細胞内メカニズムに関連する概念
</target>
     </trans-unit>
     <trans-unit id="PEO_59_synonyms">
       <source>Molecular and cellular mechanism</source>
     </trans-unit>
     <trans-unit id="PEO_59_synonyms_1">
       <source>Molecular and cellular mechanisms</source>
     </trans-unit>
     <trans-unit id="PEO_60_label">
       <source>Molecular entity</source>
       <target>分子に関する語彙
</target>
     </trans-unit>
     <trans-unit id="PEO_60_synonyms">
       <source>molecular entities</source>
     </trans-unit>
     <trans-unit id="PEO_60_synonyms_1">
       <source>molecular entity</source>
     </trans-unit>
     <trans-unit id="PEO_61_label">
       <source>Molecular process</source>
       <target>分子プロセス
</target>
     </trans-unit>
     <trans-unit id="PEO_61_synonyms">
       <source>Molecular processes</source>
     </trans-unit>
     <trans-unit id="PEO_62_label">
       <source>Monkey</source>
       <target>サル
</target>
     </trans-unit>
     <trans-unit id="PEO_62_synonyms">
       <source>Monkeys</source>
     </trans-unit>
     <trans-unit id="PEO_63_label">
       <source>thing related to morbidity</source>
       <target>罹患率に関連した概念
</target>
     </trans-unit>
     <trans-unit id="PEO_63_synonyms">
       <source>Morbidity</source>
     </trans-unit>
     <trans-unit id="PEO_64_label">
       <source>Morbidity survey</source>
       <target>罹患率調査
</target>
     </trans-unit>
     <trans-unit id="PEO_64_synonyms">
       <source>Morbidity surveys</source>
     </trans-unit>
     <trans-unit id="PEO_65_label">
       <source>Mortality</source>
       <target>死亡率
</target>
     </trans-unit>
     <trans-unit id="PEO_66_label">
       <source>Mortility rate</source>
       <target>死亡率
</target>
     </trans-unit>
     <trans-unit id="PEO_66_synonyms">
       <source>Mortility rates</source>
     </trans-unit>
     <trans-unit id="PEO_67_label">
       <source>Mouse</source>
       <target>マウス
</target>
     </trans-unit>
     <trans-unit id="PEO_67_synonyms">
       <source>mice</source>
     </trans-unit>
     <trans-unit id="PEO_68_label">
       <source>Nested case control study</source>
       <target>コホート内症例対照研究
</target>
     </trans-unit>
     <trans-unit id="PEO_68_synonyms">
       <source>Nested case control studies</source>
     </trans-unit>
     <trans-unit id="PEO_69_label">
       <source>Non clinical thing</source>
       <target>医学的ではない概念
</target>
     </trans-unit>
     <trans-unit id="PEO_69_synonyms">
       <source>non clinical</source>
     </trans-unit>
     <trans-unit id="PEO_70_label">
       <source>thing related to non pharmacotherapy clinical treatment</source>
       <target>非薬物療法に関連する概念
</target>
     </trans-unit>
     <trans-unit id="PEO_70_synonyms">
       <source>non pharmacotherapy treatment</source>
     </trans-unit>
     <trans-unit id="PEO_70_synonyms_1">
       <source>non pharmacotherapy treatments</source>
     </trans-unit>
     <trans-unit id="PEO_71_label">
       <source>Thing related to outcome</source>
       <target>アウトカムに関連する概念
</target>
     </trans-unit>
     <trans-unit id="PEO_71_synonyms">
       <source>outcome</source>
     </trans-unit>
     <trans-unit id="PEO_72_label">
       <source>thing related to pathogenesis</source>
       <target>病因に関連する概念
</target>
     </trans-unit>
     <trans-unit id="PEO_72_synonyms">
       <source>pathogenesis</source>
     </trans-unit>
     <trans-unit id="PEO_72_synonyms_1">
       <source>Alzheimer&apos;s disease (AD) pathogenesis</source>
     </trans-unit>
     <trans-unit id="PEO_73_label">
       <source>thing related to pathology</source>
       <target>病理に関連する概念
</target>
     </trans-unit>
     <trans-unit id="PEO_73_synonyms">
       <source>Preeclampsia-related pathological changes</source>
     </trans-unit>
     <trans-unit id="PEO_73_synonyms_1">
       <source>Preeclampsia-related pathology</source>
     </trans-unit>
     <trans-unit id="PEO_74_label">
       <source>Period Prevalence</source>
       <target>期間有病数
</target>
     </trans-unit>
     <trans-unit id="PEO_75_label">
       <source>Person</source>
       <target>人間
</target>
     </trans-unit>
     <trans-unit id="PEO_75_synonyms">
       <source>Alzheimer&apos;s patient</source>
     </trans-unit>
     <trans-unit id="PEO_75_synonyms_1">
       <source>Alzheimer&apos;s patients</source>
     </trans-unit>
     <trans-unit id="PEO_75_synonyms_2">
       <source>Alzheimer patients</source>
     </trans-unit>
     <trans-unit id="PEO_75_synonyms_3">
       <source>Alzheimer patient</source>
     </trans-unit>
     <trans-unit id="PEO_75_synonyms_4">
       <source>Persons</source>
     </trans-unit>
     <trans-unit id="PEO_76_label">
       <source>thing related to pharmacotherapy clinical treatment</source>
       <target>薬物療法に関連する概念
</target>
     </trans-unit>
     <trans-unit id="PEO_76_synonyms">
       <source>pharmacotherapy clinical treatments</source>
     </trans-unit>
     <trans-unit id="PEO_76_synonyms_1">
       <source>pharmacotherapy clinical treatment</source>
     </trans-unit>
     <trans-unit id="PEO_76_synonyms_2">
       <source>Pharmacotherapy</source>
     </trans-unit>
     <trans-unit id="PEO_77_label">
       <source>Point prevalence</source>
       <target>点有病数
</target>
     </trans-unit>
     <trans-unit id="PEO_78_label">
       <source>thing related to prevalence</source>
       <target>有病率に関連する概念
</target>
     </trans-unit>
     <trans-unit id="PEO_78_synonyms">
       <source>Prevalence</source>
     </trans-unit>
     <trans-unit id="PEO_79_label">
       <source>Prevalence rate</source>
       <target>有病率
</target>
     </trans-unit>
     <trans-unit id="PEO_79_synonyms">
       <source>Prevalence rates</source>
     </trans-unit>
     <trans-unit id="PEO_80_label">
       <source>Prognostic study</source>
       <target>予後研究
</target>
     </trans-unit>
     <trans-unit id="PEO_80_synonyms">
       <source>Prognostic studies</source>
     </trans-unit>
     <trans-unit id="PEO_81_label">
       <source>Proportion</source>
       <target>割合
</target>
     </trans-unit>
     <trans-unit id="PEO_81_synonyms">
       <source>quotients</source>
     </trans-unit>
     <trans-unit id="PEO_81_synonyms_1">
       <source>proportionality</source>
     </trans-unit>
     <trans-unit id="PEO_81_synonyms_2">
       <source>quotient</source>
     </trans-unit>
     <trans-unit id="PEO_81_synonyms_3">
       <source>Proportions</source>
     </trans-unit>
     <trans-unit id="PEO_81_synonyms_4">
       <source>proportion</source>
     </trans-unit>
     <trans-unit id="PEO_81_synonyms_5">
       <source>ratios</source>
     </trans-unit>
     <trans-unit id="PEO_81_synonyms_6">
       <source>ratio</source>
     </trans-unit>
     <trans-unit id="PEO_81_synonyms_7">
       <source>proportionalities</source>
     </trans-unit>
     <trans-unit id="PEO_82_label">
       <source>Race</source>
       <target>人種
</target>
     </trans-unit>
     <trans-unit id="PEO_83_label">
       <source>Race specific mortality rate</source>
       <target>人種特異的死亡率
</target>
     </trans-unit>
     <trans-unit id="PEO_83_synonyms">
       <source>Race specific mortality rates</source>
     </trans-unit>
     <trans-unit id="PEO_84_label">
       <source>Rat</source>
       <target>ラット
</target>
     </trans-unit>
     <trans-unit id="PEO_84_synonyms">
       <source>Rats</source>
     </trans-unit>
     <trans-unit id="PEO_85_label">
       <source>Recruitment criterion</source>
       <target>募集要項
</target>
     </trans-unit>
     <trans-unit id="PEO_85_synonyms">
       <source>Recruitment criteria</source>
     </trans-unit>
     <trans-unit id="PEO_86_label">
       <source>Regulation of gene expression</source>
       <target>遺伝子発現制御
</target>
     </trans-unit>
     <trans-unit id="PEO_87_label">
       <source>Retrospective cohort study</source>
       <target>レトロスペクティブコホート研究⇒後方視的コホート研究
</target>
     </trans-unit>
     <trans-unit id="PEO_87_synonyms">
       <source>Retrospective cohort studies</source>
     </trans-unit>
     <trans-unit id="PEO_88_label">
       <source>Risk factor</source>
       <target>リスク因子
</target>
     </trans-unit>
     <trans-unit id="PEO_88_synonyms">
       <source>lifestyle factor</source>
     </trans-unit>
     <trans-unit id="PEO_88_synonyms_1">
       <source>increased risk</source>
     </trans-unit>
     <trans-unit id="PEO_88_synonyms_2">
       <source>lifestyle factors</source>
     </trans-unit>
     <trans-unit id="PEO_88_synonyms_3">
       <source>risk</source>
     </trans-unit>
     <trans-unit id="PEO_88_synonyms_4">
       <source>risk factors for Alzheimer</source>
     </trans-unit>
     <trans-unit id="PEO_88_synonyms_5">
       <source>risk factor</source>
     </trans-unit>
     <trans-unit id="PEO_88_synonyms_6">
       <source>Risk factors</source>
     </trans-unit>
     <trans-unit id="PEO_89_label">
       <source>Rodent</source>
       <target>げっ歯類
</target>
     </trans-unit>
     <trans-unit id="PEO_89_synonyms">
       <source>Rodents</source>
     </trans-unit>
     <trans-unit id="PEO_90_label">
       <source>Sampling</source>
       <target>サンプリング
</target>
     </trans-unit>
     <trans-unit id="PEO_91_label">
       <source>Screening</source>
       <target>スクリーニング
</target>
     </trans-unit>
     <trans-unit id="PEO_92_label">
       <source>Second generation migrant</source>
       <target>移民 2 世
</target>
     </trans-unit>
     <trans-unit id="PEO_93_label">
       <source>Sex specific mortality rate</source>
       <target>性特異的死亡率
</target>
     </trans-unit>
     <trans-unit id="PEO_93_synonyms">
       <source>Sex specific mortality rates</source>
     </trans-unit>
     <trans-unit id="PEO_94_label">
       <source>Standardized mortality rate</source>
       <target>標準化死亡比
</target>
     </trans-unit>
     <trans-unit id="PEO_94_synonyms">
       <source>Standardized mortality rates</source>
     </trans-unit>
     <trans-unit id="PEO_95_label">
       <source>Standardized mortality ratio</source>
       <target>標準化死亡比
</target>
     </trans-unit>
     <trans-unit id="PEO_95_synonyms">
       <source>Standardized mortality ratios</source>
     </trans-unit>
     <trans-unit id="PEO_96_label">
       <source>statistics entity</source>
       <target>統計学的概念
</target>
     </trans-unit>
     <trans-unit id="PEO_96_synonyms">
       <source>Statistics</source>
     </trans-unit>
     <trans-unit id="PEO_97_label">
       <source>Study design</source>
       <target>研究デザイン
</target>
     </trans-unit>
     <trans-unit id="PEO_97_synonyms">
       <source>Study designs</source>
     </trans-unit>
     <trans-unit id="PEO_98_label">
       <source>Study phase</source>
       <target>研究段階
</target>
     </trans-unit>
     <trans-unit id="PEO_98_synonyms">
       <source>Study phases</source>
     </trans-unit>
     <trans-unit id="PEO_99_label">
       <source>clinical trial study</source>
       <target>臨床試験
</target>
     </trans-unit>
     <trans-unit id="PEO_99_synonyms">
       <source>studies</source>
     </trans-unit>
     <trans-unit id="PEO_99_synonyms_1">
       <source>study</source>
     </trans-unit>
     <trans-unit id="PEO_99_synonyms_2">
       <source>clinical trial studies</source>
     </trans-unit>
     <trans-unit id="PEO_100_label">
       <source>Symptom or sign</source>
       <target>症状と徴候
</target>
     </trans-unit>
     <trans-unit id="PEO_100_synonyms">
       <source>sign</source>
     </trans-unit>
     <trans-unit id="PEO_100_synonyms_1">
       <source>symptoms</source>
     </trans-unit>
     <trans-unit id="PEO_100_synonyms_2">
       <source>symptom</source>
     </trans-unit>
     <trans-unit id="PEO_100_synonyms_3">
       <source>signs</source>
     </trans-unit>
     <trans-unit id="PEO_101_label">
       <source>Thing that can act as a protective factor</source>
       <target>リスク低減因子に関係する概念
</target>
     </trans-unit>
     <trans-unit id="PEO_101_synonyms">
       <source>protective factor</source>
     </trans-unit>
     <trans-unit id="PEO_101_synonyms_1">
       <source>protective factors</source>
     </trans-unit>
     <trans-unit id="PEO_101_synonyms_2">
       <source>Thing that can act as a protective factor for Alzheimer</source>
     </trans-unit>
     <trans-unit id="PEO_102_label">
       <source>Trend</source>
       <target>傾向
</target>
     </trans-unit>
     <trans-unit id="PEO_102_synonyms">
       <source>Trends</source>
     </trans-unit>
     <trans-unit id="PEO_103_label">
       <source>Vertebrate</source>
       <target>脊椎動物
</target>
     </trans-unit>
     <trans-unit id="PEO_103_synonyms">
       <source>Vertebrate</source>
     </trans-unit>
     <trans-unit id="PEO_104_label">
       <source>add-on treatment context</source>
       <target>追加処置のコンテクスト
</target>
     </trans-unit>
     <trans-unit id="PEO_105_label">
       <source>allocation design</source>
       <target>割付けのデザイン
</target>
     </trans-unit>
     <trans-unit id="PEO_105_synonyms">
       <source>allocation designs</source>
     </trans-unit>
     <trans-unit id="PEO_106_label">
       <source>antidepressant</source>
       <target>抗うつ薬
</target>
     </trans-unit>
     <trans-unit id="PEO_106_synonyms">
       <source>antidepressants</source>
     </trans-unit>
     <trans-unit id="PEO_107_label">
       <source>antirheumatic drug</source>
       <target>抗リウマチ薬
</target>
     </trans-unit>
     <trans-unit id="PEO_107_synonyms">
       <source>antirheumatic drugs</source>
     </trans-unit>
     <trans-unit id="PEO_108_label">
       <source>applied epidemiology context</source>
       <target>応用疫学のコンテクスト
</target>
     </trans-unit>
     <trans-unit id="PEO_109_label">
       <source>biomarker</source>
       <target>バイオマーカー
</target>
     </trans-unit>
     <trans-unit id="PEO_109_synonyms">
       <source>markers</source>
     </trans-unit>
     <trans-unit id="PEO_109_synonyms_1">
       <source>marker</source>
     </trans-unit>
     <trans-unit id="PEO_109_synonyms_2">
       <source>biomarkers</source>
     </trans-unit>
     <trans-unit id="PEO_110_label">
       <source>cellular context</source>
       <target>細胞内のコンテクスト
</target>
     </trans-unit>
     <trans-unit id="PEO_111_label">
       <source>clinical context</source>
       <target>臨床のコンテクスト
</target>
     </trans-unit>
     <trans-unit id="PEO_112_label">
       <source>clinical treatment context</source>
       <target>治療のコンテクスト
</target>
     </trans-unit>
     <trans-unit id="PEO_113_label">
       <source>clinical trial context</source>
       <target>臨床試験のコンテクスト
</target>
     </trans-unit>
     <trans-unit id="PEO_114_label">
       <source>context</source>
       <target>コンテクスト
</target>
     </trans-unit>
     <trans-unit id="PEO_115_label">
       <source>descriptive epidemiology context</source>
       <target>記述疫学のコンテクスト
</target>
     </trans-unit>
     <trans-unit id="PEO_116_label">
       <source>descriptive statistical context</source>
       <target>記述統計のコンテクスト
</target>
     </trans-unit>
     <trans-unit id="PEO_117_label">
       <source>diagnosis context</source>
       <target>診断のコンテクスト
</target>
     </trans-unit>
     <trans-unit id="PEO_118_label">
       <source>disease cause</source>
       <target>病因
</target>
     </trans-unit>
     <trans-unit id="PEO_118_synonyms">
       <source>disease causes</source>
     </trans-unit>
     <trans-unit id="PEO_119_label">
       <source>disorder</source>
       <target>疾患
</target>
     </trans-unit>
     <trans-unit id="PEO_119_synonyms">
       <source>neurodegenerative disorder</source>
     </trans-unit>
     <trans-unit id="PEO_119_synonyms_1">
       <source>disorders</source>
     </trans-unit>
     <trans-unit id="PEO_120_label">
       <source>drug role</source>
       <target>薬理
</target>
     </trans-unit>
     <trans-unit id="PEO_120_synonyms">
       <source>drug roles</source>
     </trans-unit>
     <trans-unit id="PEO_121_label">
       <source>drug side effect</source>
       <target>薬の副作用
</target>
     </trans-unit>
     <trans-unit id="PEO_121_synonyms">
       <source>drug side effects</source>
     </trans-unit>
     <trans-unit id="PEO_122_label">
       <source>endpoint classification design</source>
       <target>エンドポイント分類デザイン
</target>
     </trans-unit>
     <trans-unit id="PEO_122_synonyms">
       <source>endpoint classification designs</source>
     </trans-unit>
     <trans-unit id="PEO_123_label">
       <source>epidemiology context</source>
       <target>疫学的なコンテクスト
</target>
     </trans-unit>
     <trans-unit id="PEO_124_label">
       <source>equipment</source>
       <target>設備
</target>
     </trans-unit>
     <trans-unit id="PEO_125_label">
       <source>etiological context</source>
       <target>病因のコンテクスト
</target>
     </trans-unit>
     <trans-unit id="PEO_126_label">
       <source>ex vivo context</source>
       <target>培養細胞実験のコンテクスト
</target>
     </trans-unit>
     <trans-unit id="PEO_127_label">
       <source>exclusion criterion</source>
       <target>除外基準
</target>
     </trans-unit>
     <trans-unit id="PEO_127_synonyms">
       <source>exclusion criteria</source>
     </trans-unit>
     <trans-unit id="PEO_128_label">
       <source>family based analytical study</source>
       <target>家系関連解析
</target>
     </trans-unit>
     <trans-unit id="PEO_128_synonyms">
       <source>family based analytical studies</source>
     </trans-unit>
     <trans-unit id="PEO_129_label">
       <source>female</source>
       <target>女性
</target>
     </trans-unit>
     <trans-unit id="PEO_130_label">
       <source>genetic cause context</source>
       <target>遺伝因子に関するコンテクスト
</target>
     </trans-unit>
     <trans-unit id="PEO_131_label">
       <source>in silico context</source>
       <target>インシリコのコンテクスト
</target>
     </trans-unit>
     <trans-unit id="PEO_132_label">
       <source>in vitro context</source>
       <target>試験管内のコンテクスト
</target>
     </trans-unit>
     <trans-unit id="PEO_133_label">
       <source>in vivo context</source>
       <target>動物実験のコンテクスト
</target>
     </trans-unit>
     <trans-unit id="PEO_134_label">
       <source>inclusion criterion</source>
       <target>組み入れ基準
</target>
     </trans-unit>
     <trans-unit id="PEO_134_synonyms">
       <source>inclusion criteria</source>
     </trans-unit>
     <trans-unit id="PEO_135_label">
       <source>infectious cause context</source>
       <target>感染原因のコンテクスト
</target>
     </trans-unit>
     <trans-unit id="PEO_136_label">
       <source>inhibitor</source>
       <target>阻害剤
</target>
     </trans-unit>
     <trans-unit id="PEO_136_synonyms">
       <source>inhibitors</source>
     </trans-unit>
     <trans-unit id="PEO_137_label">
       <source>intervention context</source>
       <target>介入のコンテクスト
</target>
     </trans-unit>
     <trans-unit id="PEO_138_label">
       <source>male</source>
       <target>男性
</target>
     </trans-unit>
     <trans-unit id="PEO_138_synonyms">
       <source>men</source>
     </trans-unit>
     <trans-unit id="PEO_139_label">
       <source>masking design</source>
       <target>盲検化
</target>
     </trans-unit>
     <trans-unit id="PEO_139_synonyms">
       <source>masking designs</source>
     </trans-unit>
     <trans-unit id="PEO_140_label">
       <source>measure of disease occurrence context</source>
       <target>疾患発生の測定に関するコンテクスト
</target>
     </trans-unit>
     <trans-unit id="PEO_141_label">
       <source>mechanism of action context</source>
       <target>薬理のコンテクスト
</target>
     </trans-unit>
     <trans-unit id="PEO_142_label">
       <source>mild stage context</source>
       <target>軽症のコンテクスト
</target>
     </trans-unit>
     <trans-unit id="PEO_143_label">
       <source>model</source>
       <target>モデル
</target>
     </trans-unit>
     <trans-unit id="PEO_143_synonyms">
       <source>models</source>
     </trans-unit>
     <trans-unit id="PEO_144_label">
       <source>molecular and cellular mechanism context</source>
       <target>分子・細胞内メカニズムに関連する概念
</target>
     </trans-unit>
     <trans-unit id="PEO_145_label">
       <source>molecular context</source>
       <target>分子のコンテクスト
</target>
     </trans-unit>
     <trans-unit id="PEO_146_label">
       <source>morbidity context</source>
       <target>罹患率のコンテクスト
</target>
     </trans-unit>
     <trans-unit id="PEO_147_label">
       <source>non clinical context</source>
       <target>臨床以外のコンテクスト
</target>
     </trans-unit>
     <trans-unit id="PEO_148_label">
       <source>non-pharma therapy</source>
       <target>非医薬品療法
</target>
     </trans-unit>
     <trans-unit id="PEO_148_synonyms">
       <source>non-pharma therapies</source>
     </trans-unit>
     <trans-unit id="PEO_149_label">
       <source>non-pharmacotherapy procedure</source>
       <target>非薬物療法に関する手順
</target>
     </trans-unit>
     <trans-unit id="PEO_149_synonyms">
       <source>non-pharmacotherapy procedures</source>
     </trans-unit>
     <trans-unit id="PEO_150_label">
       <source>non pharmacotherapy clinical treatment context</source>
       <target>非薬物療法の処置に関する手順
</target>
     </trans-unit>
     <trans-unit id="PEO_151_label">
       <source>outcome context</source>
       <target>アウトカムのコンテクスト
</target>
     </trans-unit>
     <trans-unit id="PEO_152_label">
       <source>outcome measure</source>
       <target>アウトカム測定
</target>
     </trans-unit>
     <trans-unit id="PEO_152_synonyms">
       <source>outcome measures</source>
     </trans-unit>
     <trans-unit id="PEO_153_label">
       <source>pathogenesis context</source>
       <target>病理のコンテクスト
</target>
     </trans-unit>
     <trans-unit id="PEO_154_label">
       <source>pathology context</source>
       <target>病因に関するコンテクスト
</target>
     </trans-unit>
     <trans-unit id="PEO_155_label">
       <source>pharmacotherapy clinical treatment context</source>
       <target>薬物療法のコンテクスト
</target>
     </trans-unit>
     <trans-unit id="PEO_156_label">
       <source>phase 1</source>
       <target>第1相臨床試験
</target>
     </trans-unit>
     <trans-unit id="PEO_157_label">
       <source>phase 2</source>
       <target>第2相臨床試験
</target>
     </trans-unit>
     <trans-unit id="PEO_158_label">
       <source>phase 3</source>
       <target>第3相臨床試験
</target>
     </trans-unit>
     <trans-unit id="PEO_159_label">
       <source>phase 4</source>
       <target>第4相臨床試験
</target>
     </trans-unit>
     <trans-unit id="PEO_160_label">
       <source>population based analytical study</source>
       <target>人口ベース解析研究
</target>
     </trans-unit>
     <trans-unit id="PEO_160_synonyms">
       <source>population based analytical studies</source>
     </trans-unit>
     <trans-unit id="PEO_161_label">
       <source>pre clinical context</source>
       <target>前臨床のコンテクスト
</target>
     </trans-unit>
     <trans-unit id="PEO_162_label">
       <source>prevalence</source>
       <target>有病率
</target>
     </trans-unit>
     <trans-unit id="PEO_163_label">
       <source>prevalence context</source>
       <target>有病率のコンテクスト
</target>
     </trans-unit>
     <trans-unit id="PEO_164_label">
       <source>primary measure context</source>
       <target>一次測定のコンテクスト
</target>
     </trans-unit>
     <trans-unit id="PEO_165_label">
       <source>primary outcome measure</source>
       <target>主要評価項目
</target>
     </trans-unit>
     <trans-unit id="PEO_165_synonyms">
       <source>primary outcome measures</source>
     </trans-unit>
     <trans-unit id="PEO_166_label">
       <source>procedures using biomarkers context</source>
       <target>バイオマーカーを利用するコンテクスト
</target>
     </trans-unit>
     <trans-unit id="PEO_167_label">
       <source>rate</source>
       <target>割合
</target>
     </trans-unit>
     <trans-unit id="PEO_167_synonyms">
       <source>rates</source>
     </trans-unit>
     <trans-unit id="PEO_168_label">
       <source>secondary measure context</source>
       <target>二次アウトカムに関するコンテクスト
</target>
     </trans-unit>
     <trans-unit id="PEO_169_label">
       <source>secondary outcome measure</source>
       <target>二次アウトカムの測定
</target>
     </trans-unit>
     <trans-unit id="PEO_169_synonyms">
       <source>secondary outcome measure</source>
     </trans-unit>
     <trans-unit id="PEO_170_label">
       <source>severe stage context</source>
       <target>重症のコンテクスト
</target>
     </trans-unit>
     <trans-unit id="PEO_171_label">
       <source>stage context</source>
       <target>ステージのコンテクスト
</target>
     </trans-unit>
     <trans-unit id="PEO_172_label">
       <source>statistical context</source>
       <target>統計学的なコンテクスト
</target>
     </trans-unit>
     <trans-unit id="PEO_173_label">
       <source>study design context</source>
       <target>研究デザインのコンテクスト
</target>
     </trans-unit>
     <trans-unit id="PEO_174_label">
       <source>surgery context</source>
       <target>手術のコンテクスト
</target>
     </trans-unit>
     <trans-unit id="PEO_175_label">
       <source>surgical context</source>
       <target>手術のコンテクスト
</target>
     </trans-unit>
     <trans-unit id="PEO_176_label">
       <source>syndrome context</source>
       <target>症候群のコンテクスト
</target>
     </trans-unit>
     <trans-unit id="PEO_177_label">
       <source>thing related to surgery</source>
       <target>手術に関する概念
</target>
     </trans-unit>
     <trans-unit id="PEO_229_label">
       <source>ACE</source>
       <target>ACE
</target>
     </trans-unit>
     <trans-unit id="PEO_230_label">
       <source>ACE2</source>
       <target>ACE2
</target>
     </trans-unit>
     <trans-unit id="PEO_231_label">
       <source>ACHE</source>
       <target>ACHE
</target>
     </trans-unit>
     <trans-unit id="PEO_232_label">
       <source>ADIPOQ</source>
       <target>ADIPOQ
</target>
     </trans-unit>
     <trans-unit id="PEO_233_label">
       <source>ADRB2</source>
       <target>ADRB2
</target>
     </trans-unit>
     <trans-unit id="PEO_234_label">
       <source>ADTRP</source>
       <target>ADTRP
</target>
     </trans-unit>
     <trans-unit id="PEO_235_label">
       <source>AGT</source>
       <target>AGT
</target>
     </trans-unit>
     <trans-unit id="PEO_236_label">
       <source>AGTR</source>
       <target>AGTR
</target>
     </trans-unit>
     <trans-unit id="PEO_236_synonyms">
       <source>AGTR family</source>
     </trans-unit>
     <trans-unit id="PEO_237_label">
       <source>AGTR1</source>
       <target>AGTR1
</target>
     </trans-unit>
     <trans-unit id="PEO_238_label">
       <source>AGTR2</source>
       <target>AGTR2
</target>
     </trans-unit>
     <trans-unit id="PEO_239_label">
       <source>ANKS1B</source>
       <target>ANKS1B
</target>
     </trans-unit>
     <trans-unit id="PEO_240_label">
       <source>ATF6</source>
       <target>ATF6
</target>
     </trans-unit>
     <trans-unit id="PEO_241_label">
       <source>Angiogenic factors</source>
       <target>血管新生因子
</target>
     </trans-unit>
     <trans-unit id="PEO_242_label">
       <source>BAX</source>
       <target>BAX
</target>
     </trans-unit>
     <trans-unit id="PEO_243_label">
       <source>BCL2</source>
       <target>BCL2
</target>
     </trans-unit>
     <trans-unit id="PEO_244_label">
       <source>BTC</source>
       <target>BTC
</target>
     </trans-unit>
     <trans-unit id="PEO_245_label">
       <source>Bradykinin receptors</source>
       <target>ブラジキニン受容体
</target>
     </trans-unit>
     <trans-unit id="PEO_245_synonyms">
       <source>BDKR family</source>
     </trans-unit>
     <trans-unit id="PEO_246_label">
       <source>CAT</source>
       <target>CAT
</target>
     </trans-unit>
     <trans-unit id="PEO_247_label">
       <source>CHI3L1</source>
       <target>CHI3L1
</target>
     </trans-unit>
     <trans-unit id="PEO_248_label">
       <source>CORIN</source>
       <target>CORIN
</target>
     </trans-unit>
     <trans-unit id="PEO_249_label">
       <source>CST3</source>
       <target>CST3
</target>
     </trans-unit>
     <trans-unit id="PEO_250_label">
       <source>CUEDC1</source>
       <target>CUEDC1
</target>
     </trans-unit>
     <trans-unit id="PEO_251_label">
       <source>CXCL2</source>
       <target>CXCL2
</target>
     </trans-unit>
     <trans-unit id="PEO_252_label">
       <source>CXCL8</source>
       <target>CXCL8
</target>
     </trans-unit>
     <trans-unit id="PEO_253_label">
       <source>Cytokines</source>
       <target>サイトカイン
</target>
     </trans-unit>
     <trans-unit id="PEO_253_definition">
       <source>Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner.</source>
     </trans-unit>
     <trans-unit id="PEO_254_label">
       <source>DHX34</source>
       <target>DHX34
</target>
     </trans-unit>
     <trans-unit id="PEO_255_label">
       <source>DNAJC5G</source>
       <target>DNAJC5G
</target>
     </trans-unit>
     <trans-unit id="PEO_256_label">
       <source>EDN1</source>
       <target>EDN1
</target>
     </trans-unit>
     <trans-unit id="PEO_257_label">
       <source>EDNRB</source>
       <target>EDNRB
</target>
     </trans-unit>
     <trans-unit id="PEO_257_synonyms">
       <source>http://www.ncbi.nlm.nih.gov/gene/1910</source>
     </trans-unit>
     <trans-unit id="PEO_258_label">
       <source>EGF family</source>
       <target>上皮成長因子ファミリー
</target>
     </trans-unit>
     <trans-unit id="PEO_258_synonyms">
       <source>Growth Factor-Urogastrone, Epidermal</source>
     </trans-unit>
     <trans-unit id="PEO_258_definition">
       <source>A 6-kDa polypeptide growth factor initially discovered in mouse submaxillary glands. Human epidermal growth factor was originally isolated from urine based on its ability to inhibit gastric secretion and called urogastrone. Epidermal growth factor exerts a wide variety of biological effects including the promotion of proliferation and differentiation of mesenchymal and EPITHELIAL CELLS. It is synthesized as a transmembrane protein which can be cleaved to release a soluble active form.</source>
     </trans-unit>
     <trans-unit id="PEO_258_synonyms_1">
       <source>beta Urogastrone</source>
     </trans-unit>
     <trans-unit id="PEO_258_synonyms_2">
       <source>beta-Urogastrone</source>
     </trans-unit>
     <trans-unit id="PEO_258_synonyms_3">
       <source>EGF</source>
     </trans-unit>
     <trans-unit id="PEO_258_synonyms_4">
       <source>Growth Factor, Epidermal</source>
     </trans-unit>
     <trans-unit id="PEO_258_synonyms_5">
       <source>Epidermal Growth Factor-Urogastrone</source>
     </trans-unit>
     <trans-unit id="PEO_258_synonyms_6">
       <source>Urogastrone</source>
     </trans-unit>
     <trans-unit id="PEO_258_synonyms_7">
       <source>Human Urinary Gastric Inhibitor</source>
     </trans-unit>
     <trans-unit id="PEO_258_synonyms_8">
       <source>Epidermal growth factor</source>
     </trans-unit>
     <trans-unit id="PEO_259_label">
       <source>EIF2</source>
       <target>EIF2
</target>
     </trans-unit>
     <trans-unit id="PEO_259_synonyms">
       <source>eukaryotic translation initiation factor 2</source>
     </trans-unit>
     <trans-unit id="PEO_260_label">
       <source>EIF2AK3</source>
       <target>EIF2AK3
</target>
     </trans-unit>
     <trans-unit id="PEO_261_label">
       <source>EMD</source>
       <target>EMD
</target>
     </trans-unit>
     <trans-unit id="PEO_262_label">
       <source>ENG</source>
       <target>ENG
</target>
     </trans-unit>
     <trans-unit id="PEO_263_label">
       <source>ENV</source>
       <target>ENV
</target>
     </trans-unit>
     <trans-unit id="PEO_264_label">
       <source>ERN1</source>
       <target>ERN1
</target>
     </trans-unit>
     <trans-unit id="PEO_265_label">
       <source>ERVFRD-1</source>
       <target>ERVFRD-1
</target>
     </trans-unit>
     <trans-unit id="PEO_266_label">
       <source>ERVW-1</source>
       <target>ERVW-1
</target>
     </trans-unit>
     <trans-unit id="PEO_267_label">
       <source>ESR1</source>
       <target>ESR1
</target>
     </trans-unit>
     <trans-unit id="PEO_268_label">
       <source>ESR2</source>
       <target>ESR2
</target>
     </trans-unit>
     <trans-unit id="PEO_269_label">
       <source>Endogenous ligands</source>
       <target>内因性リガンド
</target>
     </trans-unit>
     <trans-unit id="PEO_270_label">
       <source>F7</source>
       <target>F7
</target>
     </trans-unit>
     <trans-unit id="PEO_271_label">
       <source>F9</source>
       <target>F9
</target>
     </trans-unit>
     <trans-unit id="PEO_272_label">
       <source>FASLG</source>
       <target>FASLG
</target>
     </trans-unit>
     <trans-unit id="PEO_273_label">
       <source>FLT1</source>
       <target>FLT1
</target>
     </trans-unit>
     <trans-unit id="PEO_274_label">
       <source>FURIN</source>
       <target>FURIN
</target>
     </trans-unit>
     <trans-unit id="PEO_275_label">
       <source>GOT</source>
       <target>グルタミン酸オキサロ酢酸トランスアミナーゼ
</target>
     </trans-unit>
     <trans-unit id="PEO_275_synonyms">
       <source>glutamic-oxaloacetic transaminase</source>
     </trans-unit>
     <trans-unit id="PEO_276_label">
       <source>GPT</source>
       <target>GPT
</target>
     </trans-unit>
     <trans-unit id="PEO_277_label">
       <source>GTSF1</source>
       <target>GTSF1
</target>
     </trans-unit>
     <trans-unit id="PEO_278_label">
       <source>G protein coupled receptors</source>
       <target>Gタンパク質共役受容体
</target>
     </trans-unit>
     <trans-unit id="PEO_278_synonyms">
       <source>Receptors, G Protein Coupled</source>
     </trans-unit>
     <trans-unit id="PEO_278_definition">
       <source>The largest family of cell surface receptors involved in SIGNAL TRANSDUCTION. They share a common structure and signal through HETEROTRIMERIC G-PROTEINS.</source>
     </trans-unit>
     <trans-unit id="PEO_278_synonyms_1">
       <source>G-Protein-Coupled Receptors</source>
     </trans-unit>
     <trans-unit id="PEO_278_synonyms_2">
       <source>G Protein Coupled Receptors</source>
     </trans-unit>
     <trans-unit id="PEO_279_label">
       <source>Groucho</source>
       <target>Groucho
</target>
     </trans-unit>
     <trans-unit id="PEO_280_label">
       <source>HCG26</source>
       <target>HCG26
</target>
     </trans-unit>
     <trans-unit id="PEO_281_label">
       <source>HMOX1</source>
       <target>HMOX1
</target>
     </trans-unit>
     <trans-unit id="PEO_282_label">
       <source>HSP90B1</source>
       <target>HSP90B1
</target>
     </trans-unit>
     <trans-unit id="PEO_283_label">
       <source>HSPA5</source>
       <target>HSPA5
</target>
     </trans-unit>
     <trans-unit id="PEO_284_label">
       <source>IFNG</source>
       <target>IFNG
</target>
     </trans-unit>
     <trans-unit id="PEO_285_label">
       <source>IGF</source>
       <target>IGF
</target>
     </trans-unit>
     <trans-unit id="PEO_285_synonyms">
       <source>insulin-like growth factor</source>
     </trans-unit>
     <trans-unit id="PEO_286_label">
       <source>IGF1R</source>
       <target>IGF1R
</target>
     </trans-unit>
     <trans-unit id="PEO_287_label">
       <source>IL10</source>
       <target>IL10
</target>
     </trans-unit>
     <trans-unit id="PEO_288_label">
       <source>IL17A</source>
       <target>IL17A
</target>
     </trans-unit>
     <trans-unit id="PEO_289_label">
       <source>IL1A</source>
       <target>IL1A
</target>
     </trans-unit>
     <trans-unit id="PEO_290_label">
       <source>IL2</source>
       <target>IL2
</target>
     </trans-unit>
     <trans-unit id="PEO_291_label">
       <source>IL4</source>
       <target>IL4
</target>
     </trans-unit>
     <trans-unit id="PEO_292_label">
       <source>IL6</source>
       <target>IL6
</target>
     </trans-unit>
     <trans-unit id="PEO_293_label">
       <source>INGX</source>
       <target>INGX
</target>
     </trans-unit>
     <trans-unit id="PEO_294_label">
       <source>KCNN</source>
       <target>KCNN
</target>
     </trans-unit>
     <trans-unit id="PEO_295_label">
       <source>KCNN2</source>
       <target>KCNN2
</target>
     </trans-unit>
     <trans-unit id="PEO_296_label">
       <source>KCNN3</source>
       <target>KCNN3
</target>
     </trans-unit>
     <trans-unit id="PEO_297_label">
       <source>KLK</source>
       <target>KLK
</target>
     </trans-unit>
     <trans-unit id="PEO_298_label">
       <source>KLRK1</source>
       <target>KLRK1
</target>
     </trans-unit>
     <trans-unit id="PEO_299_label">
       <source>KNG1</source>
       <target>KNG1
</target>
     </trans-unit>
     <trans-unit id="PEO_300_label">
       <source>LAIR2</source>
       <target>LAIR2
</target>
     </trans-unit>
     <trans-unit id="PEO_301_label">
       <source>LAMA3</source>
       <target>LAMA3
</target>
     </trans-unit>
     <trans-unit id="PEO_302_label">
       <source>LDH</source>
       <target>LDH
</target>
     </trans-unit>
     <trans-unit id="PEO_302_synonyms">
       <source>lactate dehydrogenase</source>
     </trans-unit>
     <trans-unit id="PEO_303_label">
       <source>LDLR</source>
       <target>LDLR
</target>
     </trans-unit>
     <trans-unit id="PEO_304_label">
       <source>LEMD1</source>
       <target>LEMD1
</target>
     </trans-unit>
     <trans-unit id="PEO_305_label">
       <source>LTBR</source>
       <target>LTBR
</target>
     </trans-unit>
     <trans-unit id="PEO_306_label">
       <source>LY6K</source>
       <target>LY6K
</target>
     </trans-unit>
     <trans-unit id="PEO_307_label">
       <source>LYZ</source>
       <target>LYZ
</target>
     </trans-unit>
     <trans-unit id="PEO_308_label">
       <source>LYZL1</source>
       <target>LYZL1
</target>
     </trans-unit>
     <trans-unit id="PEO_309_label">
       <source>Laminins</source>
       <target>ラミニン
</target>
     </trans-unit>
     <trans-unit id="PEO_309_synonyms">
       <source>Laminin M</source>
     </trans-unit>
     <trans-unit id="PEO_309_synonyms_1">
       <source>Merosin</source>
     </trans-unit>
     <trans-unit id="PEO_309_synonyms_2">
       <source>Glycoprotein GP-2</source>
     </trans-unit>
     <trans-unit id="PEO_309_definition">
       <source>Large, noncollagenous glycoprotein with antigenic properties. It is localized in the basement membrane lamina lucida and functions to bind epithelial cells to the basement membrane. Evidence suggests that the protein plays a role in tumor invasion.</source>
     </trans-unit>
     <trans-unit id="PEO_309_synonyms_3">
       <source>M Chain, Laminin</source>
     </trans-unit>
     <trans-unit id="PEO_309_synonyms_4">
       <source>Chain, Laminin M</source>
     </trans-unit>
     <trans-unit id="PEO_309_synonyms_5">
       <source>Laminin M Chain</source>
     </trans-unit>
     <trans-unit id="PEO_309_synonyms_6">
       <source>Glycoprotein GP 2</source>
     </trans-unit>
     <trans-unit id="PEO_310_label">
       <source>MADCAM1</source>
       <target>MADCAM1
</target>
     </trans-unit>
     <trans-unit id="PEO_311_label">
       <source>MDA</source>
       <target>MDA
</target>
     </trans-unit>
     <trans-unit id="PEO_311_synonyms">
       <source>Melanoma Differentiation-Associated protein</source>
     </trans-unit>
     <trans-unit id="PEO_312_label">
       <source>MFSD2A</source>
       <target>MFSD2A
</target>
     </trans-unit>
     <trans-unit id="PEO_313_label">
       <source>MMP2</source>
       <target>MMP2
</target>
     </trans-unit>
     <trans-unit id="PEO_314_label">
       <source>MMP9</source>
       <target>MMP9
</target>
     </trans-unit>
     <trans-unit id="PEO_315_label">
       <source>MMPs</source>
       <target>MMPs
</target>
     </trans-unit>
     <trans-unit id="PEO_315_definition">
       <source>A family of zinc-dependent metalloendopeptidases that is involved in the degradation of EXTRACELLULAR MATRIX components.</source>
     </trans-unit>
     <trans-unit id="PEO_315_synonyms">
       <source>Matrix Metalloproteinases</source>
     </trans-unit>
     <trans-unit id="PEO_315_synonyms_1">
       <source>Metalloproteinases, Matrix</source>
     </trans-unit>
     <trans-unit id="PEO_316_label">
       <source>MXRA5</source>
       <target>MXRA5
</target>
     </trans-unit>
     <trans-unit id="PEO_317_label">
       <source>NME9</source>
       <target>NME9
</target>
     </trans-unit>
     <trans-unit id="PEO_318_label">
       <source>NR3C2</source>
       <target>NR3C2
</target>
     </trans-unit>
     <trans-unit id="PEO_319_label">
       <source>OR51G1</source>
       <target>OR51G1
</target>
     </trans-unit>
     <trans-unit id="PEO_320_label">
       <source>Oxidase</source>
       <target>オキシダーゼ
</target>
     </trans-unit>
     <trans-unit id="PEO_320_synonyms">
       <source>Oxidase (substance)</source>
     </trans-unit>
     <trans-unit id="PEO_321_label">
       <source>PAPPA</source>
       <target>PAPPA
</target>
     </trans-unit>
     <trans-unit id="PEO_322_label">
       <source>PGF</source>
       <target>PGF
</target>
     </trans-unit>
     <trans-unit id="PEO_323_label">
       <source>PIGF</source>
       <target>PIGF
</target>
     </trans-unit>
     <trans-unit id="PEO_324_label">
       <source>PRIMA1</source>
       <target>PRIMA1
</target>
     </trans-unit>
     <trans-unit id="PEO_325_label">
       <source>PROC</source>
       <target>PROC
</target>
     </trans-unit>
     <trans-unit id="PEO_326_label">
       <source>PROS1</source>
       <target>PROS1
</target>
     </trans-unit>
     <trans-unit id="PEO_327_label">
       <source>REN</source>
       <target>REN
</target>
     </trans-unit>
     <trans-unit id="PEO_328_label">
       <source>RGS2</source>
       <target>RGS2
</target>
     </trans-unit>
     <trans-unit id="PEO_329_label">
       <source>RIPPLY1</source>
       <target>RIPPLY1
</target>
     </trans-unit>
     <trans-unit id="PEO_330_label">
       <source>RNASE11</source>
       <target>RNASE11
</target>
     </trans-unit>
     <trans-unit id="PEO_331_label">
       <source>ROS1</source>
       <target>ROS1
</target>
     </trans-unit>
     <trans-unit id="PEO_332_label">
       <source>SERPINC1</source>
       <target>SERPINC1
</target>
     </trans-unit>
     <trans-unit id="PEO_333_label">
       <source>SERPINE1</source>
       <target>SERPINE1
</target>
     </trans-unit>
     <trans-unit id="PEO_334_label">
       <source>SGSM1</source>
       <target>SGSM1
</target>
     </trans-unit>
     <trans-unit id="PEO_335_label">
       <source>SLAMF1</source>
       <target>SLAMF1
</target>
     </trans-unit>
     <trans-unit id="PEO_336_label">
       <source>SLC17A5</source>
       <target>SLC17A5
</target>
     </trans-unit>
     <trans-unit id="PEO_337_label">
       <source>SLC1A4</source>
       <target>SLC1A4
</target>
     </trans-unit>
     <trans-unit id="PEO_338_label">
       <source>SLC1A5</source>
       <target>SLC1A5
</target>
     </trans-unit>
     <trans-unit id="PEO_339_label">
       <source>SOD</source>
       <target>スーパーオキシドジスムターゼ
</target>
     </trans-unit>
     <trans-unit id="PEO_339_synonyms">
       <source>Superoxide Dismutase</source>
     </trans-unit>
     <trans-unit id="PEO_340_label">
       <source>SSTR</source>
       <target>SSTR
</target>
     </trans-unit>
     <trans-unit id="PEO_340_synonyms">
       <source>somatostatin receptor</source>
     </trans-unit>
     <trans-unit id="PEO_341_label">
       <source>SSTR1</source>
       <target>SSTR1
</target>
     </trans-unit>
     <trans-unit id="PEO_341_synonyms">
       <source>http://www.ncbi.nlm.nih.gov/gene/6751</source>
     </trans-unit>
     <trans-unit id="PEO_342_label">
       <source>SYNC</source>
       <target>SYNC
</target>
     </trans-unit>
     <trans-unit id="PEO_343_label">
       <source>SYT6</source>
       <target>SYT6
</target>
     </trans-unit>
     <trans-unit id="PEO_343_synonyms">
       <source>http://www.ncbi.nlm.nih.gov/gene/148281</source>
     </trans-unit>
     <trans-unit id="PEO_344_label">
       <source>TGFB1</source>
       <target>TGFB1
</target>
     </trans-unit>
     <trans-unit id="PEO_345_label">
       <source>TIMPs</source>
       <target>組織性メタロプロテアーゼ阻害因子
</target>
     </trans-unit>
     <trans-unit id="PEO_345_synonyms">
       <source>Metalloproteinases Tissue Inhibitor</source>
     </trans-unit>
     <trans-unit id="PEO_345_definition">
       <source>A family of secreted protease inhibitory proteins that regulates the activity of SECRETED MATRIX METALLOENDOPEPTIDASES. They play an important role in modulating the proteolysis of EXTRACELLULAR MATRIX, most notably during tissue remodeling and inflammatory processes.</source>
     </trans-unit>
     <trans-unit id="PEO_345_synonyms_1">
       <source>Tissue Inhibitor of Metalloproteinases</source>
     </trans-unit>
     <trans-unit id="PEO_346_label">
       <source>TNF</source>
       <target>腫瘍壊死因子
</target>
     </trans-unit>
     <trans-unit id="PEO_346_synonyms">
       <source>tumor necrosis factor-alpha promoter allele-2 protein, human</source>
     </trans-unit>
     <trans-unit id="PEO_346_synonyms_1">
       <source>tumor necrosis factor 2 protein, human</source>
     </trans-unit>
     <trans-unit id="PEO_346_synonyms_2">
       <source>tumor necrosis factor-2 protein, human</source>
     </trans-unit>
     <trans-unit id="PEO_346_synonyms_3">
       <source>TNF protein, human</source>
     </trans-unit>
     <trans-unit id="PEO_346_synonyms_4">
       <source>TNFSF2 protein, human</source>
     </trans-unit>
     <trans-unit id="PEO_346_synonyms_5">
       <source>TNF-2 protein, human</source>
     </trans-unit>
     <trans-unit id="PEO_346_synonyms_6">
       <source>TNF superfamily, member 2 protein, human</source>
     </trans-unit>
     <trans-unit id="PEO_346_synonyms_7">
       <source>tumor necrosis factor, human</source>
     </trans-unit>
     <trans-unit id="PEO_347_label">
       <source>TNFRSF14</source>
       <target>TNFRSF14
</target>
     </trans-unit>
     <trans-unit id="PEO_348_label">
       <source>TNFRSF6B</source>
       <target>TNFRSF6B
</target>
     </trans-unit>
     <trans-unit id="PEO_349_label">
       <source>TNFSF14</source>
       <target>TNFSF14
</target>
     </trans-unit>
     <trans-unit id="PEO_350_label">
       <source>TNFSF15</source>
       <target>TNFSF15
</target>
     </trans-unit>
     <trans-unit id="PEO_351_label">
       <source>TPSAB1</source>
       <target>TPSAB1
</target>
     </trans-unit>
     <trans-unit id="PEO_352_label">
       <source>TRIM31</source>
       <target>TRIM31
</target>
     </trans-unit>
     <trans-unit id="PEO_353_label">
       <source>VEGFA</source>
       <target>VEGFA
</target>
     </trans-unit>
     <trans-unit id="PEO_354_label">
       <source>VEGFR</source>
       <target>VEGFR
</target>
     </trans-unit>
     <trans-unit id="PEO_354_synonyms">
       <source>VEGFR2</source>
     </trans-unit>
     <trans-unit id="PEO_354_synonyms_1">
       <source>VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2</source>
     </trans-unit>
     <trans-unit id="PEO_354_synonyms_2">
       <source>VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR</source>
     </trans-unit>
     <trans-unit id="PEO_354_synonyms_3">
       <source>FLK1</source>
     </trans-unit>
     <trans-unit id="PEO_354_synonyms_4">
       <source>KDR</source>
     </trans-unit>
     <trans-unit id="PEO_354_synonyms_5">
       <source>TYROSINE KINASE GROWTH FACTOR RECEPTOR</source>
     </trans-unit>
     <trans-unit id="PEO_354_synonyms_6">
       <source>KINASE INSERT DOMAIN RECEPTOR</source>
     </trans-unit>
     <trans-unit id="PEO_355_label">
       <source>WNT</source>
       <target>WNT
</target>
     </trans-unit>
     <trans-unit id="PEO_355_definition">
       <source>Wnt proteins are a large family of secreted glycoproteins that play essential roles in EMBRYONIC AND FETAL DEVELOPMENT, and tissue maintenance. They bind to FRIZZLED RECEPTORS and act as PARACRINE PROTEIN FACTORS to initiate a variety of SIGNAL TRANSDUCTION PATHWAYS. The canonical Wnt signaling pathway stabilizes the transcriptional coactivator BETA CATENIN.</source>
     </trans-unit>
     <trans-unit id="PEO_355_synonyms">
       <source>Wingless Type Proteins</source>
     </trans-unit>
     <trans-unit id="PEO_355_synonyms_1">
       <source>Wnt Proteins</source>
     </trans-unit>
     <trans-unit id="PEO_355_synonyms_2">
       <source>Wnt Factors</source>
     </trans-unit>
     <trans-unit id="PEO_356_label">
       <source>gene</source>
       <target>遺伝子
</target>
     </trans-unit>
     <trans-unit id="PEO_357_label">
       <source>A-type natriuretic peptide</source>
       <target>心房性ナトリウム利尿ペプチド
</target>
     </trans-unit>
     <trans-unit id="PEO_357_synonyms">
       <source>ANP - Atrial natriuretic peptide</source>
     </trans-unit>
     <trans-unit id="PEO_357_synonyms_1">
       <source>Atrial natriuretic peptide</source>
     </trans-unit>
     <trans-unit id="PEO_357_synonyms_2">
       <source>Atrial natriuretic factor (substance)</source>
     </trans-unit>
     <trans-unit id="PEO_357_synonyms_3">
       <source>Atrial natriuretic hormone</source>
     </trans-unit>
     <trans-unit id="PEO_357_synonyms_4">
       <source>ANH - Atrial natriuretic hormone</source>
     </trans-unit>
     <trans-unit id="PEO_357_synonyms_5">
       <source>Atriopeptin</source>
     </trans-unit>
     <trans-unit id="PEO_357_synonyms_6">
       <source>Atrial natriuretic factor</source>
     </trans-unit>
     <trans-unit id="PEO_358_label">
       <source>ACE inhibitor</source>
       <target>アンジオテンシン変換酵素阻害薬
</target>
     </trans-unit>
     <trans-unit id="PEO_358_synonyms">
       <source>angiotensin-converting enzyme inhibitor</source>
     </trans-unit>
     <trans-unit id="PEO_358_synonyms_1">
       <source>ACE inhibitors</source>
     </trans-unit>
     <trans-unit id="PEO_359_label">
       <source>ADRB blockers</source>
       <target>ADRBブロッカー
</target>
     </trans-unit>
     <trans-unit id="PEO_360_label">
       <source>AGT precursor</source>
       <target>AGT
</target>
     </trans-unit>
     <trans-unit id="PEO_361_label">
       <source>AT1R antagonists</source>
       <target>AT1Rアンタゴニスト
</target>
     </trans-unit>
     <trans-unit id="PEO_362_label">
       <source>AT2R antagonists</source>
       <target>AT2Rアンタゴニスト
</target>
     </trans-unit>
     <trans-unit id="PEO_363_label">
       <source>Abdominal pain</source>
       <target>腹痛
</target>
     </trans-unit>
     <trans-unit id="PEO_363_synonyms">
       <source>acute abdominal pain</source>
     </trans-unit>
     <trans-unit id="PEO_364_label">
       <source>Abortion, Habitual</source>
       <target>習慣流産
</target>
     </trans-unit>
     <trans-unit id="PEO_364_definition">
       <source>Three or more consecutive spontaneous abortions.</source>
     </trans-unit>
     <trans-unit id="PEO_365_label">
       <source>Absolute risk</source>
       <target>絶対リスク
</target>
     </trans-unit>
     <trans-unit id="PEO_366_label">
       <source>Academic progress</source>
       <target>学業の進み具合
</target>
     </trans-unit>
     <trans-unit id="PEO_366_synonyms">
       <source>Academic progress (observable entity)</source>
     </trans-unit>
     <trans-unit id="PEO_367_label">
       <source>Acetylation</source>
       <target>アセチル化
</target>
     </trans-unit>
     <trans-unit id="PEO_367_synonyms">
       <source>protein amino acid acetylation</source>
     </trans-unit>
     <trans-unit id="PEO_368_label">
       <source>Acute disease of cardiovascular system</source>
       <target>心臓血管系の急性疾患
</target>
     </trans-unit>
     <trans-unit id="PEO_368_synonyms">
       <source>Acute disease of cardiovascular system (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_368_synonyms_1">
       <source>Acute disorder of cardiovascular system</source>
     </trans-unit>
     <trans-unit id="PEO_368_synonyms_2">
       <source>Acute cardiovascular disease</source>
     </trans-unit>
     <trans-unit id="PEO_368_synonyms_3">
       <source>Acute cardiovascular disorder</source>
     </trans-unit>
     <trans-unit id="PEO_369_label">
       <source>Acute pulmonary edema</source>
       <target>急性肺水腫
</target>
     </trans-unit>
     <trans-unit id="PEO_369_synonyms">
       <source>Acute pulmonary oedema</source>
     </trans-unit>
     <trans-unit id="PEO_369_synonyms_1">
       <source>Acute edema of lung</source>
     </trans-unit>
     <trans-unit id="PEO_369_synonyms_2">
       <source>Pulmonary edema - acute</source>
     </trans-unit>
     <trans-unit id="PEO_369_synonyms_3">
       <source>Acute oedema of lung</source>
     </trans-unit>
     <trans-unit id="PEO_369_synonyms_4">
       <source>Pulmonary oedema - acute</source>
     </trans-unit>
     <trans-unit id="PEO_369_synonyms_5">
       <source>Acute pulmonary edema (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_370_label">
       <source>Admission to intensive care unit</source>
       <target>ICU入院
</target>
     </trans-unit>
     <trans-unit id="PEO_370_synonyms">
       <source>Admission to intensive care unit (procedure)</source>
     </trans-unit>
     <trans-unit id="PEO_370_synonyms_1">
       <source>ICU - Admission to intensive care unit</source>
     </trans-unit>
     <trans-unit id="PEO_370_synonyms_2">
       <source>Admit to intensive care unit</source>
     </trans-unit>
     <trans-unit id="PEO_370_synonyms_3">
       <source>Admit to ITU</source>
     </trans-unit>
     <trans-unit id="PEO_371_label">
       <source>Admission to neonatal intensive care unit</source>
       <target>NICU入院
</target>
     </trans-unit>
     <trans-unit id="PEO_371_synonyms">
       <source>Admission to NICU</source>
     </trans-unit>
     <trans-unit id="PEO_372_label">
       <source>Adrenal disease</source>
       <target>副腎疾患
</target>
     </trans-unit>
     <trans-unit id="PEO_373_label">
       <source>After full dilatation of cervix</source>
       <target>子宮口全開大後
</target>
     </trans-unit>
     <trans-unit id="PEO_373_synonyms">
       <source>After full dilatation of cervix (qualifier value)</source>
     </trans-unit>
     <trans-unit id="PEO_374_label">
       <source>Age at birth</source>
       <target>出産年齢
</target>
     </trans-unit>
     <trans-unit id="PEO_374_synonyms">
       <source>age-at-birth</source>
     </trans-unit>
     <trans-unit id="PEO_374_synonyms_1">
       <source>maternal age</source>
     </trans-unit>
     <trans-unit id="PEO_374_synonyms_2">
       <source>age at birth</source>
     </trans-unit>
     <trans-unit id="PEO_375_label">
       <source>Age at leaving school</source>
       <target>退学時年齢
</target>
     </trans-unit>
     <trans-unit id="PEO_375_synonyms">
       <source>Age at leaving school (observable entity)</source>
     </trans-unit>
     <trans-unit id="PEO_376_label">
       <source>Age at menarche</source>
       <target>初潮年齢
</target>
     </trans-unit>
     <trans-unit id="PEO_376_synonyms">
       <source>Age at menarche (observable entity)</source>
     </trans-unit>
     <trans-unit id="PEO_377_label">
       <source>Age at onset</source>
       <target>発症年齢
</target>
     </trans-unit>
     <trans-unit id="PEO_377_synonyms">
       <source>age-at-onset</source>
     </trans-unit>
     <trans-unit id="PEO_377_synonyms_1">
       <source>maternal age</source>
     </trans-unit>
     <trans-unit id="PEO_377_synonyms_2">
       <source>age at onset</source>
     </trans-unit>
     <trans-unit id="PEO_378_label">
       <source>Age at starting school</source>
       <target>就学時年齢
</target>
     </trans-unit>
     <trans-unit id="PEO_378_synonyms">
       <source>Age at starting school (observable entity)</source>
     </trans-unit>
     <trans-unit id="PEO_379_label">
       <source>Albuminuria</source>
       <target>アルブミン尿
</target>
     </trans-unit>
     <trans-unit id="PEO_379_synonyms">
       <source>Albuminuria (finding)</source>
     </trans-unit>
     <trans-unit id="PEO_380_label">
       <source>Alcohol abuse</source>
       <target>アルコール乱⇒アルコール乱用
</target>
     </trans-unit>
     <trans-unit id="PEO_380_synonyms">
       <source>Alcohol abuse (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_380_synonyms_1">
       <source>Ethanol abuse</source>
     </trans-unit>
     <trans-unit id="PEO_380_synonyms_2">
       <source>AA - Alcohol abuse</source>
     </trans-unit>
     <trans-unit id="PEO_381_label">
       <source>Alcohol intake</source>
       <target>アルコール摂取
</target>
     </trans-unit>
     <trans-unit id="PEO_381_synonyms">
       <source>Alcohol intake (observable entity)</source>
     </trans-unit>
     <trans-unit id="PEO_381_synonyms_1">
       <source>Ethanol intake</source>
     </trans-unit>
     <trans-unit id="PEO_381_synonyms_2">
       <source>ETOH - Alcohol intake</source>
     </trans-unit>
     <trans-unit id="PEO_381_synonyms_3">
       <source>Alcohol consumption</source>
     </trans-unit>
     <trans-unit id="PEO_381_synonyms_4">
       <source>AI - Alcohol intake</source>
     </trans-unit>
     <trans-unit id="PEO_381_synonyms_5">
       <source>Alcoholic drink intake</source>
     </trans-unit>
     <trans-unit id="PEO_382_label">
       <source>Allergy to substance</source>
       <target>薬剤アレルギー
</target>
     </trans-unit>
     <trans-unit id="PEO_382_synonyms">
       <source>Allergy to substance (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_383_label">
       <source>Ambulatory blood pressure recording</source>
       <target>自由行動下血圧測定
</target>
     </trans-unit>
     <trans-unit id="PEO_383_synonyms">
       <source>Ambulatory blood pressure recording (procedure)</source>
     </trans-unit>
     <trans-unit id="PEO_384_label">
       <source>Aminopterin</source>
       <target>アミノプテリン
</target>
     </trans-unit>
     <trans-unit id="PEO_385_label">
       <source>Amnesia</source>
       <target>健忘症
</target>
     </trans-unit>
     <trans-unit id="PEO_385_synonyms">
       <source>Amnesia (finding)</source>
     </trans-unit>
     <trans-unit id="PEO_385_synonyms_1">
       <source>LOM - Loss of memory</source>
     </trans-unit>
     <trans-unit id="PEO_385_synonyms_2">
       <source>Memory loss - amnesia</source>
     </trans-unit>
     <trans-unit id="PEO_385_synonyms_3">
       <source>Dysmnesia</source>
     </trans-unit>
     <trans-unit id="PEO_385_synonyms_4">
       <source>Loss of memory</source>
     </trans-unit>
     <trans-unit id="PEO_385_synonyms_5">
       <source>Memory gone</source>
     </trans-unit>
     <trans-unit id="PEO_385_synonyms_6">
       <source>Memory loss</source>
     </trans-unit>
     <trans-unit id="PEO_386_label">
       <source>Amnion</source>
       <target>羊膜
</target>
     </trans-unit>
     <trans-unit id="PEO_386_synonyms">
       <source>Amniotic Membranes</source>
     </trans-unit>
     <trans-unit id="PEO_386_definition">
       <source>The innermost membranous sac that surrounds and protects the developing embryo which is bathed in the AMNIOTIC FLUID. Amnion cells are secretory EPITHELIAL CELLS and contribute to the amniotic fluid.</source>
     </trans-unit>
     <trans-unit id="PEO_386_synonyms_1">
       <source>Amnions</source>
     </trans-unit>
     <trans-unit id="PEO_386_synonyms_2">
       <source>Amniotic Membrane</source>
     </trans-unit>
     <trans-unit id="PEO_386_synonyms_3">
       <source>Membranes, Amniotic</source>
     </trans-unit>
     <trans-unit id="PEO_386_synonyms_4">
       <source>Membrane, Amniotic</source>
     </trans-unit>
     <trans-unit id="PEO_387_label">
       <source>Amnion nodosum</source>
       <target>羊膜結節
</target>
     </trans-unit>
     <trans-unit id="PEO_387_synonyms">
       <source>Amnion nodosum (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_388_label">
       <source>Amniotic fluid</source>
       <target>羊水
</target>
     </trans-unit>
     <trans-unit id="PEO_388_synonyms">
       <source>AF - Amniotic fluid</source>
     </trans-unit>
     <trans-unit id="PEO_388_synonyms_1">
       <source>Liquor</source>
     </trans-unit>
     <trans-unit id="PEO_388_synonyms_2">
       <source>Amniotic fluid (substance)</source>
     </trans-unit>
     <trans-unit id="PEO_389_label">
       <source>Amount of blood loss</source>
       <target>総出血量
</target>
     </trans-unit>
     <trans-unit id="PEO_390_label">
       <source>Analysis of cohort studies</source>
       <target>コホート研究の解析
</target>
     </trans-unit>
     <trans-unit id="PEO_390_synonyms">
       <source>check subclasses!!</source>
     </trans-unit>
     <trans-unit id="PEO_391_label">
       <source>Androgen level</source>
       <target>アンドロゲンレベル
</target>
     </trans-unit>
     <trans-unit id="PEO_391_synonyms">
       <source>Androgen level (procedure)</source>
     </trans-unit>
     <trans-unit id="PEO_391_synonyms_1">
       <source>Androgen measurement</source>
     </trans-unit>
     <trans-unit id="PEO_392_label">
       <source>Androgen receptor level</source>
       <target>アンドロゲン受容体レベル
</target>
     </trans-unit>
     <trans-unit id="PEO_392_synonyms">
       <source>androgen receptor levels</source>
     </trans-unit>
     <trans-unit id="PEO_393_label">
       <source>Anemia</source>
       <target>貧血
</target>
     </trans-unit>
     <trans-unit id="PEO_393_synonyms">
       <source>Absolute anemia</source>
     </trans-unit>
     <trans-unit id="PEO_393_synonyms_1">
       <source>Anaemia</source>
     </trans-unit>
     <trans-unit id="PEO_393_synonyms_2">
       <source>Anemia (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_393_synonyms_3">
       <source>Absolute anaemia</source>
     </trans-unit>
     <trans-unit id="PEO_394_label">
       <source>Angioedema</source>
       <target>血管浮腫
</target>
     </trans-unit>
     <trans-unit id="PEO_394_synonyms">
       <source>Angioedema (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_394_synonyms_1">
       <source>Angio-oedema-urticaria</source>
     </trans-unit>
     <trans-unit id="PEO_394_synonyms_2">
       <source>Quincke&apos;s oedema</source>
     </trans-unit>
     <trans-unit id="PEO_394_synonyms_3">
       <source>Angioedema-urticaria</source>
     </trans-unit>
     <trans-unit id="PEO_394_synonyms_4">
       <source>Giant urticaria</source>
     </trans-unit>
     <trans-unit id="PEO_394_synonyms_5">
       <source>Angio-oedema</source>
     </trans-unit>
     <trans-unit id="PEO_394_synonyms_6">
       <source>Angioneurotic edema</source>
     </trans-unit>
     <trans-unit id="PEO_394_synonyms_7">
       <source>Quincke&apos;s disease</source>
     </trans-unit>
     <trans-unit id="PEO_394_synonyms_8">
       <source>Urticaria-angio-oedema</source>
     </trans-unit>
     <trans-unit id="PEO_394_synonyms_9">
       <source>Angioneurotic oedema</source>
     </trans-unit>
     <trans-unit id="PEO_394_synonyms_10">
       <source>Urticaria-angioedema</source>
     </trans-unit>
     <trans-unit id="PEO_394_synonyms_11">
       <source>Quincke&apos;s edema</source>
     </trans-unit>
     <trans-unit id="PEO_395_label">
       <source>Angiotensin II</source>
       <target>アンジオテンシンII
</target>
     </trans-unit>
     <trans-unit id="PEO_395_definition">
       <source>An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS.</source>
     </trans-unit>
     <trans-unit id="PEO_396_label">
       <source>Angiotensin II system</source>
       <target>アンジオテンシンIIシステム
</target>
     </trans-unit>
     <trans-unit id="PEO_397_label">
       <source>Antenatal</source>
       <target>出産前
</target>
     </trans-unit>
     <trans-unit id="PEO_397_synonyms">
       <source>AN - Antenatal</source>
     </trans-unit>
     <trans-unit id="PEO_397_synonyms_1">
       <source>Antenatal (qualifier value)</source>
     </trans-unit>
     <trans-unit id="PEO_398_label">
       <source>Antepartum</source>
       <target>分娩前
</target>
     </trans-unit>
     <trans-unit id="PEO_398_synonyms">
       <source>Antepartum (qualifier value)</source>
     </trans-unit>
     <trans-unit id="PEO_399_label">
       <source>Antepartum hemorrhage</source>
       <target>分娩前出血
</target>
     </trans-unit>
     <trans-unit id="PEO_399_synonyms">
       <source>APH - Antepartum hemorrhage</source>
     </trans-unit>
     <trans-unit id="PEO_399_synonyms_1">
       <source>Antepartum hemorrhage (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_399_synonyms_2">
       <source>APH - Antepartum haemorrhage</source>
     </trans-unit>
     <trans-unit id="PEO_399_synonyms_3">
       <source>Antepartum haemorrhage</source>
     </trans-unit>
     <trans-unit id="PEO_400_label">
       <source>Antibody</source>
       <target>抗体
</target>
     </trans-unit>
     <trans-unit id="PEO_400_synonyms">
       <source>Antibody (substance)</source>
     </trans-unit>
     <trans-unit id="PEO_401_label">
       <source>Antihypertensive medication</source>
       <target>降圧薬
</target>
     </trans-unit>
     <trans-unit id="PEO_402_label">
       <source>Antihypertensive therapy</source>
       <target>降圧療法
</target>
     </trans-unit>
     <trans-unit id="PEO_402_synonyms">
       <source>Antihypertensive therapy (procedure)</source>
     </trans-unit>
     <trans-unit id="PEO_403_label">
       <source>Antiphospholipid syndrome in pregnancy</source>
       <target>妊娠中の抗リン脂質抗体症候群
</target>
     </trans-unit>
     <trans-unit id="PEO_403_synonyms">
       <source>Antiphospholipid syndrome in pregnancy (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_403_synonyms_1">
       <source>systemic lupus erythematosus</source>
     </trans-unit>
     <trans-unit id="PEO_404_label">
       <source>Antiproliferative effects</source>
       <target>抗増殖効果
</target>
     </trans-unit>
     <trans-unit id="PEO_405_label">
       <source>Antipsychotic drug</source>
       <target>統合失調症治療薬
</target>
     </trans-unit>
     <trans-unit id="PEO_405_synonyms">
       <source>Neuroleptic</source>
     </trans-unit>
     <trans-unit id="PEO_405_synonyms_1">
       <source>Antipsychotic drugs</source>
     </trans-unit>
     <trans-unit id="PEO_405_synonyms_2">
       <source>antipsychotics</source>
     </trans-unit>
     <trans-unit id="PEO_405_synonyms_3">
       <source>antipsychotic</source>
     </trans-unit>
     <trans-unit id="PEO_406_label">
       <source>Antithyroid agent</source>
       <target>抗甲状腺薬
</target>
     </trans-unit>
     <trans-unit id="PEO_406_synonyms">
       <source>Antithyroid agent (substance)</source>
     </trans-unit>
     <trans-unit id="PEO_407_label">
       <source>Apgar score low</source>
       <target>低アプガースコア
</target>
     </trans-unit>
     <trans-unit id="PEO_408_label">
       <source>Apoptosis</source>
       <target>アポトーシス
</target>
     </trans-unit>
     <trans-unit id="PEO_408_definition">
       <source>Apoptosis that is triggered via cell stress and mitochondrial damage. One of the mechanisms by which CELL DEATH occurs (compare with NECROSIS and AUTOPHAGOCYTOSIS). Apoptosis is the mechanism responsible for the physiological deletion of cells and appears to be intrinsically programmed. It is characterized by distinctive morphologic changes in the nucleus and cytoplasm, chromatin cleavage at regularly spaced sites, and the endonucleolytic cleavage of genomic DNA; (DNA FRAGMENTATION); at internucleosomal sites. This mode of cell death serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis that is triggered via CELL SURFACE RECEPTORS such as TUMOR NECROSIS FACTOR RECEPTORS and DEATH DOMAIN RECEPTORS.</source>
     </trans-unit>
     <trans-unit id="PEO_408_synonyms">
       <source>Programmed Cell Death, Type I</source>
     </trans-unit>
     <trans-unit id="PEO_408_synonyms_1">
       <source>Apoptosis, Extrinsic Pathway</source>
     </trans-unit>
     <trans-unit id="PEO_408_synonyms_2">
       <source>Intrinsic Pathway Apoptoses</source>
     </trans-unit>
     <trans-unit id="PEO_408_synonyms_3">
       <source>Apoptoses, Intrinsic Pathway</source>
     </trans-unit>
     <trans-unit id="PEO_408_synonyms_4">
       <source>Apoptoses, Extrinsic Pathway</source>
     </trans-unit>
     <trans-unit id="PEO_408_synonyms_5">
       <source>Apoptosis, Intrinsic Pathway</source>
     </trans-unit>
     <trans-unit id="PEO_408_synonyms_6">
       <source>Extrinsic Pathway Apoptosis</source>
     </trans-unit>
     <trans-unit id="PEO_408_synonyms_7">
       <source>Intrinsic Pathway Apoptosis</source>
     </trans-unit>
     <trans-unit id="PEO_408_synonyms_8">
       <source>Extrinsic Pathway Apoptoses</source>
     </trans-unit>
     <trans-unit id="PEO_409_label">
       <source>Arterial Pressure</source>
       <target>動脈圧
</target>
     </trans-unit>
     <trans-unit id="PEO_409_synonyms">
       <source>Arterial Tensions</source>
     </trans-unit>
     <trans-unit id="PEO_409_synonyms_1">
       <source>Pressure, Arterial Blood</source>
     </trans-unit>
     <trans-unit id="PEO_409_synonyms_2">
       <source>Pressures, Mean Arterial</source>
     </trans-unit>
     <trans-unit id="PEO_409_synonyms_3">
       <source>Pressures, Aortic Blood</source>
     </trans-unit>
     <trans-unit id="PEO_409_synonyms_4">
       <source>Tensions, Arterial</source>
     </trans-unit>
     <trans-unit id="PEO_409_synonyms_5">
       <source>Pressures, Aortic Pulse</source>
     </trans-unit>
     <trans-unit id="PEO_409_synonyms_6">
       <source>Pressure, Aortic Blood</source>
     </trans-unit>
     <trans-unit id="PEO_409_synonyms_7">
       <source>Aortic Blood Pressure</source>
     </trans-unit>
     <trans-unit id="PEO_409_synonyms_8">
       <source>Mean Arterial Pressures</source>
     </trans-unit>
     <trans-unit id="PEO_409_synonyms_9">
       <source>Aortic Tension</source>
     </trans-unit>
     <trans-unit id="PEO_409_synonyms_10">
       <source>Pulse Pressure, Aortic</source>
     </trans-unit>
     <trans-unit id="PEO_409_synonyms_11">
       <source>Arterial Blood Pressures</source>
     </trans-unit>
     <trans-unit id="PEO_409_synonyms_12">
       <source>Tensions, Aortic</source>
     </trans-unit>
     <trans-unit id="PEO_409_synonyms_13">
       <source>Aortic Pressures</source>
     </trans-unit>
     <trans-unit id="PEO_409_synonyms_14">
       <source>Mean Aortic Pressures</source>
     </trans-unit>
     <trans-unit id="PEO_409_synonyms_15">
       <source>Pulse Pressures, Aortic</source>
     </trans-unit>
     <trans-unit id="PEO_409_synonyms_16">
       <source>Pressure, Aortic Pulse</source>
     </trans-unit>
     <trans-unit id="PEO_409_synonyms_17">
       <source>Pressure, Mean Aortic</source>
     </trans-unit>
     <trans-unit id="PEO_409_synonyms_18">
       <source>Pressures, Mean Aortic</source>
     </trans-unit>
     <trans-unit id="PEO_409_synonyms_19">
       <source>Arterial Pressures, Mean</source>
     </trans-unit>
     <trans-unit id="PEO_409_synonyms_20">
       <source>Pressures, Arterial Blood</source>
     </trans-unit>
     <trans-unit id="PEO_409_synonyms_21">
       <source>Pressure, Aortic</source>
     </trans-unit>
     <trans-unit id="PEO_409_synonyms_22">
       <source>Arterial Pressures</source>
     </trans-unit>
     <trans-unit id="PEO_409_synonyms_23">
       <source>Tension, Arterial</source>
     </trans-unit>
     <trans-unit id="PEO_409_synonyms_24">
       <source>Arterial Pressure, Mean</source>
     </trans-unit>
     <trans-unit id="PEO_409_synonyms_25">
       <source>Aortic Tensions</source>
     </trans-unit>
     <trans-unit id="PEO_409_synonyms_26">
       <source>Pressure, Mean Arterial</source>
     </trans-unit>
     <trans-unit id="PEO_409_synonyms_27">
       <source>Tension, Aortic</source>
     </trans-unit>
     <trans-unit id="PEO_409_synonyms_28">
       <source>Aortic Pulse Pressure</source>
     </trans-unit>
     <trans-unit id="PEO_409_synonyms_29">
       <source>Pressure, Arterial</source>
     </trans-unit>
     <trans-unit id="PEO_409_synonyms_30">
       <source>Blood Pressures, Arterial</source>
     </trans-unit>
     <trans-unit id="PEO_409_definition">
       <source>Difference between systolic and diastolic pressures within AORTA Blood pressure within AORTA The blood pressure in the ARTERIES. It is commonly measured with a SPHYGMOMANOMETER on the upper arm which represents the arterial pressure in the BRACHIAL ARTERY. The average pressure during the aortic pulse cycle. The average arterial pressure during a single cardiac cycle. It can be estimated as diastolic blood pressure plus one third of the difference of diastolic and systolic blood pressures.</source>
     </trans-unit>
     <trans-unit id="PEO_409_synonyms_31">
       <source>Mean Aortic Pressure</source>
     </trans-unit>
     <trans-unit id="PEO_409_synonyms_32">
       <source>Blood Pressures, Aortic</source>
     </trans-unit>
     <trans-unit id="PEO_409_synonyms_33">
       <source>Aortic Pressures, Mean</source>
     </trans-unit>
     <trans-unit id="PEO_409_synonyms_34">
       <source>Arterial Tension</source>
     </trans-unit>
     <trans-unit id="PEO_409_synonyms_35">
       <source>Mean Arterial Pressure</source>
     </trans-unit>
     <trans-unit id="PEO_409_synonyms_36">
       <source>Aortic Pulse Pressures</source>
     </trans-unit>
     <trans-unit id="PEO_409_synonyms_37">
       <source>Blood Pressure, Arterial</source>
     </trans-unit>
     <trans-unit id="PEO_409_synonyms_38">
       <source>Aortic Pressure, Mean</source>
     </trans-unit>
     <trans-unit id="PEO_409_synonyms_39">
       <source>Arterial Blood Pressure</source>
     </trans-unit>
     <trans-unit id="PEO_409_synonyms_40">
       <source>Aortic Blood Pressures</source>
     </trans-unit>
     <trans-unit id="PEO_409_synonyms_41">
       <source>Pressures, Arterial</source>
     </trans-unit>
     <trans-unit id="PEO_409_synonyms_42">
       <source>Blood Pressure, Aortic</source>
     </trans-unit>
     <trans-unit id="PEO_409_synonyms_43">
       <source>Aortic Pressure</source>
     </trans-unit>
     <trans-unit id="PEO_409_synonyms_44">
       <source>Pressures, Aortic</source>
     </trans-unit>
     <trans-unit id="PEO_410_label">
       <source>Arterial thrombosis</source>
       <target>動脈血栓症
</target>
     </trans-unit>
     <trans-unit id="PEO_410_synonyms">
       <source>Arterial thrombosis (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_411_label">
       <source>Arteries</source>
       <target>動脈
</target>
     </trans-unit>
     <trans-unit id="PEO_411_definition">
       <source>The vessels carrying blood away from the heart.</source>
     </trans-unit>
     <trans-unit id="PEO_411_synonyms">
       <source>Artery</source>
     </trans-unit>
     <trans-unit id="PEO_412_label">
       <source>Arteriosclerosis</source>
       <target>動脈硬化症
</target>
     </trans-unit>
     <trans-unit id="PEO_412_synonyms">
       <source>Arteriosclerosis (morphologic abnormality)</source>
     </trans-unit>
     <trans-unit id="PEO_413_label">
       <source>Arthritis</source>
       <target>関節炎
</target>
     </trans-unit>
     <trans-unit id="PEO_413_synonyms">
       <source>Inflammatory arthritis</source>
     </trans-unit>
     <trans-unit id="PEO_413_synonyms_1">
       <source>Arthritis (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_413_synonyms_2">
       <source>Joint inflammation</source>
     </trans-unit>
     <trans-unit id="PEO_414_label">
       <source>Artificial insemination</source>
       <target>人工授精
</target>
     </trans-unit>
     <trans-unit id="PEO_414_synonyms">
       <source>AI - Artificial insemination</source>
     </trans-unit>
     <trans-unit id="PEO_414_synonyms_1">
       <source>Artificial insemination (procedure)</source>
     </trans-unit>
     <trans-unit id="PEO_415_label">
       <source>Asian race</source>
       <target>アジア人種
</target>
     </trans-unit>
     <trans-unit id="PEO_415_synonyms">
       <source>Asian race (racial group)</source>
     </trans-unit>
     <trans-unit id="PEO_415_synonyms_1">
       <source>Asian</source>
     </trans-unit>
     <trans-unit id="PEO_416_label">
       <source>Aspirin</source>
       <target>アスピリン
</target>
     </trans-unit>
     <trans-unit id="PEO_416_synonyms">
       <source>Acetylsalicylic acid</source>
     </trans-unit>
     <trans-unit id="PEO_416_synonyms_1">
       <source>Aspirin (product)</source>
     </trans-unit>
     <trans-unit id="PEO_417_label">
       <source>Aspirin allergy</source>
       <target>アスピリン過敏症
</target>
     </trans-unit>
     <trans-unit id="PEO_417_synonyms">
       <source>Aspirin allergy (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_418_label">
       <source>Asthma</source>
       <target>喘息
</target>
     </trans-unit>
     <trans-unit id="PEO_418_synonyms">
       <source>Airway hyperreactivity</source>
     </trans-unit>
     <trans-unit id="PEO_418_synonyms_1">
       <source>Bronchial hyperreactivity</source>
     </trans-unit>
     <trans-unit id="PEO_418_synonyms_2">
       <source>BHR - Bronchial hyperreactivity</source>
     </trans-unit>
     <trans-unit id="PEO_418_synonyms_3">
       <source>Asthma (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_418_synonyms_4">
       <source>Hyperreactive airway disease</source>
     </trans-unit>
     <trans-unit id="PEO_418_synonyms_5">
       <source>Bronchial hypersensitivity</source>
     </trans-unit>
     <trans-unit id="PEO_418_synonyms_6">
       <source>Bronchial hyperresponsiveness</source>
     </trans-unit>
     <trans-unit id="PEO_418_synonyms_7">
       <source>Asthmatic</source>
     </trans-unit>
     <trans-unit id="PEO_418_synonyms_8">
       <source>Bronchial asthma</source>
     </trans-unit>
     <trans-unit id="PEO_419_label">
       <source>At crowning of head</source>
       <target>児頭発露
</target>
     </trans-unit>
     <trans-unit id="PEO_419_synonyms">
       <source>At crowning of head (qualifier value)</source>
     </trans-unit>
     <trans-unit id="PEO_420_label">
       <source>At delivery before labor</source>
       <target>At delivery before labor
</target>
     </trans-unit>
     <trans-unit id="PEO_421_label">
       <source>At delivery of anterior shoulder</source>
       <target>At delivery of anterior shoulder
</target>
     </trans-unit>
     <trans-unit id="PEO_421_synonyms">
       <source>At delivery of anterior shoulder (qualifier value)</source>
     </trans-unit>
     <trans-unit id="PEO_422_label">
       <source>At discharge from hospital</source>
       <target>退院時
</target>
     </trans-unit>
     <trans-unit id="PEO_423_label">
       <source>Atherogenic lipoprotein</source>
       <target>アテローム形成性リポタンパク質
</target>
     </trans-unit>
     <trans-unit id="PEO_424_label">
       <source>Atherosclerosis</source>
       <target>アテローム動脈硬化症
</target>
     </trans-unit>
     <trans-unit id="PEO_424_synonyms">
       <source>Atheromatosis</source>
     </trans-unit>
     <trans-unit id="PEO_424_synonyms_1">
       <source>Atherosclerosis (morphologic abnormality)</source>
     </trans-unit>
     <trans-unit id="PEO_425_label">
       <source>Atrial fibrillation</source>
       <target>心房細動
</target>
     </trans-unit>
     <trans-unit id="PEO_425_synonyms">
       <source>AF - Atrial fibrillation</source>
     </trans-unit>
     <trans-unit id="PEO_425_synonyms_1">
       <source>Atrial fibrillation (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_426_label">
       <source>Attributable risks</source>
       <target>寄与リスク
</target>
     </trans-unit>
     <trans-unit id="PEO_427_label">
       <source>Autoimmune Diseases</source>
       <target>自己免疫疾患
</target>
     </trans-unit>
     <trans-unit id="PEO_427_definition">
       <source>Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides.</source>
     </trans-unit>
     <trans-unit id="PEO_427_synonyms">
       <source>Diseases, Autoimmune</source>
     </trans-unit>
     <trans-unit id="PEO_427_synonyms_1">
       <source>Disease, Autoimmune</source>
     </trans-unit>
     <trans-unit id="PEO_427_synonyms_2">
       <source>Autoimmune Disease</source>
     </trans-unit>
     <trans-unit id="PEO_428_label">
       <source>Availability of caesarean section</source>
       <target>帝王切開の利用可能性
</target>
     </trans-unit>
     <trans-unit id="PEO_429_label">
       <source>Availability of medical resources</source>
       <target>医療リソースの利用可能性
</target>
     </trans-unit>
     <trans-unit id="PEO_430_label">
       <source>B-lines</source>
       <target>コメットサイン
</target>
     </trans-unit>
     <trans-unit id="PEO_430_synonyms">
       <source>comet tail artifact</source>
     </trans-unit>
     <trans-unit id="PEO_431_label">
       <source>BK channel</source>
       <target>BKチャネル
</target>
     </trans-unit>
     <trans-unit id="PEO_432_label">
       <source>B lymphocyte</source>
       <target>Bリンパ球
</target>
     </trans-unit>
     <trans-unit id="PEO_432_synonyms">
       <source>B lymphocyte (cell)</source>
     </trans-unit>
     <trans-unit id="PEO_432_synonyms_1">
       <source>B-cell</source>
     </trans-unit>
     <trans-unit id="PEO_432_synonyms_2">
       <source>B cell</source>
     </trans-unit>
     <trans-unit id="PEO_433_label">
       <source>Bariatric Surgery</source>
       <target>肥満外科手術
</target>
     </trans-unit>
     <trans-unit id="PEO_433_synonyms">
       <source>Stomach Stapling</source>
     </trans-unit>
     <trans-unit id="PEO_433_synonyms_1">
       <source>Metabolic Surgeries</source>
     </trans-unit>
     <trans-unit id="PEO_433_synonyms_2">
       <source>Surgeries, Metabolic</source>
     </trans-unit>
     <trans-unit id="PEO_433_synonyms_3">
       <source>Stapling, Stomach</source>
     </trans-unit>
     <trans-unit id="PEO_433_synonyms_4">
       <source>Bariatric Surgeries</source>
     </trans-unit>
     <trans-unit id="PEO_433_synonyms_5">
       <source>Surgery, Metabolic</source>
     </trans-unit>
     <trans-unit id="PEO_433_synonyms_6">
       <source>Surgery, Bariatric</source>
     </trans-unit>
     <trans-unit id="PEO_433_synonyms_7">
       <source>Metabolic Surgery</source>
     </trans-unit>
     <trans-unit id="PEO_433_synonyms_8">
       <source>Procedures, Bariatric Surgical</source>
     </trans-unit>
     <trans-unit id="PEO_433_synonyms_9">
       <source>Procedure, Bariatric Surgical</source>
     </trans-unit>
     <trans-unit id="PEO_433_synonyms_10">
       <source>Surgical Procedure, Bariatric</source>
     </trans-unit>
     <trans-unit id="PEO_433_definition">
       <source>Surgical procedures aimed at affecting metabolism and producing major WEIGHT REDUCTION in patients with MORBID OBESITY.</source>
     </trans-unit>
     <trans-unit id="PEO_433_synonyms_11">
       <source>Surgical Procedures, Bariatric</source>
     </trans-unit>
     <trans-unit id="PEO_433_synonyms_12">
       <source>Bariatric Surgical Procedures</source>
     </trans-unit>
     <trans-unit id="PEO_433_synonyms_13">
       <source>Surgeries, Bariatric</source>
     </trans-unit>
     <trans-unit id="PEO_433_synonyms_14">
       <source>Bariatric Surgical Procedure</source>
     </trans-unit>
     <trans-unit id="PEO_434_label">
       <source>Basement membrane</source>
       <target>基底膜
</target>
     </trans-unit>
     <trans-unit id="PEO_434_synonyms">
       <source>Basal lamina</source>
     </trans-unit>
     <trans-unit id="PEO_434_synonyms_1">
       <source>Membrana basalis</source>
     </trans-unit>
     <trans-unit id="PEO_434_synonyms_2">
       <source>Basement membrane (body structure)</source>
     </trans-unit>
     <trans-unit id="PEO_434_synonyms_3">
       <source>External lamina</source>
     </trans-unit>
     <trans-unit id="PEO_435_label">
       <source>Basic attribute on pregnancy</source>
       <target>妊娠時の基礎属性
</target>
     </trans-unit>
     <trans-unit id="PEO_435_synonyms">
       <source>Basic attrubute</source>
     </trans-unit>
     <trans-unit id="PEO_436_label">
       <source>Before full dilatation of cervix</source>
       <target>子宮口全開大前
</target>
     </trans-unit>
     <trans-unit id="PEO_436_synonyms">
       <source>Before full dilatation of cervix (qualifier value)</source>
     </trans-unit>
     <trans-unit id="PEO_437_label">
       <source>Bilateral notching</source>
       <target>両側子宮動脈血流のnotchサイン
</target>
     </trans-unit>
     <trans-unit id="PEO_438_label">
       <source>Bilateral protodiastolic notches</source>
       <target>両側子宮動脈血流の拡張前期notchサイン
</target>
     </trans-unit>
     <trans-unit id="PEO_439_label">
       <source>Bilirubin, total measurement</source>
       <target>ビリルビンレベル
</target>
     </trans-unit>
     <trans-unit id="PEO_439_synonyms">
       <source>Total bilirubin level</source>
     </trans-unit>
     <trans-unit id="PEO_439_synonyms_1">
       <source>Total bilirubin</source>
     </trans-unit>
     <trans-unit id="PEO_439_synonyms_2">
       <source>Bilirubin, total measurement (procedure)</source>
     </trans-unit>
     <trans-unit id="PEO_440_label">
       <source>Biochemical test</source>
       <target>生化学検査
</target>
     </trans-unit>
     <trans-unit id="PEO_441_label">
       <source>Birth</source>
       <target>出生
</target>
     </trans-unit>
     <trans-unit id="PEO_441_synonyms">
       <source>Birth (finding)</source>
     </trans-unit>
     <trans-unit id="PEO_442_label">
       <source>Birth weight</source>
       <target>出生体重
</target>
     </trans-unit>
     <trans-unit id="PEO_442_synonyms">
       <source>Birth weight (observable entity)</source>
     </trans-unit>
     <trans-unit id="PEO_443_label">
       <source>Birth weight of the pregnant woman</source>
       <target>妊婦の出生体重
</target>
     </trans-unit>
     <trans-unit id="PEO_444_label">
       <source>Black - ethnic group</source>
       <target>黒人
</target>
     </trans-unit>
     <trans-unit id="PEO_444_synonyms">
       <source>Black - ethnic group (ethnic group)</source>
     </trans-unit>
     <trans-unit id="PEO_444_synonyms_1">
       <source>Black</source>
     </trans-unit>
     <trans-unit id="PEO_445_label">
       <source>blood Biomarker</source>
       <target>血液バイオマーカー
</target>
     </trans-unit>
     <trans-unit id="PEO_445_synonyms">
       <source>blood Biomarkers</source>
     </trans-unit>
     <trans-unit id="PEO_446_label">
       <source>Blood Transfusion</source>
       <target>輸血
</target>
     </trans-unit>
     <trans-unit id="PEO_446_synonyms">
       <source>Transfusions, Blood</source>
     </trans-unit>
     <trans-unit id="PEO_446_synonyms_1">
       <source>Blood Transfusions</source>
     </trans-unit>
     <trans-unit id="PEO_446_synonyms_2">
       <source>Transfusion, Blood</source>
     </trans-unit>
     <trans-unit id="PEO_446_definition">
       <source>The introduction of whole blood or blood component directly into the blood stream. (Dorland, 27th ed)</source>
     </trans-unit>
     <trans-unit id="PEO_447_label">
       <source>Blood Transfusion in life-time</source>
       <target>生涯の輸血
</target>
     </trans-unit>
     <trans-unit id="PEO_448_label">
       <source>Blood transfusion in present pregnancy</source>
       <target>今回の妊娠における輸血
</target>
     </trans-unit>
     <trans-unit id="PEO_449_label">
       <source>Blood cell</source>
       <target>血液細胞
</target>
     </trans-unit>
     <trans-unit id="PEO_449_synonyms">
       <source>Blood cell (cell)</source>
     </trans-unit>
     <trans-unit id="PEO_450_label">
       <source>Blood coagulation disorder</source>
       <target>血液凝固異常
</target>
     </trans-unit>
     <trans-unit id="PEO_450_synonyms">
       <source>Clotting disorder</source>
     </trans-unit>
     <trans-unit id="PEO_450_synonyms_1">
       <source>Bleeding tendency</source>
     </trans-unit>
     <trans-unit id="PEO_450_synonyms_2">
       <source>Disorder of hemostasis</source>
     </trans-unit>
     <trans-unit id="PEO_450_synonyms_3">
       <source>Coagulopathy</source>
     </trans-unit>
     <trans-unit id="PEO_450_synonyms_4">
       <source>Disorder of haemostasis</source>
     </trans-unit>
     <trans-unit id="PEO_450_synonyms_5">
       <source>Coagulation disorder</source>
     </trans-unit>
     <trans-unit id="PEO_450_synonyms_6">
       <source>Blood clotting disorder</source>
     </trans-unit>
     <trans-unit id="PEO_450_synonyms_7">
       <source>Bleeding diathesis</source>
     </trans-unit>
     <trans-unit id="PEO_450_synonyms_8">
       <source>Bleeding disorder</source>
     </trans-unit>
     <trans-unit id="PEO_450_synonyms_9">
       <source>Blood coagulation disorder (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_451_label">
       <source>Blood pressure at first visit</source>
       <target>初診時の血圧
</target>
     </trans-unit>
     <trans-unit id="PEO_451_synonyms">
       <source>Blood pressure at first booking</source>
     </trans-unit>
     <trans-unit id="PEO_452_label">
       <source>Blood pressure finding</source>
       <target>血圧所見
</target>
     </trans-unit>
     <trans-unit id="PEO_452_synonyms">
       <source>Blood pressure finding (finding)</source>
     </trans-unit>
     <trans-unit id="PEO_453_label">
       <source>Blood test</source>
       <target>血液検査
</target>
     </trans-unit>
     <trans-unit id="PEO_453_synonyms">
       <source>Blood test (procedure)</source>
     </trans-unit>
     <trans-unit id="PEO_454_label">
       <source>Blue-collar worker</source>
       <target>ブルーカラー
</target>
     </trans-unit>
     <trans-unit id="PEO_455_label">
       <source>Body height measure</source>
       <target>体長の測定
</target>
     </trans-unit>
     <trans-unit id="PEO_455_synonyms">
       <source>Body height</source>
     </trans-unit>
     <trans-unit id="PEO_455_synonyms_1">
       <source>Body height measure (observable entity)</source>
     </trans-unit>
     <trans-unit id="PEO_456_label">
       <source>Body mass index</source>
       <target>肥満度指数
</target>
     </trans-unit>
     <trans-unit id="PEO_456_synonyms">
       <source>Quetelet index</source>
     </trans-unit>
     <trans-unit id="PEO_456_synonyms_1">
       <source>BMI - Body mass index</source>
     </trans-unit>
     <trans-unit id="PEO_456_synonyms_2">
       <source>Body mass index (observable entity)</source>
     </trans-unit>
     <trans-unit id="PEO_456_synonyms_3">
       <source>Weight: body mass</source>
     </trans-unit>
     <trans-unit id="PEO_457_label">
       <source>Body measure</source>
       <target>身体測定
</target>
     </trans-unit>
     <trans-unit id="PEO_457_synonyms">
       <source>Body measure (observable entity)</source>
     </trans-unit>
     <trans-unit id="PEO_457_synonyms_1">
       <source>Body measurements</source>
     </trans-unit>
     <trans-unit id="PEO_458_label">
       <source>Body weight measure</source>
       <target>体重の測定
</target>
     </trans-unit>
     <trans-unit id="PEO_458_synonyms">
       <source>Body weight measure (observable entity)</source>
     </trans-unit>
     <trans-unit id="PEO_459_label">
       <source>Borderline poverty status</source>
       <target>貧困すれすれの状態
</target>
     </trans-unit>
     <trans-unit id="PEO_459_synonyms">
       <source>Borderline poverty (economic status)</source>
     </trans-unit>
     <trans-unit id="PEO_459_synonyms_1">
       <source>Borderline poverty (economic status) (social concept)</source>
     </trans-unit>
     <trans-unit id="PEO_459_synonyms_2">
       <source>Poverty line status</source>
     </trans-unit>
     <trans-unit id="PEO_460_label">
       <source>Born from pre-eclamptic mother</source>
       <target>妊娠高血圧腎症の母親からの出生
</target>
     </trans-unit>
     <trans-unit id="PEO_461_label">
       <source>Bowman Capsule</source>
       <target>ボウマン嚢
</target>
     </trans-unit>
     <trans-unit id="PEO_461_synonyms">
       <source>Capsule, Bowman&apos;s</source>
     </trans-unit>
     <trans-unit id="PEO_461_synonyms_1">
       <source>Bowmans Capsule</source>
     </trans-unit>
     <trans-unit id="PEO_461_synonyms_2">
       <source>Bowman&apos;s Capsule</source>
     </trans-unit>
     <trans-unit id="PEO_461_definition">
       <source>A double-walled epithelial capsule that is the bulbous closed proximal end of the kidney tubular system. It surrounds the cluster of convoluted capillaries of KIDNEY GLOMERULUS and is continuous with the convoluted PROXIMAL KIDNEY TUBULE.</source>
     </trans-unit>
     <trans-unit id="PEO_461_synonyms_3">
       <source>Capsule, Bowman</source>
     </trans-unit>
     <trans-unit id="PEO_462_label">
       <source>Brain Diseases</source>
       <target>脳疾患
</target>
     </trans-unit>
     <trans-unit id="PEO_462_synonyms">
       <source>Encephalon Diseases</source>
     </trans-unit>
     <trans-unit id="PEO_462_synonyms_1">
       <source>Intracranial Central Nervous System Disorders</source>
     </trans-unit>
     <trans-unit id="PEO_462_synonyms_2">
       <source>Brain Disorder</source>
     </trans-unit>
     <trans-unit id="PEO_462_synonyms_3">
       <source>Encephalon Disease</source>
     </trans-unit>
     <trans-unit id="PEO_462_synonyms_4">
       <source>Central Nervous System Intracranial Disorders</source>
     </trans-unit>
     <trans-unit id="PEO_462_synonyms_5">
       <source>Intracranial CNS Disorder</source>
     </trans-unit>
     <trans-unit id="PEO_462_synonyms_6">
       <source>Central Nervous System Disorders, Intracranial</source>
     </trans-unit>
     <trans-unit id="PEO_462_synonyms_7">
       <source>CNS Disorders, Intracranial</source>
     </trans-unit>
     <trans-unit id="PEO_462_synonyms_8">
       <source>CNS Disorder, Intracranial</source>
     </trans-unit>
     <trans-unit id="PEO_462_synonyms_9">
       <source>Brain Disease</source>
     </trans-unit>
     <trans-unit id="PEO_462_synonyms_10">
       <source>Intracranial CNS Disorders</source>
     </trans-unit>
     <trans-unit id="PEO_462_synonyms_11">
       <source>Brain Disorders</source>
     </trans-unit>
     <trans-unit id="PEO_463_label">
       <source>C10AA:HMG CoA reductase inhibitor</source>
       <target>C10AA:HMG CoA還元酵素阻害剤
</target>
     </trans-unit>
     <trans-unit id="PEO_463_synonyms">
       <source>C10AA:HMG CoA reductase inhibitors</source>
     </trans-unit>
     <trans-unit id="PEO_464_label">
       <source>C / H - Chronic disease</source>
       <target>慢性疾患の既往
</target>
     </trans-unit>
     <trans-unit id="PEO_464_synonyms">
       <source>Chronic disease (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_465_label">
       <source>C / H - Mental disorder</source>
       <target>精神疾患既往歴
</target>
     </trans-unit>
     <trans-unit id="PEO_465_synonyms">
       <source>Clinical history of mental disorder</source>
     </trans-unit>
     <trans-unit id="PEO_466_label">
       <source>Calcium release</source>
       <target>カルシウム遊離
</target>
     </trans-unit>
     <trans-unit id="PEO_467_label">
       <source>Calcium supplement</source>
       <target>カルシウムサプリメント
</target>
     </trans-unit>
     <trans-unit id="PEO_467_synonyms">
       <source>Calcium supplement (substance)</source>
     </trans-unit>
     <trans-unit id="PEO_468_label">
       <source>Cannabis abuse</source>
       <target>大麻乱用
</target>
     </trans-unit>
     <trans-unit id="PEO_469_label">
       <source>Capillary lumens</source>
       <target>毛細血管腔
</target>
     </trans-unit>
     <trans-unit id="PEO_470_label">
       <source>Capillary space</source>
       <target>毛細血管腔
</target>
     </trans-unit>
     <trans-unit id="PEO_471_label">
       <source>Cardiac fibrosis</source>
       <target>心筋繊維化
</target>
     </trans-unit>
     <trans-unit id="PEO_472_label">
       <source>Cardiac output</source>
       <target>心拍出量
</target>
     </trans-unit>
     <trans-unit id="PEO_472_synonyms">
       <source>Cardiac output (observable entity)</source>
     </trans-unit>
     <trans-unit id="PEO_472_synonyms_1">
       <source>CO - Cardiac output</source>
     </trans-unit>
     <trans-unit id="PEO_473_label">
       <source>Cardiac preload</source>
       <target>心前負荷
</target>
     </trans-unit>
     <trans-unit id="PEO_474_label">
       <source>Cardiac ventricular structure</source>
       <target>心室
</target>
     </trans-unit>
     <trans-unit id="PEO_474_synonyms">
       <source>Cardiac ventricular structure (body structure)</source>
     </trans-unit>
     <trans-unit id="PEO_474_synonyms_1">
       <source>Ventricle</source>
     </trans-unit>
     <trans-unit id="PEO_474_synonyms_2">
       <source>Cardiac ventricle</source>
     </trans-unit>
     <trans-unit id="PEO_475_label">
       <source>Cardiomegaly</source>
       <target>心肥大
</target>
     </trans-unit>
     <trans-unit id="PEO_475_synonyms">
       <source>Heart, Enlarged</source>
     </trans-unit>
     <trans-unit id="PEO_475_synonyms_1">
       <source>Cardiac Hypertrophy</source>
     </trans-unit>
     <trans-unit id="PEO_475_synonyms_2">
       <source>Heart Enlargement</source>
     </trans-unit>
     <trans-unit id="PEO_475_synonyms_3">
       <source>Heart Hypertrophy</source>
     </trans-unit>
     <trans-unit id="PEO_475_definition">
       <source>Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix. Enlargement of the HEART, usually indicated by a cardiothoracic ratio above 0.50. Heart enlargement may involve the right, the left, or both HEART VENTRICLES or HEART ATRIA. Cardiomegaly is a nonspecific symptom seen in patients with chronic systolic heart failure (HEART FAILURE) or several forms of CARDIOMYOPATHIES.</source>
     </trans-unit>
     <trans-unit id="PEO_475_synonyms_4">
       <source>Enlargement, Heart</source>
     </trans-unit>
     <trans-unit id="PEO_475_synonyms_5">
       <source>Enlarged Heart</source>
     </trans-unit>
     <trans-unit id="PEO_476_label">
       <source>Cardiomyocyte death</source>
       <target>心筋細胞死
</target>
     </trans-unit>
     <trans-unit id="PEO_477_label">
       <source>Cardioprotection</source>
       <target>心保護
</target>
     </trans-unit>
     <trans-unit id="PEO_478_label">
       <source>Cardiotocography</source>
       <target>胎児心拍陣痛図
</target>
     </trans-unit>
     <trans-unit id="PEO_478_synonyms">
       <source>Cardiotocograms</source>
     </trans-unit>
     <trans-unit id="PEO_478_synonyms_1">
       <source>Internal Cardiotocography</source>
     </trans-unit>
     <trans-unit id="PEO_478_synonyms_2">
       <source>CTG, Antepartum</source>
     </trans-unit>
     <trans-unit id="PEO_478_synonyms_3">
       <source>External Fetal Monitoring</source>
     </trans-unit>
     <trans-unit id="PEO_478_synonyms_4">
       <source>Monitoring, Internal Fetal</source>
     </trans-unit>
     <trans-unit id="PEO_478_synonyms_5">
       <source>Fetal Monitoring, External</source>
     </trans-unit>
     <trans-unit id="PEO_478_synonyms_6">
       <source>Antepartum CTG</source>
     </trans-unit>
     <trans-unit id="PEO_478_synonyms_7">
       <source>Internal Fetal Monitoring</source>
     </trans-unit>
     <trans-unit id="PEO_478_synonyms_8">
       <source>External Cardiotocography</source>
     </trans-unit>
     <trans-unit id="PEO_478_synonyms_9">
       <source>Cardiotocography, External</source>
     </trans-unit>
     <trans-unit id="PEO_478_synonyms_10">
       <source>Electronic Fetal Monitoring</source>
     </trans-unit>
     <trans-unit id="PEO_478_synonyms_11">
       <source>Fetal Monitoring, Electronic</source>
     </trans-unit>
     <trans-unit id="PEO_478_synonyms_12">
       <source>Monitoring, Electronic Fetal</source>
     </trans-unit>
     <trans-unit id="PEO_478_synonyms_13">
       <source>Fetal Monitoring, Internal</source>
     </trans-unit>
     <trans-unit id="PEO_478_synonyms_14">
       <source>Monitoring, External Fetal</source>
     </trans-unit>
     <trans-unit id="PEO_478_synonyms_15">
       <source>Cardiotocography, Internal</source>
     </trans-unit>
     <trans-unit id="PEO_478_definition">
       <source>Monitoring of FETAL HEART frequency before birth in order to assess impending prematurity in relation to the pattern or intensity of antepartum UTERINE CONTRACTION.</source>
     </trans-unit>
     <trans-unit id="PEO_479_label">
       <source>Case control study</source>
       <target>症例対照研究
</target>
     </trans-unit>
     <trans-unit id="PEO_480_label">
       <source>Case fatality rate</source>
       <target>致死率
</target>
     </trans-unit>
     <trans-unit id="PEO_481_label">
       <source>Cell invasion</source>
       <target>細胞侵入
</target>
     </trans-unit>
     <trans-unit id="PEO_482_label">
       <source>Cell treatment model</source>
       <target>細胞モデル
</target>
     </trans-unit>
     <trans-unit id="PEO_482_synonyms">
       <source>Cell treatment models</source>
     </trans-unit>
     <trans-unit id="PEO_483_label">
       <source>Cellular uptake</source>
       <target>細胞取込
</target>
     </trans-unit>
     <trans-unit id="PEO_484_label">
       <source>Cerebral blood flow</source>
       <target>脳血流量
</target>
     </trans-unit>
     <trans-unit id="PEO_484_synonyms">
       <source>CBF - Cerebral blood flow</source>
     </trans-unit>
     <trans-unit id="PEO_484_synonyms_1">
       <source>Cerebral blood flow (observable entity)</source>
     </trans-unit>
     <trans-unit id="PEO_485_label">
       <source>Cerebral hyperperfusion syndrome</source>
       <target>脳過灌流症候群
</target>
     </trans-unit>
     <trans-unit id="PEO_486_label">
       <source>Cerebral palsy</source>
       <target>脳性麻痺
</target>
     </trans-unit>
     <trans-unit id="PEO_486_synonyms">
       <source>Congenital cerebral palsy</source>
     </trans-unit>
     <trans-unit id="PEO_486_synonyms_1">
       <source>Cerebral palsy (CP)</source>
     </trans-unit>
     <trans-unit id="PEO_486_synonyms_2">
       <source>Infantile cerebral palsy</source>
     </trans-unit>
     <trans-unit id="PEO_486_synonyms_3">
       <source>Cerebral palsy (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_486_synonyms_4">
       <source>CP - Cerebral palsy</source>
     </trans-unit>
     <trans-unit id="PEO_486_definition">
       <source>A permanent disorder of the development of movement, posture and motor function, causing activity limitation, caused by non-progressive disturbances in the developing fetal or infant brain.</source>
     </trans-unit>
     <trans-unit id="PEO_487_label">
       <source>Cerebral perfusion pressure</source>
       <target>脳灌流圧
</target>
     </trans-unit>
     <trans-unit id="PEO_487_synonyms">
       <source>CPP</source>
     </trans-unit>
     <trans-unit id="PEO_488_label">
       <source>Cerebrovascular Disorders</source>
       <target>脳血管障害
</target>
     </trans-unit>
     <trans-unit id="PEO_488_synonyms">
       <source>Insufficiencies, Cerebrovascular</source>
     </trans-unit>
     <trans-unit id="PEO_488_synonyms_1">
       <source>Intracranial Vascular Disorder</source>
     </trans-unit>
     <trans-unit id="PEO_488_synonyms_2">
       <source>Cerebrovascular Occlusion</source>
     </trans-unit>
     <trans-unit id="PEO_488_synonyms_3">
       <source>Vascular Disorders, Brain</source>
     </trans-unit>
     <trans-unit id="PEO_488_synonyms_4">
       <source>Insufficiency, Cerebrovascular</source>
     </trans-unit>
     <trans-unit id="PEO_488_synonyms_5">
       <source>Brain Vascular Disorder</source>
     </trans-unit>
     <trans-unit id="PEO_488_synonyms_6">
       <source>Cerebrovascular Insufficiency</source>
     </trans-unit>
     <trans-unit id="PEO_488_synonyms_7">
       <source>Vascular Disorder, Intracranial</source>
     </trans-unit>
     <trans-unit id="PEO_488_synonyms_8">
       <source>Vascular Disorder, Brain</source>
     </trans-unit>
     <trans-unit id="PEO_488_synonyms_9">
       <source>Occlusions, Cerebrovascular</source>
     </trans-unit>
     <trans-unit id="PEO_488_synonyms_10">
       <source>Intracranial Vascular Disease</source>
     </trans-unit>
     <trans-unit id="PEO_488_synonyms_11">
       <source>Vascular Disease, Intracranial</source>
     </trans-unit>
     <trans-unit id="PEO_488_synonyms_12">
       <source>Cerebrovascular Insufficiencies</source>
     </trans-unit>
     <trans-unit id="PEO_488_synonyms_13">
       <source>Intracranial Vascular Disorders</source>
     </trans-unit>
     <trans-unit id="PEO_488_synonyms_14">
       <source>Intracranial Vascular Diseases</source>
     </trans-unit>
     <trans-unit id="PEO_488_synonyms_15">
       <source>Cerebrovascular Occlusions</source>
     </trans-unit>
     <trans-unit id="PEO_488_synonyms_16">
       <source>Occlusion, Cerebrovascular</source>
     </trans-unit>
     <trans-unit id="PEO_488_synonyms_17">
       <source>Vascular Diseases, Intracranial</source>
     </trans-unit>
     <trans-unit id="PEO_488_synonyms_18">
       <source>Cerebrovascular Disorder</source>
     </trans-unit>
     <trans-unit id="PEO_488_synonyms_19">
       <source>Vascular Disorders, Intracranial</source>
     </trans-unit>
     <trans-unit id="PEO_488_synonyms_20">
       <source>Brain Vascular Disorders</source>
     </trans-unit>
     <trans-unit id="PEO_489_label">
       <source>Cerebrovascular accident</source>
       <target>脳血管発作
</target>
     </trans-unit>
     <trans-unit id="PEO_489_synonyms">
       <source>Stroke</source>
     </trans-unit>
     <trans-unit id="PEO_489_synonyms_1">
       <source>CVA - Cerebrovascular accident</source>
     </trans-unit>
     <trans-unit id="PEO_489_synonyms_2">
       <source>Cerebrovascular accident (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_489_synonyms_3">
       <source>Cerebrovascular stroke</source>
     </trans-unit>
     <trans-unit id="PEO_490_label">
       <source>Cesarean section</source>
       <target>帝王切開
</target>
     </trans-unit>
     <trans-unit id="PEO_490_synonyms">
       <source>Cesarean section (procedure)</source>
     </trans-unit>
     <trans-unit id="PEO_490_synonyms_1">
       <source>Caesarean section</source>
     </trans-unit>
     <trans-unit id="PEO_490_synonyms_2">
       <source>CS - Caesarean section</source>
     </trans-unit>
     <trans-unit id="PEO_490_synonyms_3">
       <source>CS - Cesarean section</source>
     </trans-unit>
     <trans-unit id="PEO_491_label">
       <source>Change of partner</source>
       <target>パートナーの変更
</target>
     </trans-unit>
     <trans-unit id="PEO_492_label">
       <source>Chemical exposure</source>
       <target>化学暴露
</target>
     </trans-unit>
     <trans-unit id="PEO_493_label">
       <source>Cholesterol reducing drug</source>
       <target>抗コレステロール薬
</target>
     </trans-unit>
     <trans-unit id="PEO_493_synonyms">
       <source>anticholesteremic drugs</source>
     </trans-unit>
     <trans-unit id="PEO_493_synonyms_1">
       <source>anticholesteremic drug</source>
     </trans-unit>
     <trans-unit id="PEO_493_synonyms_2">
       <source>Cholesterol reducing drugs</source>
     </trans-unit>
     <trans-unit id="PEO_494_label">
       <source>Chorioallantoic placenta</source>
       <target>絨毛膜尿膜胎盤
</target>
     </trans-unit>
     <trans-unit id="PEO_494_synonyms">
       <source>Chorioallantoic placenta (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_495_label">
       <source>Chorioamnionitis</source>
       <target>絨毛羊膜炎
</target>
     </trans-unit>
     <trans-unit id="PEO_495_synonyms">
       <source>Chorioamnionitis (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_495_synonyms_1">
       <source>Membranitis</source>
     </trans-unit>
     <trans-unit id="PEO_496_label">
       <source>Chorionic villi structure</source>
       <target>絨毛膜絨毛
</target>
     </trans-unit>
     <trans-unit id="PEO_496_synonyms">
       <source>Chorionic villi structure (body structure)</source>
     </trans-unit>
     <trans-unit id="PEO_496_synonyms_1">
       <source>Chorionic villi</source>
     </trans-unit>
     <trans-unit id="PEO_497_label">
       <source>Chronic active hepatitis</source>
       <target>慢性活動性肝炎
</target>
     </trans-unit>
     <trans-unit id="PEO_498_label">
       <source>Chronic arthritis</source>
       <target>慢性関節炎
</target>
     </trans-unit>
     <trans-unit id="PEO_498_synonyms">
       <source>Chronic arthritis (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_499_label">
       <source>Chronic hypertension in obstetric context</source>
       <target>慢性高血圧
</target>
     </trans-unit>
     <trans-unit id="PEO_499_synonyms">
       <source>Chronic hypertension in obstetric context (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_500_label">
       <source>Circulating</source>
       <target>循環血中の
</target>
     </trans-unit>
     <trans-unit id="PEO_500_synonyms">
       <source>Circulating (qualifier value)</source>
     </trans-unit>
     <trans-unit id="PEO_501_label">
       <source>Climate</source>
       <target>気候
</target>
     </trans-unit>
     <trans-unit id="PEO_501_synonyms">
       <source>Climates</source>
     </trans-unit>
     <trans-unit id="PEO_501_definition">
       <source>The longterm manifestations of WEATHER. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)</source>
     </trans-unit>
     <trans-unit id="PEO_502_label">
       <source>Clinical situation</source>
       <target>臨床
</target>
     </trans-unit>
     <trans-unit id="PEO_503_label">
       <source>Closed populations</source>
       <target>閉じた集団
</target>
     </trans-unit>
     <trans-unit id="PEO_504_label">
       <source>Coagulation factor I</source>
       <target>凝固因子I
</target>
     </trans-unit>
     <trans-unit id="PEO_504_synonyms">
       <source>Fibrinogen</source>
     </trans-unit>
     <trans-unit id="PEO_504_synonyms_1">
       <source>Coagulation factor I (substance)</source>
     </trans-unit>
     <trans-unit id="PEO_505_label">
       <source>Coagulation protein</source>
       <target>凝固タンパク質疾患
</target>
     </trans-unit>
     <trans-unit id="PEO_505_synonyms">
       <source>Coagulation protein (substance)</source>
     </trans-unit>
     <trans-unit id="PEO_506_label">
       <source>Cocaine abuse</source>
       <target>コカイン乱用
</target>
     </trans-unit>
     <trans-unit id="PEO_507_label">
       <source>Codeine abuse</source>
       <target>コデイン乱用
</target>
     </trans-unit>
     <trans-unit id="PEO_508_label">
       <source>Coenzyme Q10</source>
       <target>コエンザイムQ10
</target>
     </trans-unit>
     <trans-unit id="PEO_508_synonyms">
       <source>Ubiquinone</source>
     </trans-unit>
     <trans-unit id="PEO_508_synonyms_1">
       <source>Coenzyme Q10 (product)</source>
     </trans-unit>
     <trans-unit id="PEO_508_synonyms_2">
       <source>Ubidecarenone</source>
     </trans-unit>
     <trans-unit id="PEO_509_label">
       <source>Cohort effect</source>
       <target>コホート効果
</target>
     </trans-unit>
     <trans-unit id="PEO_509_synonyms">
       <source>cohort</source>
     </trans-unit>
     <trans-unit id="PEO_510_label">
       <source>Colitis</source>
       <target>大腸炎
</target>
     </trans-unit>
     <trans-unit id="PEO_510_synonyms">
       <source>Colitis (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_511_label">
       <source>Collagen</source>
       <target>コラーゲン
</target>
     </trans-unit>
     <trans-unit id="PEO_511_synonyms">
       <source>Zyderm</source>
     </trans-unit>
     <trans-unit id="PEO_511_synonyms_1">
       <source>Collagen Fleece</source>
     </trans-unit>
     <trans-unit id="PEO_511_synonyms_2">
       <source>Collagen Felt</source>
     </trans-unit>
     <trans-unit id="PEO_511_synonyms_3">
       <source>Avitene</source>
     </trans-unit>
     <trans-unit id="PEO_511_synonyms_4">
       <source>alpha-Collagen</source>
     </trans-unit>
     <trans-unit id="PEO_511_synonyms_5">
       <source>Microfibril Collagen Hemostat</source>
     </trans-unit>
     <trans-unit id="PEO_511_synonyms_6">
       <source>Collagens</source>
     </trans-unit>
     <trans-unit id="PEO_511_synonyms_7">
       <source>Avicon</source>
     </trans-unit>
     <trans-unit id="PEO_511_definition">
       <source>A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). A topical hemostatic agent prepared from collagen.</source>
     </trans-unit>
     <trans-unit id="PEO_511_synonyms_8">
       <source>Dermodress</source>
     </trans-unit>
     <trans-unit id="PEO_511_synonyms_9">
       <source>Collagenfleece</source>
     </trans-unit>
     <trans-unit id="PEO_511_synonyms_10">
       <source>Collagen Hemostat, Microfibril</source>
     </trans-unit>
     <trans-unit id="PEO_511_synonyms_11">
       <source>alpha Collagen</source>
     </trans-unit>
     <trans-unit id="PEO_511_synonyms_12">
       <source>Collastat</source>
     </trans-unit>
     <trans-unit id="PEO_511_synonyms_13">
       <source>Pangen</source>
     </trans-unit>
     <trans-unit id="PEO_512_label">
       <source>Collagen matrix</source>
       <target>コラーゲンマトリックス
</target>
     </trans-unit>
     <trans-unit id="PEO_513_label">
       <source>Collateral flow index</source>
       <target>側副路の流速インデックス
</target>
     </trans-unit>
     <trans-unit id="PEO_513_synonyms">
       <source>CFI</source>
     </trans-unit>
     <trans-unit id="PEO_514_label">
       <source>Complementary health approach</source>
       <target>補完的健康アプローチ
</target>
     </trans-unit>
     <trans-unit id="PEO_514_synonyms">
       <source>Complementary health approaches</source>
     </trans-unit>
     <trans-unit id="PEO_515_label">
       <source>Compression of umbilical cord</source>
       <target>臍帯圧迫
</target>
     </trans-unit>
     <trans-unit id="PEO_515_synonyms">
       <source>Compression of umbilical cord (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_516_label">
       <source>Congestive heart failure</source>
       <target>うっ血性心不全
</target>
     </trans-unit>
     <trans-unit id="PEO_516_synonyms">
       <source>Congestive heart failure (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_516_synonyms_1">
       <source>CCF - Congestive cardiac failure</source>
     </trans-unit>
     <trans-unit id="PEO_516_synonyms_2">
       <source>CHF - Congestive heart failure</source>
     </trans-unit>
     <trans-unit id="PEO_516_synonyms_3">
       <source>Congestive heart disease</source>
     </trans-unit>
     <trans-unit id="PEO_516_synonyms_4">
       <source>Congestive cardiac failure</source>
     </trans-unit>
     <trans-unit id="PEO_517_label">
       <source>Connective tissue disease overlap syndrome</source>
       <target>膠原病オーバーラップ症候群
</target>
     </trans-unit>
     <trans-unit id="PEO_517_synonyms">
       <source>Connective tissue disease overlap syndrome (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_518_label">
       <source>Conscious blood pressure control</source>
       <target>血圧コントロール
</target>
     </trans-unit>
     <trans-unit id="PEO_518_synonyms">
       <source>Conscious blood pressure control (regime/therapy)</source>
     </trans-unit>
     <trans-unit id="PEO_518_synonyms_1">
       <source>Conscious B.P. control</source>
     </trans-unit>
     <trans-unit id="PEO_519_label">
       <source>Coronary arteriosclerosis</source>
       <target>冠動脈硬化
</target>
     </trans-unit>
     <trans-unit id="PEO_519_synonyms">
       <source>CHD - Coronary heart disease</source>
     </trans-unit>
     <trans-unit id="PEO_519_synonyms_1">
       <source>Coronary artery disease</source>
     </trans-unit>
     <trans-unit id="PEO_519_synonyms_2">
       <source>CAD - Coronary artery disease</source>
     </trans-unit>
     <trans-unit id="PEO_519_synonyms_3">
       <source>Coronary sclerosis</source>
     </trans-unit>
     <trans-unit id="PEO_519_synonyms_4">
       <source>Coronary arteriosclerosis (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_519_synonyms_5">
       <source>Arteriosclerotic heart disease</source>
     </trans-unit>
     <trans-unit id="PEO_519_synonyms_6">
       <source>Coronary heart disease</source>
     </trans-unit>
     <trans-unit id="PEO_520_label">
       <source>Cough</source>
       <target>咳
</target>
     </trans-unit>
     <trans-unit id="PEO_520_synonyms">
       <source>Observation of cough</source>
     </trans-unit>
     <trans-unit id="PEO_520_synonyms_1">
       <source>Cough (finding)</source>
     </trans-unit>
     <trans-unit id="PEO_520_synonyms_2">
       <source>Finding of cough</source>
     </trans-unit>
     <trans-unit id="PEO_521_label">
       <source>Country of birth</source>
       <target>出生国
</target>
     </trans-unit>
     <trans-unit id="PEO_521_synonyms">
       <source>Country of birth (observable entity)</source>
     </trans-unit>
     <trans-unit id="PEO_521_synonyms_1">
       <source>Born in - country</source>
     </trans-unit>
     <trans-unit id="PEO_522_label">
       <source>Craniocerebral Trauma</source>
       <target>頭蓋脳損傷
</target>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms">
       <source>Crushing Skull Injuries</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_1">
       <source>Crushing Skull Injury</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_2">
       <source>Injuries, Open Head</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_3">
       <source>Trauma, Craniocerebral</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_4">
       <source>Injury, Superficial Head</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_5">
       <source>Region Traumas, Frontal</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_6">
       <source>Frontal Region Traumas</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_7">
       <source>Trauma, Head</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_8">
       <source>Craniocerebral Injuries</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_9">
       <source>Craniocerebral Injury</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_10">
       <source>Trauma, Forehead</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_11">
       <source>Head Injury, Superficial</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_12">
       <source>Traumas, Occipital Region</source>
     </trans-unit>
     <trans-unit id="PEO_522_definition">
       <source>Traumatic injuries involving the cranium and intracranial structures (i.e., BRAIN; CRANIAL NERVES; MENINGES; and other structures). Injuries may be classified by whether or not the skull is penetrated (i.e., penetrating vs. nonpenetrating) or whether there is an associated hemorrhage.</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_13">
       <source>Head Injury</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_14">
       <source>Trauma, Frontal Region</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_15">
       <source>Craniocerebral Traumas</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_16">
       <source>Open Head Injuries</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_17">
       <source>Skull Injuries, Crushing</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_18">
       <source>Parietal Region Trauma</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_19">
       <source>Minor Head Injury</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_20">
       <source>Injury, Minor Head</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_21">
       <source>Trauma, Occipital Region</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_22">
       <source>Trauma, Occipital</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_23">
       <source>Region Trauma, Frontal</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_24">
       <source>Head Traumas</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_25">
       <source>Occipital Region Traumas</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_26">
       <source>Skull Injury, Crushing</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_27">
       <source>Superficial Head Injury</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_28">
       <source>Superficial Head Injuries</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_29">
       <source>Traumas, Frontal Region</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_30">
       <source>Forehead Traumas</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_31">
       <source>Head Injuries, Multiple</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_32">
       <source>Open Head Injury</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_33">
       <source>Traumas, Temporal Region</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_34">
       <source>Minor Head Injuries</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_35">
       <source>Temporal Region Traumas</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_36">
       <source>Occipital Traumas</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_37">
       <source>Head Injury, Multiple</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_38">
       <source>Region Trauma, Occipital</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_39">
       <source>Head Injury, Open</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_40">
       <source>Traumas, Parietal Region</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_41">
       <source>Head Injuries, Minor</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_42">
       <source>Injury, Head</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_43">
       <source>Region Traumas, Parietal</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_44">
       <source>Head Injuries, Open</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_45">
       <source>Frontal Region Trauma</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_46">
       <source>Injuries, Minor Head</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_47">
       <source>Region Trauma, Parietal</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_48">
       <source>Traumas, Forehead</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_49">
       <source>Head Injuries</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_50">
       <source>Trauma, Parietal Region</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_51">
       <source>Head Trauma</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_52">
       <source>Injuries, Head</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_53">
       <source>Forehead Trauma</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_54">
       <source>Parietal Region Traumas</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_55">
       <source>Traumas, Occipital</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_56">
       <source>Injury, Multiple Head</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_57">
       <source>Multiple Head Injuries</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_58">
       <source>Head Injuries, Superficial</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_59">
       <source>Traumas, Head</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_60">
       <source>Head Injury, Minor</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_61">
       <source>Injury, Open Head</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_62">
       <source>Trauma, Temporal Region</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_63">
       <source>Region Traumas, Occipital</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_64">
       <source>Occipital Region Trauma</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_65">
       <source>Multiple Head Injury</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_66">
       <source>Injury, Craniocerebral</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_67">
       <source>Temporal Region Trauma</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_68">
       <source>Injuries, Craniocerebral</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_69">
       <source>Injuries, Superficial Head</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_70">
       <source>Traumas, Craniocerebral</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_71">
       <source>Occipital Trauma</source>
     </trans-unit>
     <trans-unit id="PEO_522_synonyms_72">
       <source>Injuries, Multiple Head</source>
     </trans-unit>
     <trans-unit id="PEO_523_label">
       <source>Crohn&apos;s disease</source>
       <target>クローン病
</target>
     </trans-unit>
     <trans-unit id="PEO_523_synonyms">
       <source>Crohn&apos;s disease (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_523_synonyms_1">
       <source>RE - Regional enteritis</source>
     </trans-unit>
     <trans-unit id="PEO_523_synonyms_2">
       <source>Granulomatous enteritis</source>
     </trans-unit>
     <trans-unit id="PEO_523_synonyms_3">
       <source>Crohns disease</source>
     </trans-unit>
     <trans-unit id="PEO_523_synonyms_4">
       <source>Crohn disease</source>
     </trans-unit>
     <trans-unit id="PEO_523_synonyms_5">
       <source>Crohn&apos;s regional enteritis</source>
     </trans-unit>
     <trans-unit id="PEO_523_synonyms_6">
       <source>CD - Crohn&apos;s disease</source>
     </trans-unit>
     <trans-unit id="PEO_523_synonyms_7">
       <source>Regional enteritis</source>
     </trans-unit>
     <trans-unit id="PEO_524_label">
       <source>Crude incidence</source>
       <target>粗発生数
</target>
     </trans-unit>
     <trans-unit id="PEO_525_label">
       <source>Cumulative incidence</source>
       <target>累積発生率
</target>
     </trans-unit>
     <trans-unit id="PEO_526_label">
       <source>Cumulative incidence rate</source>
       <target>累積罹患率
</target>
     </trans-unit>
     <trans-unit id="PEO_527_label">
       <source>Current intake</source>
       <target>現在の服用
</target>
     </trans-unit>
     <trans-unit id="PEO_528_label">
       <source>Current pregnancy</source>
       <target>今回の妊娠
</target>
     </trans-unit>
     <trans-unit id="PEO_529_label">
       <source>Cytodiagnosis</source>
       <target>細胞診
</target>
     </trans-unit>
     <trans-unit id="PEO_529_synonyms">
       <source>Cytodiagnoses</source>
     </trans-unit>
     <trans-unit id="PEO_529_definition">
       <source>Diagnosis of the type and, when feasible, the cause of a pathologic process by means of microscopic study of cells in an exudate or other form of body fluid. (Stedman, 26th ed)</source>
     </trans-unit>
     <trans-unit id="PEO_530_label">
       <source>Cytoprotection</source>
       <target>細胞保護
</target>
     </trans-unit>
     <trans-unit id="PEO_530_synonyms">
       <source>Cell Protection</source>
     </trans-unit>
     <trans-unit id="PEO_530_synonyms_1">
       <source>Protection, Cell</source>
     </trans-unit>
     <trans-unit id="PEO_530_definition">
       <source>The process by which chemical compounds provide protection to cells against harmful agents.</source>
     </trans-unit>
     <trans-unit id="PEO_531_label">
       <source>Cytotrophoblast invasion</source>
       <target>栄養膜細胞層の浸潤
</target>
     </trans-unit>
     <trans-unit id="PEO_532_label">
       <source>D-dimer</source>
       <target>D-ダイマー
</target>
     </trans-unit>
     <trans-unit id="PEO_532_synonyms">
       <source>D-dimer (substance)</source>
     </trans-unit>
     <trans-unit id="PEO_532_synonyms_1">
       <source>DDimer</source>
     </trans-unit>
     <trans-unit id="PEO_533_label">
       <source>De-acetylation</source>
       <target>脱アセチル化
</target>
     </trans-unit>
     <trans-unit id="PEO_533_synonyms">
       <source>protein amino acid deacetylation</source>
     </trans-unit>
     <trans-unit id="PEO_534_label">
       <source>De-methylation</source>
       <target>脱メチル化
</target>
     </trans-unit>
     <trans-unit id="PEO_535_label">
       <source>De-phosphorylation</source>
       <target>脱リン酸化
</target>
     </trans-unit>
     <trans-unit id="PEO_536_label">
       <source>Decidual Arteriopathy</source>
       <target>脱落膜性動脈症
</target>
     </trans-unit>
     <trans-unit id="PEO_537_label">
       <source>Decidual cell</source>
       <target>脱落膜細胞
</target>
     </trans-unit>
     <trans-unit id="PEO_538_label">
       <source>Decidual lymphocyte</source>
       <target>脱落膜リンパ球
</target>
     </trans-unit>
     <trans-unit id="PEO_539_label">
       <source>Delivery by vacuum extraction</source>
       <target>吸引分娩
</target>
     </trans-unit>
     <trans-unit id="PEO_539_synonyms">
       <source>Vacuum extraction</source>
     </trans-unit>
     <trans-unit id="PEO_539_synonyms_1">
       <source>Delivery by vacuum extraction (procedure)</source>
     </trans-unit>
     <trans-unit id="PEO_539_synonyms_2">
       <source>Vacuum extraction of fetus</source>
     </trans-unit>
     <trans-unit id="PEO_539_synonyms_3">
       <source>Ventouse extraction</source>
     </trans-unit>
     <trans-unit id="PEO_540_label">
       <source>Dementia</source>
       <target>認知症
</target>
     </trans-unit>
     <trans-unit id="PEO_540_synonyms">
       <source>Organic dementia</source>
     </trans-unit>
     <trans-unit id="PEO_540_synonyms_1">
       <source>Dementia (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_541_label">
       <source>Dengue</source>
       <target>デング熱
</target>
     </trans-unit>
     <trans-unit id="PEO_541_synonyms">
       <source>Dengue fever</source>
     </trans-unit>
     <trans-unit id="PEO_541_synonyms_1">
       <source>Breakbone fever</source>
     </trans-unit>
     <trans-unit id="PEO_541_synonyms_2">
       <source>Dengue (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_542_label">
       <source>Details of education</source>
       <target>教育の詳細
</target>
     </trans-unit>
     <trans-unit id="PEO_542_synonyms">
       <source>Education</source>
     </trans-unit>
     <trans-unit id="PEO_542_synonyms_1">
       <source>Details of education (observable entity)</source>
     </trans-unit>
     <trans-unit id="PEO_543_label">
       <source>Developed Countries</source>
       <target>開発国
</target>
     </trans-unit>
     <trans-unit id="PEO_543_definition">
       <source>Countries that have reached a level of economic achievement through an increase of production, per capita income and consumption, and utilization of natural and human resources.</source>
     </trans-unit>
     <trans-unit id="PEO_543_synonyms">
       <source>Countries, Industrialized</source>
     </trans-unit>
     <trans-unit id="PEO_543_synonyms_1">
       <source>Industrialized Nation</source>
     </trans-unit>
     <trans-unit id="PEO_543_synonyms_2">
       <source>Developed Nations</source>
     </trans-unit>
     <trans-unit id="PEO_543_synonyms_3">
       <source>Industrialized Country</source>
     </trans-unit>
     <trans-unit id="PEO_543_synonyms_4">
       <source>Industrialized Countries</source>
     </trans-unit>
     <trans-unit id="PEO_543_synonyms_5">
       <source>Nations, Industrialized</source>
     </trans-unit>
     <trans-unit id="PEO_543_synonyms_6">
       <source>Country, Industrialized</source>
     </trans-unit>
     <trans-unit id="PEO_543_synonyms_7">
       <source>Developed Country</source>
     </trans-unit>
     <trans-unit id="PEO_543_synonyms_8">
       <source>Country, Developed</source>
     </trans-unit>
     <trans-unit id="PEO_543_synonyms_9">
       <source>Industrialized Nations</source>
     </trans-unit>
     <trans-unit id="PEO_543_synonyms_10">
       <source>Nation, Industrialized</source>
     </trans-unit>
     <trans-unit id="PEO_543_synonyms_11">
       <source>Countries, Developed</source>
     </trans-unit>
     <trans-unit id="PEO_543_synonyms_12">
       <source>Developed Nation</source>
     </trans-unit>
     <trans-unit id="PEO_543_synonyms_13">
       <source>Nation, Developed</source>
     </trans-unit>
     <trans-unit id="PEO_543_synonyms_14">
       <source>Nations, Developed</source>
     </trans-unit>
     <trans-unit id="PEO_544_label">
       <source>Developmental</source>
       <target>発達
</target>
     </trans-unit>
     <trans-unit id="PEO_544_synonyms">
       <source>Developmental (qualifier value)</source>
     </trans-unit>
     <trans-unit id="PEO_545_label">
       <source>Diabetes</source>
       <target>糖尿病
</target>
     </trans-unit>
     <trans-unit id="PEO_546_label">
       <source>Diabetic renal disease</source>
       <target>糖尿病性腎症
</target>
     </trans-unit>
     <trans-unit id="PEO_546_synonyms">
       <source>Diabetic renal disease (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_546_synonyms_1">
       <source>Diabetic nephropathy</source>
     </trans-unit>
     <trans-unit id="PEO_546_synonyms_2">
       <source>Renal disorder associated with diabetes mellitus</source>
     </trans-unit>
     <trans-unit id="PEO_547_label">
       <source>Diastolic blood pressure</source>
       <target>拡張期血圧
</target>
     </trans-unit>
     <trans-unit id="PEO_547_synonyms">
       <source>Diastolic blood pressure (observable entity)</source>
     </trans-unit>
     <trans-unit id="PEO_547_synonyms_1">
       <source>DBP - Diastolic blood pressure</source>
     </trans-unit>
     <trans-unit id="PEO_547_synonyms_2">
       <source>Diastolic arterial pressure</source>
     </trans-unit>
     <trans-unit id="PEO_547_synonyms_3">
       <source>DAP - Diastolic arterial pressure</source>
     </trans-unit>
     <trans-unit id="PEO_548_label">
       <source>Diet poor</source>
       <target>貧相な食生活
</target>
     </trans-unit>
     <trans-unit id="PEO_548_synonyms">
       <source>Diet poor (finding)</source>
     </trans-unit>
     <trans-unit id="PEO_549_label">
       <source>Dimerization</source>
       <target>二量体形成
</target>
     </trans-unit>
     <trans-unit id="PEO_550_label">
       <source>Dimers</source>
       <target>二量体
</target>
     </trans-unit>
     <trans-unit id="PEO_551_label">
       <source>Direct injection of sperm into cytoplasm of the oocyte</source>
       <target>顕微授精
</target>
     </trans-unit>
     <trans-unit id="PEO_551_synonyms">
       <source>DISCO - Direct inject of sperm into cytoplasm of the oocyte</source>
     </trans-unit>
     <trans-unit id="PEO_551_synonyms_1">
       <source>Direct injection of sperm into cytoplasm of the oocyte (procedure)</source>
     </trans-unit>
     <trans-unit id="PEO_551_synonyms_2">
       <source>Intracytoplasmic sperm injection</source>
     </trans-unit>
     <trans-unit id="PEO_551_synonyms_3">
       <source>ICSI - Intracytoplasmic sperm injection</source>
     </trans-unit>
     <trans-unit id="PEO_552_label">
       <source>Disorder of cardiovascular system</source>
       <target>循環器疾患
</target>
     </trans-unit>
     <trans-unit id="PEO_552_synonyms">
       <source>Disorder of the circulatory system</source>
     </trans-unit>
     <trans-unit id="PEO_552_synonyms_1">
       <source>Cardiovascular disease</source>
     </trans-unit>
     <trans-unit id="PEO_552_synonyms_2">
       <source>CVD - cardiovascular disease</source>
     </trans-unit>
     <trans-unit id="PEO_552_synonyms_3">
       <source>Disorder of cardiovascular system (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_552_synonyms_4">
       <source>CVS disease - cardiovascular system disease</source>
     </trans-unit>
     <trans-unit id="PEO_552_synonyms_5">
       <source>Cardiovascular disorder</source>
     </trans-unit>
     <trans-unit id="PEO_552_synonyms_6">
       <source>Cardiovascular system disease</source>
     </trans-unit>
     <trans-unit id="PEO_552_synonyms_7">
       <source>Disorder of circulatory system</source>
     </trans-unit>
     <trans-unit id="PEO_553_label">
       <source>Disorder of fetus or newborn</source>
       <target>胎児・新生児の疾患
</target>
     </trans-unit>
     <trans-unit id="PEO_553_synonyms">
       <source>Disorder of fetus or newborn (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_553_synonyms_1">
       <source>Fetus and neonate conditions</source>
     </trans-unit>
     <trans-unit id="PEO_553_synonyms_2">
       <source>Disorder of foetus or newborn</source>
     </trans-unit>
     <trans-unit id="PEO_554_label">
       <source>Disorder of placenta</source>
       <target>胎盤の疾患
</target>
     </trans-unit>
     <trans-unit id="PEO_554_synonyms">
       <source>Disorder of placenta (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_554_synonyms_1">
       <source>Disorder of placenta and placental transfusion</source>
     </trans-unit>
     <trans-unit id="PEO_555_label">
       <source>Doppler studies</source>
       <target>ドップラー
</target>
     </trans-unit>
     <trans-unit id="PEO_555_synonyms">
       <source>Doppler studies (procedure)</source>
     </trans-unit>
     <trans-unit id="PEO_555_synonyms_1">
       <source>Doppler</source>
     </trans-unit>
     <trans-unit id="PEO_556_label">
       <source>Downregulation</source>
       <target>下方制御
</target>
     </trans-unit>
     <trans-unit id="PEO_557_label">
       <source>Drug abuse</source>
       <target>薬物乱用
</target>
     </trans-unit>
     <trans-unit id="PEO_558_label">
       <source>Dura Mater</source>
       <target>硬膜
</target>
     </trans-unit>
     <trans-unit id="PEO_558_synonyms">
       <source>Falx Cerebelli</source>
     </trans-unit>
     <trans-unit id="PEO_559_label">
       <source>Duration of dilatation stage</source>
       <target>Duration of dilatation stage
</target>
     </trans-unit>
     <trans-unit id="PEO_560_label">
       <source>Duration of formal education</source>
       <target>学校教育中
</target>
     </trans-unit>
     <trans-unit id="PEO_560_synonyms">
       <source>Duration of formal education (observable entity)</source>
     </trans-unit>
     <trans-unit id="PEO_561_label">
       <source>Dyslipidemia</source>
       <target>脂質異常症
</target>
     </trans-unit>
     <trans-unit id="PEO_561_synonyms">
       <source>Dyslipidemia (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_561_synonyms_1">
       <source>Dyslipidaemia</source>
     </trans-unit>
     <trans-unit id="PEO_562_label">
       <source>E/E&apos; ratio</source>
       <target>E/E' ratio
</target>
     </trans-unit>
     <trans-unit id="PEO_563_label">
       <source>Earlier miscarriage</source>
       <target>早期流産
</target>
     </trans-unit>
     <trans-unit id="PEO_564_label">
       <source>Early neonatal death</source>
       <target>早期新生児死亡 
</target>
     </trans-unit>
     <trans-unit id="PEO_564_synonyms">
       <source>Early neonatal death (event)</source>
     </trans-unit>
     <trans-unit id="PEO_565_label">
       <source>Echocardiographic calcium score</source>
       <target>Echocardiographic calcium score
</target>
     </trans-unit>
     <trans-unit id="PEO_565_synonyms">
       <source>ECS</source>
     </trans-unit>
     <trans-unit id="PEO_566_label">
       <source>Echocardiography</source>
       <target>心エコー
</target>
     </trans-unit>
     <trans-unit id="PEO_566_synonyms">
       <source>Diagnostic ultrasound of heart</source>
     </trans-unit>
     <trans-unit id="PEO_566_synonyms_1">
       <source>Ultrasonography of heart</source>
     </trans-unit>
     <trans-unit id="PEO_566_synonyms_2">
       <source>US heart scan</source>
     </trans-unit>
     <trans-unit id="PEO_566_synonyms_3">
       <source>US scan of heart</source>
     </trans-unit>
     <trans-unit id="PEO_566_synonyms_4">
       <source>Echocardiogram</source>
     </trans-unit>
     <trans-unit id="PEO_566_synonyms_5">
       <source>Cardiac US scan</source>
     </trans-unit>
     <trans-unit id="PEO_566_synonyms_6">
       <source>Echocardiographic procedure</source>
     </trans-unit>
     <trans-unit id="PEO_566_synonyms_7">
       <source>Echocardiography (procedure)</source>
     </trans-unit>
     <trans-unit id="PEO_566_synonyms_8">
       <source>Cardiac echo</source>
     </trans-unit>
     <trans-unit id="PEO_567_label">
       <source>Eclampsia</source>
       <target>子癇
</target>
     </trans-unit>
     <trans-unit id="PEO_567_synonyms">
       <source>Eclamptic toxaemia</source>
     </trans-unit>
     <trans-unit id="PEO_567_synonyms_1">
       <source>Toxemia with convulsions</source>
     </trans-unit>
     <trans-unit id="PEO_567_synonyms_2">
       <source>Eclamptic toxemia</source>
     </trans-unit>
     <trans-unit id="PEO_567_synonyms_3">
       <source>Toxaemia with convulsions</source>
     </trans-unit>
     <trans-unit id="PEO_567_synonyms_4">
       <source>Eclampsia (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_568_label">
       <source>Eclamptic encephalopathy</source>
       <target>子癇脳症
</target>
     </trans-unit>
     <trans-unit id="PEO_569_label">
       <source>Economic independence status</source>
       <target>経済的自立
</target>
     </trans-unit>
     <trans-unit id="PEO_569_synonyms">
       <source>Economically independent (economic status) (social concept)</source>
     </trans-unit>
     <trans-unit id="PEO_569_synonyms_1">
       <source>Economically independent (economic status)</source>
     </trans-unit>
     <trans-unit id="PEO_570_label">
       <source>Economic status</source>
       <target>経済状態
</target>
     </trans-unit>
     <trans-unit id="PEO_570_synonyms">
       <source>Economic status (social concept)</source>
     </trans-unit>
     <trans-unit id="PEO_571_label">
       <source>Edema</source>
       <target>浮腫
</target>
     </trans-unit>
     <trans-unit id="PEO_571_synonyms">
       <source>Oedema - lesion</source>
     </trans-unit>
     <trans-unit id="PEO_571_synonyms_1">
       <source>Edema - lesion</source>
     </trans-unit>
     <trans-unit id="PEO_571_synonyms_2">
       <source>Edematous</source>
     </trans-unit>
     <trans-unit id="PEO_571_synonyms_3">
       <source>Oedema</source>
     </trans-unit>
     <trans-unit id="PEO_571_synonyms_4">
       <source>Oedematous</source>
     </trans-unit>
     <trans-unit id="PEO_571_synonyms_5">
       <source>Edema (morphologic abnormality)</source>
     </trans-unit>
     <trans-unit id="PEO_572_label">
       <source>Education and schooling detail</source>
       <target>学歴・教育歴の詳細
</target>
     </trans-unit>
     <trans-unit id="PEO_572_synonyms">
       <source>Education and schooling</source>
     </trans-unit>
     <trans-unit id="PEO_572_synonyms_1">
       <source>Education and schooling detail (observable entity)</source>
     </trans-unit>
     <trans-unit id="PEO_573_label">
       <source>Education currently received</source>
       <target>現在受けている教育
</target>
     </trans-unit>
     <trans-unit id="PEO_573_synonyms">
       <source>Education currently received (observable entity)</source>
     </trans-unit>
     <trans-unit id="PEO_574_label">
       <source>Education received in the past</source>
       <target>学歴
</target>
     </trans-unit>
     <trans-unit id="PEO_574_synonyms">
       <source>Education received in the past (observable entity)</source>
     </trans-unit>
     <trans-unit id="PEO_575_label">
       <source>Educational achievement</source>
       <target>学歴
</target>
     </trans-unit>
     <trans-unit id="PEO_575_synonyms">
       <source>Educational achievement (observable entity)</source>
     </trans-unit>
     <trans-unit id="PEO_575_synonyms_1">
       <source>Academic achievement</source>
     </trans-unit>
     <trans-unit id="PEO_575_synonyms_2">
       <source>Level of educational attainment</source>
     </trans-unit>
     <trans-unit id="PEO_575_synonyms_3">
       <source>Educational qualification</source>
     </trans-unit>
     <trans-unit id="PEO_576_label">
       <source>Educational level of guardian of subject</source>
       <target>保護者の教育レベル
</target>
     </trans-unit>
     <trans-unit id="PEO_576_synonyms">
       <source>Educational level of guardian of subject (observable entity)</source>
     </trans-unit>
     <trans-unit id="PEO_577_label">
       <source>Educational level of parent of subject</source>
       <target>両親の教育レベル
</target>
     </trans-unit>
     <trans-unit id="PEO_577_synonyms">
       <source>Educational level of parent of subject (observable entity)</source>
     </trans-unit>
     <trans-unit id="PEO_578_label">
       <source>Embryo Implantation</source>
       <target>胚移植
</target>
     </trans-unit>
     <trans-unit id="PEO_578_synonyms">
       <source>Decidual Cell Reaction</source>
     </trans-unit>
     <trans-unit id="PEO_578_synonyms_1">
       <source>Implantations, Ovum</source>
     </trans-unit>
     <trans-unit id="PEO_578_synonyms_2">
       <source>Ovum Implantation</source>
     </trans-unit>
     <trans-unit id="PEO_578_synonyms_3">
       <source>Implantation, Embryo</source>
     </trans-unit>
     <trans-unit id="PEO_578_synonyms_4">
       <source>Blastocyst Implantations</source>
     </trans-unit>
     <trans-unit id="PEO_578_synonyms_5">
       <source>Implantations, Blastocyst</source>
     </trans-unit>
     <trans-unit id="PEO_578_synonyms_6">
       <source>Implantation, Blastocyst</source>
     </trans-unit>
     <trans-unit id="PEO_578_synonyms_7">
       <source>Decidual Cell Reactions</source>
     </trans-unit>
     <trans-unit id="PEO_578_synonyms_8">
       <source>Ovum Implantations</source>
     </trans-unit>
     <trans-unit id="PEO_578_synonyms_9">
       <source>Blastocyst Implantation</source>
     </trans-unit>
     <trans-unit id="PEO_578_synonyms_10">
       <source>Nidations</source>
     </trans-unit>
     <trans-unit id="PEO_578_synonyms_11">
       <source>Embryo Implantations</source>
     </trans-unit>
     <trans-unit id="PEO_578_synonyms_12">
       <source>Implantations, Embryo</source>
     </trans-unit>
     <trans-unit id="PEO_578_definition">
       <source>Endometrial implantation of EMBRYO, MAMMALIAN at the BLASTOCYST stage.</source>
     </trans-unit>
     <trans-unit id="PEO_578_synonyms_13">
       <source>Implantation, Ovum</source>
     </trans-unit>
     <trans-unit id="PEO_578_synonyms_14">
       <source>Nidation</source>
     </trans-unit>
     <trans-unit id="PEO_579_label">
       <source>Embryonic Development</source>
       <target>胚発生
</target>
     </trans-unit>
     <trans-unit id="PEO_579_definition">
       <source>Morphological and physiological development of EMBRYOS. Permanent alteration of tissue structures and functions in the EMBRYO as a result of its environment, either positive or negative. The cellular development between the time of mammalian gamete FERTILIZATION and EMBRYO IMPLANTATION. This represents the development in the FALLOPIAN TUBES.</source>
     </trans-unit>
     <trans-unit id="PEO_580_label">
       <source>Emergency cesarean section</source>
       <target>緊急帝王切開
</target>
     </trans-unit>
     <trans-unit id="PEO_580_synonyms">
       <source>Emergency caesarean section</source>
     </trans-unit>
     <trans-unit id="PEO_580_synonyms_1">
       <source>Emergency cesarean section (procedure)</source>
     </trans-unit>
     <trans-unit id="PEO_581_label">
       <source>Employment detail</source>
       <target>職業の詳細
</target>
     </trans-unit>
     <trans-unit id="PEO_581_synonyms">
       <source>Employment detail (observable entity)</source>
     </trans-unit>
     <trans-unit id="PEO_582_label">
       <source>Endocrine cell</source>
       <target>内分泌細胞
</target>
     </trans-unit>
     <trans-unit id="PEO_582_synonyms">
       <source>Endocrine cell (cell)</source>
     </trans-unit>
     <trans-unit id="PEO_583_label">
       <source>Endocrine defects</source>
       <target>内分泌障害
</target>
     </trans-unit>
     <trans-unit id="PEO_584_label">
       <source>Endocrine disorder</source>
       <target>内分泌疾患
</target>
     </trans-unit>
     <trans-unit id="PEO_585_label">
       <source>Endocytosis</source>
       <target>エンドサイトーシス
</target>
     </trans-unit>
     <trans-unit id="PEO_585_synonyms">
       <source>plasma membrane invagination</source>
     </trans-unit>
     <trans-unit id="PEO_585_synonyms_1">
       <source>vesicle endocytosis</source>
     </trans-unit>
     <trans-unit id="PEO_586_label">
       <source>Endoplasmic Reticulum Stress</source>
       <target>小胞体ストレス
</target>
     </trans-unit>
     <trans-unit id="PEO_586_synonyms">
       <source>Reticulum Stresses, Endoplasmic</source>
     </trans-unit>
     <trans-unit id="PEO_586_definition">
       <source>Various physiological or molecular disturbances that impair ENDOPLASMIC RETICULUM function. It triggers many responses, including UNFOLDED PROTEIN RESPONSE, which may lead to APOPTOSIS; and AUTOPHAGY.</source>
     </trans-unit>
     <trans-unit id="PEO_586_synonyms_1">
       <source>Endoplasmic Reticulum Stresses</source>
     </trans-unit>
     <trans-unit id="PEO_586_synonyms_2">
       <source>Stresses, Endoplasmic Reticulum</source>
     </trans-unit>
     <trans-unit id="PEO_586_synonyms_3">
       <source>Stress, Endoplasmic Reticulum</source>
     </trans-unit>
     <trans-unit id="PEO_586_synonyms_4">
       <source>Reticulum Stress, Endoplasmic</source>
     </trans-unit>
     <trans-unit id="PEO_587_label">
       <source>Endoplasmic reticulum</source>
       <target>小胞体
</target>
     </trans-unit>
     <trans-unit id="PEO_587_synonyms">
       <source>ER</source>
     </trans-unit>
     <trans-unit id="PEO_587_synonyms_1">
       <source>Endoplasmic reticulum (cell structure)</source>
     </trans-unit>
     <trans-unit id="PEO_588_label">
       <source>Endothelial cell</source>
       <target>内皮細胞
</target>
     </trans-unit>
     <trans-unit id="PEO_588_synonyms">
       <source>Endothelial cell (cell)</source>
     </trans-unit>
     <trans-unit id="PEO_589_label">
       <source>Endothelial dysfunction</source>
       <target>内皮障害
</target>
     </trans-unit>
     <trans-unit id="PEO_590_label">
       <source>Endothelial lining</source>
       <target>内膜
</target>
     </trans-unit>
     <trans-unit id="PEO_591_label">
       <source>Endothelium</source>
       <target>血管内皮
</target>
     </trans-unit>
     <trans-unit id="PEO_591_synonyms">
       <source>Endothelial tissue</source>
     </trans-unit>
     <trans-unit id="PEO_591_synonyms_1">
       <source>Endothelium (body structure)</source>
     </trans-unit>
     <trans-unit id="PEO_592_label">
       <source>Endothelium-derived hyperpolarizing factor</source>
       <target>内皮由来過分極因子
</target>
     </trans-unit>
     <trans-unit id="PEO_592_synonyms">
       <source>EDHF</source>
     </trans-unit>
     <trans-unit id="PEO_593_label">
       <source>Energy metabolism</source>
       <target>エネルギー代謝
</target>
     </trans-unit>
     <trans-unit id="PEO_594_label">
       <source>Enlarged uterus</source>
       <target>拡大した子宮
</target>
     </trans-unit>
     <trans-unit id="PEO_594_synonyms">
       <source>Enlarged uterus (finding)</source>
     </trans-unit>
     <trans-unit id="PEO_594_synonyms_1">
       <source>Uterine enlargement</source>
     </trans-unit>
     <trans-unit id="PEO_594_synonyms_2">
       <source>Large uterus</source>
     </trans-unit>
     <trans-unit id="PEO_595_label">
       <source>Enoxaparin</source>
       <target>エノキサパリン
</target>
     </trans-unit>
     <trans-unit id="PEO_596_label">
       <source>Entire blood vessel</source>
       <target>血管
</target>
     </trans-unit>
     <trans-unit id="PEO_596_synonyms">
       <source>Entire blood vessel (body structure)</source>
     </trans-unit>
     <trans-unit id="PEO_596_synonyms_1">
       <source>Blood vessel</source>
     </trans-unit>
     <trans-unit id="PEO_597_label">
       <source>Entire cytotrophoblast</source>
       <target>細胞栄養芽層
</target>
     </trans-unit>
     <trans-unit id="PEO_597_synonyms">
       <source>Cytotrophoblast</source>
     </trans-unit>
     <trans-unit id="PEO_597_synonyms_1">
       <source>Entire cytotrophoblast (body structure)</source>
     </trans-unit>
     <trans-unit id="PEO_598_label">
       <source>Entire endometrium</source>
       <target>子宮内膜
</target>
     </trans-unit>
     <trans-unit id="PEO_598_synonyms">
       <source>Tunica mucosa uteri</source>
     </trans-unit>
     <trans-unit id="PEO_598_synonyms_1">
       <source>Entire endometrium (body structure)</source>
     </trans-unit>
     <trans-unit id="PEO_598_synonyms_2">
       <source>Endometrium</source>
     </trans-unit>
     <trans-unit id="PEO_599_label">
       <source>Entire heart</source>
       <target>心臓
</target>
     </trans-unit>
     <trans-unit id="PEO_599_synonyms">
       <source>Entire heart (body structure)</source>
     </trans-unit>
     <trans-unit id="PEO_599_synonyms_1">
       <source>Heart</source>
     </trans-unit>
     <trans-unit id="PEO_600_label">
       <source>Entire kidney</source>
       <target>腎臓
</target>
     </trans-unit>
     <trans-unit id="PEO_600_synonyms">
       <source>Entire kidney (body structure)</source>
     </trans-unit>
     <trans-unit id="PEO_600_synonyms_1">
       <source>Kidney</source>
     </trans-unit>
     <trans-unit id="PEO_601_label">
       <source>Entire lymph node</source>
       <target>リンパ節
</target>
     </trans-unit>
     <trans-unit id="PEO_601_synonyms">
       <source>Lymph node</source>
     </trans-unit>
     <trans-unit id="PEO_601_synonyms_1">
       <source>LN - Lymph node</source>
     </trans-unit>
     <trans-unit id="PEO_601_synonyms_2">
       <source>Entire lymph node (body structure)</source>
     </trans-unit>
     <trans-unit id="PEO_602_label">
       <source>Entire placenta</source>
       <target>胎盤
</target>
     </trans-unit>
     <trans-unit id="PEO_602_synonyms">
       <source>Entire placenta (body structure)</source>
     </trans-unit>
     <trans-unit id="PEO_602_synonyms_1">
       <source>Placenta</source>
     </trans-unit>
     <trans-unit id="PEO_603_label">
       <source>Entire placental cotyledon</source>
       <target>胎盤子葉
</target>
     </trans-unit>
     <trans-unit id="PEO_603_synonyms">
       <source>Entire placental cotyledon (body structure)</source>
     </trans-unit>
     <trans-unit id="PEO_603_synonyms_1">
       <source>Placental cotyledon</source>
     </trans-unit>
     <trans-unit id="PEO_604_label">
       <source>Entire testis</source>
       <target>精巣
</target>
     </trans-unit>
     <trans-unit id="PEO_604_synonyms">
       <source>Testis</source>
     </trans-unit>
     <trans-unit id="PEO_604_synonyms_1">
       <source>Entire testis (body structure)</source>
     </trans-unit>
     <trans-unit id="PEO_605_label">
       <source>Entire uterus</source>
       <target>子宮
</target>
     </trans-unit>
     <trans-unit id="PEO_605_synonyms">
       <source>Entire uterus (body structure)</source>
     </trans-unit>
     <trans-unit id="PEO_605_synonyms_1">
       <source>Uterus</source>
     </trans-unit>
     <trans-unit id="PEO_605_synonyms_2">
       <source>Womb</source>
     </trans-unit>
     <trans-unit id="PEO_605_synonyms_3">
       <source>UT - Uterus</source>
     </trans-unit>
     <trans-unit id="PEO_606_label">
       <source>Entity relating to environmental cause</source>
       <target>環境因子に関連した概念
</target>
     </trans-unit>
     <trans-unit id="PEO_607_label">
       <source>Environmental cause</source>
       <target>環境因子
</target>
     </trans-unit>
     <trans-unit id="PEO_607_synonyms">
       <source>Environmental causes</source>
     </trans-unit>
     <trans-unit id="PEO_607_synonyms_1">
       <source>environmental factor</source>
     </trans-unit>
     <trans-unit id="PEO_607_synonyms_2">
       <source>environmental factors</source>
     </trans-unit>
     <trans-unit id="PEO_608_label">
       <source>Environmental manipulation</source>
       <target>環境調整
</target>
     </trans-unit>
     <trans-unit id="PEO_608_synonyms">
       <source>Environmental manipulations</source>
     </trans-unit>
     <trans-unit id="PEO_609_label">
       <source>Environmental features</source>
       <target>環境因子
</target>
     </trans-unit>
     <trans-unit id="PEO_609_synonyms">
       <source>Environmental factor</source>
     </trans-unit>
     <trans-unit id="PEO_609_synonyms_1">
       <source>Environmental factors</source>
     </trans-unit>
     <trans-unit id="PEO_609_synonyms_2">
       <source>Environmental feature</source>
     </trans-unit>
     <trans-unit id="PEO_610_label">
       <source>Epidural hemorrhage</source>
       <target>硬膜外出血
</target>
     </trans-unit>
     <trans-unit id="PEO_611_label">
       <source>Epigastric pain</source>
       <target>心窩部痛
</target>
     </trans-unit>
     <trans-unit id="PEO_611_synonyms">
       <source>Epigastric pain (finding)</source>
     </trans-unit>
     <trans-unit id="PEO_612_label">
       <source>Epigenetics</source>
       <target>エピジェネティック
</target>
     </trans-unit>
     <trans-unit id="PEO_613_label">
       <source>Epilepsy</source>
       <target>てんかん
</target>
     </trans-unit>
     <trans-unit id="PEO_613_synonyms">
       <source>Epilepsy (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_613_synonyms_1">
       <source>EP - Epilepsy</source>
     </trans-unit>
     <trans-unit id="PEO_613_synonyms_2">
       <source>Epileptic attack</source>
     </trans-unit>
     <trans-unit id="PEO_614_label">
       <source>Episiotomy</source>
       <target>会陰切開術
</target>
     </trans-unit>
     <trans-unit id="PEO_614_synonyms">
       <source>Episiotomy (procedure)</source>
     </trans-unit>
     <trans-unit id="PEO_615_label">
       <source>Erythrocyte production</source>
       <target>赤血球産生
</target>
     </trans-unit>
     <trans-unit id="PEO_615_synonyms">
       <source>Erythrocyte production, function</source>
     </trans-unit>
     <trans-unit id="PEO_615_synonyms_1">
       <source>Erythropoiesis</source>
     </trans-unit>
     <trans-unit id="PEO_615_synonyms_2">
       <source>Erythrocyte production, function (observable entity)</source>
     </trans-unit>
     <trans-unit id="PEO_616_label">
       <source>Esophageal Squamous Cell Carcinoma</source>
       <target>食道扁平上皮癌
</target>
     </trans-unit>
     <trans-unit id="PEO_617_label">
       <source>Estimated fetal gestational age at delivery</source>
       <target>分娩時の推定妊娠週数
</target>
     </trans-unit>
     <trans-unit id="PEO_617_synonyms">
       <source>Estimated foetal gestational age at delivery</source>
     </trans-unit>
     <trans-unit id="PEO_617_synonyms_1">
       <source>Estimated fetal gestational age at delivery (observable entity)</source>
     </trans-unit>
     <trans-unit id="PEO_618_label">
       <source>Estrogen level</source>
       <target>エストロゲンレベル
</target>
     </trans-unit>
     <trans-unit id="PEO_619_label">
       <source>Eventual cause</source>
       <target>最終的な原因
</target>
     </trans-unit>
     <trans-unit id="PEO_619_synonyms">
       <source>Eventual causes</source>
     </trans-unit>
     <trans-unit id="PEO_620_label">
       <source>Ex-tobacco user</source>
       <target>禁煙者
</target>
     </trans-unit>
     <trans-unit id="PEO_620_synonyms">
       <source>Ex-tobacco user (finding)</source>
     </trans-unit>
     <trans-unit id="PEO_621_label">
       <source>Exceptionally large at birth</source>
       <target>巨大児
</target>
     </trans-unit>
     <trans-unit id="PEO_621_synonyms">
       <source>Macrosomic infant</source>
     </trans-unit>
     <trans-unit id="PEO_621_synonyms_1">
       <source>Macrosomic baby</source>
     </trans-unit>
     <trans-unit id="PEO_621_synonyms_2">
       <source>Fetal giant</source>
     </trans-unit>
     <trans-unit id="PEO_621_synonyms_3">
       <source>Hypertrophic baby</source>
     </trans-unit>
     <trans-unit id="PEO_621_synonyms_4">
       <source>Exceptionally large at birth (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_621_synonyms_5">
       <source>Birth weight 4500 grams OR more</source>
     </trans-unit>
     <trans-unit id="PEO_621_synonyms_6">
       <source>Macrosomia</source>
     </trans-unit>
     <trans-unit id="PEO_622_label">
       <source>Exocytosis</source>
       <target>エキソサイトーシス
</target>
     </trans-unit>
     <trans-unit id="PEO_622_synonyms">
       <source>vesicle exocytosis</source>
     </trans-unit>
     <trans-unit id="PEO_622_synonyms_1">
       <source>Reverse Pinocytosis</source>
     </trans-unit>
     <trans-unit id="PEO_623_label">
       <source>Exosome entry</source>
       <target>エキソソームエントリ
</target>
     </trans-unit>
     <trans-unit id="PEO_624_label">
       <source>Exosomes</source>
       <target>エキソソーム
</target>
     </trans-unit>
     <trans-unit id="PEO_624_definition">
       <source>Vesicles secreted from MULTIVESICULAR BODIES into the extracellular environment when the multivesicular bodies fuse with the PLASMA MEMBRANE. Multivesicular bodies are formed from ENDOSOMES when they accumulate vesicles (sometimes referred to as &quot;intraluminal vesicles&quot;) from inward budding of the endosome membrane.</source>
     </trans-unit>
     <trans-unit id="PEO_625_label">
       <source>Extravillous cytotrophoblast</source>
       <target>絨毛外栄養膜細胞層
</target>
     </trans-unit>
     <trans-unit id="PEO_626_label">
       <source>FGV parcentage</source>
       <target>FGVパーセンテージ
</target>
     </trans-unit>
     <trans-unit id="PEO_626_synonyms">
       <source>%FGV</source>
     </trans-unit>
     <trans-unit id="PEO_627_label">
       <source>Family History</source>
       <target>家族歴
</target>
     </trans-unit>
     <trans-unit id="PEO_627_synonyms">
       <source>family history</source>
     </trans-unit>
     <trans-unit id="PEO_627_synonyms_1">
       <source>Family History risk factors</source>
     </trans-unit>
     <trans-unit id="PEO_628_label">
       <source>Family history</source>
       <target>家族歴
</target>
     </trans-unit>
     <trans-unit id="PEO_628_synonyms">
       <source>http://www.ebi.ac.uk/efo/EFO_0000493</source>
     </trans-unit>
     <trans-unit id="PEO_628_synonyms_1">
       <source>Family histories</source>
     </trans-unit>
     <trans-unit id="PEO_629_label">
       <source>Family history of cardiovascular disease</source>
       <target>循環器疾患の家族歴
</target>
     </trans-unit>
     <trans-unit id="PEO_630_label">
       <source>Family history of diabetes mellitus</source>
       <target>糖尿病の家族歴
</target>
     </trans-unit>
     <trans-unit id="PEO_631_label">
       <source>Family history of preeclampsia</source>
       <target>妊娠高血圧腎症の家族歴
</target>
     </trans-unit>
     <trans-unit id="PEO_632_label">
       <source>Female infertility of anovulatory origin</source>
       <target>排卵不全
</target>
     </trans-unit>
     <trans-unit id="PEO_632_synonyms">
       <source>Female infertility of anovulatory origin (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_632_synonyms_1">
       <source>Anovular cycle</source>
     </trans-unit>
     <trans-unit id="PEO_632_synonyms_2">
       <source>Anovulatory infertility</source>
     </trans-unit>
     <trans-unit id="PEO_633_label">
       <source>Fetal gestational age</source>
       <target>出生時の妊娠週数
</target>
     </trans-unit>
     <trans-unit id="PEO_633_synonyms">
       <source>Fetal gestational age (observable entity)</source>
     </trans-unit>
     <trans-unit id="PEO_633_synonyms_1">
       <source>Length of gestation</source>
     </trans-unit>
     <trans-unit id="PEO_634_label">
       <source>Fetal growth restriction</source>
       <target>胎児発育遅延
</target>
     </trans-unit>
     <trans-unit id="PEO_634_synonyms">
       <source>Poor fetal growth state</source>
     </trans-unit>
     <trans-unit id="PEO_634_synonyms_1">
       <source>Microsomia</source>
     </trans-unit>
     <trans-unit id="PEO_634_synonyms_2">
       <source>Fetal growth retardation</source>
     </trans-unit>
     <trans-unit id="PEO_634_synonyms_3">
       <source>Microsomic baby</source>
     </trans-unit>
     <trans-unit id="PEO_634_synonyms_4">
       <source>Poor fetal growth</source>
     </trans-unit>
     <trans-unit id="PEO_634_synonyms_5">
       <source>IUGR - Intrauterine growth retardation</source>
     </trans-unit>
     <trans-unit id="PEO_634_synonyms_6">
       <source>FGR - Fetal growth retardation</source>
     </trans-unit>
     <trans-unit id="PEO_634_synonyms_7">
       <source>Intrauterine growth retardation</source>
     </trans-unit>
     <trans-unit id="PEO_634_synonyms_8">
       <source>Fetal growth retardation (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_635_label">
       <source>Fetal intrapartum death</source>
       <target>胎児分娩中死
</target>
     </trans-unit>
     <trans-unit id="PEO_635_synonyms">
       <source>Intrapartum fetal death (event)</source>
     </trans-unit>
     <trans-unit id="PEO_635_synonyms_1">
       <source>Intrapartum foetal death</source>
     </trans-unit>
     <trans-unit id="PEO_635_synonyms_2">
       <source>Intrapartum fetal death</source>
     </trans-unit>
     <trans-unit id="PEO_635_synonyms_3">
       <source>Foetal intrapartum death</source>
     </trans-unit>
     <trans-unit id="PEO_636_label">
       <source>Fetal lung maturation</source>
       <target>胎児肺成熟
</target>
     </trans-unit>
     <trans-unit id="PEO_637_label">
       <source>Fetal observable</source>
       <target>胎児所見
</target>
     </trans-unit>
     <trans-unit id="PEO_637_synonyms">
       <source>Fetal observable (observable entity)</source>
     </trans-unit>
     <trans-unit id="PEO_638_label">
       <source>Fetal thrombotic vasculopathy</source>
       <target>胎児血栓性血管障害)
</target>
     </trans-unit>
     <trans-unit id="PEO_639_label">
       <source>Fetal umbilical vein structure</source>
       <target>胎児臍静脈構造
</target>
     </trans-unit>
     <trans-unit id="PEO_639_synonyms">
       <source>Fetal umbilical vein</source>
     </trans-unit>
     <trans-unit id="PEO_639_synonyms_1">
       <source>Umbilical vein</source>
     </trans-unit>
     <trans-unit id="PEO_639_synonyms_2">
       <source>Left umbilical vein</source>
     </trans-unit>
     <trans-unit id="PEO_639_synonyms_3">
       <source>Fetal umbilical vein structure (body structure)</source>
     </trans-unit>
     <trans-unit id="PEO_640_label">
       <source>Fetus Organs</source>
       <target>胎児臓器
</target>
     </trans-unit>
     <trans-unit id="PEO_641_label">
       <source>Fetus with chromosomal abnormality</source>
       <target>染色体異常
</target>
     </trans-unit>
     <trans-unit id="PEO_641_synonyms">
       <source>Fetus with chromosomal abnormality (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_642_label">
       <source>Fibrin</source>
       <target>フィブリン
</target>
     </trans-unit>
     <trans-unit id="PEO_642_synonyms">
       <source>Fibrin (substance)</source>
     </trans-unit>
     <trans-unit id="PEO_643_label">
       <source>Fibrinogen measurement</source>
       <target>フィブリノーゲンの測定
</target>
     </trans-unit>
     <trans-unit id="PEO_643_synonyms">
       <source>Fibrinogen level</source>
     </trans-unit>
     <trans-unit id="PEO_643_synonyms_1">
       <source>Fibrinogen measurement (procedure)</source>
     </trans-unit>
     <trans-unit id="PEO_644_label">
       <source>Fibrosis of Chorionic Villi</source>
       <target>絨毛の線維化
</target>
     </trans-unit>
     <trans-unit id="PEO_644_synonyms">
       <source>Villous Fibrosis</source>
     </trans-unit>
     <trans-unit id="PEO_645_label">
       <source>Finding of brain</source>
       <target>脳の所見
</target>
     </trans-unit>
     <trans-unit id="PEO_646_label">
       <source>Finding of measures of cervix</source>
       <target>子宮頸部の所見
</target>
     </trans-unit>
     <trans-unit id="PEO_646_synonyms">
       <source>Finding of measures of cervix (finding)</source>
     </trans-unit>
     <trans-unit id="PEO_646_synonyms_1">
       <source>Observation of measures of cervix</source>
     </trans-unit>
     <trans-unit id="PEO_647_label">
       <source>First trimester</source>
       <target>妊娠初期
</target>
     </trans-unit>
     <trans-unit id="PEO_647_synonyms">
       <source>1st trimester</source>
     </trans-unit>
     <trans-unit id="PEO_647_synonyms_1">
       <source>First trimester (qualifier value)</source>
     </trans-unit>
     <trans-unit id="PEO_648_label">
       <source>Fresh late fetal deaths</source>
       <target>Fresh late fetal deaths
</target>
     </trans-unit>
     <trans-unit id="PEO_649_label">
       <source>G protein coupled signal transduction pathway</source>
       <target>Gタンパク共役型シグナル伝達系
</target>
     </trans-unit>
     <trans-unit id="PEO_649_synonyms">
       <source>Gq/11-coupled signal transduction pathway</source>
     </trans-unit>
     <trans-unit id="PEO_650_label">
       <source>Gave up before pregnancy</source>
       <target>妊娠前にやめた
</target>
     </trans-unit>
     <trans-unit id="PEO_651_label">
       <source>Gave up during pregnancy</source>
       <target>妊娠中にやめた
</target>
     </trans-unit>
     <trans-unit id="PEO_652_label">
       <source>Genetic Biomarker</source>
       <target>遺伝子バイオマーカー
</target>
     </trans-unit>
     <trans-unit id="PEO_652_synonyms">
       <source>Genetic Biomarkers</source>
     </trans-unit>
     <trans-unit id="PEO_653_label">
       <source>Genotype</source>
       <target>遺伝子型
</target>
     </trans-unit>
     <trans-unit id="PEO_653_synonyms">
       <source>genetic risk factors</source>
     </trans-unit>
     <trans-unit id="PEO_653_synonyms_1">
       <source>Genetics</source>
     </trans-unit>
     <trans-unit id="PEO_653_synonyms_2">
       <source>genetic risk factor</source>
     </trans-unit>
     <trans-unit id="PEO_654_label">
       <source>Genomic features</source>
       <target>遺伝因子
</target>
     </trans-unit>
     <trans-unit id="PEO_654_synonyms">
       <source>Genomic factors</source>
     </trans-unit>
     <trans-unit id="PEO_654_synonyms_1">
       <source>Genomic feature</source>
     </trans-unit>
     <trans-unit id="PEO_654_synonyms_2">
       <source>Genomic factor</source>
     </trans-unit>
     <trans-unit id="PEO_655_label">
       <source>Geography</source>
       <target>地理学
</target>
     </trans-unit>
     <trans-unit id="PEO_655_synonyms">
       <source>Factors, Geographic</source>
     </trans-unit>
     <trans-unit id="PEO_655_synonyms_1">
       <source>Geography, Human</source>
     </trans-unit>
     <trans-unit id="PEO_655_synonyms_2">
       <source>Human Geography</source>
     </trans-unit>
     <trans-unit id="PEO_655_synonyms_3">
       <source>Factor, Geographic</source>
     </trans-unit>
     <trans-unit id="PEO_655_synonyms_4">
       <source>Geographic Factor</source>
     </trans-unit>
     <trans-unit id="PEO_655_synonyms_5">
       <source>Geographic Factors</source>
     </trans-unit>
     <trans-unit id="PEO_655_definition">
       <source>The science dealing with the earth and its life, especially the description of land, sea, and air and the distribution of plant and animal life, including humanity and human industries with reference to the mutual relations of these elements. (From Webster, 3d ed)</source>
     </trans-unit>
     <trans-unit id="PEO_656_label">
       <source>Gestational</source>
       <target>妊娠性の
</target>
     </trans-unit>
     <trans-unit id="PEO_656_synonyms">
       <source>Gestational (qualifier value)</source>
     </trans-unit>
     <trans-unit id="PEO_657_label">
       <source>Gestational diabetes mellitus</source>
       <target>妊娠糖尿病
</target>
     </trans-unit>
     <trans-unit id="PEO_657_synonyms">
       <source>Diabetes mellitus arising in pregnancy</source>
     </trans-unit>
     <trans-unit id="PEO_657_synonyms_1">
       <source>GDM - Gestational diabetes mellitus</source>
     </trans-unit>
     <trans-unit id="PEO_657_synonyms_2">
       <source>Gestational diabetes</source>
     </trans-unit>
     <trans-unit id="PEO_657_synonyms_3">
       <source>GDM</source>
     </trans-unit>
     <trans-unit id="PEO_657_synonyms_4">
       <source>Gestational diabetes mellitus (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_657_synonyms_5">
       <source>Maternal gestational diabetes mellitus</source>
     </trans-unit>
     <trans-unit id="PEO_658_label">
       <source>Gestational hypertension</source>
       <target>妊娠高血圧症
</target>
     </trans-unit>
     <trans-unit id="PEO_659_label">
       <source>Gestational trophoblastic disease</source>
       <target>妊娠性絨毛性疾患
</target>
     </trans-unit>
     <trans-unit id="PEO_659_synonyms">
       <source>Gestational trophoblastic disease (morphologic abnormality)</source>
     </trans-unit>
     <trans-unit id="PEO_660_label">
       <source>Gestational weight gain</source>
       <target>妊娠中の体重増加量
</target>
     </trans-unit>
     <trans-unit id="PEO_660_synonyms">
       <source>GWG</source>
     </trans-unit>
     <trans-unit id="PEO_661_label">
       <source>Glomerular dysfunction (variable)</source>
       <target>糸球体機能不全
</target>
     </trans-unit>
     <trans-unit id="PEO_662_label">
       <source>Glucose transport</source>
       <target>グルコース輸送
</target>
     </trans-unit>
     <trans-unit id="PEO_663_label">
       <source>Glycosylation</source>
       <target>グリコシル化
</target>
     </trans-unit>
     <trans-unit id="PEO_664_label">
       <source>Guinea pig</source>
       <target>モルモット
</target>
     </trans-unit>
     <trans-unit id="PEO_665_label">
       <source>Gynecological history</source>
       <target>婦人科既往歴
</target>
     </trans-unit>
     <trans-unit id="PEO_665_synonyms">
       <source>Gynaecological history</source>
     </trans-unit>
     <trans-unit id="PEO_665_synonyms_1">
       <source>Gynecological history (observable entity)</source>
     </trans-unit>
     <trans-unit id="PEO_666_label">
       <source>HELLP syndrome</source>
       <target>HELLP症候群
</target>
     </trans-unit>
     <trans-unit id="PEO_666_synonyms">
       <source>HELLP - Syndrome of hemolysis, elevated liver enzymes and low platelet</source>
     </trans-unit>
     <trans-unit id="PEO_666_synonyms_1">
       <source>Hemolysis-elevated liver enzymes-low platelet count syndrome (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_666_synonyms_2">
       <source>Haemolysis-elevated liver enzymes-low platelet count syndrome</source>
     </trans-unit>
     <trans-unit id="PEO_666_synonyms_3">
       <source>Hemolysis-elevated liver enzymes-low platelet count syndrome</source>
     </trans-unit>
     <trans-unit id="PEO_666_synonyms_4">
       <source>HELLP - Syndrome of haemolysis, elevated liver enzymes and low platelet</source>
     </trans-unit>
     <trans-unit id="PEO_667_label">
       <source>HIV</source>
       <target>ヒト免疫不全ウイルス
</target>
     </trans-unit>
     <trans-unit id="PEO_667_synonyms">
       <source>AIDS Viruses</source>
     </trans-unit>
     <trans-unit id="PEO_668_label">
       <source>Haematological disorders</source>
       <target>血液疾患
</target>
     </trans-unit>
     <trans-unit id="PEO_668_synonyms">
       <source>Hematological disorders</source>
     </trans-unit>
     <trans-unit id="PEO_669_label">
       <source>Haemorrhage finding</source>
       <target>出血所見
</target>
     </trans-unit>
     <trans-unit id="PEO_670_label">
       <source>Hazard ratio</source>
       <target>ハザード比
</target>
     </trans-unit>
     <trans-unit id="PEO_671_label">
       <source>Headache</source>
       <target>頭痛
</target>
     </trans-unit>
     <trans-unit id="PEO_671_synonyms">
       <source>cephalalgia</source>
     </trans-unit>
     <trans-unit id="PEO_671_synonyms_1">
       <source>Headaches</source>
     </trans-unit>
     <trans-unit id="PEO_672_label">
       <source>Heart disease</source>
       <target>心疾患
</target>
     </trans-unit>
     <trans-unit id="PEO_672_synonyms">
       <source>Morbus cordis</source>
     </trans-unit>
     <trans-unit id="PEO_672_synonyms_1">
       <source>Cardiac disorder</source>
     </trans-unit>
     <trans-unit id="PEO_672_synonyms_2">
       <source>Heart disease (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_672_synonyms_3">
       <source>Disorder of heart</source>
     </trans-unit>
     <trans-unit id="PEO_672_synonyms_4">
       <source>Cardiopathy</source>
     </trans-unit>
     <trans-unit id="PEO_673_label">
       <source>Heart failure</source>
       <target>心不全
</target>
     </trans-unit>
     <trans-unit id="PEO_673_synonyms">
       <source>Cardiac failure</source>
     </trans-unit>
     <trans-unit id="PEO_673_synonyms_1">
       <source>Weak heart</source>
     </trans-unit>
     <trans-unit id="PEO_673_synonyms_2">
       <source>HF - Heart failure</source>
     </trans-unit>
     <trans-unit id="PEO_673_synonyms_3">
       <source>Myocardial failure</source>
     </trans-unit>
     <trans-unit id="PEO_673_synonyms_4">
       <source>Cardiac insufficiency</source>
     </trans-unit>
     <trans-unit id="PEO_673_synonyms_5">
       <source>Heart failure (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_674_label">
       <source>Heart rate</source>
       <target>心拍数
</target>
     </trans-unit>
     <trans-unit id="PEO_674_synonyms">
       <source>Heart rate (observable entity)</source>
     </trans-unit>
     <trans-unit id="PEO_674_synonyms_1">
       <source>Cardiac rate</source>
     </trans-unit>
     <trans-unit id="PEO_675_label">
       <source>Hematopoietic stem cell</source>
       <target>造血幹細胞
</target>
     </trans-unit>
     <trans-unit id="PEO_675_synonyms">
       <source>Hematopoietic stem cell (cell)</source>
     </trans-unit>
     <trans-unit id="PEO_675_synonyms_1">
       <source>Haematopoietic stem cell</source>
     </trans-unit>
     <trans-unit id="PEO_676_label">
       <source>Hemolysis</source>
       <target>溶血
</target>
     </trans-unit>
     <trans-unit id="PEO_676_synonyms">
       <source>Hemolysis (attribute)</source>
     </trans-unit>
     <trans-unit id="PEO_676_synonyms_1">
       <source>Haemolysis</source>
     </trans-unit>
     <trans-unit id="PEO_677_label">
       <source>Hemorrhagic endovasculitis</source>
       <target>出血性血管炎
</target>
     </trans-unit>
     <trans-unit id="PEO_677_synonyms">
       <source>hemorrhagic endovasculitis of the placenta</source>
     </trans-unit>
     <trans-unit id="PEO_677_synonyms_1">
       <source>HEV</source>
     </trans-unit>
     <trans-unit id="PEO_678_label">
       <source>Hemostatic function</source>
       <target>止血機能
</target>
     </trans-unit>
     <trans-unit id="PEO_678_synonyms">
       <source>Haemostasis</source>
     </trans-unit>
     <trans-unit id="PEO_678_synonyms_1">
       <source>Haemostatic function</source>
     </trans-unit>
     <trans-unit id="PEO_678_synonyms_2">
       <source>Hemostasis</source>
     </trans-unit>
     <trans-unit id="PEO_678_synonyms_3">
       <source>Blood clotting</source>
     </trans-unit>
     <trans-unit id="PEO_678_synonyms_4">
       <source>Hemostatic function (observable entity)</source>
     </trans-unit>
     <trans-unit id="PEO_678_synonyms_5">
       <source>Blood coagulation</source>
     </trans-unit>
     <trans-unit id="PEO_679_label">
       <source>Heparin, Low-Molecular-Weight</source>
       <target>低分子量ヘパリン
</target>
     </trans-unit>
     <trans-unit id="PEO_679_synonyms">
       <source>Low-Molecular-Weight Heparin</source>
     </trans-unit>
     <trans-unit id="PEO_679_synonyms_1">
       <source>Low Molecular Weight Heparin</source>
     </trans-unit>
     <trans-unit id="PEO_679_definition">
       <source>Heparin fractions with a molecular weight usually between 4000 and 6000 kD. These low-molecular-weight fractions are effective antithrombotic agents. Their administration reduces the risk of hemorrhage, they have a longer half-life, and their platelet interactions are reduced in comparison to unfractionated heparin. They also provide an effective prophylaxis against postoperative major pulmonary embolism.</source>
     </trans-unit>
     <trans-unit id="PEO_679_synonyms_2">
       <source>Heparin, Low Molecular Weight</source>
     </trans-unit>
     <trans-unit id="PEO_679_synonyms_3">
       <source>LMWH</source>
     </trans-unit>
     <trans-unit id="PEO_680_label">
       <source>Hepatic disease</source>
       <target>肝疾患
</target>
     </trans-unit>
     <trans-unit id="PEO_680_synonyms">
       <source>Liver disease</source>
     </trans-unit>
     <trans-unit id="PEO_681_label">
       <source>Hernia</source>
       <target>ヘルニア
</target>
     </trans-unit>
     <trans-unit id="PEO_681_synonyms">
       <source>Herniated tissue</source>
     </trans-unit>
     <trans-unit id="PEO_681_synonyms_1">
       <source>Herniated structure (morphologic abnormality)</source>
     </trans-unit>
     <trans-unit id="PEO_681_synonyms_2">
       <source>Herniated structure</source>
     </trans-unit>
     <trans-unit id="PEO_681_synonyms_3">
       <source>Herniation</source>
     </trans-unit>
     <trans-unit id="PEO_682_label">
       <source>Heroin abuse</source>
       <target>ヘロイン乱用
</target>
     </trans-unit>
     <trans-unit id="PEO_683_label">
       <source>High birth weight</source>
       <target>高出生体重
</target>
     </trans-unit>
     <trans-unit id="PEO_683_synonyms">
       <source>High birth weight (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_683_synonyms_1">
       <source>High birth weight baby</source>
     </trans-unit>
     <trans-unit id="PEO_684_label">
       <source>High physical activity</source>
       <target>高い身体活動
</target>
     </trans-unit>
     <trans-unit id="PEO_685_label">
       <source>Higher education</source>
       <target>高学歴
</target>
     </trans-unit>
     <trans-unit id="PEO_685_synonyms">
       <source>Higher education (finding)</source>
     </trans-unit>
     <trans-unit id="PEO_686_label">
       <source>Histmorphological presents</source>
       <target>組織形態学的な所見
</target>
     </trans-unit>
     <trans-unit id="PEO_687_label">
       <source>Homeostasis</source>
       <target>恒常性
</target>
     </trans-unit>
     <trans-unit id="PEO_687_synonyms">
       <source>Homeostasis, function</source>
     </trans-unit>
     <trans-unit id="PEO_687_synonyms_1">
       <source>Homeostasis, function (observable entity)</source>
     </trans-unit>
     <trans-unit id="PEO_687_synonyms_2">
       <source>Homoeostasis</source>
     </trans-unit>
     <trans-unit id="PEO_688_label">
       <source>Human chorionic gonadotropin</source>
       <target>ヒト絨毛性ゴナドトロピン
</target>
     </trans-unit>
     <trans-unit id="PEO_688_synonyms">
       <source>Chorionic gonadotrophin human</source>
     </trans-unit>
     <trans-unit id="PEO_688_synonyms_1">
       <source>Human chorionic gonadotropin (substance)</source>
     </trans-unit>
     <trans-unit id="PEO_688_synonyms_2">
       <source>Human chorionic gonadotrophin</source>
     </trans-unit>
     <trans-unit id="PEO_688_synonyms_3">
       <source>HCG</source>
     </trans-unit>
     <trans-unit id="PEO_688_synonyms_4">
       <source>HCG - Human chorionic gonadotropin</source>
     </trans-unit>
     <trans-unit id="PEO_688_synonyms_5">
       <source>Chorionic gonadotropin human</source>
     </trans-unit>
     <trans-unit id="PEO_688_synonyms_6">
       <source>Chorionic gonadotrophin</source>
     </trans-unit>
     <trans-unit id="PEO_688_synonyms_7">
       <source>HCG - Human chorionic gonadotrophin</source>
     </trans-unit>
     <trans-unit id="PEO_689_label">
       <source>Hydatidiform mole</source>
       <target>胞状奇胎
</target>
     </trans-unit>
     <trans-unit id="PEO_689_synonyms">
       <source>Hydatidiform mole, no International Classification of Diseases for Oncology subtype</source>
     </trans-unit>
     <trans-unit id="PEO_689_synonyms_1">
       <source>Complete hydatidiform mole</source>
     </trans-unit>
     <trans-unit id="PEO_689_synonyms_2">
       <source>Hydatid mole</source>
     </trans-unit>
     <trans-unit id="PEO_689_synonyms_3">
       <source>Hydatidiform mole, no ICD-O subtype</source>
     </trans-unit>
     <trans-unit id="PEO_689_synonyms_4">
       <source>Hydatidiform mole, no International Classification of Diseases for Oncology subtype (morphologic abnormality)</source>
     </trans-unit>
     <trans-unit id="PEO_690_label">
       <source>Hydatidiform mole, benign</source>
       <target>胞状奇胎
</target>
     </trans-unit>
     <trans-unit id="PEO_690_synonyms">
       <source>Hydatidiform mole</source>
     </trans-unit>
     <trans-unit id="PEO_690_synonyms_1">
       <source>Molar pregnancy with hydatid mole</source>
     </trans-unit>
     <trans-unit id="PEO_690_synonyms_2">
       <source>Hydatidiform mole, benign (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_690_synonyms_3">
       <source>Molar pregnancy with vesicular mole</source>
     </trans-unit>
     <trans-unit id="PEO_690_synonyms_4">
       <source>Hydatid mole</source>
     </trans-unit>
     <trans-unit id="PEO_691_label">
       <source>Hydropic placenta</source>
       <target>水腫性胎盤　要確認　用語集
</target>
     </trans-unit>
     <trans-unit id="PEO_691_synonyms">
       <source>Hydropic placenta</source>
     </trans-unit>
     <trans-unit id="PEO_692_label">
       <source>Hydrops fetalis</source>
       <target>胎児水腫
</target>
     </trans-unit>
     <trans-unit id="PEO_692_synonyms">
       <source>Hydrops fetalis (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_692_synonyms_1">
       <source>HF - Hydrops fetalis</source>
     </trans-unit>
     <trans-unit id="PEO_693_label">
       <source>Hyperandrogenemia</source>
       <target>高アンドロゲン血症
</target>
     </trans-unit>
     <trans-unit id="PEO_693_synonyms">
       <source>Hyperandrogenemia (finding)</source>
     </trans-unit>
     <trans-unit id="PEO_694_label">
       <source>Hyperandrogenization syndrome</source>
       <target>高アンドロゲン症
</target>
     </trans-unit>
     <trans-unit id="PEO_694_synonyms">
       <source>Hyperandrogenism</source>
     </trans-unit>
     <trans-unit id="PEO_694_synonyms_1">
       <source>Hyperandrogenization syndrome (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_694_synonyms_2">
       <source>Hyperandrogenisation syndrome</source>
     </trans-unit>
     <trans-unit id="PEO_695_label">
       <source>Hypercoiled umbilical cord</source>
       <target>臍帯過捻転
</target>
     </trans-unit>
     <trans-unit id="PEO_696_label">
       <source>Hyperemesis</source>
       <target>悪阻
</target>
     </trans-unit>
     <trans-unit id="PEO_696_synonyms">
       <source>Hyperemesis (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_697_label">
       <source>Hyperglycemia</source>
       <target>高血糖
</target>
     </trans-unit>
     <trans-unit id="PEO_697_synonyms">
       <source>Hyperglycaemia</source>
     </trans-unit>
     <trans-unit id="PEO_697_synonyms_1">
       <source>Hyperglycemia (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_698_label">
       <source>Hyperhomocysteinemia</source>
       <target>高ホモシステイン血症
</target>
     </trans-unit>
     <trans-unit id="PEO_698_synonyms">
       <source>Hyperhomocysteinemia (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_699_label">
       <source>Hyperlipidemia</source>
       <target>高脂血症
</target>
     </trans-unit>
     <trans-unit id="PEO_700_label">
       <source>Hypertension associated disorders of pregnancy</source>
       <target>妊娠中の高血圧関連疾患
</target>
     </trans-unit>
     <trans-unit id="PEO_700_synonyms">
       <source>http://purl.bioontology.org/ontology/MEDDRA/10020776</source>
     </trans-unit>
     <trans-unit id="PEO_701_label">
       <source>Hypertensive Encephalopathy</source>
       <target>高血圧性脳症
</target>
     </trans-unit>
     <trans-unit id="PEO_701_definition">
       <source>Brain dysfunction or damage resulting from sustained MALIGNANT HYPERTENSION. When BLOOD PRESSURE exceeds the limits of cerebral autoregulation, cerebral blood flow is impaired (BRAIN ISCHEMIA). Clinical manifestations include HEADACHE; NAUSEA; VOMITING; SEIZURES; altered mental status (in some cases progressing to COMA); PAPILLEDEMA; and RETINAL HEMORRHAGE.</source>
     </trans-unit>
     <trans-unit id="PEO_701_synonyms">
       <source>Encephalopathy, Hypertensive</source>
     </trans-unit>
     <trans-unit id="PEO_702_label">
       <source>Hypertensive disorder</source>
       <target>高血圧性疾患
</target>
     </trans-unit>
     <trans-unit id="PEO_702_synonyms">
       <source>BP - High blood pressure</source>
     </trans-unit>
     <trans-unit id="PEO_702_synonyms_1">
       <source>Hypertensive vascular disease</source>
     </trans-unit>
     <trans-unit id="PEO_702_synonyms_2">
       <source>HBP - High blood pressure</source>
     </trans-unit>
     <trans-unit id="PEO_702_synonyms_3">
       <source>Hypertensive disorder, systemic arterial (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_702_synonyms_4">
       <source>Hypertensive vascular degeneration</source>
     </trans-unit>
     <trans-unit id="PEO_702_synonyms_5">
       <source>High blood pressure</source>
     </trans-unit>
     <trans-unit id="PEO_702_synonyms_6">
       <source>Hyperpiesis</source>
     </trans-unit>
     <trans-unit id="PEO_702_synonyms_7">
       <source>HTN - Hypertension</source>
     </trans-unit>
     <trans-unit id="PEO_702_synonyms_8">
       <source>BP+ - Hypertension</source>
     </trans-unit>
     <trans-unit id="PEO_702_synonyms_9">
       <source>HT - Hypertension</source>
     </trans-unit>
     <trans-unit id="PEO_702_synonyms_10">
       <source>Hypertensive disorder, systemic arterial</source>
     </trans-unit>
     <trans-unit id="PEO_702_synonyms_11">
       <source>Elevated blood pressure</source>
     </trans-unit>
     <trans-unit id="PEO_702_synonyms_12">
       <source>Hypertension</source>
     </trans-unit>
     <trans-unit id="PEO_702_synonyms_13">
       <source>High blood pressure disorder</source>
     </trans-unit>
     <trans-unit id="PEO_702_synonyms_14">
       <source>Hyperpiesia</source>
     </trans-unit>
     <trans-unit id="PEO_702_synonyms_15">
       <source>Systemic arterial hypertension</source>
     </trans-unit>
     <trans-unit id="PEO_702_synonyms_16">
       <source>Raised blood pressure</source>
     </trans-unit>
     <trans-unit id="PEO_703_label">
       <source>Hypoxia</source>
       <target>低酸素
</target>
     </trans-unit>
     <trans-unit id="PEO_704_label">
       <source>Hysterectomy</source>
       <target>子宮摘出術
</target>
     </trans-unit>
     <trans-unit id="PEO_704_synonyms">
       <source>Uterus excision</source>
     </trans-unit>
     <trans-unit id="PEO_704_synonyms_1">
       <source>Excision procedure on uterus</source>
     </trans-unit>
     <trans-unit id="PEO_704_synonyms_2">
       <source>Hysterectomy (procedure)</source>
     </trans-unit>
     <trans-unit id="PEO_705_label">
       <source>Image based biomarker</source>
       <target>画像バイオマーカー
</target>
     </trans-unit>
     <trans-unit id="PEO_705_synonyms">
       <source>Image based biomarkers</source>
     </trans-unit>
     <trans-unit id="PEO_705_synonyms_1">
       <source>molecular imaging biomarker</source>
     </trans-unit>
     <trans-unit id="PEO_705_synonyms_2">
       <source>molecular imaging biomarkers</source>
     </trans-unit>
     <trans-unit id="PEO_705_synonyms_3">
       <source>imaging biomarker</source>
     </trans-unit>
     <trans-unit id="PEO_705_synonyms_4">
       <source>neuroimaging biomarker</source>
     </trans-unit>
     <trans-unit id="PEO_705_synonyms_5">
       <source>imaging biomarkers</source>
     </trans-unit>
     <trans-unit id="PEO_705_synonyms_6">
       <source>neuroimaging biomarkers</source>
     </trans-unit>
     <trans-unit id="PEO_706_label">
       <source>Immunosuppression</source>
       <target>免疫抑制
</target>
     </trans-unit>
     <trans-unit id="PEO_706_synonyms">
       <source>Immunosuppression (finding)</source>
     </trans-unit>
     <trans-unit id="PEO_707_label">
       <source>Immunotolerance</source>
       <target>免疫寛容
</target>
     </trans-unit>
     <trans-unit id="PEO_708_label">
       <source>In vitro fertilization</source>
       <target>体外受精
</target>
     </trans-unit>
     <trans-unit id="PEO_708_synonyms">
       <source>In vitro fertilization procedure</source>
     </trans-unit>
     <trans-unit id="PEO_708_synonyms_1">
       <source>Test tube ovum fertilization</source>
     </trans-unit>
     <trans-unit id="PEO_708_synonyms_2">
       <source>Test tube baby technique</source>
     </trans-unit>
     <trans-unit id="PEO_708_synonyms_3">
       <source>Test tube ovum fertilization (procedure)</source>
     </trans-unit>
     <trans-unit id="PEO_708_synonyms_4">
       <source>In vitro fertilisation procedure</source>
     </trans-unit>
     <trans-unit id="PEO_708_synonyms_5">
       <source>Test tube ovum fertilisation</source>
     </trans-unit>
     <trans-unit id="PEO_708_synonyms_6">
       <source>IVF</source>
     </trans-unit>
     <trans-unit id="PEO_708_synonyms_7">
       <source>In vitro fertilisation</source>
     </trans-unit>
     <trans-unit id="PEO_709_label">
       <source>Incidence</source>
       <target>発生率
</target>
     </trans-unit>
     <trans-unit id="PEO_710_label">
       <source>Incidence density ratio</source>
       <target>罹患率比
</target>
     </trans-unit>
     <trans-unit id="PEO_711_label">
       <source>Incidence in non exposed</source>
       <target>非曝露下の発病
</target>
     </trans-unit>
     <trans-unit id="PEO_712_label">
       <source>Incidence rate</source>
       <target>発生率
</target>
     </trans-unit>
     <trans-unit id="PEO_713_label">
       <source>Indian</source>
       <target>インド人
</target>
     </trans-unit>
     <trans-unit id="PEO_713_synonyms">
       <source>Indian (racial group)</source>
     </trans-unit>
     <trans-unit id="PEO_714_label">
       <source>Induced labour</source>
       <target>誘発分娩
</target>
     </trans-unit>
     <trans-unit id="PEO_715_label">
       <source>Infection</source>
       <target>感染
</target>
     </trans-unit>
     <trans-unit id="PEO_716_label">
       <source>Infectious cause</source>
       <target>感染源
</target>
     </trans-unit>
     <trans-unit id="PEO_716_synonyms">
       <source>infections</source>
     </trans-unit>
     <trans-unit id="PEO_716_synonyms_1">
       <source>Infectious causes</source>
     </trans-unit>
     <trans-unit id="PEO_716_synonyms_2">
       <source>infection</source>
     </trans-unit>
     <trans-unit id="PEO_717_label">
       <source>Inflammatory disorder</source>
       <target>炎症性疾患
</target>
     </trans-unit>
     <trans-unit id="PEO_717_synonyms">
       <source>Inflammatory disorder (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_717_synonyms_1">
       <source>Inflammatory disease</source>
     </trans-unit>
     <trans-unit id="PEO_718_label">
       <source>Inflammatory marker</source>
       <target>炎症マーカー
</target>
     </trans-unit>
     <trans-unit id="PEO_718_synonyms">
       <source>Inflammatory markers</source>
     </trans-unit>
     <trans-unit id="PEO_718_synonyms_1">
       <source>inflammatory biomarkers</source>
     </trans-unit>
     <trans-unit id="PEO_718_synonyms_2">
       <source>inflammatory biomarker</source>
     </trans-unit>
     <trans-unit id="PEO_719_label">
       <source>Initial cause</source>
       <target>一次的原因
</target>
     </trans-unit>
     <trans-unit id="PEO_719_synonyms">
       <source>Initial causes</source>
     </trans-unit>
     <trans-unit id="PEO_720_label">
       <source>Insufficient endocervical / transformation zone component in a cervical specimen</source>
       <target>子宮頚部移行帯における不十分なサンプリング
</target>
     </trans-unit>
     <trans-unit id="PEO_720_synonyms">
       <source>Insufficient endocervical / transformation zone component in a cervical specimen (finding)</source>
     </trans-unit>
     <trans-unit id="PEO_721_label">
       <source>Insulin</source>
       <target>インスリン
</target>
     </trans-unit>
     <trans-unit id="PEO_721_synonyms">
       <source>Insulin (substance)</source>
     </trans-unit>
     <trans-unit id="PEO_722_label">
       <source>Insulin resistance</source>
       <target>インスリン抵抗性
</target>
     </trans-unit>
     <trans-unit id="PEO_722_definition">
       <source>`Increased resistance` (PATO:0001650) towards `insulin` (PRO:000009054), that is, diminished effectiveness of insulin in reducing blood glucose levels.</source>
     </trans-unit>
     <trans-unit id="PEO_722_synonyms">
       <source>Sensitivity, Insulin</source>
     </trans-unit>
     <trans-unit id="PEO_722_synonyms_1">
       <source>Resistance, Insulin</source>
     </trans-unit>
     <trans-unit id="PEO_722_synonyms_2">
       <source>Insulin Sensitivity</source>
     </trans-unit>
     <trans-unit id="PEO_723_label">
       <source>Intervillous blood space</source>
       <target>絨毛間腔
</target>
     </trans-unit>
     <trans-unit id="PEO_724_label">
       <source>Intracerebral hemorrhage</source>
       <target>脳内出血
</target>
     </trans-unit>
     <trans-unit id="PEO_725_label">
       <source>Intracranial hemorrhage</source>
       <target>頭蓋内出血
</target>
     </trans-unit>
     <trans-unit id="PEO_725_synonyms">
       <source>Intracranial hemorrhage (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_725_synonyms_1">
       <source>Intracranial haemorrhage</source>
     </trans-unit>
     <trans-unit id="PEO_726_label">
       <source>Intrapartum</source>
       <target>分娩時
</target>
     </trans-unit>
     <trans-unit id="PEO_726_synonyms">
       <source>Intrapartum (qualifier value)</source>
     </trans-unit>
     <trans-unit id="PEO_727_label">
       <source>Intravascular Coagulation</source>
       <target>血管内凝
</target>
     </trans-unit>
     <trans-unit id="PEO_727_synonyms">
       <source></source>
     </trans-unit>
     <trans-unit id="PEO_728_label">
       <source>Intravillous hemorrhage</source>
       <target>絨毛間出血
</target>
     </trans-unit>
     <trans-unit id="PEO_729_label">
       <source>Involving patient in structured therapeutic activities</source>
       <target>Involving patient in structured therapeutic activities
</target>
     </trans-unit>
     <trans-unit id="PEO_730_label">
       <source>Iron supplement</source>
       <target>鉄分サプリメント
</target>
     </trans-unit>
     <trans-unit id="PEO_730_synonyms">
       <source>Iron supplement (substance)</source>
     </trans-unit>
     <trans-unit id="PEO_731_label">
       <source>Irregularly used</source>
       <target>不規則な使用
</target>
     </trans-unit>
     <trans-unit id="PEO_732_label">
       <source>Ischemia placental</source>
       <target>虚血性胎盤
</target>
     </trans-unit>
     <trans-unit id="PEO_733_label">
       <source>Ischemic heart disease</source>
       <target>虚血性心疾患
</target>
     </trans-unit>
     <trans-unit id="PEO_733_synonyms">
       <source>Ischaemic heart disease</source>
     </trans-unit>
     <trans-unit id="PEO_733_synonyms_1">
       <source>Ischemic heart disease (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_733_synonyms_2">
       <source>IHD - Ischaemic heart disease</source>
     </trans-unit>
     <trans-unit id="PEO_733_synonyms_3">
       <source>IHD - Ischemic heart disease</source>
     </trans-unit>
     <trans-unit id="PEO_734_label">
       <source>Ischemic stroke</source>
       <target>虚血性脳卒中
</target>
     </trans-unit>
     <trans-unit id="PEO_734_synonyms">
       <source>Ischaemic stroke</source>
     </trans-unit>
     <trans-unit id="PEO_734_synonyms_1">
       <source>Ischemic stroke (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_735_label">
       <source>Kallidin I</source>
       <target>ブラジキニン
</target>
     </trans-unit>
     <trans-unit id="PEO_735_synonyms">
       <source>Bradykinin</source>
     </trans-unit>
     <trans-unit id="PEO_735_synonyms_1">
       <source>Kallidin I (substance)</source>
     </trans-unit>
     <trans-unit id="PEO_736_label">
       <source>Kidney disease</source>
       <target>腎疾患
</target>
     </trans-unit>
     <trans-unit id="PEO_736_synonyms">
       <source>Nephropathy</source>
     </trans-unit>
     <trans-unit id="PEO_736_synonyms_1">
       <source>Disorder of kidney</source>
     </trans-unit>
     <trans-unit id="PEO_736_synonyms_2">
       <source>Disease of kidney</source>
     </trans-unit>
     <trans-unit id="PEO_736_synonyms_3">
       <source>Kidney disease (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_736_synonyms_4">
       <source>Renal disease</source>
     </trans-unit>
     <trans-unit id="PEO_736_synonyms_5">
       <source>Nephrosis</source>
     </trans-unit>
     <trans-unit id="PEO_736_synonyms_6">
       <source>Renal disorder</source>
     </trans-unit>
     <trans-unit id="PEO_737_label">
       <source>LIGHT Signaling</source>
       <target>LIGHTシグナリング
</target>
     </trans-unit>
     <trans-unit id="PEO_738_label">
       <source>LVEDP</source>
       <target>左室拡張末期圧
</target>
     </trans-unit>
     <trans-unit id="PEO_739_label">
       <source>Labyrinth zone</source>
       <target>ラビリンス（マウスの胎盤構造）
</target>
     </trans-unit>
     <trans-unit id="PEO_740_label">
       <source>Lack of social support</source>
       <target>社会的支援の欠如
</target>
     </trans-unit>
     <trans-unit id="PEO_741_label">
       <source>Large for gestational age</source>
       <target>胎児発育過剰
</target>
     </trans-unit>
     <trans-unit id="PEO_742_label">
       <source>Late-preterm</source>
       <target>後期早産
</target>
     </trans-unit>
     <trans-unit id="PEO_743_label">
       <source>Late fetal death</source>
       <target>後期死産
</target>
     </trans-unit>
     <trans-unit id="PEO_744_label">
       <source>Later in life</source>
       <target>晩年
</target>
     </trans-unit>
     <trans-unit id="PEO_745_label">
       <source>Latitude</source>
       <target>緯度
</target>
     </trans-unit>
     <trans-unit id="PEO_746_label">
       <source>Left-sided unilateral notching</source>
       <target>左側子宮動脈血流のnotch
</target>
     </trans-unit>
     <trans-unit id="PEO_746_synonyms">
       <source>left unilateral notch</source>
     </trans-unit>
     <trans-unit id="PEO_747_label">
       <source>Left ventricular end-diastolic pressure</source>
       <target>左室拡張末期圧
</target>
     </trans-unit>
     <trans-unit id="PEO_747_synonyms">
       <source>Left ventricular end-diastolic pressure (observable entity)</source>
     </trans-unit>
     <trans-unit id="PEO_747_synonyms_1">
       <source>LVEDP - Left ventricular end-diastolic pressure</source>
     </trans-unit>
     <trans-unit id="PEO_748_label">
       <source>Length of gestation at birth</source>
       <target>出生時の妊娠週数
</target>
     </trans-unit>
     <trans-unit id="PEO_748_synonyms">
       <source>Length of gestation at birth (observable entity)</source>
     </trans-unit>
     <trans-unit id="PEO_748_definition">
       <source>Duration of the pregnancy</source>
     </trans-unit>
     <trans-unit id="PEO_748_synonyms_1">
       <source>Gestational age at birth</source>
     </trans-unit>
     <trans-unit id="PEO_749_label">
       <source>Length of gestation at time of procedure</source>
       <target>処置時の妊娠週数
</target>
     </trans-unit>
     <trans-unit id="PEO_749_synonyms">
       <source>Length of gestation at time of procedure (observable entity)</source>
     </trans-unit>
     <trans-unit id="PEO_750_label">
       <source>Lipid metabolism</source>
       <target>脂質代謝
</target>
     </trans-unit>
     <trans-unit id="PEO_750_synonyms">
       <source>lipid metabolism</source>
     </trans-unit>
     <trans-unit id="PEO_751_label">
       <source>Lipid overload</source>
       <target>Lipid overload
</target>
     </trans-unit>
     <trans-unit id="PEO_752_label">
       <source>Live Birth</source>
       <target>出生
</target>
     </trans-unit>
     <trans-unit id="PEO_752_definition">
       <source>The event that a FETUS is born alive with heartbeats or RESPIRATION regardless of GESTATIONAL AGE. Such liveborn is called a newborn infant (INFANT, NEWBORN).</source>
     </trans-unit>
     <trans-unit id="PEO_752_synonyms">
       <source>Live Births</source>
     </trans-unit>
     <trans-unit id="PEO_753_label">
       <source>Loan foreclosure status</source>
       <target>ローン差し押さえ状態
</target>
     </trans-unit>
     <trans-unit id="PEO_753_synonyms">
       <source>Foreclosure on loan</source>
     </trans-unit>
     <trans-unit id="PEO_753_synonyms_1">
       <source>Loan foreclosure status (social concept)</source>
     </trans-unit>
     <trans-unit id="PEO_754_label">
       <source>Longitudinal study</source>
       <target>縦断的研究
</target>
     </trans-unit>
     <trans-unit id="PEO_755_label">
       <source>Low birthweight</source>
       <target>低出生体重
</target>
     </trans-unit>
     <trans-unit id="PEO_756_label">
       <source>Low physical activity</source>
       <target>低い身体活動
</target>
     </trans-unit>
     <trans-unit id="PEO_757_label">
       <source>Lower class economic status</source>
       <target>貧困層
</target>
     </trans-unit>
     <trans-unit id="PEO_757_synonyms">
       <source>poor socio-economic status</source>
     </trans-unit>
     <trans-unit id="PEO_757_synonyms_1">
       <source>low socio-economic</source>
     </trans-unit>
     <trans-unit id="PEO_757_synonyms_2">
       <source>low regional economic status</source>
     </trans-unit>
     <trans-unit id="PEO_757_synonyms_3">
       <source>lower socio-economic status</source>
     </trans-unit>
     <trans-unit id="PEO_757_synonyms_4">
       <source>poverty</source>
     </trans-unit>
     <trans-unit id="PEO_757_synonyms_5">
       <source>low socio economic status</source>
     </trans-unit>
     <trans-unit id="PEO_757_synonyms_6">
       <source>Low income status</source>
     </trans-unit>
     <trans-unit id="PEO_757_synonyms_7">
       <source>Lower class economic status (social concept)</source>
     </trans-unit>
     <trans-unit id="PEO_758_label">
       <source>Lower middle class economic status</source>
       <target>中流層
</target>
     </trans-unit>
     <trans-unit id="PEO_758_synonyms">
       <source>Lower middle class economic status (social concept)</source>
     </trans-unit>
     <trans-unit id="PEO_759_label">
       <source>Lung disease</source>
       <target>肺疾患
</target>
     </trans-unit>
     <trans-unit id="PEO_760_label">
       <source>Lymphopoiesis</source>
       <target>リンパ球新生
</target>
     </trans-unit>
     <trans-unit id="PEO_760_definition">
       <source>Formation of LYMPHOCYTES and PLASMA CELLS from the lymphoid stem cells which develop from the pluripotent HEMATOPOIETIC STEM CELLS in the BONE MARROW. These lymphoid stem cells differentiate into T-LYMPHOCYTES; B-LYMPHOCYTES; PLASMA CELLS; or NK-cells (KILLER CELLS, NATURAL) depending on the organ or tissues (LYMPHOID TISSUE) to which they migrate.</source>
     </trans-unit>
     <trans-unit id="PEO_761_label">
       <source>Macerated stillbirth</source>
       <target>浸軟死産 
</target>
     </trans-unit>
     <trans-unit id="PEO_761_synonyms">
       <source>Macerated stillbirth (finding)</source>
     </trans-unit>
     <trans-unit id="PEO_762_label">
       <source>Magnesium sulfate</source>
       <target>硫酸マグネシウム
</target>
     </trans-unit>
     <trans-unit id="PEO_762_synonyms">
       <source>Magnesium sulphate</source>
     </trans-unit>
     <trans-unit id="PEO_762_synonyms_1">
       <source>Epsom salt</source>
     </trans-unit>
     <trans-unit id="PEO_762_synonyms_2">
       <source>Magnesium sulfate (product)</source>
     </trans-unit>
     <trans-unit id="PEO_763_label">
       <source>Maintaining overall health through regular medical care, diet, and exercise</source>
       <target>通常の治療、食生活、運動で健康を維持する
</target>
     </trans-unit>
     <trans-unit id="PEO_764_label">
       <source>Malaria (disorder)</source>
       <target>マラリア
</target>
     </trans-unit>
     <trans-unit id="PEO_764_label_1">
       <source>Paludism</source>
       <target>マラリア
</target>
     </trans-unit>
     <trans-unit id="PEO_764_label_2">
       <source>Plasmodiosis</source>
       <target>マラリア
</target>
     </trans-unit>
     <trans-unit id="PEO_764_label_3">
       <source>Malaria</source>
       <target>マラリア
</target>
     </trans-unit>
     <trans-unit id="PEO_765_label">
       <source>Malignant tumor of breast</source>
       <target>乳がん
</target>
     </trans-unit>
     <trans-unit id="PEO_765_synonyms">
       <source>Malignant tumour of breast</source>
     </trans-unit>
     <trans-unit id="PEO_765_synonyms_1">
       <source>CA - Breast cancer</source>
     </trans-unit>
     <trans-unit id="PEO_765_synonyms_2">
       <source>Breast cancer</source>
     </trans-unit>
     <trans-unit id="PEO_765_synonyms_3">
       <source>Malignant tumor of breast (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_766_label">
       <source>Malignant tumor of lung</source>
       <target>肺がん
</target>
     </trans-unit>
     <trans-unit id="PEO_766_synonyms">
       <source>Malignant tumor of lung (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_766_synonyms_1">
       <source>Malignant tumour of lung</source>
     </trans-unit>
     <trans-unit id="PEO_766_synonyms_2">
       <source>CA - Lung cancer</source>
     </trans-unit>
     <trans-unit id="PEO_767_label">
       <source>Malnourishment</source>
       <target>栄養不良状態
</target>
     </trans-unit>
     <trans-unit id="PEO_768_label">
       <source>Mann-Whitney test</source>
       <target>マン・ホイットニーのU検定
</target>
     </trans-unit>
     <trans-unit id="PEO_768_synonyms">
       <source>Mann-Whitney tests</source>
     </trans-unit>
     <trans-unit id="PEO_768_synonyms_1">
       <source>Mann-Whitney</source>
     </trans-unit>
     <trans-unit id="PEO_769_label">
       <source>Marital status</source>
       <target>婚姻状態
</target>
     </trans-unit>
     <trans-unit id="PEO_769_synonyms">
       <source>Marital status (observable entity)</source>
     </trans-unit>
     <trans-unit id="PEO_770_label">
       <source>Massive perivillous fibrin deposition</source>
       <target>絨毛周囲の過度の線維素沈着
</target>
     </trans-unit>
     <trans-unit id="PEO_771_label">
       <source>Maternal Organs</source>
       <target>母体臓器
</target>
     </trans-unit>
     <trans-unit id="PEO_772_label">
       <source>Maternal death</source>
       <target>母体死亡
</target>
     </trans-unit>
     <trans-unit id="PEO_772_synonyms">
       <source>Maternal mortality</source>
     </trans-unit>
     <trans-unit id="PEO_772_synonyms_1">
       <source>Maternal death (event)</source>
     </trans-unit>
     <trans-unit id="PEO_773_label">
       <source>Maternal floor infarction</source>
       <target>母体梗塞
</target>
     </trans-unit>
     <trans-unit id="PEO_773_synonyms">
       <source>MFI</source>
     </trans-unit>
     <trans-unit id="PEO_774_label">
       <source>Maternal mortality rate</source>
       <target>母体死亡率
</target>
     </trans-unit>
     <trans-unit id="PEO_775_label">
       <source>Maternal near miss</source>
       <target>Maternal near miss
</target>
     </trans-unit>
     <trans-unit id="PEO_776_label">
       <source>Maternal tobacco use</source>
       <target>母親の喫煙
</target>
     </trans-unit>
     <trans-unit id="PEO_776_synonyms">
       <source>Maternal tobacco use (finding)</source>
     </trans-unit>
     <trans-unit id="PEO_777_label">
       <source>Meconium</source>
       <target>胎便
</target>
     </trans-unit>
     <trans-unit id="PEO_777_synonyms">
       <source>Meconiums</source>
     </trans-unit>
     <trans-unit id="PEO_777_definition">
       <source>The thick green-to-black mucilaginous material found in the intestines of a full-term fetus. It consists of secretions of the INTESTINAL GLANDS; BILE PIGMENTS; FATTY ACIDS; AMNIOTIC FLUID; and intrauterine debris. It constitutes the first stools passed by a newborn.</source>
     </trans-unit>
     <trans-unit id="PEO_778_label">
       <source>Medical history</source>
       <target>病歴
</target>
     </trans-unit>
     <trans-unit id="PEO_778_synonyms">
       <source>Clinical history</source>
     </trans-unit>
     <trans-unit id="PEO_779_label">
       <source>Mental disorder</source>
       <target>精神疾患
</target>
     </trans-unit>
     <trans-unit id="PEO_779_synonyms">
       <source>Psychiatric disorder</source>
     </trans-unit>
     <trans-unit id="PEO_779_synonyms_1">
       <source>Mental disorder (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_779_synonyms_2">
       <source>Mental illness</source>
     </trans-unit>
     <trans-unit id="PEO_779_synonyms_3">
       <source>Psychiatric illness</source>
     </trans-unit>
     <trans-unit id="PEO_779_synonyms_4">
       <source>Mental disease</source>
     </trans-unit>
     <trans-unit id="PEO_779_synonyms_5">
       <source>Mental health disorder</source>
     </trans-unit>
     <trans-unit id="PEO_780_label">
       <source>Metabolic Marker</source>
       <target>代謝マーカー
</target>
     </trans-unit>
     <trans-unit id="PEO_780_synonyms">
       <source>metabolic biomarkers</source>
     </trans-unit>
     <trans-unit id="PEO_780_synonyms_1">
       <source>metabolic biomarker</source>
     </trans-unit>
     <trans-unit id="PEO_780_synonyms_2">
       <source>Metabolic Markers</source>
     </trans-unit>
     <trans-unit id="PEO_781_label">
       <source>Metabolic disease</source>
       <target>代謝疾患
</target>
     </trans-unit>
     <trans-unit id="PEO_781_synonyms">
       <source>MD - Metabolic disorders</source>
     </trans-unit>
     <trans-unit id="PEO_781_synonyms_1">
       <source>Metabolic disorder</source>
     </trans-unit>
     <trans-unit id="PEO_781_synonyms_2">
       <source>Metabolic disease (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_782_label">
       <source>Metabolic encephalopathy</source>
       <target>代謝性脳症
</target>
     </trans-unit>
     <trans-unit id="PEO_782_synonyms">
       <source>Metabolic encephalopathy (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_782_synonyms_1">
       <source>Metabolic brain syndrome</source>
     </trans-unit>
     <trans-unit id="PEO_783_label">
       <source>Metabolic syndrome X</source>
       <target>内臓脂肪症候群
</target>
     </trans-unit>
     <trans-unit id="PEO_783_synonyms">
       <source>Dysmetabolic syndrome X</source>
     </trans-unit>
     <trans-unit id="PEO_783_synonyms_1">
       <source>Reaven&apos;s syndrome</source>
     </trans-unit>
     <trans-unit id="PEO_783_synonyms_2">
       <source>Insulin resistance syndrome</source>
     </trans-unit>
     <trans-unit id="PEO_783_synonyms_3">
       <source>Metabolic syndrome</source>
     </trans-unit>
     <trans-unit id="PEO_783_synonyms_4">
       <source>Metabolic syndrome X (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_784_label">
       <source>Methadone abuse</source>
       <target>メサドン乱用
</target>
     </trans-unit>
     <trans-unit id="PEO_785_label">
       <source>Methamphetamine abuse</source>
       <target>メタンフェタミン乱用
</target>
     </trans-unit>
     <trans-unit id="PEO_786_label">
       <source>Methylation</source>
       <target>メチル化
</target>
     </trans-unit>
     <trans-unit id="PEO_787_label">
       <source>Microvascular Marker</source>
       <target>微小血管マーカ
</target>
     </trans-unit>
     <trans-unit id="PEO_787_synonyms">
       <source>microvascular biomarkers</source>
     </trans-unit>
     <trans-unit id="PEO_787_synonyms_1">
       <source>microvascular biomarker</source>
     </trans-unit>
     <trans-unit id="PEO_787_synonyms_2">
       <source>Microvascular Markers</source>
     </trans-unit>
     <trans-unit id="PEO_788_label">
       <source>Microvillus plasma membrane</source>
       <target>微絨毛細胞膜
</target>
     </trans-unit>
     <trans-unit id="PEO_789_label">
       <source>Mid pregnancy</source>
       <target>妊娠中期
</target>
     </trans-unit>
     <trans-unit id="PEO_790_label">
       <source>Middle cerebral artery</source>
       <target>中大脳動脈
</target>
     </trans-unit>
     <trans-unit id="PEO_790_synonyms">
       <source>MCA</source>
     </trans-unit>
     <trans-unit id="PEO_791_label">
       <source>Middle class economic status</source>
       <target>中流階級
</target>
     </trans-unit>
     <trans-unit id="PEO_791_synonyms">
       <source>Middle class economic status (social concept)</source>
     </trans-unit>
     <trans-unit id="PEO_792_label">
       <source>Miscarriage</source>
       <target>自然流産
</target>
     </trans-unit>
     <trans-unit id="PEO_792_synonyms">
       <source>Vaginal expulsion of product of conception</source>
     </trans-unit>
     <trans-unit id="PEO_792_synonyms_1">
       <source>Vaginal expulsion of fetus</source>
     </trans-unit>
     <trans-unit id="PEO_792_synonyms_2">
       <source>Spontaneous abortion</source>
     </trans-unit>
     <trans-unit id="PEO_792_synonyms_3">
       <source>Miscarriage (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_793_label">
       <source>Miscarriage in first trimester</source>
       <target>妊娠初期の流産
</target>
     </trans-unit>
     <trans-unit id="PEO_793_synonyms">
       <source>Miscarriage in first trimester (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_793_synonyms_1">
       <source>Spontaneous abortion in first trimester</source>
     </trans-unit>
     <trans-unit id="PEO_794_label">
       <source>Miscarriage in second trimester</source>
       <target>妊娠中期の流産
</target>
     </trans-unit>
     <trans-unit id="PEO_794_synonyms">
       <source>Spontaneous abortion in second trimester</source>
     </trans-unit>
     <trans-unit id="PEO_794_synonyms_1">
       <source>Miscarriage in second trimester (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_795_label">
       <source>Mitochondria transport</source>
       <target>ミトコンドリア輸送
</target>
     </trans-unit>
     <trans-unit id="PEO_796_label">
       <source>Mixed collagen vascular disease</source>
       <target>混合膠原血管病
</target>
     </trans-unit>
     <trans-unit id="PEO_796_synonyms">
       <source>Mixed connective tissue disease</source>
     </trans-unit>
     <trans-unit id="PEO_796_synonyms_1">
       <source>Mixed collagen vascular disease (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_796_synonyms_2">
       <source>MCTD - Mixed connective tissue disease</source>
     </trans-unit>
     <trans-unit id="PEO_796_synonyms_3">
       <source>Sharp&apos;s syndrome</source>
     </trans-unit>
     <trans-unit id="PEO_797_label">
       <source>Molecular rolls</source>
       <target>分子の役割
</target>
     </trans-unit>
     <trans-unit id="PEO_798_label">
       <source>Morphine abuse</source>
       <target>モルヒネ乱用
</target>
     </trans-unit>
     <trans-unit id="PEO_799_label">
       <source>Morphologically abnormal structure</source>
       <target>形態異常
</target>
     </trans-unit>
     <trans-unit id="PEO_799_synonyms">
       <source>Morphologically abnormal structure (morphologic abnormality)</source>
     </trans-unit>
     <trans-unit id="PEO_799_synonyms_1">
       <source>Abnormal tissue appearance</source>
     </trans-unit>
     <trans-unit id="PEO_799_synonyms_2">
       <source>Lesion</source>
     </trans-unit>
     <trans-unit id="PEO_800_label">
       <source>Multiorgan failure</source>
       <target>多臓器不全
</target>
     </trans-unit>
     <trans-unit id="PEO_801_label">
       <source>Multiparous</source>
       <target>経産婦
</target>
     </trans-unit>
     <trans-unit id="PEO_801_synonyms">
       <source>Multiparous (finding)</source>
     </trans-unit>
     <trans-unit id="PEO_802_label">
       <source>Multiple pregnancy</source>
       <target>多胎妊娠
</target>
     </trans-unit>
     <trans-unit id="PEO_802_synonyms">
       <source>Multiple pregnancy (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_803_label">
       <source>Multivitamins</source>
       <target>マルチビタミン剤
</target>
     </trans-unit>
     <trans-unit id="PEO_804_label">
       <source>Myometrial structure</source>
       <target>子宮筋腫の構造
</target>
     </trans-unit>
     <trans-unit id="PEO_804_synonyms">
       <source>Myometrial structure (body structure)</source>
     </trans-unit>
     <trans-unit id="PEO_804_synonyms_1">
       <source>Myometrium</source>
     </trans-unit>
     <trans-unit id="PEO_805_label">
       <source>N-Acetyl-Cysteine</source>
       <target>アセチルシステイン
</target>
     </trans-unit>
     <trans-unit id="PEO_805_synonyms">
       <source>NAC</source>
     </trans-unit>
     <trans-unit id="PEO_806_label">
       <source>NFKB</source>
       <target>NFKB
</target>
     </trans-unit>
     <trans-unit id="PEO_807_label">
       <source>NS1619</source>
       <target>NS1619
</target>
     </trans-unit>
     <trans-unit id="PEO_807_synonyms">
       <source>A selective large conductance calcium activated potassium channel activator</source>
     </trans-unit>
     <trans-unit id="PEO_808_label">
       <source>NS309</source>
       <target>NS309
</target>
     </trans-unit>
     <trans-unit id="PEO_808_synonyms">
       <source>A Ca2+-activated IK/SK potassium channel activator</source>
     </trans-unit>
     <trans-unit id="PEO_809_label">
       <source>Neonatal disorder</source>
       <target>新生児障害
</target>
     </trans-unit>
     <trans-unit id="PEO_809_synonyms">
       <source>Neonatal disorder (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_809_synonyms_1">
       <source>Neonatal disease</source>
     </trans-unit>
     <trans-unit id="PEO_810_label">
       <source>Neonatal mortality rate</source>
       <target>新生児死亡率
</target>
     </trans-unit>
     <trans-unit id="PEO_811_label">
       <source>Neonate observable</source>
       <target>新生児の所見
</target>
     </trans-unit>
     <trans-unit id="PEO_811_synonyms">
       <source>Neonate observable (observable entity)</source>
     </trans-unit>
     <trans-unit id="PEO_812_label">
       <source>Neoplasm by body site</source>
       <target>腫瘍
</target>
     </trans-unit>
     <trans-unit id="PEO_812_synonyms">
       <source>Neoplasm by body site (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_813_label">
       <source>Neurodegeneration</source>
       <target>神経変性
</target>
     </trans-unit>
     <trans-unit id="PEO_814_label">
       <source>Neurodevelopment</source>
       <target>神経発生
</target>
     </trans-unit>
     <trans-unit id="PEO_815_label">
       <source>Neurological dysfunction</source>
       <target>神経疾患
</target>
     </trans-unit>
     <trans-unit id="PEO_816_label">
       <source>Never intake alcohol</source>
       <target>非飲酒者
</target>
     </trans-unit>
     <trans-unit id="PEO_817_label">
       <source>Never used tobacco</source>
       <target>非喫煙者
</target>
     </trans-unit>
     <trans-unit id="PEO_817_synonyms">
       <source>Never used tobacco (finding)</source>
     </trans-unit>
     <trans-unit id="PEO_818_label">
       <source>Newborn death</source>
       <target>新生児死亡
</target>
     </trans-unit>
     <trans-unit id="PEO_818_synonyms">
       <source>Newborn death (event)</source>
     </trans-unit>
     <trans-unit id="PEO_818_synonyms_1">
       <source>Neonatal death</source>
     </trans-unit>
     <trans-unit id="PEO_819_label">
       <source>Nitrosylation</source>
       <target>ニトロシル化
</target>
     </trans-unit>
     <trans-unit id="PEO_819_synonyms">
       <source>protein amino acid nitrosylation</source>
     </trans-unit>
     <trans-unit id="PEO_820_label">
       <source>Non-HDL- C</source>
       <target>nonHDLコレステロール
</target>
     </trans-unit>
     <trans-unit id="PEO_821_label">
       <source>Nonreassuring fetal status</source>
       <target>胎児機能不全
</target>
     </trans-unit>
     <trans-unit id="PEO_821_synonyms">
       <source>Fetal distress</source>
     </trans-unit>
     <trans-unit id="PEO_821_synonyms_1">
       <source>Fetal distress (finding)</source>
     </trans-unit>
     <trans-unit id="PEO_821_synonyms_2">
       <source>Nonreassuring foetal status</source>
     </trans-unit>
     <trans-unit id="PEO_821_synonyms_3">
       <source>Foetal distress</source>
     </trans-unit>
     <trans-unit id="PEO_822_label">
       <source>Nonsteroidal Antiinflamatory drug</source>
       <target>非ステロイド性抗炎症薬
</target>
     </trans-unit>
     <trans-unit id="PEO_822_synonyms">
       <source>non-steroidal anti-inflammatory drug</source>
     </trans-unit>
     <trans-unit id="PEO_822_synonyms_1">
       <source>NAIDs</source>
     </trans-unit>
     <trans-unit id="PEO_822_synonyms_2">
       <source>Non steroidal antiinflamatory analgesics</source>
     </trans-unit>
     <trans-unit id="PEO_822_synonyms_3">
       <source>nonsteroidal anti-inflammatory drugs</source>
     </trans-unit>
     <trans-unit id="PEO_822_synonyms_4">
       <source>non-steroidal anti-inflammatory drugs</source>
     </trans-unit>
     <trans-unit id="PEO_822_synonyms_5">
       <source>Non steroidal antiinflamatory agents</source>
     </trans-unit>
     <trans-unit id="PEO_822_synonyms_6">
       <source>NSAIMS</source>
     </trans-unit>
     <trans-unit id="PEO_822_synonyms_7">
       <source>Nonsteroidal Antiinflamatory drugs</source>
     </trans-unit>
     <trans-unit id="PEO_822_synonyms_8">
       <source>Non steroidal antiinflamatory medicines</source>
     </trans-unit>
     <trans-unit id="PEO_822_synonyms_9">
       <source>NSAID&apos;s</source>
     </trans-unit>
     <trans-unit id="PEO_822_synonyms_10">
       <source>NSAID</source>
     </trans-unit>
     <trans-unit id="PEO_823_label">
       <source>Normal functions of organs</source>
       <target>臓器の正常機能
</target>
     </trans-unit>
     <trans-unit id="PEO_824_label">
       <source>Nulliparous</source>
       <target>未産婦
</target>
     </trans-unit>
     <trans-unit id="PEO_824_synonyms">
       <source>Nulliparous (finding)</source>
     </trans-unit>
     <trans-unit id="PEO_825_label">
       <source>Nutritional condition</source>
       <target>栄養状態
</target>
     </trans-unit>
     <trans-unit id="PEO_826_label">
       <source>Obesity</source>
       <target>肥満
</target>
     </trans-unit>
     <trans-unit id="PEO_826_synonyms">
       <source>Adiposity</source>
     </trans-unit>
     <trans-unit id="PEO_826_definition">
       <source>BMI over 30</source>
     </trans-unit>
     <trans-unit id="PEO_826_synonyms_1">
       <source>Adiposis</source>
     </trans-unit>
     <trans-unit id="PEO_826_synonyms_2">
       <source>Obesity (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_827_label">
       <source>Obstetric complications</source>
       <target>分娩合併症
</target>
     </trans-unit>
     <trans-unit id="PEO_827_synonyms">
       <source>Obstetric labor complication</source>
     </trans-unit>
     <trans-unit id="PEO_828_label">
       <source>Obstetric umbilical artery Doppler</source>
       <target>産科臍帯動脈ドプラー
</target>
     </trans-unit>
     <trans-unit id="PEO_828_synonyms">
       <source>Doppler ultrasound scan of umbilical artery</source>
     </trans-unit>
     <trans-unit id="PEO_828_synonyms_1">
       <source>Obstetric umbilical artery Doppler (procedure)</source>
     </trans-unit>
     <trans-unit id="PEO_829_label">
       <source>Obstetric uterine artery Doppler</source>
       <target>産科子宮動脈ドプラー
</target>
     </trans-unit>
     <trans-unit id="PEO_829_synonyms">
       <source>Doppler ultrasound scan of uterine artery</source>
     </trans-unit>
     <trans-unit id="PEO_829_synonyms_1">
       <source>Obstetric uterine artery Doppler (procedure)</source>
     </trans-unit>
     <trans-unit id="PEO_830_label">
       <source>Obstructed labor</source>
       <target>分娩停止
</target>
     </trans-unit>
     <trans-unit id="PEO_830_synonyms">
       <source>Obstructed labor (finding)</source>
     </trans-unit>
     <trans-unit id="PEO_830_synonyms_1">
       <source>Obstructed labour</source>
     </trans-unit>
     <trans-unit id="PEO_831_label">
       <source>Odds ratio</source>
       <target>オッズ比
</target>
     </trans-unit>
     <trans-unit id="PEO_832_label">
       <source>Oligohydramnios</source>
       <target>羊水過少
</target>
     </trans-unit>
     <trans-unit id="PEO_832_synonyms">
       <source>Deficient liquor</source>
     </trans-unit>
     <trans-unit id="PEO_832_synonyms_1">
       <source>Scanty liquor</source>
     </trans-unit>
     <trans-unit id="PEO_832_synonyms_2">
       <source>Oligohydramnios (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_832_synonyms_3">
       <source>Reduced liquor volume</source>
     </trans-unit>
     <trans-unit id="PEO_833_label">
       <source>Oliguria</source>
       <target>乏尿
</target>
     </trans-unit>
     <trans-unit id="PEO_833_synonyms">
       <source>Oligouria</source>
     </trans-unit>
     <trans-unit id="PEO_833_synonyms_1">
       <source>Oliguria (finding)</source>
     </trans-unit>
     <trans-unit id="PEO_833_synonyms_2">
       <source>Urine output low</source>
     </trans-unit>
     <trans-unit id="PEO_833_synonyms_3">
       <source>Passes too little urine</source>
     </trans-unit>
     <trans-unit id="PEO_834_label">
       <source>Omental Vessels</source>
       <target>大網血管
</target>
     </trans-unit>
     <trans-unit id="PEO_835_label">
       <source>Open populations</source>
       <target>開放人口
</target>
     </trans-unit>
     <trans-unit id="PEO_836_label">
       <source>Organelle</source>
       <target>細胞小器官
</target>
     </trans-unit>
     <trans-unit id="PEO_836_synonyms">
       <source>Organelle structure</source>
     </trans-unit>
     <trans-unit id="PEO_836_synonyms_1">
       <source>Organelle (cell structure)</source>
     </trans-unit>
     <trans-unit id="PEO_837_label">
       <source>Ovarian Diseases</source>
       <target>卵巣疾患
</target>
     </trans-unit>
     <trans-unit id="PEO_837_synonyms">
       <source>Diseases, Ovarian</source>
     </trans-unit>
     <trans-unit id="PEO_837_synonyms_1">
       <source>Ovarian Disease</source>
     </trans-unit>
     <trans-unit id="PEO_837_synonyms_2">
       <source>Disease, Ovarian</source>
     </trans-unit>
     <trans-unit id="PEO_838_label">
       <source>Ovarian hyperstimulation syndrome</source>
       <target>卵巣過剰刺激症候群
</target>
     </trans-unit>
     <trans-unit id="PEO_838_synonyms">
       <source>Secondary Meig&apos;s syndrome</source>
     </trans-unit>
     <trans-unit id="PEO_838_synonyms_1">
       <source>Ovarian hyperstimulation syndrome (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_839_label">
       <source>Overweight</source>
       <target>過体重
</target>
     </trans-unit>
     <trans-unit id="PEO_839_synonyms">
       <source>Patient overweight</source>
     </trans-unit>
     <trans-unit id="PEO_839_synonyms_1">
       <source>Overweight (finding)</source>
     </trans-unit>
     <trans-unit id="PEO_840_label">
       <source>Oxidative stress</source>
       <target>酸化ストレス
</target>
     </trans-unit>
     <trans-unit id="PEO_840_synonyms">
       <source>oxidative damage</source>
     </trans-unit>
     <trans-unit id="PEO_841_label">
       <source>Pain</source>
       <target>疼痛
</target>
     </trans-unit>
     <trans-unit id="PEO_841_synonyms">
       <source>Part hurts</source>
     </trans-unit>
     <trans-unit id="PEO_841_synonyms_1">
       <source>Painful</source>
     </trans-unit>
     <trans-unit id="PEO_841_synonyms_2">
       <source>Dolor</source>
     </trans-unit>
     <trans-unit id="PEO_841_synonyms_3">
       <source>Pain (finding)</source>
     </trans-unit>
     <trans-unit id="PEO_841_synonyms_4">
       <source>Pain observations</source>
     </trans-unit>
     <trans-unit id="PEO_842_label">
       <source>Paralysis from birth trauma</source>
       <target>出生時の障害による麻痺
</target>
     </trans-unit>
     <trans-unit id="PEO_842_synonyms">
       <source>Paralysis from birth trauma (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_843_label">
       <source>Parents’ country of birth</source>
     </trans-unit>
     <trans-unit id="PEO_844_label">
       <source>Parity</source>
       <target>出産歴
</target>
     </trans-unit>
     <trans-unit id="PEO_844_synonyms">
       <source>Parity (observable entity)</source>
     </trans-unit>
     <trans-unit id="PEO_845_label">
       <source>Partial Thromboplastin Time</source>
       <target>部分トロンボプラスチン時間
</target>
     </trans-unit>
     <trans-unit id="PEO_845_synonyms">
       <source>Coagulation Time, Kaolin-Cephalin</source>
     </trans-unit>
     <trans-unit id="PEO_845_definition">
       <source>The time required for the appearance of FIBRIN strands following the mixing of PLASMA with phospholipid platelet substitute (e.g., crude cephalins, soybean phosphatides). It is a test of the intrinsic pathway (factors VIII, IX, XI, and XII) and the common pathway (fibrinogen, prothrombin, factors V and X) of BLOOD COAGULATION. It is used as a screening test and to monitor HEPARIN therapy.</source>
     </trans-unit>
     <trans-unit id="PEO_845_synonyms_1">
       <source>Kaolin Cephalin Coagulation Time</source>
     </trans-unit>
     <trans-unit id="PEO_845_synonyms_2">
       <source>Coagulation Time, Cephalin-Kaolin</source>
     </trans-unit>
     <trans-unit id="PEO_845_synonyms_3">
       <source>Activated Partial Thromboplastin Time</source>
     </trans-unit>
     <trans-unit id="PEO_845_synonyms_4">
       <source>Thromboplastin Time, Partial</source>
     </trans-unit>
     <trans-unit id="PEO_845_synonyms_5">
       <source>Coagulation Time, Cephalin Kaolin</source>
     </trans-unit>
     <trans-unit id="PEO_845_synonyms_6">
       <source>Kaolin-Cephalin Coagulation Time</source>
     </trans-unit>
     <trans-unit id="PEO_845_synonyms_7">
       <source>Cephalin-Kaolin Coagulation Time</source>
     </trans-unit>
     <trans-unit id="PEO_845_synonyms_8">
       <source>Cephalin Kaolin Coagulation Time</source>
     </trans-unit>
     <trans-unit id="PEO_846_label">
       <source>Passive smoker</source>
       <target>受動喫煙者 
</target>
     </trans-unit>
     <trans-unit id="PEO_846_synonyms">
       <source>ETS - Exposed to tobacco smoke</source>
     </trans-unit>
     <trans-unit id="PEO_846_synonyms_1">
       <source>Involuntary smoker</source>
     </trans-unit>
     <trans-unit id="PEO_846_synonyms_2">
       <source>Exposed to environmental tobacco smoke</source>
     </trans-unit>
     <trans-unit id="PEO_846_synonyms_3">
       <source>Passive smoker (finding)</source>
     </trans-unit>
     <trans-unit id="PEO_846_synonyms_4">
       <source>Exposed to second hand tobacco smoke</source>
     </trans-unit>
     <trans-unit id="PEO_846_synonyms_5">
       <source>Exposed to tobacco smoke</source>
     </trans-unit>
     <trans-unit id="PEO_847_label">
       <source>Pathway</source>
       <target>パスウェイ
</target>
     </trans-unit>
     <trans-unit id="PEO_848_label">
       <source>Peptide</source>
       <target>ペプチド
</target>
     </trans-unit>
     <trans-unit id="PEO_849_label">
       <source>Perfluoroalkylated acids and related compounds</source>
       <target>ペルフルオロオクタンスルホン酸と関連化合物
</target>
     </trans-unit>
     <trans-unit id="PEO_849_synonyms">
       <source>PFAS</source>
     </trans-unit>
     <trans-unit id="PEO_850_label">
       <source>Perfluorohexanesulfonic acid</source>
       <target>ペルフルオロヘキサンスルホン酸
</target>
     </trans-unit>
     <trans-unit id="PEO_850_synonyms">
       <source>PFHS cpd</source>
     </trans-unit>
     <trans-unit id="PEO_850_synonyms_1">
       <source>perfluorohexanesulfonate</source>
     </trans-unit>
     <trans-unit id="PEO_850_synonyms_2">
       <source>PFHxS</source>
     </trans-unit>
     <trans-unit id="PEO_851_label">
       <source>Periconceptional</source>
       <target>妊娠前後
</target>
     </trans-unit>
     <trans-unit id="PEO_852_label">
       <source>Perinatal asphyxia</source>
       <target>周産期仮死
</target>
     </trans-unit>
     <trans-unit id="PEO_852_synonyms">
       <source>Perinatal asphyxia (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_853_label">
       <source>Peripheral vascular</source>
       <target>末梢血管
</target>
     </trans-unit>
     <trans-unit id="PEO_854_label">
       <source>Peripheral vascular disease</source>
       <target>末梢血管疾患
</target>
     </trans-unit>
     <trans-unit id="PEO_854_synonyms">
       <source>PVD-peripheral vascular disease</source>
     </trans-unit>
     <trans-unit id="PEO_854_synonyms_1">
       <source>Peripheral vascular disease (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_855_label">
       <source>Person time incidence rate</source>
       <target>人時発生率
</target>
     </trans-unit>
     <trans-unit id="PEO_856_label">
       <source>Phenotypic functions</source>
       <target>表現系機能
</target>
     </trans-unit>
     <trans-unit id="PEO_857_label">
       <source>Phosphorylation</source>
       <target>リン酸化
</target>
     </trans-unit>
     <trans-unit id="PEO_858_label">
       <source>Physically active</source>
       <target>身体機能が活発な
</target>
     </trans-unit>
     <trans-unit id="PEO_858_synonyms">
       <source>Physically active (finding)</source>
     </trans-unit>
     <trans-unit id="PEO_859_label">
       <source>Physiological stress</source>
       <target>生理的ストレス
</target>
     </trans-unit>
     <trans-unit id="PEO_859_synonyms">
       <source>Physiological stress (attribute)</source>
     </trans-unit>
     <trans-unit id="PEO_860_label">
       <source>Physiological test</source>
       <target>生理学的検査
</target>
     </trans-unit>
     <trans-unit id="PEO_861_label">
       <source>Pituitary apoplexy</source>
       <target>下垂体卒中
</target>
     </trans-unit>
     <trans-unit id="PEO_861_synonyms">
       <source>Pituitary apoplexy (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_862_label">
       <source>Placebo controlled study</source>
       <target>プラセボ対照研究
</target>
     </trans-unit>
     <trans-unit id="PEO_862_synonyms">
       <source>Placebo controlled studies</source>
     </trans-unit>
     <trans-unit id="PEO_862_synonyms_1">
       <source>placebo-controlled trials</source>
     </trans-unit>
     <trans-unit id="PEO_862_synonyms_2">
       <source>placebo-controlled trial</source>
     </trans-unit>
     <trans-unit id="PEO_862_synonyms_3">
       <source>placebo-controlled studies</source>
     </trans-unit>
     <trans-unit id="PEO_862_synonyms_4">
       <source>placebo-controlled study</source>
     </trans-unit>
     <trans-unit id="PEO_863_label">
       <source>Placenta previa</source>
       <target>前置胎盤
</target>
     </trans-unit>
     <trans-unit id="PEO_863_synonyms">
       <source>Placenta praevia</source>
     </trans-unit>
     <trans-unit id="PEO_863_synonyms_1">
       <source>PP - Placenta praevia</source>
     </trans-unit>
     <trans-unit id="PEO_863_synonyms_2">
       <source>Placenta previa (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_863_synonyms_3">
       <source>PP - Placenta previa</source>
     </trans-unit>
     <trans-unit id="PEO_864_label">
       <source>Placental Apoptosis</source>
       <target>胎盤のアポトーシス
</target>
     </trans-unit>
     <trans-unit id="PEO_865_label">
       <source>Placental Hematoma</source>
       <target>胎盤血腫
</target>
     </trans-unit>
     <trans-unit id="PEO_865_synonyms">
       <source>Subchorionic Hematoma</source>
     </trans-unit>
     <trans-unit id="PEO_865_synonyms_1">
       <source>Subchorionic Hemorrhage</source>
     </trans-unit>
     <trans-unit id="PEO_866_label">
       <source>Placental Villous Explant</source>
       <target>胎盤絨毛器官培養
</target>
     </trans-unit>
     <trans-unit id="PEO_867_label">
       <source>Placental abruption</source>
       <target>胎盤早期剥離
</target>
     </trans-unit>
     <trans-unit id="PEO_867_synonyms">
       <source>Premature detachment of placenta</source>
     </trans-unit>
     <trans-unit id="PEO_867_synonyms_1">
       <source>Abruptio placentae</source>
     </trans-unit>
     <trans-unit id="PEO_867_synonyms_2">
       <source>Placental abruption (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_867_synonyms_3">
       <source>Premature separation of placenta</source>
     </trans-unit>
     <trans-unit id="PEO_867_synonyms_4">
       <source>Premature detachment of normally implanted placenta</source>
     </trans-unit>
     <trans-unit id="PEO_867_synonyms_5">
       <source>Ablatio placentae</source>
     </trans-unit>
     <trans-unit id="PEO_868_label">
       <source>Placental cell</source>
       <target>胎盤細胞
</target>
     </trans-unit>
     <trans-unit id="PEO_869_label">
       <source>Placental damage</source>
       <target>胎盤のダメージ
</target>
     </trans-unit>
     <trans-unit id="PEO_870_label">
       <source>Placental edema</source>
       <target>胎盤水腫
</target>
     </trans-unit>
     <trans-unit id="PEO_871_label">
       <source>Placental explants</source>
       <target>胎盤器官培養
</target>
     </trans-unit>
     <trans-unit id="PEO_872_label">
       <source>Placental finding</source>
       <target>胎盤所見
</target>
     </trans-unit>
     <trans-unit id="PEO_872_synonyms">
       <source>Placental finding (finding)</source>
     </trans-unit>
     <trans-unit id="PEO_872_synonyms_1">
       <source>Placental details</source>
     </trans-unit>
     <trans-unit id="PEO_873_label">
       <source>Placental implantation</source>
       <target>胎盤着床
</target>
     </trans-unit>
     <trans-unit id="PEO_874_label">
       <source>Placental infarct</source>
       <target>胎盤梗塞
</target>
     </trans-unit>
     <trans-unit id="PEO_874_synonyms">
       <source>Placental infarct (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_874_synonyms_1">
       <source>Placental infarction</source>
     </trans-unit>
     <trans-unit id="PEO_875_label">
       <source>Placental microvesicles</source>
       <target>胎盤由来の微小胞
</target>
     </trans-unit>
     <trans-unit id="PEO_875_synonyms">
       <source>STBM</source>
     </trans-unit>
     <trans-unit id="PEO_875_synonyms_1">
       <source>Syncytiotrophoblast microvesicles</source>
     </trans-unit>
     <trans-unit id="PEO_876_label">
       <source>Placental perfusion</source>
       <target>胎盤灌流
</target>
     </trans-unit>
     <trans-unit id="PEO_876_synonyms">
       <source>perfusion</source>
     </trans-unit>
     <trans-unit id="PEO_877_label">
       <source>Placental remodeling</source>
       <target>胎盤リモデリング
</target>
     </trans-unit>
     <trans-unit id="PEO_878_label">
       <source>Placental uterine interface</source>
       <target>胎盤子宮インターフェース
</target>
     </trans-unit>
     <trans-unit id="PEO_879_label">
       <source>Placental vascularization</source>
       <target>胎盤血管新生
</target>
     </trans-unit>
     <trans-unit id="PEO_880_label">
       <source>Placentation</source>
       <target>胎盤形成
</target>
     </trans-unit>
     <trans-unit id="PEO_880_synonyms">
       <source>Placentation, function (observable entity)</source>
     </trans-unit>
     <trans-unit id="PEO_880_synonyms_1">
       <source>Placentation, function</source>
     </trans-unit>
     <trans-unit id="PEO_881_label">
       <source>Plasma</source>
       <target>血漿
</target>
     </trans-unit>
     <trans-unit id="PEO_881_synonyms">
       <source>Plasma (substance)</source>
     </trans-unit>
     <trans-unit id="PEO_882_label">
       <source>Plasma cell</source>
       <target>プラズマ細胞
</target>
     </trans-unit>
     <trans-unit id="PEO_882_synonyms">
       <source>Plasmocyte</source>
     </trans-unit>
     <trans-unit id="PEO_882_synonyms_1">
       <source>Plasma cell (cell)</source>
     </trans-unit>
     <trans-unit id="PEO_882_synonyms_2">
       <source>Plasmacyte</source>
     </trans-unit>
     <trans-unit id="PEO_883_label">
       <source>Platelet</source>
       <target>血小板
</target>
     </trans-unit>
     <trans-unit id="PEO_883_synonyms">
       <source>Platelets</source>
     </trans-unit>
     <trans-unit id="PEO_883_synonyms_1">
       <source>Thrombocyte</source>
     </trans-unit>
     <trans-unit id="PEO_883_synonyms_2">
       <source>Platelet (cell structure)</source>
     </trans-unit>
     <trans-unit id="PEO_883_synonyms_3">
       <source>PLT - Platelet</source>
     </trans-unit>
     <trans-unit id="PEO_883_synonyms_4">
       <source>PLT - Platelets</source>
     </trans-unit>
     <trans-unit id="PEO_883_synonyms_5">
       <source>http://purl.bioontology.org/ontology/SNOMEDCT/16378004</source>
     </trans-unit>
     <trans-unit id="PEO_884_label">
       <source>Platelet active drugs</source>
       <target>血小板活性化薬
</target>
     </trans-unit>
     <trans-unit id="PEO_885_label">
       <source>Platelet count</source>
       <target>血小板数
</target>
     </trans-unit>
     <trans-unit id="PEO_885_synonyms">
       <source>Platelet count (procedure)</source>
     </trans-unit>
     <trans-unit id="PEO_885_synonyms_1">
       <source>Plt - Platelet count</source>
     </trans-unit>
     <trans-unit id="PEO_885_synonyms_2">
       <source>Platelet count - observation</source>
     </trans-unit>
     <trans-unit id="PEO_886_label">
       <source>Platelet count below reference range</source>
       <target>血小板減少症
</target>
     </trans-unit>
     <trans-unit id="PEO_886_synonyms">
       <source>Platelet count below reference range (finding)</source>
     </trans-unit>
     <trans-unit id="PEO_886_synonyms_1">
       <source>Thrombocytopenia</source>
     </trans-unit>
     <trans-unit id="PEO_887_label">
       <source>Polycystic ovaries</source>
       <target>多嚢胞性卵巣
</target>
     </trans-unit>
     <trans-unit id="PEO_887_synonyms">
       <source>Multicystic ovaries</source>
     </trans-unit>
     <trans-unit id="PEO_887_synonyms_1">
       <source>Polycystic ovarian disease</source>
     </trans-unit>
     <trans-unit id="PEO_887_synonyms_2">
       <source>Stein-Leventhal syndrome</source>
     </trans-unit>
     <trans-unit id="PEO_887_synonyms_3">
       <source>Sclerocystic ovary syndrome</source>
     </trans-unit>
     <trans-unit id="PEO_887_synonyms_4">
       <source>PCOS - Polycystic ovarian syndrome</source>
     </trans-unit>
     <trans-unit id="PEO_887_synonyms_5">
       <source>Polycystic ovarian syndrome</source>
     </trans-unit>
     <trans-unit id="PEO_887_synonyms_6">
       <source>PCO - Polycystic ovaries</source>
     </trans-unit>
     <trans-unit id="PEO_887_synonyms_7">
       <source>Polycystic ovaries (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_887_synonyms_8">
       <source>Polycystic ovary syndrome</source>
     </trans-unit>
     <trans-unit id="PEO_887_synonyms_9">
       <source>PCOD - Polycystic ovarian disease</source>
     </trans-unit>
     <trans-unit id="PEO_887_synonyms_10">
       <source>Cystic disease of ovaries</source>
     </trans-unit>
     <trans-unit id="PEO_888_label">
       <source>Polyhydramnios</source>
       <target>羊水過多
</target>
     </trans-unit>
     <trans-unit id="PEO_888_synonyms">
       <source>Polyhydramnios (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_888_synonyms_1">
       <source>Excessive liquor</source>
     </trans-unit>
     <trans-unit id="PEO_888_synonyms_2">
       <source>Hydramnios</source>
     </trans-unit>
     <trans-unit id="PEO_889_label">
       <source>Poor education</source>
       <target>貧しい教育
</target>
     </trans-unit>
     <trans-unit id="PEO_889_synonyms">
       <source>Poor education (finding)</source>
     </trans-unit>
     <trans-unit id="PEO_890_label">
       <source>Poor neonatal condition</source>
       <target>新生児の状態不良
</target>
     </trans-unit>
     <trans-unit id="PEO_891_label">
       <source>Poor placental development</source>
       <target>胎盤形成不全
</target>
     </trans-unit>
     <trans-unit id="PEO_892_label">
       <source>Poor uteroplacental perfusion</source>
       <target>子宮胎盤灌流不全
</target>
     </trans-unit>
     <trans-unit id="PEO_893_label">
       <source>Population</source>
       <target>母集団
</target>
     </trans-unit>
     <trans-unit id="PEO_893_synonyms">
       <source>Populations</source>
     </trans-unit>
     <trans-unit id="PEO_894_label">
       <source>Post translational modification</source>
       <target>翻訳後修飾
</target>
     </trans-unit>
     <trans-unit id="PEO_894_synonyms">
       <source>posttranslational amino acid modifications</source>
     </trans-unit>
     <trans-unit id="PEO_894_synonyms_1">
       <source>post-translational amino acid modification</source>
     </trans-unit>
     <trans-unit id="PEO_894_synonyms_2">
       <source>posttranslational protein modification</source>
     </trans-unit>
     <trans-unit id="PEO_894_synonyms_3">
       <source>PTM</source>
     </trans-unit>
     <trans-unit id="PEO_894_synonyms_4">
       <source>post-translational modifications</source>
     </trans-unit>
     <trans-unit id="PEO_894_synonyms_5">
       <source>post-translational amino acid modifications</source>
     </trans-unit>
     <trans-unit id="PEO_894_synonyms_6">
       <source>post-translational modification</source>
     </trans-unit>
     <trans-unit id="PEO_894_synonyms_7">
       <source>posttranslational protein modifications</source>
     </trans-unit>
     <trans-unit id="PEO_894_synonyms_8">
       <source>posttranslational modifications</source>
     </trans-unit>
     <trans-unit id="PEO_894_synonyms_9">
       <source>posttranslational modification</source>
     </trans-unit>
     <trans-unit id="PEO_894_synonyms_10">
       <source>Post translational modifications</source>
     </trans-unit>
     <trans-unit id="PEO_894_synonyms_11">
       <source>posttranslational amino acid modification</source>
     </trans-unit>
     <trans-unit id="PEO_895_label">
       <source>Postmenopausal state</source>
       <target>閉経期後状態
</target>
     </trans-unit>
     <trans-unit id="PEO_896_label">
       <source>Postnatal</source>
       <target>出生後
</target>
     </trans-unit>
     <trans-unit id="PEO_896_synonyms">
       <source>Postnatal (qualifier value)</source>
     </trans-unit>
     <trans-unit id="PEO_897_label">
       <source>Postneonatal death</source>
       <target>乳児死亡
</target>
     </trans-unit>
     <trans-unit id="PEO_897_synonyms">
       <source>Postneonatal death (event)</source>
     </trans-unit>
     <trans-unit id="PEO_897_definition">
       <source>Death of an infant after 28 days of age and before 1 year of age</source>
     </trans-unit>
     <trans-unit id="PEO_898_label">
       <source>Postpartum</source>
       <target>分娩後
</target>
     </trans-unit>
     <trans-unit id="PEO_898_synonyms">
       <source>Puerperal</source>
     </trans-unit>
     <trans-unit id="PEO_898_synonyms_1">
       <source>Postpartum (qualifier value)</source>
     </trans-unit>
     <trans-unit id="PEO_899_label">
       <source>Postpartum Infections</source>
       <target>産後感染
</target>
     </trans-unit>
     <trans-unit id="PEO_900_label">
       <source>Postpartum hemorrhage</source>
       <target>分娩後出血
</target>
     </trans-unit>
     <trans-unit id="PEO_900_synonyms">
       <source>PPH - Postpartum haemorrhage</source>
     </trans-unit>
     <trans-unit id="PEO_900_synonyms_1">
       <source>Haemorrhage after delivery of foetus</source>
     </trans-unit>
     <trans-unit id="PEO_900_synonyms_2">
       <source>Hemorrhage after delivery of fetus</source>
     </trans-unit>
     <trans-unit id="PEO_900_synonyms_3">
       <source>Bleeding postpartum</source>
     </trans-unit>
     <trans-unit id="PEO_900_synonyms_4">
       <source>Postpartum haemorrhage</source>
     </trans-unit>
     <trans-unit id="PEO_900_synonyms_5">
       <source>Postpartum hemorrhage (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_900_synonyms_6">
       <source>PPH - Postpartum hemorrhage</source>
     </trans-unit>
     <trans-unit id="PEO_901_label">
       <source>Postpartum state</source>
       <target>分娩後状態
</target>
     </trans-unit>
     <trans-unit id="PEO_901_synonyms">
       <source>Postpartum period</source>
     </trans-unit>
     <trans-unit id="PEO_901_synonyms_1">
       <source>Puerperium</source>
     </trans-unit>
     <trans-unit id="PEO_901_synonyms_2">
       <source>Postpartum state (finding)</source>
     </trans-unit>
     <trans-unit id="PEO_902_label">
       <source>Potassium transport</source>
       <target>カリウム輸送
</target>
     </trans-unit>
     <trans-unit id="PEO_902_synonyms">
       <source>K+ conductance</source>
     </trans-unit>
     <trans-unit id="PEO_902_synonyms_1">
       <source>potassium transport</source>
     </trans-unit>
     <trans-unit id="PEO_903_label">
       <source>Pre-eclampsia</source>
       <target>妊娠高血圧腎症
</target>
     </trans-unit>
     <trans-unit id="PEO_903_synonyms">
       <source>PET - Pre-eclamptic toxaemia</source>
     </trans-unit>
     <trans-unit id="PEO_903_synonyms_1">
       <source>Pre-eclampsia (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_903_synonyms_2">
       <source>Pre-eclamptic toxemia</source>
     </trans-unit>
     <trans-unit id="PEO_903_synonyms_3">
       <source>PE - Pre-eclampsia</source>
     </trans-unit>
     <trans-unit id="PEO_903_synonyms_4">
       <source>EPH - Edema, proteinuria and hypertension of pregnancy</source>
     </trans-unit>
     <trans-unit id="PEO_903_synonyms_5">
       <source>Proteinuric hypertension of pregnancy</source>
     </trans-unit>
     <trans-unit id="PEO_903_synonyms_6">
       <source>EPH - Oedema, proteinuria and hypertension of pregnancy</source>
     </trans-unit>
     <trans-unit id="PEO_903_synonyms_7">
       <source>Preeclampsia</source>
     </trans-unit>
     <trans-unit id="PEO_903_synonyms_8">
       <source>Pre-eclamptic toxaemia</source>
     </trans-unit>
     <trans-unit id="PEO_903_synonyms_9">
       <source>PET - Pre-eclamptic toxemia</source>
     </trans-unit>
     <trans-unit id="PEO_904_label">
       <source>Pre-gestational period</source>
       <target>妊娠前の期間
</target>
     </trans-unit>
     <trans-unit id="PEO_905_label">
       <source>Precursors</source>
       <target>前駆物質
</target>
     </trans-unit>
     <trans-unit id="PEO_906_label">
       <source>Pregnancy</source>
       <target>妊娠
</target>
     </trans-unit>
     <trans-unit id="PEO_906_synonyms">
       <source>Gravidity</source>
     </trans-unit>
     <trans-unit id="PEO_907_label">
       <source>Pregnancy-induced hypertension</source>
       <target>妊娠高血圧症候群
</target>
     </trans-unit>
     <trans-unit id="PEO_907_synonyms">
       <source>Hypertension complicating childbirth</source>
     </trans-unit>
     <trans-unit id="PEO_907_synonyms_1">
       <source>Hypertension complicating pregnancy, childbirth AND/OR puerperium</source>
     </trans-unit>
     <trans-unit id="PEO_907_synonyms_2">
       <source>PIH - Pregnancy-induced hypertension</source>
     </trans-unit>
     <trans-unit id="PEO_907_synonyms_3">
       <source>Gestational hypertension</source>
     </trans-unit>
     <trans-unit id="PEO_907_synonyms_4">
       <source>GH - Gestational hypertension</source>
     </trans-unit>
     <trans-unit id="PEO_907_synonyms_5">
       <source>Hypertension induced by pregnancy</source>
     </trans-unit>
     <trans-unit id="PEO_907_synonyms_6">
       <source>Hypertension complicating pregnancy</source>
     </trans-unit>
     <trans-unit id="PEO_907_synonyms_7">
       <source>Pregnancy-induced hypertension (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_907_synonyms_8">
       <source>Unspecified hypertension complicating pregnancy, childbirth or puerperium</source>
     </trans-unit>
     <trans-unit id="PEO_907_synonyms_9">
       <source>Hypertension in the obstetric context</source>
     </trans-unit>
     <trans-unit id="PEO_908_label">
       <source>Pregnancy, Ectopic</source>
       <target>異所性妊娠
</target>
     </trans-unit>
     <trans-unit id="PEO_908_definition">
       <source>A potentially life-threatening condition in which EMBRYO IMPLANTATION occurs outside the cavity of the UTERUS. Most ectopic pregnancies (&gt;96%) occur in the FALLOPIAN TUBES, known as TUBAL PREGNANCY. They can be in other locations, such as UTERINE CERVIX; OVARY; and abdominal cavity (PREGNANCY, ABDOMINAL).</source>
     </trans-unit>
     <trans-unit id="PEO_908_synonyms">
       <source>Extrauterine Pregnancies</source>
     </trans-unit>
     <trans-unit id="PEO_908_synonyms_1">
       <source>Extrauterine Pregnancy</source>
     </trans-unit>
     <trans-unit id="PEO_908_synonyms_2">
       <source>Ectopic Pregnancies</source>
     </trans-unit>
     <trans-unit id="PEO_908_synonyms_3">
       <source>Pregnancy, Extrauterine</source>
     </trans-unit>
     <trans-unit id="PEO_908_synonyms_4">
       <source>Pregnancies, Extrauterine</source>
     </trans-unit>
     <trans-unit id="PEO_908_synonyms_5">
       <source>Pregnancies, Ectopic</source>
     </trans-unit>
     <trans-unit id="PEO_908_synonyms_6">
       <source>Ectopic Pregnancy</source>
     </trans-unit>
     <trans-unit id="PEO_909_label">
       <source>Pregnancy Outcome</source>
       <target>妊娠結果
</target>
     </trans-unit>
     <trans-unit id="PEO_909_definition">
       <source>Results of conception and ensuing pregnancy, including LIVE BIRTH; STILLBIRTH; SPONTANEOUS ABORTION; INDUCED ABORTION. The outcome may follow natural or artificial insemination or any of the various ASSISTED REPRODUCTIVE TECHNIQUES, such as EMBRYO TRANSFER or FERTILIZATION IN VITRO.</source>
     </trans-unit>
     <trans-unit id="PEO_909_synonyms">
       <source>Outcome, Pregnancy</source>
     </trans-unit>
     <trans-unit id="PEO_909_synonyms_1">
       <source>Pregnancy Outcomes</source>
     </trans-unit>
     <trans-unit id="PEO_909_synonyms_2">
       <source>Outcomes, Pregnancy</source>
     </trans-unit>
     <trans-unit id="PEO_910_label">
       <source>Pregnancy observable</source>
       <target>Pregnancy observable
</target>
     </trans-unit>
     <trans-unit id="PEO_910_synonyms">
       <source>Pregnancy observable (observable entity)</source>
     </trans-unit>
     <trans-unit id="PEO_911_label">
       <source>Pregnancy termination care</source>
       <target>妊娠の終結
</target>
     </trans-unit>
     <trans-unit id="PEO_911_synonyms">
       <source>Pregnancy termination care (regime/therapy)</source>
     </trans-unit>
     <trans-unit id="PEO_912_label">
       <source>Pregnancy test urine</source>
       <target>妊娠中の尿検査
</target>
     </trans-unit>
     <trans-unit id="PEO_913_label">
       <source>Pregnancy time period</source>
       <target>妊娠中の期間
</target>
     </trans-unit>
     <trans-unit id="PEO_913_synonyms">
       <source>Pregnancy time period (qualifier value)</source>
     </trans-unit>
     <trans-unit id="PEO_914_label">
       <source>Premature Birth</source>
       <target>早産
</target>
     </trans-unit>
     <trans-unit id="PEO_914_synonyms">
       <source>Preterm Birth</source>
     </trans-unit>
     <trans-unit id="PEO_914_synonyms_1">
       <source>Births, Preterm</source>
     </trans-unit>
     <trans-unit id="PEO_914_synonyms_2">
       <source>Births, Premature</source>
     </trans-unit>
     <trans-unit id="PEO_914_synonyms_3">
       <source>Preterm Births</source>
     </trans-unit>
     <trans-unit id="PEO_914_synonyms_4">
       <source>Premature Births</source>
     </trans-unit>
     <trans-unit id="PEO_914_definition">
       <source>CHILDBIRTH before 37 weeks of PREGNANCY (259 days from the first day of the mother&apos;s last menstrual period, or 245 days after FERTILIZATION).</source>
     </trans-unit>
     <trans-unit id="PEO_914_synonyms_5">
       <source>Birth, Preterm</source>
     </trans-unit>
     <trans-unit id="PEO_914_synonyms_6">
       <source>Birth, Premature</source>
     </trans-unit>
     <trans-unit id="PEO_915_label">
       <source>Prenatal Nutritional Physiological Phenomena</source>
       <target>妊娠中の栄養生理学的現象
</target>
     </trans-unit>
     <trans-unit id="PEO_915_synonyms">
       <source>Prenatal Nutritional Physiological Phenomenon</source>
     </trans-unit>
     <trans-unit id="PEO_915_synonyms_1">
       <source>Nutritional Physiology, Prenatal</source>
     </trans-unit>
     <trans-unit id="PEO_915_definition">
       <source>Nutrition of FEMALE during PREGNANCY.</source>
     </trans-unit>
     <trans-unit id="PEO_915_synonyms_2">
       <source>Prenatal Nutrition Physiology</source>
     </trans-unit>
     <trans-unit id="PEO_915_synonyms_3">
       <source>Pregnancy Nutrition</source>
     </trans-unit>
     <trans-unit id="PEO_915_synonyms_4">
       <source>Physiology, Prenatal Nutrition</source>
     </trans-unit>
     <trans-unit id="PEO_915_synonyms_5">
       <source>Nutrition, Pregnancy</source>
     </trans-unit>
     <trans-unit id="PEO_915_synonyms_6">
       <source>Prenatal Nutritional Physiology</source>
     </trans-unit>
     <trans-unit id="PEO_915_synonyms_7">
       <source>Nutrition During Pregnancy</source>
     </trans-unit>
     <trans-unit id="PEO_915_synonyms_8">
       <source>Physiology, Prenatal Nutritional</source>
     </trans-unit>
     <trans-unit id="PEO_915_synonyms_9">
       <source>Nutrition Physiology, Prenatal</source>
     </trans-unit>
     <trans-unit id="PEO_916_label">
       <source>Prepregnancy BMI</source>
       <target>妊娠前BMI
</target>
     </trans-unit>
     <trans-unit id="PEO_916_synonyms">
       <source>pre-gestational BMI</source>
     </trans-unit>
     <trans-unit id="PEO_916_synonyms_1">
       <source>prepregnancy body mass index</source>
     </trans-unit>
     <trans-unit id="PEO_917_label">
       <source>Previous HELLP syndrome</source>
       <target>過去のHELLP症候群
</target>
     </trans-unit>
     <trans-unit id="PEO_918_label">
       <source>Previous IUGR</source>
       <target>過去のIUGR
</target>
     </trans-unit>
     <trans-unit id="PEO_919_label">
       <source>Previous SGA</source>
       <target>過去のSGA
</target>
     </trans-unit>
     <trans-unit id="PEO_920_label">
       <source>Previous eclampsia</source>
       <target>過去の子癇
</target>
     </trans-unit>
     <trans-unit id="PEO_921_label">
       <source>Previous gestational diabetes</source>
       <target>過去の妊娠糖尿病
</target>
     </trans-unit>
     <trans-unit id="PEO_922_label">
       <source>Previous gestational hypertension</source>
       <target>過去の妊娠高血圧症
</target>
     </trans-unit>
     <trans-unit id="PEO_923_label">
       <source>Previous induced abortion</source>
       <target>過去の人工中絶
</target>
     </trans-unit>
     <trans-unit id="PEO_924_label">
       <source>Previous miscarriage</source>
       <target>過去の流産
</target>
     </trans-unit>
     <trans-unit id="PEO_925_label">
       <source>Previous neonatal death</source>
       <target>過去の新生児死亡
</target>
     </trans-unit>
     <trans-unit id="PEO_926_label">
       <source>Previous preeclampsia</source>
       <target>過去の妊娠高血圧腎症
</target>
     </trans-unit>
     <trans-unit id="PEO_927_label">
       <source>Previous pregnancies</source>
       <target>過去の妊娠
</target>
     </trans-unit>
     <trans-unit id="PEO_927_synonyms">
       <source>Previous pregnancies (finding)</source>
     </trans-unit>
     <trans-unit id="PEO_928_label">
       <source>Previous preterm delivery</source>
       <target>過去の早産
</target>
     </trans-unit>
     <trans-unit id="PEO_929_label">
       <source>Previous stillbirth</source>
       <target>過去の死産
</target>
     </trans-unit>
     <trans-unit id="PEO_930_label">
       <source>Pro-inflammatory mediators</source>
       <target>炎症誘発のメディエーター
</target>
     </trans-unit>
     <trans-unit id="PEO_931_label">
       <source>Pro-inflammatory responses</source>
       <target>炎症誘発反応
</target>
     </trans-unit>
     <trans-unit id="PEO_932_label">
       <source>Prolonged labor</source>
       <target>遷延分娩
</target>
     </trans-unit>
     <trans-unit id="PEO_932_synonyms">
       <source>Prolonged labor (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_932_synonyms_1">
       <source>Long labor</source>
     </trans-unit>
     <trans-unit id="PEO_932_synonyms_2">
       <source>Prolonged labour</source>
     </trans-unit>
     <trans-unit id="PEO_932_synonyms_3">
       <source>Long labour</source>
     </trans-unit>
     <trans-unit id="PEO_933_label">
       <source>Protein aggregation</source>
       <target>タンパク質凝集
</target>
     </trans-unit>
     <trans-unit id="PEO_934_label">
       <source>Protein degradation</source>
       <target>タンパク質分解
</target>
     </trans-unit>
     <trans-unit id="PEO_934_synonyms">
       <source>protein degradation</source>
     </trans-unit>
     <trans-unit id="PEO_934_synonyms_1">
       <source>protein catabolism</source>
     </trans-unit>
     <trans-unit id="PEO_934_synonyms_2">
       <source>proteolytic process</source>
     </trans-unit>
     <trans-unit id="PEO_934_synonyms_3">
       <source>protein breakdown</source>
     </trans-unit>
     <trans-unit id="PEO_935_label">
       <source>Protein misfolding</source>
       <target>タンパク質のミスフォールディング
</target>
     </trans-unit>
     <trans-unit id="PEO_935_synonyms">
       <source>Protein misfoldings</source>
     </trans-unit>
     <trans-unit id="PEO_936_label">
       <source>Proteinuria</source>
       <target>蛋白尿
</target>
     </trans-unit>
     <trans-unit id="PEO_936_synonyms">
       <source>Abnormal presence of protein in urine</source>
     </trans-unit>
     <trans-unit id="PEO_936_synonyms_1">
       <source>Proteinuria (finding)</source>
     </trans-unit>
     <trans-unit id="PEO_937_label">
       <source>Prothrombin time</source>
       <target>プロトロンビン時間
</target>
     </trans-unit>
     <trans-unit id="PEO_937_synonyms">
       <source>PT assay</source>
     </trans-unit>
     <trans-unit id="PEO_937_synonyms_1">
       <source>Protime</source>
     </trans-unit>
     <trans-unit id="PEO_937_synonyms_2">
       <source>Quick one stage prothrombin time</source>
     </trans-unit>
     <trans-unit id="PEO_937_synonyms_3">
       <source>PT - Prothrombin time</source>
     </trans-unit>
     <trans-unit id="PEO_937_synonyms_4">
       <source>Prothrombin time (procedure)</source>
     </trans-unit>
     <trans-unit id="PEO_938_label">
       <source>Prothrombotic state</source>
       <target>Prothrombotic state
</target>
     </trans-unit>
     <trans-unit id="PEO_939_label">
       <source>Psoriasis with arthropathy</source>
       <target>乾癬性関節炎
</target>
     </trans-unit>
     <trans-unit id="PEO_939_synonyms">
       <source>PA - Psoriatic arthritis</source>
     </trans-unit>
     <trans-unit id="PEO_939_synonyms_1">
       <source>Psoriatic arthritis</source>
     </trans-unit>
     <trans-unit id="PEO_939_synonyms_2">
       <source>Psoriatic arthropathy</source>
     </trans-unit>
     <trans-unit id="PEO_939_synonyms_3">
       <source>PsA - Psoriatic arthritis</source>
     </trans-unit>
     <trans-unit id="PEO_939_synonyms_4">
       <source>Psoriasis with arthropathy (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_940_label">
       <source>Puerperal endometritis</source>
       <target>産床子宮内膜炎
</target>
     </trans-unit>
     <trans-unit id="PEO_940_synonyms">
       <source>Puerperal endometritis (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_941_label">
       <source>Pulasatility index</source>
       <target>拍動係数　PI
</target>
     </trans-unit>
     <trans-unit id="PEO_941_synonyms">
       <source>PI</source>
     </trans-unit>
     <trans-unit id="PEO_942_label">
       <source>Pulmonary embolism</source>
       <target>肺塞栓症
</target>
     </trans-unit>
     <trans-unit id="PEO_942_synonyms">
       <source>PE - Pulmonary embolism</source>
     </trans-unit>
     <trans-unit id="PEO_942_synonyms_1">
       <source>Pulmonary embolism (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_943_label">
       <source>Purpose</source>
       <target>目的
</target>
     </trans-unit>
     <trans-unit id="PEO_944_label">
       <source>RAS targeting drugs</source>
       <target>RAS標的薬
</target>
     </trans-unit>
     <trans-unit id="PEO_944_synonyms">
       <source>Renin-angiotensin-aldosterone system-targeting drugs</source>
     </trans-unit>
     <trans-unit id="PEO_945_label">
       <source>RYGB</source>
       <target>ルーワイ胃バイパス術
</target>
     </trans-unit>
     <trans-unit id="PEO_945_synonyms">
       <source>Roux-en-Y gastric-bypass</source>
     </trans-unit>
     <trans-unit id="PEO_946_label">
       <source>Relative risk</source>
       <target>相対リスク
</target>
     </trans-unit>
     <trans-unit id="PEO_947_label">
       <source>Recurrent miscarriage</source>
       <target>不育症
</target>
     </trans-unit>
     <trans-unit id="PEO_947_synonyms">
       <source>Recurrent aborter</source>
     </trans-unit>
     <trans-unit id="PEO_947_synonyms_1">
       <source>Recurrent abortion</source>
     </trans-unit>
     <trans-unit id="PEO_947_synonyms_2">
       <source>Recurrent miscarriage (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_947_synonyms_3">
       <source>Habitual abortion</source>
     </trans-unit>
     <trans-unit id="PEO_947_synonyms_4">
       <source>Habitual aborter</source>
     </trans-unit>
     <trans-unit id="PEO_948_label">
       <source>Red blood cell count</source>
       <target>赤血球数
</target>
     </trans-unit>
     <trans-unit id="PEO_948_synonyms">
       <source>Red blood cell count (procedure)</source>
     </trans-unit>
     <trans-unit id="PEO_948_synonyms_1">
       <source>RBC - Red blood cell count</source>
     </trans-unit>
     <trans-unit id="PEO_948_synonyms_2">
       <source>RBC count</source>
     </trans-unit>
     <trans-unit id="PEO_949_label">
       <source>Red blood cell disorder</source>
       <target>赤血球障害
</target>
     </trans-unit>
     <trans-unit id="PEO_949_synonyms">
       <source>Red blood cell disorder (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_950_label">
       <source>Regularly used</source>
       <target>常用
</target>
     </trans-unit>
     <trans-unit id="PEO_951_label">
       <source>Regulation of transcription</source>
       <target>転写調節
</target>
     </trans-unit>
     <trans-unit id="PEO_951_synonyms">
       <source>regulation of cellular transcription, DNA-dependent</source>
     </trans-unit>
     <trans-unit id="PEO_952_label">
       <source>Remote Hypertension</source>
       <target>Remote Hypertension
</target>
     </trans-unit>
     <trans-unit id="PEO_953_label">
       <source>Renal failure</source>
       <target>腎不全
</target>
     </trans-unit>
     <trans-unit id="PEO_954_label">
       <source>Renin inhibitor</source>
       <target>レニン阻害物質
</target>
     </trans-unit>
     <trans-unit id="PEO_954_synonyms">
       <source>Renin inhibitor (substance)</source>
     </trans-unit>
     <trans-unit id="PEO_955_label">
       <source>Reperfusion Injury</source>
       <target>再灌流傷害
</target>
     </trans-unit>
     <trans-unit id="PEO_955_synonyms">
       <source>Reperfusion Injuries</source>
     </trans-unit>
     <trans-unit id="PEO_955_synonyms_1">
       <source>Damages, Reperfusion</source>
     </trans-unit>
     <trans-unit id="PEO_955_synonyms_2">
       <source>Injury, Ischemia Reperfusion</source>
     </trans-unit>
     <trans-unit id="PEO_955_synonyms_3">
       <source>Ischemia Reperfusion Injury</source>
     </trans-unit>
     <trans-unit id="PEO_955_synonyms_4">
       <source>Injuries, Reperfusion</source>
     </trans-unit>
     <trans-unit id="PEO_955_synonyms_5">
       <source>Reperfusion Damages</source>
     </trans-unit>
     <trans-unit id="PEO_955_synonyms_6">
       <source>Ischemia-Reperfusion Injury</source>
     </trans-unit>
     <trans-unit id="PEO_955_synonyms_7">
       <source>Injuries, Ischemia-Reperfusion</source>
     </trans-unit>
     <trans-unit id="PEO_955_synonyms_8">
       <source>Ischemia-Reperfusion Injuries</source>
     </trans-unit>
     <trans-unit id="PEO_955_synonyms_9">
       <source>Injury, Reperfusion</source>
     </trans-unit>
     <trans-unit id="PEO_955_synonyms_10">
       <source>Damage, Reperfusion</source>
     </trans-unit>
     <trans-unit id="PEO_955_synonyms_11">
       <source>Reperfusion Damage</source>
     </trans-unit>
     <trans-unit id="PEO_955_definition">
       <source>Adverse functional, metabolic, or structural changes in ischemic tissues resulting from the restoration of blood flow to the tissue (REPERFUSION), including swelling; HEMORRHAGE; NECROSIS; and damage from FREE RADICALS. The most common instance is MYOCARDIAL REPERFUSION INJURY.</source>
     </trans-unit>
     <trans-unit id="PEO_955_synonyms_12">
       <source>Injury, Ischemia-Reperfusion</source>
     </trans-unit>
     <trans-unit id="PEO_956_label">
       <source>Reproductive Techniques, Assisted</source>
       <target>生殖補助医療
</target>
     </trans-unit>
     <trans-unit id="PEO_956_synonyms">
       <source>ART</source>
     </trans-unit>
     <trans-unit id="PEO_956_synonyms_1">
       <source>Assisted Reproductive Techniques</source>
     </trans-unit>
     <trans-unit id="PEO_957_label">
       <source>Resveratrol</source>
       <target>レスベラトロール
</target>
     </trans-unit>
     <trans-unit id="PEO_957_synonyms">
       <source>Resveratrol (substance)</source>
     </trans-unit>
     <trans-unit id="PEO_958_label">
       <source>Retention of placenta</source>
       <target>胎盤遺残
</target>
     </trans-unit>
     <trans-unit id="PEO_959_label">
       <source>Rheumatoid arthritis</source>
       <target>関節リウマチ
</target>
     </trans-unit>
     <trans-unit id="PEO_959_synonyms">
       <source>RA - Rheumatoid arthritis</source>
     </trans-unit>
     <trans-unit id="PEO_959_synonyms_1">
       <source>Proliferative arthritis</source>
     </trans-unit>
     <trans-unit id="PEO_959_synonyms_2">
       <source>Rheumatoid arthritis (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_959_synonyms_3">
       <source>Rheumatoid disease</source>
     </trans-unit>
     <trans-unit id="PEO_959_synonyms_4">
       <source>RhA - Rheumatoid arthritis</source>
     </trans-unit>
     <trans-unit id="PEO_959_synonyms_5">
       <source>Rheumatic gout</source>
     </trans-unit>
     <trans-unit id="PEO_959_synonyms_6">
       <source>Chronic rheumatic arthritis</source>
     </trans-unit>
     <trans-unit id="PEO_959_synonyms_7">
       <source>Atrophic arthritis</source>
     </trans-unit>
     <trans-unit id="PEO_960_label">
       <source>Right-sided unilateral notching</source>
       <target>右側子宮動脈血流notch
</target>
     </trans-unit>
     <trans-unit id="PEO_960_synonyms">
       <source>Unilateral right notch</source>
     </trans-unit>
     <trans-unit id="PEO_961_label">
       <source>Rupture of gravid uterus</source>
       <target>妊娠子宮破裂
</target>
     </trans-unit>
     <trans-unit id="PEO_961_synonyms">
       <source>Rupture of gravid uterus (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_961_synonyms_1">
       <source>Obstetrical rupture of uterus</source>
     </trans-unit>
     <trans-unit id="PEO_962_label">
       <source>Ruptured membranes</source>
       <target>破水
</target>
     </trans-unit>
     <trans-unit id="PEO_962_synonyms">
       <source>Spontaneous rupture of foetal membranes</source>
     </trans-unit>
     <trans-unit id="PEO_962_synonyms_1">
       <source>Spontaneous rupture of fetal membranes</source>
     </trans-unit>
     <trans-unit id="PEO_962_synonyms_2">
       <source>Rupture of membranes</source>
     </trans-unit>
     <trans-unit id="PEO_962_synonyms_3">
       <source>Ruptured membranes (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_962_synonyms_4">
       <source>Rupture of fetal membranes</source>
     </trans-unit>
     <trans-unit id="PEO_962_synonyms_5">
       <source>Waters broken</source>
     </trans-unit>
     <trans-unit id="PEO_962_synonyms_6">
       <source>Rupture of foetal membranes</source>
     </trans-unit>
     <trans-unit id="PEO_962_synonyms_7">
       <source>ROM - Ruptured membranes</source>
     </trans-unit>
     <trans-unit id="PEO_963_label">
       <source>Schizophrenia</source>
       <target>統合失調症
</target>
     </trans-unit>
     <trans-unit id="PEO_963_synonyms">
       <source>Schizophrenia (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_964_label">
       <source>School attendance</source>
       <target>通学
</target>
     </trans-unit>
     <trans-unit id="PEO_964_synonyms">
       <source>School attendance (observable entity)</source>
     </trans-unit>
     <trans-unit id="PEO_965_label">
       <source>Schooling</source>
       <target>学校教育
</target>
     </trans-unit>
     <trans-unit id="PEO_965_synonyms">
       <source>Schooling (observable entity)</source>
     </trans-unit>
     <trans-unit id="PEO_966_label">
       <source>Seasons</source>
       <target>季節
</target>
     </trans-unit>
     <trans-unit id="PEO_966_synonyms">
       <source>Seasonal Variations</source>
     </trans-unit>
     <trans-unit id="PEO_966_synonyms_1">
       <source>Seasonal Variation</source>
     </trans-unit>
     <trans-unit id="PEO_966_synonyms_2">
       <source>Variations, Seasonal</source>
     </trans-unit>
     <trans-unit id="PEO_966_definition">
       <source>Divisions of the year according to some regularly recurrent phenomena usually astronomical or climatic. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)</source>
     </trans-unit>
     <trans-unit id="PEO_966_synonyms_3">
       <source>Season</source>
     </trans-unit>
     <trans-unit id="PEO_966_synonyms_4">
       <source>Variation, Seasonal</source>
     </trans-unit>
     <trans-unit id="PEO_967_label">
       <source>Second trimester</source>
       <target>妊娠中期
</target>
     </trans-unit>
     <trans-unit id="PEO_967_synonyms">
       <source>Second trimester (qualifier value)</source>
     </trans-unit>
     <trans-unit id="PEO_967_synonyms_1">
       <source>2nd trimester</source>
     </trans-unit>
     <trans-unit id="PEO_968_label">
       <source>Segmentation</source>
       <target>卵割
</target>
     </trans-unit>
     <trans-unit id="PEO_968_synonyms">
       <source>Segmentation (qualifier value)</source>
     </trans-unit>
     <trans-unit id="PEO_969_label">
       <source>Seizure disorder</source>
       <target>発作性疾患
</target>
     </trans-unit>
     <trans-unit id="PEO_969_synonyms">
       <source>Seizure disorder (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_970_label">
       <source>Selenium</source>
       <target>セレン
</target>
     </trans-unit>
     <trans-unit id="PEO_970_synonyms">
       <source>Selenium (substance)</source>
     </trans-unit>
     <trans-unit id="PEO_970_synonyms_1">
       <source>Se - Selenium</source>
     </trans-unit>
     <trans-unit id="PEO_971_label">
       <source>Sepsis</source>
       <target>敗血症
</target>
     </trans-unit>
     <trans-unit id="PEO_971_synonyms">
       <source>Systemic infection</source>
     </trans-unit>
     <trans-unit id="PEO_971_synonyms_1">
       <source>Sepsis (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_972_label">
       <source>Serum lipid levels - finding</source>
       <target>血中タンパクレベル
</target>
     </trans-unit>
     <trans-unit id="PEO_972_synonyms">
       <source>Finding of serum lipid levels (finding)</source>
     </trans-unit>
     <trans-unit id="PEO_972_synonyms_1">
       <source>Finding of serum lipid levels</source>
     </trans-unit>
     <trans-unit id="PEO_972_synonyms_2">
       <source>Serum lipid levels</source>
     </trans-unit>
     <trans-unit id="PEO_973_label">
       <source>Serum testosterone measurement</source>
       <target>血中テストステロン測定値
</target>
     </trans-unit>
     <trans-unit id="PEO_973_synonyms">
       <source>Serum testosterone measurement (procedure)</source>
     </trans-unit>
     <trans-unit id="PEO_973_synonyms_1">
       <source>Serum testosterone level</source>
     </trans-unit>
     <trans-unit id="PEO_974_label">
       <source>Serum total HCG measurement</source>
       <target>血中HCG量
</target>
     </trans-unit>
     <trans-unit id="PEO_974_synonyms">
       <source>Measurement of serum total human chorionic gonadotrophin</source>
     </trans-unit>
     <trans-unit id="PEO_974_synonyms_1">
       <source>Measurement of serum total human chorionic gonadotropin (procedure)</source>
     </trans-unit>
     <trans-unit id="PEO_974_synonyms_2">
       <source>Measurement of serum total human chorionic gonadotropin</source>
     </trans-unit>
     <trans-unit id="PEO_974_synonyms_3">
       <source>Serum total HCG level</source>
     </trans-unit>
     <trans-unit id="PEO_974_synonyms_4">
       <source>Serum total human chorionic gonadotropin measurement</source>
     </trans-unit>
     <trans-unit id="PEO_974_synonyms_5">
       <source>Serum total human chorionic gonadotrophin measurement</source>
     </trans-unit>
     <trans-unit id="PEO_975_label">
       <source>Sexually transmitted infectious disease</source>
       <target>性感染症
</target>
     </trans-unit>
     <trans-unit id="PEO_975_synonyms">
       <source>Disease with a predominantly sexual mode of transmission</source>
     </trans-unit>
     <trans-unit id="PEO_975_synonyms_1">
       <source>VD - Venereal disease</source>
     </trans-unit>
     <trans-unit id="PEO_975_synonyms_2">
       <source>STD - Sexually transmitted disease</source>
     </trans-unit>
     <trans-unit id="PEO_975_synonyms_3">
       <source>Sexually transmitted disease</source>
     </trans-unit>
     <trans-unit id="PEO_976_label">
       <source>Single person</source>
       <target>独身
</target>
     </trans-unit>
     <trans-unit id="PEO_976_definition">
       <source>Not currently married</source>
     </trans-unit>
     <trans-unit id="PEO_976_synonyms">
       <source>Single person (finding)</source>
     </trans-unit>
     <trans-unit id="PEO_976_synonyms_1">
       <source>Single</source>
     </trans-unit>
     <trans-unit id="PEO_977_label">
       <source>Single pregnancy</source>
       <target>単胎妊娠
</target>
     </trans-unit>
     <trans-unit id="PEO_977_synonyms">
       <source>Single pregnancy (finding)</source>
     </trans-unit>
     <trans-unit id="PEO_978_label">
       <source>Singleton delivery</source>
       <target>単胎分娩
</target>
     </trans-unit>
     <trans-unit id="PEO_979_label">
       <source>Sjögren&apos;s syndrome</source>
     </trans-unit>
     <trans-unit id="PEO_979_synonyms">
       <source>Sjögren syndrome</source>
     </trans-unit>
     <trans-unit id="PEO_979_synonyms_1">
       <source>Sjögren&apos;s syndrome (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_979_synonyms_2">
       <source>Sjögren&apos;s disease</source>
     </trans-unit>
     <trans-unit id="PEO_979_synonyms_3">
       <source>Sjogren&apos;s syndrome</source>
     </trans-unit>
     <trans-unit id="PEO_979_synonyms_4">
       <source>Sjogrens syndrome</source>
     </trans-unit>
     <trans-unit id="PEO_979_synonyms_5">
       <source>Sicca syndrome</source>
     </trans-unit>
     <trans-unit id="PEO_980_label">
       <source>Small for gestational age fetus</source>
       <target>SGA
</target>
     </trans-unit>
     <trans-unit id="PEO_981_label">
       <source>Small molecules</source>
       <target>小分子
</target>
     </trans-unit>
     <trans-unit id="PEO_982_label">
       <source>Smoking during pregnancy</source>
       <target>妊娠中の喫煙
</target>
     </trans-unit>
     <trans-unit id="PEO_983_label">
       <source>Smooth muscle cells of vessel</source>
       <target>血管平滑筋細胞
</target>
     </trans-unit>
     <trans-unit id="PEO_984_label">
       <source>Snuff user</source>
       <target>スナッフ使用者
</target>
     </trans-unit>
     <trans-unit id="PEO_984_synonyms">
       <source>Snuff user (finding)</source>
     </trans-unit>
     <trans-unit id="PEO_984_synonyms_1">
       <source>Snuff taker</source>
     </trans-unit>
     <trans-unit id="PEO_985_label">
       <source>Social context</source>
       <target>社会的なコンテクスト
</target>
     </trans-unit>
     <trans-unit id="PEO_985_synonyms">
       <source>Social context (social concept)</source>
     </trans-unit>
     <trans-unit id="PEO_986_label">
       <source>Social support status</source>
       <target>社会的支援の状況
</target>
     </trans-unit>
     <trans-unit id="PEO_986_synonyms">
       <source>Social support status (finding)</source>
     </trans-unit>
     <trans-unit id="PEO_987_label">
       <source>Sodium transport</source>
       <target>ナトリウム輸送
</target>
     </trans-unit>
     <trans-unit id="PEO_987_synonyms">
       <source>sodium transport</source>
     </trans-unit>
     <trans-unit id="PEO_988_label">
       <source>Spermatogenesis</source>
       <target>精子形成
</target>
     </trans-unit>
     <trans-unit id="PEO_988_synonyms">
       <source>Spermatogenesis, function</source>
     </trans-unit>
     <trans-unit id="PEO_988_synonyms_1">
       <source>Spermatogenesis, function (observable entity)</source>
     </trans-unit>
     <trans-unit id="PEO_988_synonyms_2">
       <source>Spermatocytogenesis</source>
     </trans-unit>
     <trans-unit id="PEO_989_label">
       <source>Spiral arteries</source>
       <target>らせん動脈
</target>
     </trans-unit>
     <trans-unit id="PEO_990_label">
       <source>Spiral artery remodeling</source>
       <target>らせん動脈のリモデリング
</target>
     </trans-unit>
     <trans-unit id="PEO_991_label">
       <source>regulation via splicing variants</source>
       <target>スプライシングバリアント
</target>
     </trans-unit>
     <trans-unit id="PEO_991_synonyms">
       <source>Splicing variant</source>
     </trans-unit>
     <trans-unit id="PEO_992_label">
       <source>Spontaneous labor</source>
       <target>自然分娩
</target>
     </trans-unit>
     <trans-unit id="PEO_993_label">
       <source>Sporadic miscarriage</source>
       <target>孤発性の流産
</target>
     </trans-unit>
     <trans-unit id="PEO_994_label">
       <source>Stage 2 hypertension</source>
       <target>ステージ２高血圧
</target>
     </trans-unit>
     <trans-unit id="PEO_995_label">
       <source>Stage 2 systolic hypertension</source>
       <target>ステージ2の収縮期高血圧
</target>
     </trans-unit>
     <trans-unit id="PEO_996_label">
       <source>Standardized incidence ratio</source>
       <target>調整後罹患率
</target>
     </trans-unit>
     <trans-unit id="PEO_997_label">
       <source>Status epilepticus</source>
       <target>てんかん重積
</target>
     </trans-unit>
     <trans-unit id="PEO_997_synonyms">
       <source>Status epilepticus (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_998_label">
       <source>Stillbirth</source>
       <target>死産
</target>
     </trans-unit>
     <trans-unit id="PEO_998_synonyms">
       <source>Stillbirth (finding)</source>
     </trans-unit>
     <trans-unit id="PEO_998_synonyms_1">
       <source>SB - Stillbirth</source>
     </trans-unit>
     <trans-unit id="PEO_999_label">
       <source>Stopped smoking</source>
       <target>禁煙
</target>
     </trans-unit>
     <trans-unit id="PEO_999_synonyms">
       <source>Stopped smoking (finding)</source>
     </trans-unit>
     <trans-unit id="PEO_1000_label">
       <source>Student&apos;s t-test</source>
       <target>スチューデントのt検定
</target>
     </trans-unit>
     <trans-unit id="PEO_1000_synonyms">
       <source>Student&apos;s t-tests</source>
     </trans-unit>
     <trans-unit id="PEO_1001_label">
       <source>Subarachnoid hemorrhage</source>
       <target>くも膜下出血
</target>
     </trans-unit>
     <trans-unit id="PEO_1001_synonyms">
       <source>Subarachnoid intracranial hemorrhage</source>
     </trans-unit>
     <trans-unit id="PEO_1001_synonyms_1">
       <source>SAH - Subarachnoid haemorrhage</source>
     </trans-unit>
     <trans-unit id="PEO_1001_synonyms_2">
       <source>Subarachnoid intracranial haemorrhage</source>
     </trans-unit>
     <trans-unit id="PEO_1001_synonyms_3">
       <source>Subarachnoid intracranial hemorrhage (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_1001_synonyms_4">
       <source>SAH - Subarachnoid hemorrhage</source>
     </trans-unit>
     <trans-unit id="PEO_1001_synonyms_5">
       <source>Subarachnoid haemorrhage</source>
     </trans-unit>
     <trans-unit id="PEO_1003_label">
       <source>Substances used</source>
       <target>薬物の使用
</target>
     </trans-unit>
     <trans-unit id="PEO_1003_synonyms">
       <source>Substances used (attribute)</source>
     </trans-unit>
     <trans-unit id="PEO_1004_label">
       <source>Sumoylation</source>
       <target>SUMO化
</target>
     </trans-unit>
     <trans-unit id="PEO_1004_synonyms">
       <source>small ubiquitin-related protein 1 conjugation</source>
     </trans-unit>
     <trans-unit id="PEO_1004_synonyms_1">
       <source>sumoylation</source>
     </trans-unit>
     <trans-unit id="PEO_1004_synonyms_2">
       <source>protein sumolation</source>
     </trans-unit>
     <trans-unit id="PEO_1004_synonyms_3">
       <source>SUMO-protein conjugation</source>
     </trans-unit>
     <trans-unit id="PEO_1005_label">
       <source>Supplements</source>
       <target>サプリメント
</target>
     </trans-unit>
     <trans-unit id="PEO_1006_label">
       <source>Swelling of endothelial cells</source>
       <target>内皮細胞の腫大
</target>
     </trans-unit>
     <trans-unit id="PEO_1007_label">
       <source>Systemic lupus erythematosus-related syndrome</source>
       <target>全身性エリテマトーデス症候群
</target>
     </trans-unit>
     <trans-unit id="PEO_1007_synonyms">
       <source>SLE - Systemic lupus erythematosus-related syndrome</source>
     </trans-unit>
     <trans-unit id="PEO_1007_synonyms_1">
       <source>Systemic lupus erythematosus-related syndrome (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_1008_label">
       <source>Systolic arterial pressure</source>
       <target>収縮期血圧
</target>
     </trans-unit>
     <trans-unit id="PEO_1008_synonyms">
       <source>Systolic arterial pressure (observable entity)</source>
     </trans-unit>
     <trans-unit id="PEO_1008_synonyms_1">
       <source>Systolic blood pressure</source>
     </trans-unit>
     <trans-unit id="PEO_1009_label">
       <source>THROMBOPHILIA DUE TO THROMBIN DEFECT</source>
       <target>トロンビン欠損による栓友病
</target>
     </trans-unit>
     <trans-unit id="PEO_1009_synonyms">
       <source>THROMBOSIS, PROTECTION AGAINST</source>
     </trans-unit>
     <trans-unit id="PEO_1009_synonyms_1">
       <source>THROMBOPHILIA DUE TO FACTOR 2 DEFECT</source>
     </trans-unit>
     <trans-unit id="PEO_1009_synonyms_2">
       <source>VENOUS THROMBOEMBOLISM</source>
     </trans-unit>
     <trans-unit id="PEO_1009_synonyms_3">
       <source>THPH1</source>
     </trans-unit>
     <trans-unit id="PEO_1009_synonyms_4">
       <source>VENOUS THROMBOSIS</source>
     </trans-unit>
     <trans-unit id="PEO_1010_label">
       <source>T lymphocyte</source>
       <target>Tリンパ球
</target>
     </trans-unit>
     <trans-unit id="PEO_1010_synonyms">
       <source>T cell</source>
     </trans-unit>
     <trans-unit id="PEO_1010_synonyms_1">
       <source>T lymphocyte (cell)</source>
     </trans-unit>
     <trans-unit id="PEO_1010_synonyms_2">
       <source>T-cell</source>
     </trans-unit>
     <trans-unit id="PEO_1011_label">
       <source>Termination of pregnancy</source>
       <target>妊娠中絶
</target>
     </trans-unit>
     <trans-unit id="PEO_1011_synonyms">
       <source>Induced termination of pregnancy</source>
     </trans-unit>
     <trans-unit id="PEO_1011_synonyms_1">
       <source>Induced termination of pregnancy (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_1011_synonyms_2">
       <source>Termination of pregnancy (procedure)</source>
     </trans-unit>
     <trans-unit id="PEO_1011_synonyms_3">
       <source>Abortion</source>
     </trans-unit>
     <trans-unit id="PEO_1011_synonyms_4">
       <source>Induced abortion</source>
     </trans-unit>
     <trans-unit id="PEO_1012_label">
       <source>Th1 Cells</source>
       <target>Th1細胞
</target>
     </trans-unit>
     <trans-unit id="PEO_1012_definition">
       <source>Subset of helper-inducer T-lymphocytes which synthesize and secrete interleukin-2, gamma-interferon, and interleukin-12. Due to their ability to kill antigen-presenting cells and their lymphokine-mediated effector activity, Th1 cells are associated with vigorous delayed-type hypersensitivity reactions.</source>
     </trans-unit>
     <trans-unit id="PEO_1012_synonyms">
       <source>Cells, Th1</source>
     </trans-unit>
     <trans-unit id="PEO_1012_synonyms_1">
       <source>Th1 Cell</source>
     </trans-unit>
     <trans-unit id="PEO_1012_synonyms_2">
       <source>Cell, Th1</source>
     </trans-unit>
     <trans-unit id="PEO_1013_label">
       <source>Th2 Cells</source>
       <target>Th2細胞
</target>
     </trans-unit>
     <trans-unit id="PEO_1013_synonyms">
       <source>Cell, Th2</source>
     </trans-unit>
     <trans-unit id="PEO_1013_synonyms_1">
       <source>Th2 Cell</source>
     </trans-unit>
     <trans-unit id="PEO_1013_definition">
       <source>Subset of helper-inducer T-lymphocytes which synthesize and secrete the interleukins IL-4, IL-5, IL-6, and IL-10. These cytokines influence B-cell development and antibody production as well as augmenting humoral responses.</source>
     </trans-unit>
     <trans-unit id="PEO_1013_synonyms_2">
       <source>Cells, Th2</source>
     </trans-unit>
     <trans-unit id="PEO_1014_label">
       <source>Therapeutics</source>
       <target>治療上の
</target>
     </trans-unit>
     <trans-unit id="PEO_1014_synonyms">
       <source>Therapeutic</source>
     </trans-unit>
     <trans-unit id="PEO_1014_synonyms_1">
       <source>Treatments</source>
     </trans-unit>
     <trans-unit id="PEO_1014_synonyms_2">
       <source>Treatment</source>
     </trans-unit>
     <trans-unit id="PEO_1014_synonyms_3">
       <source>Therapies</source>
     </trans-unit>
     <trans-unit id="PEO_1014_synonyms_4">
       <source>Therapy</source>
     </trans-unit>
     <trans-unit id="PEO_1015_label">
       <source>Third trimester</source>
       <target>妊娠後期
</target>
     </trans-unit>
     <trans-unit id="PEO_1015_synonyms">
       <source>3rd trimester</source>
     </trans-unit>
     <trans-unit id="PEO_1015_synonyms_1">
       <source>Third trimester (qualifier value)</source>
     </trans-unit>
     <trans-unit id="PEO_1016_label">
       <source>Thrombocytopenic disorder</source>
       <target>血小板減少症
</target>
     </trans-unit>
     <trans-unit id="PEO_1016_synonyms">
       <source>Thrombocytopenic disorder (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_1016_synonyms_1">
       <source>Thrombocytopenia</source>
     </trans-unit>
     <trans-unit id="PEO_1017_label">
       <source>Thromboembolic disorder</source>
       <target>血栓塞栓症
</target>
     </trans-unit>
     <trans-unit id="PEO_1017_synonyms">
       <source>Thromboembolic disorder (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_1017_synonyms_1">
       <source>Thromboembolic disease</source>
     </trans-unit>
     <trans-unit id="PEO_1017_synonyms_2">
       <source>Thromboembolism</source>
     </trans-unit>
     <trans-unit id="PEO_1018_label">
       <source>Thrombophilia</source>
       <target>血栓性素因
</target>
     </trans-unit>
     <trans-unit id="PEO_1018_synonyms">
       <source>Thrombophilia (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_1019_label">
       <source>Thromboprophylaxis</source>
       <target>血栓予防
</target>
     </trans-unit>
     <trans-unit id="PEO_1020_label">
       <source>Thrombosis</source>
       <target>血栓症
</target>
     </trans-unit>
     <trans-unit id="PEO_1020_synonyms">
       <source>Thrombosis (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_1021_label">
       <source>Thyroid disease</source>
       <target>甲状腺疾患
</target>
     </trans-unit>
     <trans-unit id="PEO_1022_label">
       <source>Thyroid supplements</source>
       <target>ヨウ素サプリメント
</target>
     </trans-unit>
     <trans-unit id="PEO_1023_label">
       <source>Tobacco use and exposure - finding</source>
       <target>喫煙曝露
</target>
     </trans-unit>
     <trans-unit id="PEO_1023_synonyms">
       <source>Finding of tobacco use and exposure (finding)</source>
     </trans-unit>
     <trans-unit id="PEO_1023_synonyms_1">
       <source>Finding of tobacco use and exposure</source>
     </trans-unit>
     <trans-unit id="PEO_1024_label">
       <source>Total cholesterol</source>
       <target>総コレステロール
</target>
     </trans-unit>
     <trans-unit id="PEO_1024_synonyms">
       <source>Total cholesterol (substance)</source>
     </trans-unit>
     <trans-unit id="PEO_1025_label">
       <source>Toxic cause</source>
       <target>毒性の原因
</target>
     </trans-unit>
     <trans-unit id="PEO_1025_synonyms">
       <source>Toxic causes</source>
     </trans-unit>
     <trans-unit id="PEO_1026_label">
       <source>Transaminases</source>
       <target>アミノ基転移酵素
</target>
     </trans-unit>
     <trans-unit id="PEO_1026_definition">
       <source>A subclass of enzymes of the transferase class that catalyze the transfer of an amino group from a donor (generally an amino acid) to an acceptor (generally a 2-keto acid). Most of these enzymes are pyridoxyl phosphate proteins. (Dorland, 28th ed) EC 2.6.1.</source>
     </trans-unit>
     <trans-unit id="PEO_1026_synonyms">
       <source>Aminotransferases</source>
     </trans-unit>
     <trans-unit id="PEO_1027_label">
       <source>Transfection cells model</source>
       <target>トランスフェクション細胞モデル
</target>
     </trans-unit>
     <trans-unit id="PEO_1027_synonyms">
       <source>Transfection cells models</source>
     </trans-unit>
     <trans-unit id="PEO_1028_label">
       <source>Transgenic model</source>
       <target>遺伝子組み換えモデル
</target>
     </trans-unit>
     <trans-unit id="PEO_1028_synonyms">
       <source>Transgenic models</source>
     </trans-unit>
     <trans-unit id="PEO_1029_label">
       <source>Transient cerebral ischemia</source>
       <target>一過性脳虚血
</target>
     </trans-unit>
     <trans-unit id="PEO_1029_synonyms">
       <source>TIA - Transient ischaemic attack</source>
     </trans-unit>
     <trans-unit id="PEO_1029_synonyms_1">
       <source>Intermittent cerebral ischemia</source>
     </trans-unit>
     <trans-unit id="PEO_1029_synonyms_2">
       <source>Transient ischemic attack</source>
     </trans-unit>
     <trans-unit id="PEO_1029_synonyms_3">
       <source>Transient cerebral ischaemia</source>
     </trans-unit>
     <trans-unit id="PEO_1029_synonyms_4">
       <source>Transient ischemic attack (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_1029_synonyms_5">
       <source>Transient ischaemic attack</source>
     </trans-unit>
     <trans-unit id="PEO_1029_synonyms_6">
       <source>Temporary cerebral vascular dysfunction</source>
     </trans-unit>
     <trans-unit id="PEO_1029_synonyms_7">
       <source>Intermittent cerebral ischaemia</source>
     </trans-unit>
     <trans-unit id="PEO_1029_synonyms_8">
       <source>TIA</source>
     </trans-unit>
     <trans-unit id="PEO_1030_label">
       <source>Trimesters</source>
       <target>トライメスター
</target>
     </trans-unit>
     <trans-unit id="PEO_1030_synonyms">
       <source>Trimesters (qualifier value)</source>
     </trans-unit>
     <trans-unit id="PEO_1031_label">
       <source>Trophoblast invasion</source>
       <target>栄養膜浸潤
</target>
     </trans-unit>
     <trans-unit id="PEO_1032_label">
       <source>Trophoblasts</source>
       <target>トロホブラスト
</target>
     </trans-unit>
     <trans-unit id="PEO_1032_definition">
       <source>Cells lining the outside of the BLASTOCYST. After binding to the ENDOMETRIUM, trophoblasts develop into two distinct layers, an inner layer of mononuclear cytotrophoblasts and an outer layer of continuous multinuclear cytoplasm, the syncytiotrophoblasts, which form the early fetal-maternal interface (PLACENTA). Trophoblasts with multinuclear cytoplasm and undefined cellular structures. Syncytiotrophoblasts secrete proteolytic enzymes that erode the ENDOMETRIUM for EMBRYO IMPLANTATION. They also produce steroid, peptide, and protein hormones (PLACENTAL HORMONES). Trophoblasts with single nucleus and defined cellular structures. As the PLACENTA develops, pockets of cytotrophoblasts serve as stem cells for syncytiotrophoblasts.</source>
     </trans-unit>
     <trans-unit id="PEO_1032_synonyms">
       <source>Syncytiotrophoblast</source>
     </trans-unit>
     <trans-unit id="PEO_1032_synonyms_1">
       <source>Cytotrophoblast</source>
     </trans-unit>
     <trans-unit id="PEO_1032_synonyms_2">
       <source>Trophoblast</source>
     </trans-unit>
     <trans-unit id="PEO_1032_synonyms_3">
       <source>Cytotrophoblasts</source>
     </trans-unit>
     <trans-unit id="PEO_1032_synonyms_4">
       <source>Syncytiotrophoblasts</source>
     </trans-unit>
     <trans-unit id="PEO_1033_label">
       <source>Tuberculosis</source>
       <target>結核
</target>
     </trans-unit>
     <trans-unit id="PEO_1033_synonyms">
       <source>TB - Tuberculosis</source>
     </trans-unit>
     <trans-unit id="PEO_1033_synonyms_1">
       <source>Tuberculosis (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_1034_label">
       <source>Twin birth</source>
       <target>双子
</target>
     </trans-unit>
     <trans-unit id="PEO_1034_synonyms">
       <source>Twin birth (finding)</source>
     </trans-unit>
     <trans-unit id="PEO_1035_label">
       <source>Twin pregnancy</source>
       <target>双胎妊娠
</target>
     </trans-unit>
     <trans-unit id="PEO_1035_synonyms">
       <source>Twin pregnancy (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_1036_label">
       <source>Type 1 diabetes mellitus</source>
       <target>1型糖尿病
</target>
     </trans-unit>
     <trans-unit id="PEO_1036_synonyms">
       <source>Diabetes mellitus type I</source>
     </trans-unit>
     <trans-unit id="PEO_1036_synonyms_1">
       <source>Type I diabetes mellitus</source>
     </trans-unit>
     <trans-unit id="PEO_1036_synonyms_2">
       <source>Diabetes mellitus type 1 (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_1036_synonyms_3">
       <source>Diabetes mellitus type 1</source>
     </trans-unit>
     <trans-unit id="PEO_1037_label">
       <source>Type 2 diabetes mellitus</source>
       <target>2型糖尿病
</target>
     </trans-unit>
     <trans-unit id="PEO_1037_synonyms">
       <source>Diabetes mellitus type 2 (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_1037_synonyms_1">
       <source>Type II diabetes mellitus</source>
     </trans-unit>
     <trans-unit id="PEO_1037_synonyms_2">
       <source>Diabetes mellitus type 2</source>
     </trans-unit>
     <trans-unit id="PEO_1037_synonyms_3">
       <source>Diabetes mellitus type II</source>
     </trans-unit>
     <trans-unit id="PEO_1038_label">
       <source>Ubiquitination</source>
       <target>ユビキチン化
</target>
     </trans-unit>
     <trans-unit id="PEO_1039_label">
       <source>Ultrasonography</source>
       <target>超音波検査
</target>
     </trans-unit>
     <trans-unit id="PEO_1039_synonyms">
       <source>Ultrasound scan</source>
     </trans-unit>
     <trans-unit id="PEO_1039_synonyms_1">
       <source>Ultrasound procedure</source>
     </trans-unit>
     <trans-unit id="PEO_1039_synonyms_2">
       <source>Ultrasound</source>
     </trans-unit>
     <trans-unit id="PEO_1039_synonyms_3">
       <source>USS - Ultrasound scan</source>
     </trans-unit>
     <trans-unit id="PEO_1039_synonyms_4">
       <source>Ultrasonogram</source>
     </trans-unit>
     <trans-unit id="PEO_1039_synonyms_5">
       <source>Diagnostic ultrasonography</source>
     </trans-unit>
     <trans-unit id="PEO_1039_synonyms_6">
       <source>Diagnostic ultrasonography (procedure)</source>
     </trans-unit>
     <trans-unit id="PEO_1039_synonyms_7">
       <source>Diagnostic sonar</source>
     </trans-unit>
     <trans-unit id="PEO_1039_synonyms_8">
       <source>US - Ultrasound</source>
     </trans-unit>
     <trans-unit id="PEO_1040_label">
       <source>Umbilical cord finding</source>
       <target>臍帯の所見</target>
     </trans-unit>
     <trans-unit id="PEO_1040_synonyms">
       <source>Umbilical cord finding (finding)</source>
     </trans-unit>
     <trans-unit id="PEO_1040_synonyms_1">
       <source>Umbilical cord observations</source>
     </trans-unit>
     <trans-unit id="PEO_1041_label">
       <source>Unilateral notching</source>
       <target>片側子宮動脈血流notch
</target>
     </trans-unit>
     <trans-unit id="PEO_1041_synonyms">
       <source>Bilateral notching</source>
     </trans-unit>
     <trans-unit id="PEO_1042_label">
       <source>Unsafe living conditions</source>
       <target>危険な生活環境
</target>
     </trans-unit>
     <trans-unit id="PEO_1043_label">
       <source>Upper class economic status</source>
       <target>上流層
</target>
     </trans-unit>
     <trans-unit id="PEO_1043_synonyms">
       <source>high socio economic status</source>
     </trans-unit>
     <trans-unit id="PEO_1043_synonyms_1">
       <source>high socioeconomic status</source>
     </trans-unit>
     <trans-unit id="PEO_1043_synonyms_2">
       <source>Upper class economic status (social concept)</source>
     </trans-unit>
     <trans-unit id="PEO_1043_synonyms_3">
       <source>high regional economic status</source>
     </trans-unit>
     <trans-unit id="PEO_1044_label">
       <source>Upper middle class economic status</source>
       <target>上流中産層
</target>
     </trans-unit>
     <trans-unit id="PEO_1044_synonyms">
       <source>Upper middle class economic status (social concept)</source>
     </trans-unit>
     <trans-unit id="PEO_1045_label">
       <source>Upregulation</source>
       <target>発現上昇
</target>
     </trans-unit>
     <trans-unit id="PEO_1046_label">
       <source>Urinary tract infection in pregnancy</source>
       <target>妊娠中の尿路感染
</target>
     </trans-unit>
     <trans-unit id="PEO_1046_synonyms">
       <source>UTI - urinary tract infection in pregnancy</source>
     </trans-unit>
     <trans-unit id="PEO_1046_synonyms_1">
       <source>Urinary tract infection complicating pregnancy</source>
     </trans-unit>
     <trans-unit id="PEO_1046_synonyms_2">
       <source>Urinary tract infection in pregnancy (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_1047_label">
       <source>Urinary tract infections</source>
       <target>尿路感染症
</target>
     </trans-unit>
     <trans-unit id="PEO_1048_label">
       <source>UtA-RI</source>
       <target>子宮動脈　抵抗指数（RI)
</target>
     </trans-unit>
     <trans-unit id="PEO_1048_synonyms">
       <source>uterine artery resistance index</source>
     </trans-unit>
     <trans-unit id="PEO_1049_label">
       <source>UtAD velocimetry</source>
       <target>子宮動脈血流速度ドプラー異常
</target>
     </trans-unit>
     <trans-unit id="PEO_1049_synonyms">
       <source>uterine artery Doppler velocimetry</source>
     </trans-unit>
     <trans-unit id="PEO_1050_label">
       <source>Uterine Artery</source>
       <target>子宮動脈
</target>
     </trans-unit>
     <trans-unit id="PEO_1050_definition">
       <source>A branch arising from the internal iliac artery in females, that supplies blood to the uterus.</source>
     </trans-unit>
     <trans-unit id="PEO_1050_synonyms">
       <source>Artery, Uterine</source>
     </trans-unit>
     <trans-unit id="PEO_1050_synonyms_1">
       <source>Arteries, Uterine</source>
     </trans-unit>
     <trans-unit id="PEO_1050_synonyms_2">
       <source>Uterine Arteries</source>
     </trans-unit>
     <trans-unit id="PEO_1051_label">
       <source>Uterine blood flow</source>
       <target>子宮血流
</target>
     </trans-unit>
     <trans-unit id="PEO_1052_label">
       <source>Uteroplacental blood flow</source>
       <target>子宮胎盤血流
</target>
     </trans-unit>
     <trans-unit id="PEO_1053_label">
       <source>Uterotonic</source>
       <target>子宮収縮の
</target>
     </trans-unit>
     <trans-unit id="PEO_1054_label">
       <source>VEGF system</source>
       <target>VEGFシステム
</target>
     </trans-unit>
     <trans-unit id="PEO_1055_label">
       <source>Vaginal delivery</source>
       <target>経腟分娩
</target>
     </trans-unit>
     <trans-unit id="PEO_1055_synonyms">
       <source>Vaginal delivery (finding)</source>
     </trans-unit>
     <trans-unit id="PEO_1056_label">
       <source>Vascular constriction</source>
       <target>血管狭窄
</target>
     </trans-unit>
     <trans-unit id="PEO_1056_synonyms">
       <source>Vasoconstriction</source>
     </trans-unit>
     <trans-unit id="PEO_1056_synonyms_1">
       <source>Vascular constriction, function (observable entity)</source>
     </trans-unit>
     <trans-unit id="PEO_1056_synonyms_2">
       <source>Vascular constriction, function</source>
     </trans-unit>
     <trans-unit id="PEO_1057_label">
       <source>Vascular disorders</source>
       <target>血管障害
</target>
     </trans-unit>
     <trans-unit id="PEO_1058_label">
       <source>Vascular luminal abnormality</source>
       <target>血管内腔の異常
</target>
     </trans-unit>
     <trans-unit id="PEO_1059_label">
       <source>Vascular system finding</source>
       <target>血管系の所見
</target>
     </trans-unit>
     <trans-unit id="PEO_1060_label">
       <source>Vascular tone</source>
       <target>血管緊張
</target>
     </trans-unit>
     <trans-unit id="PEO_1061_label">
       <source>Vascular wall hypertrophy</source>
       <target>血管壁肥大
</target>
     </trans-unit>
     <trans-unit id="PEO_1062_label">
       <source>Vasculitis</source>
       <target>血管炎
</target>
     </trans-unit>
     <trans-unit id="PEO_1062_synonyms">
       <source>Vasculitis (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_1062_synonyms_1">
       <source>Angiitis</source>
     </trans-unit>
     <trans-unit id="PEO_1063_label">
       <source>Vasodepressor activity</source>
       <target>血圧降下作用
</target>
     </trans-unit>
     <trans-unit id="PEO_1064_label">
       <source>Vasodilatory effects</source>
       <target>血管拡張作用
</target>
     </trans-unit>
     <trans-unit id="PEO_1065_label">
       <source>Vasogenic cerebral edema</source>
       <target>血管原性脳浮腫
</target>
     </trans-unit>
     <trans-unit id="PEO_1065_synonyms">
       <source>Vasogenic cerebral oedema</source>
     </trans-unit>
     <trans-unit id="PEO_1065_synonyms_1">
       <source>Vasogenic cerebral edema (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_1066_label">
       <source>Velocity time integral ratio</source>
       <target>左室流出路のVTI/大動脈弁のVTI　
</target>
     </trans-unit>
     <trans-unit id="PEO_1066_synonyms">
       <source>VTI ratio</source>
     </trans-unit>
     <trans-unit id="PEO_1067_label">
       <source>Vertebral artery dissection</source>
       <target>椎骨動脈解離
</target>
     </trans-unit>
     <trans-unit id="PEO_1067_synonyms">
       <source>Vertebral artery dissection (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_1068_label">
       <source>Vertex presentation</source>
       <target>頭位
</target>
     </trans-unit>
     <trans-unit id="PEO_1068_synonyms">
       <source>Vertex presentation (finding)</source>
     </trans-unit>
     <trans-unit id="PEO_1068_synonyms_1">
       <source>Cephalic presentation</source>
     </trans-unit>
     <trans-unit id="PEO_1069_label">
       <source>Vesicular transport</source>
       <target>小胞輸送
</target>
     </trans-unit>
     <trans-unit id="PEO_1069_synonyms">
       <source>vesicle transport</source>
     </trans-unit>
     <trans-unit id="PEO_1069_synonyms_1">
       <source>vesicular transport</source>
     </trans-unit>
     <trans-unit id="PEO_1070_label">
       <source>Villous Hemosiderosis</source>
       <target>絨毛性血腫症
</target>
     </trans-unit>
     <trans-unit id="PEO_1071_label">
       <source>Vitamin E</source>
       <target>ビタミンE
</target>
     </trans-unit>
     <trans-unit id="PEO_1072_label">
       <source>Vomiting</source>
       <target>嘔吐
</target>
     </trans-unit>
     <trans-unit id="PEO_1072_synonyms">
       <source>Emesis</source>
     </trans-unit>
     <trans-unit id="PEO_1072_synonyms_1">
       <source>Vomiting (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_1073_label">
       <source>White-collar worker</source>
       <target>ホワイトカラー
</target>
     </trans-unit>
     <trans-unit id="PEO_1074_label">
       <source>White - ethnic group</source>
       <target>白人
</target>
     </trans-unit>
     <trans-unit id="PEO_1074_synonyms">
       <source>White - ethnic group (ethnic group)</source>
     </trans-unit>
     <trans-unit id="PEO_1074_synonyms_1">
       <source>White</source>
     </trans-unit>
     <trans-unit id="PEO_1075_label">
       <source>Whole blood folate level - finding</source>
       <target>全血中葉酸
</target>
     </trans-unit>
     <trans-unit id="PEO_1075_synonyms">
       <source>Finding of whole blood folate level</source>
     </trans-unit>
     <trans-unit id="PEO_1075_synonyms_1">
       <source>Finding of whole blood folate level (finding)</source>
     </trans-unit>
     <trans-unit id="PEO_1075_synonyms_2">
       <source>Whole blood folate level</source>
     </trans-unit>
     <trans-unit id="PEO_1076_label">
       <source>Xiusanzhen</source>
       <target>Xiusanzhen
</target>
     </trans-unit>
     <trans-unit id="PEO_1076_synonyms">
       <source>electroacupuncture</source>
     </trans-unit>
     <trans-unit id="PEO_1077_label">
       <source>Zero flow pressure</source>
       <target>冠血管における拡張期圧-流量関係
</target>
     </trans-unit>
     <trans-unit id="PEO_1077_synonyms">
       <source>ZFP</source>
     </trans-unit>
     <trans-unit id="PEO_1078_label">
       <source>adipose control</source>
       <target>脂肪コントロール
</target>
     </trans-unit>
     <trans-unit id="PEO_1079_label">
       <source>adrenaline</source>
       <target>アドレナリン
</target>
     </trans-unit>
     <trans-unit id="PEO_1079_synonyms">
       <source>CNCC(O)c1ccc(O)c(O)c1</source>
     </trans-unit>
     <trans-unit id="PEO_1079_synonyms_1">
       <source>2-(methylamino)-1-(3,4-dihydroxyphenyl)ethanol</source>
     </trans-unit>
     <trans-unit id="PEO_1079_synonyms_2">
       <source>InChI=1S/C9H13NO3/c1-10-5-9(13)6-2-3-7(11)8(12)4-6/h2-4,9-13H,5H2,1H3</source>
     </trans-unit>
     <trans-unit id="PEO_1079_synonyms_3">
       <source>epinephrine racemic</source>
     </trans-unit>
     <trans-unit id="PEO_1079_synonyms_4">
       <source>4-[1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol</source>
     </trans-unit>
     <trans-unit id="PEO_1079_definition">
       <source>A catecholamine in which the aminoethyl side-chain is hydroxy-substituted at C-1 and methylated on nitrogen.</source>
     </trans-unit>
     <trans-unit id="PEO_1079_synonyms_5">
       <source>dl-adrenaline</source>
     </trans-unit>
     <trans-unit id="PEO_1079_synonyms_6">
       <source>C9H13NO3</source>
     </trans-unit>
     <trans-unit id="PEO_1079_synonyms_7">
       <source>racepinefrinum</source>
     </trans-unit>
     <trans-unit id="PEO_1079_synonyms_8">
       <source>(+-)-epinephrine</source>
     </trans-unit>
     <trans-unit id="PEO_1079_synonyms_9">
       <source>racepinefrina</source>
     </trans-unit>
     <trans-unit id="PEO_1079_synonyms_10">
       <source>(+-)-adrenaline</source>
     </trans-unit>
     <trans-unit id="PEO_1079_synonyms_11">
       <source>racepinefrine</source>
     </trans-unit>
     <trans-unit id="PEO_1079_synonyms_12">
       <source>InChIKey=UCTWMZQNUQWSLP-UHFFFAOYSA-N</source>
     </trans-unit>
     <trans-unit id="PEO_1080_label">
       <source>alcohol</source>
       <target>アルコール
</target>
     </trans-unit>
     <trans-unit id="PEO_1081_label">
       <source>alcohol</source>
       <target>アルコール
</target>
     </trans-unit>
     <trans-unit id="PEO_1081_synonyms">
       <source>O[*]</source>
     </trans-unit>
     <trans-unit id="PEO_1081_definition">
       <source>A compound in which a hydroxy group, -OH, is attached to a saturated carbon atom.</source>
     </trans-unit>
     <trans-unit id="PEO_1081_synonyms_1">
       <source>HOR</source>
     </trans-unit>
     <trans-unit id="PEO_1081_synonyms_2">
       <source>an alcohol</source>
     </trans-unit>
     <trans-unit id="PEO_1081_synonyms_3">
       <source>Alcohol</source>
     </trans-unit>
     <trans-unit id="PEO_1081_synonyms_4">
       <source>alcohols</source>
     </trans-unit>
     <trans-unit id="PEO_1082_label">
       <source>aldosterone</source>
       <target>アルドステロン
</target>
     </trans-unit>
     <trans-unit id="PEO_1082_synonyms">
       <source>Aldosterone</source>
     </trans-unit>
     <trans-unit id="PEO_1082_synonyms_1">
       <source>(11beta)-11,21-dihydroxy-3,20-dioxopregn-4-en-18-al</source>
     </trans-unit>
     <trans-unit id="PEO_1082_synonyms_2">
       <source>11beta,21-Dihydroxy-3,20-dioxo-4-pregnen-18-al</source>
     </trans-unit>
     <trans-unit id="PEO_1082_synonyms_3">
       <source>ALDOSTERONE</source>
     </trans-unit>
     <trans-unit id="PEO_1082_synonyms_4">
       <source>(11alpha,14beta,17alpha)-11,21-dihydroxy-3,20-dioxopregn-4-en-18-al</source>
     </trans-unit>
     <trans-unit id="PEO_1082_synonyms_5">
       <source>11beta,21-dihydroxy-3,20-dioxopregn-4-en-18-al</source>
     </trans-unit>
     <trans-unit id="PEO_1082_synonyms_6">
       <source>(+)-aldosterone</source>
     </trans-unit>
     <trans-unit id="PEO_1082_synonyms_7">
       <source>InChI=1S/C21H28O5/c1-20-7-6-13(24)8-12(20)2-3-14-15-4-5-16(18(26)10-22)21(15,11-23)9-17(25)19(14)20/h8,11,14-17,19,22,25H,2-7,9-10H2,1H3/t14-,15-,16+,17-,19+,20-,21+/m0/s1</source>
     </trans-unit>
     <trans-unit id="PEO_1082_synonyms_8">
       <source>InChIKey=PQSUYGKTWSAVDQ-ZVIOFETBSA-N</source>
     </trans-unit>
     <trans-unit id="PEO_1082_definition">
       <source>A pregnane-based steroidal hormone produced by the outer-section (zona glomerulosa) of the adrenal cortex in the adrenal gland, and acts on the distal tubules and collecting ducts of the kidney to cause the conservation of sodium, secretion of potassium, increased water retention, and increased blood pressure. The overall effect of aldosterone is to increase reabsorption of ions and water in the kidney.</source>
     </trans-unit>
     <trans-unit id="PEO_1082_synonyms_9">
       <source>aldosterone</source>
     </trans-unit>
     <trans-unit id="PEO_1082_synonyms_10">
       <source>C21H28O5</source>
     </trans-unit>
     <trans-unit id="PEO_1083_label">
       <source>angiogenesis</source>
       <target>血管新生
</target>
     </trans-unit>
     <trans-unit id="PEO_1084_label">
       <source>anti-HVEM</source>
       <target>抗HVEM抗体
</target>
     </trans-unit>
     <trans-unit id="PEO_1084_synonyms">
       <source>HVEM antibody</source>
     </trans-unit>
     <trans-unit id="PEO_1085_label">
       <source>anti-LTBR</source>
       <target>Anti-LTBR 抗体
</target>
     </trans-unit>
     <trans-unit id="PEO_1085_synonyms">
       <source>LTBR antibody</source>
     </trans-unit>
     <trans-unit id="PEO_1086_label">
       <source>anti-PLAP</source>
       <target>抗PLAP抗体
</target>
     </trans-unit>
     <trans-unit id="PEO_1086_synonyms">
       <source>anti-placental alkaline phosphatase</source>
     </trans-unit>
     <trans-unit id="PEO_1087_label">
       <source>anti-TNFRSF14</source>
       <target>Anti-TNFRSF14 抗体
</target>
     </trans-unit>
     <trans-unit id="PEO_1087_synonyms">
       <source>TNFRSF14 antibody</source>
     </trans-unit>
     <trans-unit id="PEO_1088_label">
       <source>anticoagulation</source>
       <target>抗凝固
</target>
     </trans-unit>
     <trans-unit id="PEO_1089_label">
       <source>anti-inflammatory drug</source>
       <target>抗炎症薬
</target>
     </trans-unit>
     <trans-unit id="PEO_1089_synonyms">
       <source>anti-inflammatory drugs</source>
     </trans-unit>
     <trans-unit id="PEO_1090_label">
       <source>antioxidant</source>
       <target>抗酸化剤
</target>
     </trans-unit>
     <trans-unit id="PEO_1090_synonyms">
       <source>antioxidants</source>
     </trans-unit>
     <trans-unit id="PEO_1091_label">
       <source>aortic smooth muscle cell</source>
       <target>大動脈平滑筋細胞
</target>
     </trans-unit>
     <trans-unit id="PEO_1091_definition">
       <source>A smooth muscle cell of the aorta</source>
     </trans-unit>
     <trans-unit id="PEO_1092_label">
       <source>apocynin</source>
       <target>アポシニン
</target>
     </trans-unit>
     <trans-unit id="PEO_1092_synonyms">
       <source>4&apos;-hydroxy-3&apos;-methoxyacetophenone</source>
     </trans-unit>
     <trans-unit id="PEO_1093_label">
       <source>apoptotic signalling</source>
       <target>アポトーシス誘導シグナル
</target>
     </trans-unit>
     <trans-unit id="PEO_1094_label">
       <source>arachidonic acid</source>
       <target>アラキドン酸
</target>
     </trans-unit>
     <trans-unit id="PEO_1094_synonyms">
       <source>Arachidonsaeure</source>
     </trans-unit>
     <trans-unit id="PEO_1094_synonyms_1">
       <source>Arachidonic acid</source>
     </trans-unit>
     <trans-unit id="PEO_1094_synonyms_2">
       <source>C20H32O2</source>
     </trans-unit>
     <trans-unit id="PEO_1094_synonyms_3">
       <source>cis-5,8,11,14-Eicosatetraenoic acid</source>
     </trans-unit>
     <trans-unit id="PEO_1094_synonyms_4">
       <source>ARACHIDONIC ACID</source>
     </trans-unit>
     <trans-unit id="PEO_1094_synonyms_5">
       <source>ARA</source>
     </trans-unit>
     <trans-unit id="PEO_1094_synonyms_6">
       <source>(5Z,8Z,11Z,14Z)-Icosatetraenoic acid</source>
     </trans-unit>
     <trans-unit id="PEO_1094_synonyms_7">
       <source>cis-Delta(5,8,11,14)-eicosatetraenoic acid</source>
     </trans-unit>
     <trans-unit id="PEO_1094_synonyms_8">
       <source>(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoic acid</source>
     </trans-unit>
     <trans-unit id="PEO_1094_synonyms_9">
       <source>Arachidonate</source>
     </trans-unit>
     <trans-unit id="PEO_1094_synonyms_10">
       <source>InChI=1S/C20H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-,16-15-</source>
     </trans-unit>
     <trans-unit id="PEO_1094_synonyms_11">
       <source>CCCCCC=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O</source>
     </trans-unit>
     <trans-unit id="PEO_1094_synonyms_12">
       <source>AA</source>
     </trans-unit>
     <trans-unit id="PEO_1094_synonyms_13">
       <source>all-cis-5,8,11,14-eicosatetraenoic acid</source>
     </trans-unit>
     <trans-unit id="PEO_1094_synonyms_14">
       <source>InChIKey=YZXBAPSDXZZRGB-DOFZRALJSA-N</source>
     </trans-unit>
     <trans-unit id="PEO_1094_definition">
       <source>A long-chain fatty acid that is a C20, polyunsaturated fatty acid having four (Z)-double bonds at positions 5, 8, 11 and 14.</source>
     </trans-unit>
     <trans-unit id="PEO_1094_synonyms_15">
       <source>(5Z,8Z,11Z,14Z)-5,8,11,14-icosatetraenoic acid</source>
     </trans-unit>
     <trans-unit id="PEO_1095_label">
       <source>baseline state</source>
       <target>ベースラインの状態
</target>
     </trans-unit>
     <trans-unit id="PEO_1095_synonyms">
       <source>baseline states</source>
     </trans-unit>
     <trans-unit id="PEO_1095_synonyms_1">
       <source>baseline</source>
     </trans-unit>
     <trans-unit id="PEO_1096_label">
       <source>beta Carotene</source>
       <target>ベータカロチン
</target>
     </trans-unit>
     <trans-unit id="PEO_1096_synonyms">
       <source>Betacarotene Solgar Brand</source>
     </trans-unit>
     <trans-unit id="PEO_1096_synonyms_1">
       <source>Marlyn Brand of Betacarotene</source>
     </trans-unit>
     <trans-unit id="PEO_1096_synonyms_2">
       <source>MaxCaro</source>
     </trans-unit>
     <trans-unit id="PEO_1096_synonyms_3">
       <source>Max Caro</source>
     </trans-unit>
     <trans-unit id="PEO_1096_synonyms_4">
       <source>Max-Caro</source>
     </trans-unit>
     <trans-unit id="PEO_1096_synonyms_5">
       <source>Betacarotene Roche Brand</source>
     </trans-unit>
     <trans-unit id="PEO_1096_synonyms_6">
       <source>Carotaben</source>
     </trans-unit>
     <trans-unit id="PEO_1096_synonyms_7">
       <source>Betacarotene Hermal Brand</source>
     </trans-unit>
     <trans-unit id="PEO_1096_synonyms_8">
       <source>Solatene</source>
     </trans-unit>
     <trans-unit id="PEO_1096_synonyms_9">
       <source>BellaCarotin</source>
     </trans-unit>
     <trans-unit id="PEO_1097_label">
       <source>bilirubin</source>
       <target>ビリルビン
</target>
     </trans-unit>
     <trans-unit id="PEO_1097_synonyms">
       <source>bilirubin</source>
     </trans-unit>
     <trans-unit id="PEO_1097_synonyms_1">
       <source>InChI=1S/C33H36N4O6/c1-7-20-19(6)32(42)37-27(20)14-25-18(5)23(10-12-31(40)41)29(35-25)15-28-22(9-11-30(38)39)17(4)24(34-28)13-26-16(3)21(8-2)33(43)36-26/h7-8,13-14,34-35H,1-2,9-12,15H2,3-6H3,(H,36,43)(H,37,42)(H,38,39)(H,40,41)/b26-13-,27-14-</source>
     </trans-unit>
     <trans-unit id="PEO_1097_synonyms_2">
       <source>InChIKey=BPYKTIZUTYGOLE-IFADSCNNSA-N</source>
     </trans-unit>
     <trans-unit id="PEO_1097_synonyms_3">
       <source>2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinyl-1,10,19,22,23,24-hexahydro-21H-biline-8,12-dipropanoic acid</source>
     </trans-unit>
     <trans-unit id="PEO_1097_synonyms_4">
       <source>1,10,19,22,23,24-hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinylbiline-8,12-dipropionic acid</source>
     </trans-unit>
     <trans-unit id="PEO_1097_synonyms_5">
       <source>2,17-diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-biline-8,12-dipropanoic acid</source>
     </trans-unit>
     <trans-unit id="PEO_1097_synonyms_6">
       <source>bilirubin IXalpha</source>
     </trans-unit>
     <trans-unit id="PEO_1097_synonyms_7">
       <source>8,12-bis(2-carboxyethyl)-2,7,13,17-tetramethyl-3,18-divinylbiladiene-ac-1,19(21H,24H)-dione</source>
     </trans-unit>
     <trans-unit id="PEO_1097_synonyms_8">
       <source>Bilirubin</source>
     </trans-unit>
     <trans-unit id="PEO_1097_definition">
       <source>A member of the class of biladienes that is a linear tetrapyrrole, product of heme degradation. It is produced in the reticuloendothelial system by the reduction of biliverdin and transported to the liver as a complex with serum albumin.</source>
     </trans-unit>
     <trans-unit id="PEO_1097_synonyms_9">
       <source>C33H36N4O6</source>
     </trans-unit>
     <trans-unit id="PEO_1097_synonyms_10">
       <source>CC1=C(C=C)C(NC1=O)=C\c1[nH]c(Cc2[nH]c(\C=C3NC(=O)C(C=C)=C/3C)c(C)c2CCC(O)=O)c(CCC(O)=O)c1C</source>
     </trans-unit>
     <trans-unit id="PEO_1098_label">
       <source>biliverdin</source>
       <target>ビリベルジン
</target>
     </trans-unit>
     <trans-unit id="PEO_1098_definition">
       <source>A linear tetrapyrrole produced in the reticuloendothelial system by the first step of heme degradation, catalysed by heme oxygenase.</source>
     </trans-unit>
     <trans-unit id="PEO_1098_synonyms">
       <source>InChI=1S/C33H34N4O6/c1-7-20-19(6)32(42)37-27(20)14-25-18(5)23(10-12-31(40)41)29(35-25)15-28-22(9-11-30(38)39)17(4)24(34-28)13-26-16(3)21(8-2)33(43)36-26/h7-8,13-15,35H,1-2,9-12H2,3-6H3,(H,36,43)(H,37,42)(H,38,39)(H,40,41)/b26-13-,27-14-,28-15-</source>
     </trans-unit>
     <trans-unit id="PEO_1098_synonyms_1">
       <source>BILIVERDINE IX ALPHA</source>
     </trans-unit>
     <trans-unit id="PEO_1098_synonyms_2">
       <source>InChIKey=QBUVFDKTZJNUPP-BBROENKCSA-N</source>
     </trans-unit>
     <trans-unit id="PEO_1098_synonyms_3">
       <source>CC1=C(CCC(O)=O)C(/N=C1/C=C1NC(=O)C(C=C)=C/1C)=C\c1[nH]c(\C=C2NC(=O)C(C)=C/2C=C)c(C)c1CCC(O)=O</source>
     </trans-unit>
     <trans-unit id="PEO_1098_synonyms_4">
       <source>biliverdin</source>
     </trans-unit>
     <trans-unit id="PEO_1098_synonyms_5">
       <source>C33H34N4O6</source>
     </trans-unit>
     <trans-unit id="PEO_1098_synonyms_6">
       <source>8,12-bis(2-carboxyethyl)-2,7,13,17-tetramethyl-3,18-divinylbilin-1(19)(21H,24H)-dione</source>
     </trans-unit>
     <trans-unit id="PEO_1098_synonyms_7">
       <source>Biliverdin IXalpha</source>
     </trans-unit>
     <trans-unit id="PEO_1098_synonyms_8">
       <source>Biliverdin</source>
     </trans-unit>
     <trans-unit id="PEO_1098_synonyms_9">
       <source>Biliverdine</source>
     </trans-unit>
     <trans-unit id="PEO_1099_label">
       <source>blinded study</source>
       <target>盲検試験
</target>
     </trans-unit>
     <trans-unit id="PEO_1099_synonyms">
       <source>blinded studies</source>
     </trans-unit>
     <trans-unit id="PEO_1100_label">
       <source>BMI</source>
       <target>BMI
</target>
     </trans-unit>
     <trans-unit id="PEO_1100_synonyms">
       <source>body mass index</source>
     </trans-unit>
     <trans-unit id="PEO_1101_label">
       <source>Body weight before 14 wk</source>
       <target>妊娠週数14週以前の母体体重
</target>
     </trans-unit>
     <trans-unit id="PEO_1102_label">
       <source>calcium signalling</source>
       <target>カルシウムシグナリング
</target>
     </trans-unit>
     <trans-unit id="PEO_1103_label">
       <source>carbon monoxide</source>
       <target>一酸化炭素
</target>
     </trans-unit>
     <trans-unit id="PEO_1103_synonyms">
       <source>carbon(II) oxide</source>
     </trans-unit>
     <trans-unit id="PEO_1103_definition">
       <source>A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.</source>
     </trans-unit>
     <trans-unit id="PEO_1103_synonyms_1">
       <source>C#O</source>
     </trans-unit>
     <trans-unit id="PEO_1103_synonyms_2">
       <source>[C-]#[O+]</source>
     </trans-unit>
     <trans-unit id="PEO_1103_synonyms_3">
       <source>InChI=1S/CO/c1-2</source>
     </trans-unit>
     <trans-unit id="PEO_1103_synonyms_4">
       <source>InChIKey=UGFAIRIUMAVXCW-UHFFFAOYSA-N</source>
     </trans-unit>
     <trans-unit id="PEO_1103_synonyms_5">
       <source>Carbon monoxide</source>
     </trans-unit>
     <trans-unit id="PEO_1103_synonyms_6">
       <source>[CO]</source>
     </trans-unit>
     <trans-unit id="PEO_1103_synonyms_7">
       <source>CO</source>
     </trans-unit>
     <trans-unit id="PEO_1103_synonyms_8">
       <source>CARBON MONOXIDE</source>
     </trans-unit>
     <trans-unit id="PEO_1103_synonyms_9">
       <source>carbon monooxide</source>
     </trans-unit>
     <trans-unit id="PEO_1103_synonyms_10">
       <source>carbon monoxide</source>
     </trans-unit>
     <trans-unit id="PEO_1104_label">
       <source>case report</source>
       <target>症例報告
</target>
     </trans-unit>
     <trans-unit id="PEO_1104_synonyms">
       <source>case reports</source>
     </trans-unit>
     <trans-unit id="PEO_1105_label">
       <source>cell-cycle process</source>
       <target>細胞周期
</target>
     </trans-unit>
     <trans-unit id="PEO_1105_synonyms">
       <source>cell-cycle processes</source>
     </trans-unit>
     <trans-unit id="PEO_1106_label">
       <source>cell growth</source>
       <target>細胞増殖
</target>
     </trans-unit>
     <trans-unit id="PEO_1106_synonyms">
       <source>cell expansion; non-developmental growth of a unicellular organism; metabolic process resulting in cell growth; metabolism resulting in cell growth; non-developmental cell growth</source>
     </trans-unit>
     <trans-unit id="PEO_1106_synonyms_1">
       <source>cellular growth; growth of cell</source>
     </trans-unit>
     <trans-unit id="PEO_1107_label">
       <source>cell signalling</source>
       <target>細胞内信号伝達
</target>
     </trans-unit>
     <trans-unit id="PEO_1108_label">
       <source>Chi-Square test</source>
       <target>カイ二乗検定
</target>
     </trans-unit>
     <trans-unit id="PEO_1108_synonyms">
       <source>Chi-Square</source>
     </trans-unit>
     <trans-unit id="PEO_1108_synonyms_1">
       <source>Chi-Square tests</source>
     </trans-unit>
     <trans-unit id="PEO_1109_label">
       <source>cholesterol</source>
       <target>コレステロール
</target>
     </trans-unit>
     <trans-unit id="PEO_1109_synonyms">
       <source>InChI=1S/C27H46O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h9,18-19,21-25,28H,6-8,10-17H2,1-5H3/t19-,21+,22+,23-,24+,25+,26+,27-/m1/s1</source>
     </trans-unit>
     <trans-unit id="PEO_1109_definition">
       <source>A cholestanoid consisting of cholestane having a double bond at the 5,6-position as well as a 3beta-hydroxy group.</source>
     </trans-unit>
     <trans-unit id="PEO_1109_synonyms_1">
       <source>cholesterol</source>
     </trans-unit>
     <trans-unit id="PEO_1109_synonyms_2">
       <source>(3beta,14beta,17alpha)-cholest-5-en-3-ol</source>
     </trans-unit>
     <trans-unit id="PEO_1109_synonyms_3">
       <source>InChIKey=HVYWMOMLDIMFJA-DPAQBDIFSA-N</source>
     </trans-unit>
     <trans-unit id="PEO_1109_synonyms_4">
       <source>CHOLESTEROL</source>
     </trans-unit>
     <trans-unit id="PEO_1109_synonyms_5">
       <source>Cholesterin</source>
     </trans-unit>
     <trans-unit id="PEO_1109_synonyms_6">
       <source>Cholest-5-en-3beta-ol</source>
     </trans-unit>
     <trans-unit id="PEO_1109_synonyms_7">
       <source>cholest-5-en-3beta-ol</source>
     </trans-unit>
     <trans-unit id="PEO_1109_synonyms_8">
       <source>C27H46O</source>
     </trans-unit>
     <trans-unit id="PEO_1109_synonyms_9">
       <source>Cholesterol</source>
     </trans-unit>
     <trans-unit id="PEO_1110_label">
       <source>clinical functional phenotype context</source>
       <target>機能的な表現型に関するコンテクスト
</target>
     </trans-unit>
     <trans-unit id="PEO_1111_label">
       <source>clinical main complaint context</source>
       <target>主訴に関するコンテクスト
</target>
     </trans-unit>
     <trans-unit id="PEO_1112_label">
       <source>clinical observation context</source>
       <target>所見に関するコンテクスト
</target>
     </trans-unit>
     <trans-unit id="PEO_1113_label">
       <source>clinical outcome context</source>
       <target>アウトカムに関するコンテクスト
</target>
     </trans-unit>
     <trans-unit id="PEO_1114_label">
       <source>clinical phenotypic context</source>
       <target>医学的表現型のコンテクスト
</target>
     </trans-unit>
     <trans-unit id="PEO_1115_label">
       <source>comparative study</source>
       <target>比較試験
</target>
     </trans-unit>
     <trans-unit id="PEO_1115_synonyms">
       <source>comparative studies</source>
     </trans-unit>
     <trans-unit id="PEO_1116_label">
       <source>control subject</source>
       <target>対照群
</target>
     </trans-unit>
     <trans-unit id="PEO_1116_synonyms">
       <source>control subjects</source>
     </trans-unit>
     <trans-unit id="PEO_1117_label">
       <source>corticosteroid</source>
       <target>副腎皮質ホルモン
</target>
     </trans-unit>
     <trans-unit id="PEO_1117_synonyms">
       <source>corticosteroides</source>
     </trans-unit>
     <trans-unit id="PEO_1117_synonyms_1">
       <source>corticoides</source>
     </trans-unit>
     <trans-unit id="PEO_1117_definition">
       <source>A natural or synthetic analogue of the hormones secreted by the adrenal gland.</source>
     </trans-unit>
     <trans-unit id="PEO_1117_synonyms_2">
       <source>corticosteroids</source>
     </trans-unit>
     <trans-unit id="PEO_1118_label">
       <source>delivery mode</source>
       <target>胎位
</target>
     </trans-unit>
     <trans-unit id="PEO_1118_definition">
       <source>Indicates the type of service offered, method of delivery. For example: post office box, rural route, general delivery, etc.</source>
     </trans-unit>
     <trans-unit id="PEO_1119_label">
       <source>disease onset</source>
       <target>疾患発症
</target>
     </trans-unit>
     <trans-unit id="PEO_1119_synonyms">
       <source>onset of AD</source>
     </trans-unit>
     <trans-unit id="PEO_1119_synonyms_1">
       <source>onset</source>
     </trans-unit>
     <trans-unit id="PEO_1120_label">
       <source>diuretic</source>
       <target>利尿の
</target>
     </trans-unit>
     <trans-unit id="PEO_1120_synonyms">
       <source>diuretics</source>
     </trans-unit>
     <trans-unit id="PEO_1120_definition">
       <source>An agent that promotes the excretion of urine through its effects on kidney function.</source>
     </trans-unit>
     <trans-unit id="PEO_1121_label">
       <source>dose ranging study</source>
       <target>用量範囲探索試験
</target>
     </trans-unit>
     <trans-unit id="PEO_1121_synonyms">
       <source>dose ranging studies</source>
     </trans-unit>
     <trans-unit id="PEO_1122_label">
       <source>double blinded study</source>
       <target>二重盲検比較試験
</target>
     </trans-unit>
     <trans-unit id="PEO_1122_synonyms">
       <source>double-blind</source>
     </trans-unit>
     <trans-unit id="PEO_1122_synonyms_1">
       <source>blinded</source>
     </trans-unit>
     <trans-unit id="PEO_1122_synonyms_2">
       <source>double blinded studies</source>
     </trans-unit>
     <trans-unit id="PEO_1123_label">
       <source>double masked study</source>
       <target>二重盲検試験
</target>
     </trans-unit>
     <trans-unit id="PEO_1123_synonyms">
       <source>double masked studies</source>
     </trans-unit>
     <trans-unit id="PEO_1124_label">
       <source>drug</source>
       <target>薬剤
</target>
     </trans-unit>
     <trans-unit id="PEO_1125_label">
       <source>dyslipidemia</source>
       <target>脂質異常症
</target>
     </trans-unit>
     <trans-unit id="PEO_1126_label">
       <source>early onset context</source>
       <target>早期発症のコンテクスト
</target>
     </trans-unit>
     <trans-unit id="PEO_1127_label">
       <source>eicosanoids</source>
       <target>エイコサノイド
</target>
     </trans-unit>
     <trans-unit id="PEO_1128_label">
       <source>eosin YS dye</source>
       <target>エオシン染色
</target>
     </trans-unit>
     <trans-unit id="PEO_1128_synonyms">
       <source>InChI=1S/C20H8Br4O5.2Na/c21-11-5-9-13(7-3-1-2-4-8(7)20(27)28)10-6-12(22)17(26)15(24)19(10)29-18(9)14(23)16(11)25;;/h1-6,25H,(H,27,28);;/q;2*+1/p-2</source>
     </trans-unit>
     <trans-unit id="PEO_1128_synonyms_1">
       <source>Acid red 87</source>
     </trans-unit>
     <trans-unit id="PEO_1128_synonyms_2">
       <source>Eosine G</source>
     </trans-unit>
     <trans-unit id="PEO_1128_definition">
       <source>An organobromine compound that has formula C20H6Br4Na2O5.</source>
     </trans-unit>
     <trans-unit id="PEO_1128_synonyms_3">
       <source>InChIKey=SEACYXSIPDVVMV-UHFFFAOYSA-L</source>
     </trans-unit>
     <trans-unit id="PEO_1128_synonyms_4">
       <source>2&apos;,4&apos;,5&apos;,7&apos;-Tetrabromo-3&apos;,6&apos;-dihydroxyspiro(isobenzofuran-1(3H),9-&apos;-(9H)xanthen)-3-one, disodium salt</source>
     </trans-unit>
     <trans-unit id="PEO_1128_synonyms_5">
       <source>Eosine Yellowish</source>
     </trans-unit>
     <trans-unit id="PEO_1128_synonyms_6">
       <source>C20H6Br4Na2O5</source>
     </trans-unit>
     <trans-unit id="PEO_1128_synonyms_7">
       <source>[Na+].[Na+].[O-]C(=O)c1ccccc1-c1c2cc(Br)c([O-])c(Br)c2oc2c(Br)c(=O)c(Br)cc12</source>
     </trans-unit>
     <trans-unit id="PEO_1128_synonyms_8">
       <source>Eosin Y</source>
     </trans-unit>
     <trans-unit id="PEO_1128_synonyms_9">
       <source>disodium 2-(2,4,5,7-tetrabromo-6-oxido-3-oxo-3H-xanthen-9-yl)benzoate</source>
     </trans-unit>
     <trans-unit id="PEO_1129_label">
       <source>estrogen</source>
       <target>エストロゲン
</target>
     </trans-unit>
     <trans-unit id="PEO_1129_synonyms">
       <source>Oestrogen</source>
     </trans-unit>
     <trans-unit id="PEO_1129_synonyms_1">
       <source>estrogenes Hormon</source>
     </trans-unit>
     <trans-unit id="PEO_1129_synonyms_2">
       <source>estrogene</source>
     </trans-unit>
     <trans-unit id="PEO_1129_synonyms_3">
       <source>estrogens</source>
     </trans-unit>
     <trans-unit id="PEO_1129_synonyms_4">
       <source>estrogeno</source>
     </trans-unit>
     <trans-unit id="PEO_1129_synonyms_5">
       <source>estrogenes</source>
     </trans-unit>
     <trans-unit id="PEO_1129_synonyms_6">
       <source>Oestrogene</source>
     </trans-unit>
     <trans-unit id="PEO_1129_synonyms_7">
       <source>oestrogens</source>
     </trans-unit>
     <trans-unit id="PEO_1129_synonyms_8">
       <source>estrogenos</source>
     </trans-unit>
     <trans-unit id="PEO_1129_synonyms_9">
       <source>oestrogenes</source>
     </trans-unit>
     <trans-unit id="PEO_1129_definition">
       <source>A hormone that stimulates or controls the development and maintenance of female sex characteristics in mammals by binding to oestrogen receptors. The oestrogens are named for their importance in the oestrous cycle. The oestrogens that occur naturally in the body, notably estrone, estradiol, estriol, and estetrol are steroids. Other compounds with oestrogenic activity are produced by plants (phytoestrogens) and fungi (mycoestrogens); synthetic compounds with oestrogenic activity are known as xenoestrogens.</source>
     </trans-unit>
     <trans-unit id="PEO_1129_synonyms_10">
       <source>Estrogene</source>
     </trans-unit>
     <trans-unit id="PEO_1129_synonyms_11">
       <source>oestrogen</source>
     </trans-unit>
     <trans-unit id="PEO_1129_synonyms_12">
       <source>oestrogene</source>
     </trans-unit>
     <trans-unit id="PEO_1130_label">
       <source>folic acid</source>
       <target>葉酸
</target>
     </trans-unit>
     <trans-unit id="PEO_1130_synonyms">
       <source>PteGlu</source>
     </trans-unit>
     <trans-unit id="PEO_1130_synonyms_1">
       <source>pteroyl-L-glutamic acid</source>
     </trans-unit>
     <trans-unit id="PEO_1130_synonyms_2">
       <source>N-pteroyl-L-glutamic acid</source>
     </trans-unit>
     <trans-unit id="PEO_1130_synonyms_3">
       <source>pteroyl-L-monoglutamic acid</source>
     </trans-unit>
     <trans-unit id="PEO_1130_synonyms_4">
       <source>FOLIC ACID</source>
     </trans-unit>
     <trans-unit id="PEO_1130_synonyms_5">
       <source>N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid</source>
     </trans-unit>
     <trans-unit id="PEO_1130_synonyms_6">
       <source>Folsaeure</source>
     </trans-unit>
     <trans-unit id="PEO_1130_synonyms_7">
       <source>Folate</source>
     </trans-unit>
     <trans-unit id="PEO_1130_synonyms_8">
       <source>N-(4-{[(2-amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid</source>
     </trans-unit>
     <trans-unit id="PEO_1130_synonyms_9">
       <source>C19H19N7O6</source>
     </trans-unit>
     <trans-unit id="PEO_1130_synonyms_10">
       <source>InChIKey=OVBPIULPVIDEAO-LBPRGKRZSA-N</source>
     </trans-unit>
     <trans-unit id="PEO_1130_definition">
       <source>An N-acyl-amino acid that is a form of the water-soluble vitamin B9. Its biologically active forms (tetrahydrofolate and others) are essential for nucleotide biosynthesis and homocysteine remethylation.</source>
     </trans-unit>
     <trans-unit id="PEO_1130_synonyms_11">
       <source>Folic acid</source>
     </trans-unit>
     <trans-unit id="PEO_1130_synonyms_12">
       <source>vitamin M</source>
     </trans-unit>
     <trans-unit id="PEO_1130_synonyms_13">
       <source>Pteroylglutamic acid</source>
     </trans-unit>
     <trans-unit id="PEO_1130_synonyms_14">
       <source>InChI=1S/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s1</source>
     </trans-unit>
     <trans-unit id="PEO_1130_synonyms_15">
       <source>vitamin Bc</source>
     </trans-unit>
     <trans-unit id="PEO_1130_synonyms_16">
       <source>PGA</source>
     </trans-unit>
     <trans-unit id="PEO_1131_label">
       <source>glucose</source>
       <target>グルコース
</target>
     </trans-unit>
     <trans-unit id="PEO_1131_synonyms">
       <source>C6H12O6</source>
     </trans-unit>
     <trans-unit id="PEO_1131_synonyms_1">
       <source>Glukose</source>
     </trans-unit>
     <trans-unit id="PEO_1131_synonyms_2">
       <source>Glc</source>
     </trans-unit>
     <trans-unit id="PEO_1131_synonyms_3">
       <source>gluco-hexose</source>
     </trans-unit>
     <trans-unit id="PEO_1131_synonyms_4">
       <source>glucose</source>
     </trans-unit>
     <trans-unit id="PEO_1131_definition">
       <source>An aldohexose used as a source of energy and metabolic intermediate.</source>
     </trans-unit>
     <trans-unit id="PEO_1131_synonyms_5">
       <source>Glucose</source>
     </trans-unit>
     <trans-unit id="PEO_1132_label">
       <source>hCG-PlGF ratio</source>
       <target>hCG-PlGF比
</target>
     </trans-unit>
     <trans-unit id="PEO_1133_label">
       <source>haematoxylin</source>
       <target>ヘマトキシリン
</target>
     </trans-unit>
     <trans-unit id="PEO_1133_synonyms">
       <source>7,11b-dihydrobenz[b]indeno[1,2-d]pyran-3,4,6a,9,10(6H)-pentol</source>
     </trans-unit>
     <trans-unit id="PEO_1133_synonyms_1">
       <source>7,11b-dihydroindeno[2,1-c]chromene-3,4,6a,9,10(6H)-pentol</source>
     </trans-unit>
     <trans-unit id="PEO_1133_synonyms_2">
       <source>hematoxyline</source>
     </trans-unit>
     <trans-unit id="PEO_1133_synonyms_3">
       <source>Haematoxylin</source>
     </trans-unit>
     <trans-unit id="PEO_1133_synonyms_4">
       <source>Oc1cc2CC3(O)COc4c(O)c(O)ccc4C3c2cc1O</source>
     </trans-unit>
     <trans-unit id="PEO_1133_synonyms_5">
       <source>hematoxilina</source>
     </trans-unit>
     <trans-unit id="PEO_1133_synonyms_6">
       <source>C16H14O6</source>
     </trans-unit>
     <trans-unit id="PEO_1133_synonyms_7">
       <source>InChIKey=WZUVPPKBWHMQCE-UHFFFAOYSA-N</source>
     </trans-unit>
     <trans-unit id="PEO_1133_synonyms_8">
       <source>InChI=1S/C16H14O6/c17-10-2-1-8-13-9-4-12(19)11(18)3-7(9)5-16(13,21)6-22-15(8)14(10)20/h1-4,13,17-21H,5-6H2</source>
     </trans-unit>
     <trans-unit id="PEO_1133_definition">
       <source>An organic heterotetracyclic compound that has formula C16H14O6.</source>
     </trans-unit>
     <trans-unit id="PEO_1133_synonyms_9">
       <source>hematoxylin</source>
     </trans-unit>
     <trans-unit id="PEO_1134_label">
       <source>hemoglobin</source>
       <target>ヘモグロビン
</target>
     </trans-unit>
     <trans-unit id="PEO_1134_synonyms">
       <source>vertebrate haemoglobin</source>
     </trans-unit>
     <trans-unit id="PEO_1134_synonyms_1">
       <source>hemoglobin</source>
     </trans-unit>
     <trans-unit id="PEO_1134_synonyms_2">
       <source>haemoglobin</source>
     </trans-unit>
     <trans-unit id="PEO_1135_label">
       <source>heparin</source>
       <target>ヘパリン
</target>
     </trans-unit>
     <trans-unit id="PEO_1135_synonyms">
       <source>Cy 222</source>
     </trans-unit>
     <trans-unit id="PEO_1135_synonyms_1">
       <source>heparina</source>
     </trans-unit>
     <trans-unit id="PEO_1135_synonyms_2">
       <source>(C26H40N2O36S5)n</source>
     </trans-unit>
     <trans-unit id="PEO_1135_synonyms_3">
       <source>Enoxaparin</source>
     </trans-unit>
     <trans-unit id="PEO_1135_synonyms_4">
       <source>Heparin</source>
     </trans-unit>
     <trans-unit id="PEO_1135_synonyms_5">
       <source>Certoparin</source>
     </trans-unit>
     <trans-unit id="PEO_1135_synonyms_6">
       <source>Sandoparin</source>
     </trans-unit>
     <trans-unit id="PEO_1135_synonyms_7">
       <source>Heparinic acid</source>
     </trans-unit>
     <trans-unit id="PEO_1135_synonyms_8">
       <source>heparin</source>
     </trans-unit>
     <trans-unit id="PEO_1135_synonyms_9">
       <source>Parnaparin</source>
     </trans-unit>
     <trans-unit id="PEO_1135_synonyms_10">
       <source>Reviparin</source>
     </trans-unit>
     <trans-unit id="PEO_1135_synonyms_11">
       <source>Fluxum</source>
     </trans-unit>
     <trans-unit id="PEO_1135_synonyms_12">
       <source>heparinum</source>
     </trans-unit>
     <trans-unit id="PEO_1135_definition">
       <source>A highly sulfated linear glycosaminoglycan comprising complex patterns of uronic acid-(1-&gt;4)-D-glucosamine repeating subunits. Used as an injectable anticoagulant, it has the highest negative charge density of any known biological molecule.</source>
     </trans-unit>
     <trans-unit id="PEO_1135_synonyms_13">
       <source>heparine</source>
     </trans-unit>
     <trans-unit id="PEO_1135_synonyms_14">
       <source>Bemiparin</source>
     </trans-unit>
     <trans-unit id="PEO_1136_label">
       <source>high-density lipoprotein cholesterol</source>
       <target>高密度リポタンパク質コレステロール
</target>
     </trans-unit>
     <trans-unit id="PEO_1136_synonyms">
       <source>HDL cholesterol</source>
     </trans-unit>
     <trans-unit id="PEO_1136_synonyms_1">
       <source>alpha-lipoprotein cholesterol</source>
     </trans-unit>
     <trans-unit id="PEO_1136_definition">
       <source>Cholesterol esters and free cholesterol which are contained in or bound to high-density lipoproteins (HDL).</source>
     </trans-unit>
     <trans-unit id="PEO_1136_synonyms_2">
       <source>HDL-C</source>
     </trans-unit>
     <trans-unit id="PEO_1137_label">
       <source>hormone</source>
       <target>ホルモン
</target>
     </trans-unit>
     <trans-unit id="PEO_1137_synonyms">
       <source>endocrine</source>
     </trans-unit>
     <trans-unit id="PEO_1137_synonyms_1">
       <source>hormones</source>
     </trans-unit>
     <trans-unit id="PEO_1137_definition">
       <source>Originally referring to an endogenous compound that is formed in specialized organ or group of cells and carried to another organ or group of cells, in the same organism, upon which it has a specific regulatory function, the term is now commonly used to include non-endogenous, semi-synthetic and fully synthetic analogues of such compounds.</source>
     </trans-unit>
     <trans-unit id="PEO_1138_label">
       <source>hypertension</source>
       <target>高血圧
</target>
     </trans-unit>
     <trans-unit id="PEO_1139_label">
       <source>immunotherapy</source>
       <target>免疫療法
</target>
     </trans-unit>
     <trans-unit id="PEO_1139_synonyms">
       <source>AD-directed immunotherapy</source>
     </trans-unit>
     <trans-unit id="PEO_1139_synonyms_1">
       <source>immunotherapies</source>
     </trans-unit>
     <trans-unit id="PEO_1140_label">
       <source>inflammation</source>
       <target>炎症
</target>
     </trans-unit>
     <trans-unit id="PEO_1140_synonyms">
       <source>inflammatory response</source>
     </trans-unit>
     <trans-unit id="PEO_1140_synonyms_1">
       <source>inflammations</source>
     </trans-unit>
     <trans-unit id="PEO_1140_synonyms_2">
       <source>inflammatory cascade</source>
     </trans-unit>
     <trans-unit id="PEO_1140_synonyms_3">
       <source>acute inflammatory response</source>
     </trans-unit>
     <trans-unit id="PEO_1140_synonyms_4">
       <source>peripheral inflammation</source>
     </trans-unit>
     <trans-unit id="PEO_1140_synonyms_5">
       <source>chronic inflammation</source>
     </trans-unit>
     <trans-unit id="PEO_1140_synonyms_6">
       <source>inflammatory</source>
     </trans-unit>
     <trans-unit id="PEO_1140_synonyms_7">
       <source>inflammatory cascades</source>
     </trans-unit>
     <trans-unit id="PEO_1140_synonyms_8">
       <source>inflammatory responses</source>
     </trans-unit>
     <trans-unit id="PEO_1141_label">
       <source>insulin signalling</source>
       <target>インスリン抵抗性
</target>
     </trans-unit>
     <trans-unit id="PEO_1141_synonyms">
       <source>insulin resistance</source>
     </trans-unit>
     <trans-unit id="PEO_1142_label">
       <source>intervention study</source>
       <target>介入研究
</target>
     </trans-unit>
     <trans-unit id="PEO_1142_synonyms">
       <source>intervention studies</source>
     </trans-unit>
     <trans-unit id="PEO_1143_label">
       <source>ion</source>
       <target>イオン
</target>
     </trans-unit>
     <trans-unit id="PEO_1143_definition">
       <source>A molecular entity having a net electric charge.</source>
     </trans-unit>
     <trans-unit id="PEO_1143_synonyms">
       <source>ion</source>
     </trans-unit>
     <trans-unit id="PEO_1143_synonyms_1">
       <source>iones</source>
     </trans-unit>
     <trans-unit id="PEO_1143_synonyms_2">
       <source>ions</source>
     </trans-unit>
     <trans-unit id="PEO_1143_synonyms_3">
       <source>Ion</source>
     </trans-unit>
     <trans-unit id="PEO_1143_synonyms_4">
       <source>Ionen</source>
     </trans-unit>
     <trans-unit id="PEO_1144_label">
       <source>ischemic lesion</source>
       <target>虚血性病変
</target>
     </trans-unit>
     <trans-unit id="PEO_1144_synonyms">
       <source>ischemic lesions</source>
     </trans-unit>
     <trans-unit id="PEO_1145_label">
       <source>isoflurane</source>
       <target>イソフルラン
</target>
     </trans-unit>
     <trans-unit id="PEO_1145_synonyms">
       <source>1-chloro-2,2,2-trifluoroethyl difluoromethyl ether</source>
     </trans-unit>
     <trans-unit id="PEO_1145_synonyms_1">
       <source>2-chloro-2-difluoromethoxy-1,1,1-trifluoroethane</source>
     </trans-unit>
     <trans-unit id="PEO_1145_synonyms_2">
       <source>InChIKey=PIWKPBJCKXDKJR-UHFFFAOYSA-N</source>
     </trans-unit>
     <trans-unit id="PEO_1145_synonyms_3">
       <source>C3H2ClF5O</source>
     </trans-unit>
     <trans-unit id="PEO_1145_synonyms_4">
       <source>isofluranum</source>
     </trans-unit>
     <trans-unit id="PEO_1145_synonyms_5">
       <source>isoflurane</source>
     </trans-unit>
     <trans-unit id="PEO_1145_synonyms_6">
       <source>Ethane</source>
     </trans-unit>
     <trans-unit id="PEO_1145_synonyms_7">
       <source>InChI=1S/C3H2ClF5O/c4-1(3(7,8)9)10-2(5)6/h1-2H</source>
     </trans-unit>
     <trans-unit id="PEO_1145_synonyms_8">
       <source>Aerrane</source>
     </trans-unit>
     <trans-unit id="PEO_1145_synonyms_9">
       <source>Isoflurane</source>
     </trans-unit>
     <trans-unit id="PEO_1145_synonyms_10">
       <source>Forane</source>
     </trans-unit>
     <trans-unit id="PEO_1145_synonyms_11">
       <source>FC(F)OC(Cl)C(F)(F)F</source>
     </trans-unit>
     <trans-unit id="PEO_1145_definition">
       <source>An organofluorine compound that has formula C3H2ClF5O.</source>
     </trans-unit>
     <trans-unit id="PEO_1145_synonyms_12">
       <source>isoflurano</source>
     </trans-unit>
     <trans-unit id="PEO_1145_synonyms_13">
       <source>Forene</source>
     </trans-unit>
     <trans-unit id="PEO_1146_label">
       <source>lamina-associated polypeptide 2</source>
       <target>LAP2
</target>
     </trans-unit>
     <trans-unit id="PEO_1146_synonyms">
       <source>LAP2 (protein)</source>
     </trans-unit>
     <trans-unit id="PEO_1146_synonyms_1">
       <source>LAP2beta</source>
     </trans-unit>
     <trans-unit id="PEO_1146_synonyms_2">
       <source>LAP2alpha</source>
     </trans-unit>
     <trans-unit id="PEO_1147_label">
       <source>late onset context</source>
       <target>晩期発症のコンテクスト
</target>
     </trans-unit>
     <trans-unit id="PEO_1148_label">
       <source>lateral E&apos; wave velocity</source>
       <target>lateral E' wave velocity
</target>
     </trans-unit>
     <trans-unit id="PEO_1148_synonyms">
       <source>lateral E&apos; wave velocity</source>
     </trans-unit>
     <trans-unit id="PEO_1149_label">
       <source>lipid</source>
       <target>脂質
</target>
     </trans-unit>
     <trans-unit id="PEO_1149_synonyms">
       <source>Lipid</source>
     </trans-unit>
     <trans-unit id="PEO_1149_synonyms_1">
       <source>lipids</source>
     </trans-unit>
     <trans-unit id="PEO_1150_label">
       <source>lipid peroxidation</source>
       <target>脂質過酸化
</target>
     </trans-unit>
     <trans-unit id="PEO_1151_label">
       <source>low-density lipoprotein cholesterol</source>
       <target>低密度リポタンパク質コレステロール
</target>
     </trans-unit>
     <trans-unit id="PEO_1151_definition">
       <source>Cholesterol esters and free cholesterol which are contained in or bound to low-density lipoproteins (LDL).</source>
     </trans-unit>
     <trans-unit id="PEO_1151_synonyms">
       <source>LDL-C</source>
     </trans-unit>
     <trans-unit id="PEO_1151_synonyms_1">
       <source>beta-lipoprotein cholesterol</source>
     </trans-unit>
     <trans-unit id="PEO_1151_synonyms_2">
       <source>LDL cholesterol</source>
     </trans-unit>
     <trans-unit id="PEO_1152_label">
       <source>marriageable age</source>
       <target>結婚適齢期
</target>
     </trans-unit>
     <trans-unit id="PEO_1152_synonyms">
       <source>adolescent</source>
     </trans-unit>
     <trans-unit id="PEO_1152_synonyms_1">
       <source>adolescents</source>
     </trans-unit>
     <trans-unit id="PEO_1152_synonyms_2">
       <source>adult</source>
     </trans-unit>
     <trans-unit id="PEO_1152_synonyms_3">
       <source>adults</source>
     </trans-unit>
     <trans-unit id="PEO_1153_label">
       <source>metabolic change</source>
       <target>代謝の変化
</target>
     </trans-unit>
     <trans-unit id="PEO_1153_synonyms">
       <source>metabolic changes</source>
     </trans-unit>
     <trans-unit id="PEO_1154_label">
       <source>metal chelation</source>
       <target>金属キレート
</target>
     </trans-unit>
     <trans-unit id="PEO_1154_synonyms">
       <source>chelate metals</source>
     </trans-unit>
     <trans-unit id="PEO_1155_label">
       <source>metformin</source>
       <target>メトホルミン
</target>
     </trans-unit>
     <trans-unit id="PEO_1155_synonyms">
       <source>CN(C)C(=N)NC(N)=N</source>
     </trans-unit>
     <trans-unit id="PEO_1155_definition">
       <source>A member of the class of guanidines that is the 1,1-dimethyl derivative of biguanide.</source>
     </trans-unit>
     <trans-unit id="PEO_1155_synonyms_1">
       <source>Metformin</source>
     </trans-unit>
     <trans-unit id="PEO_1155_synonyms_2">
       <source>1,1-Dimethylbiguanide</source>
     </trans-unit>
     <trans-unit id="PEO_1155_synonyms_3">
       <source>C4H11N5</source>
     </trans-unit>
     <trans-unit id="PEO_1155_synonyms_4">
       <source>N,N-dimethylimidodicarbonimidic diamide</source>
     </trans-unit>
     <trans-unit id="PEO_1155_synonyms_5">
       <source>InChIKey=XZWYZXLIPXDOLR-UHFFFAOYSA-N</source>
     </trans-unit>
     <trans-unit id="PEO_1155_synonyms_6">
       <source>InChI=1S/C4H11N5/c1-9(2)4(7)8-3(5)6/h1-2H3,(H5,5,6,7,8)</source>
     </trans-unit>
     <trans-unit id="PEO_1156_label">
       <source>mitochondrial change</source>
       <target>ミトコンドリアの変化
</target>
     </trans-unit>
     <trans-unit id="PEO_1156_synonyms">
       <source>mitochondrial changes</source>
     </trans-unit>
     <trans-unit id="PEO_1157_label">
       <source>mitochondrial dysfunctioning</source>
       <target>ミトコンドリア機能不全
</target>
     </trans-unit>
     <trans-unit id="PEO_1158_label">
       <source>Mixed racial group</source>
       <target>混血グループ
</target>
     </trans-unit>
     <trans-unit id="PEO_1158_synonyms">
       <source>Mixed racial group (racial group)</source>
     </trans-unit>
     <trans-unit id="PEO_1159_label">
       <source>6-24 month postportum</source>
       <target>産後6-24ヶ月
</target>
     </trans-unit>
     <trans-unit id="PEO_1160_label">
       <source>mononuclear cell</source>
       <target>単核細胞
</target>
     </trans-unit>
     <trans-unit id="PEO_1160_synonyms">
       <source>peripheral blood mononuclear cell</source>
     </trans-unit>
     <trans-unit id="PEO_1161_label">
       <source>negative regulation of apoptotic process</source>
       <target>アポトーシスの負の制御
</target>
     </trans-unit>
     <trans-unit id="PEO_1161_definition">
       <source>Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.</source>
     </trans-unit>
     <trans-unit id="PEO_1161_synonyms">
       <source>down-regulation of apoptosis; downregulation of apoptosis; anti-apoptosis; down regulation of apoptosis</source>
     </trans-unit>
     <trans-unit id="PEO_1161_synonyms_1">
       <source>inhibition of apoptosis; negative regulation of apoptosis</source>
     </trans-unit>
     <trans-unit id="PEO_1161_synonyms_2">
       <source>pro-survival; apoptosis inhibitor activity</source>
     </trans-unit>
     <trans-unit id="PEO_1162_label">
       <source>nitric oxide</source>
       <target>一酸化窒素
</target>
     </trans-unit>
     <trans-unit id="PEO_1162_synonyms">
       <source>oxido nitrico</source>
     </trans-unit>
     <trans-unit id="PEO_1162_synonyms_1">
       <source>NITRIC OXIDE</source>
     </trans-unit>
     <trans-unit id="PEO_1162_synonyms_2">
       <source>oxidonitrogen(.)</source>
     </trans-unit>
     <trans-unit id="PEO_1162_synonyms_3">
       <source>oxido de nitrogeno(II)</source>
     </trans-unit>
     <trans-unit id="PEO_1162_synonyms_4">
       <source>oxoazanyl</source>
     </trans-unit>
     <trans-unit id="PEO_1162_synonyms_5">
       <source>monoxido de nitrogeno</source>
     </trans-unit>
     <trans-unit id="PEO_1162_synonyms_6">
       <source>NO(.)</source>
     </trans-unit>
     <trans-unit id="PEO_1162_synonyms_7">
       <source>InChI=1S/NO/c1-2</source>
     </trans-unit>
     <trans-unit id="PEO_1162_synonyms_8">
       <source>nitrosyl</source>
     </trans-unit>
     <trans-unit id="PEO_1162_synonyms_9">
       <source>mononitrogen monoxide</source>
     </trans-unit>
     <trans-unit id="PEO_1162_synonyms_10">
       <source>[NO]</source>
     </trans-unit>
     <trans-unit id="PEO_1162_synonyms_11">
       <source>(.)NO</source>
     </trans-unit>
     <trans-unit id="PEO_1162_synonyms_12">
       <source>nitric oxide</source>
     </trans-unit>
     <trans-unit id="PEO_1162_synonyms_13">
       <source>nitrogen monoxide</source>
     </trans-unit>
     <trans-unit id="PEO_1162_synonyms_14">
       <source>NO</source>
     </trans-unit>
     <trans-unit id="PEO_1162_synonyms_15">
       <source>Nitrogen monoxide</source>
     </trans-unit>
     <trans-unit id="PEO_1162_synonyms_16">
       <source>nitrogen monooxide</source>
     </trans-unit>
     <trans-unit id="PEO_1162_synonyms_17">
       <source>(NO)(.)</source>
     </trans-unit>
     <trans-unit id="PEO_1162_synonyms_18">
       <source>[N]=O</source>
     </trans-unit>
     <trans-unit id="PEO_1162_synonyms_19">
       <source>Stickstoffmonoxid</source>
     </trans-unit>
     <trans-unit id="PEO_1162_synonyms_20">
       <source>monoxyde d&apos;azote</source>
     </trans-unit>
     <trans-unit id="PEO_1162_synonyms_21">
       <source>InChIKey=MWUXSHHQAYIFBG-UHFFFAOYSA-N</source>
     </trans-unit>
     <trans-unit id="PEO_1162_synonyms_22">
       <source>Stickstoff(II)-oxid</source>
     </trans-unit>
     <trans-unit id="PEO_1162_definition">
       <source>A nitrogen oxide which is a free radical, each molecule of which consists of one nitrogen and one oxygen atom.</source>
     </trans-unit>
     <trans-unit id="PEO_1162_synonyms_23">
       <source>Nitric oxide</source>
     </trans-unit>
     <trans-unit id="PEO_1162_synonyms_24">
       <source>EDRF</source>
     </trans-unit>
     <trans-unit id="PEO_1162_synonyms_25">
       <source>oxyde azotique</source>
     </trans-unit>
     <trans-unit id="PEO_1162_synonyms_26">
       <source>endothelium-derived relaxing factor</source>
     </trans-unit>
     <trans-unit id="PEO_1162_synonyms_27">
       <source>oxyde nitrique</source>
     </trans-unit>
     <trans-unit id="PEO_1163_label">
       <source>noradrenaline</source>
       <target>ノルアドレナリン
</target>
     </trans-unit>
     <trans-unit id="PEO_1163_synonyms">
       <source>norepinephrine</source>
     </trans-unit>
     <trans-unit id="PEO_1163_synonyms_1">
       <source>C8H11NO3</source>
     </trans-unit>
     <trans-unit id="PEO_1163_synonyms_2">
       <source>NCC(O)c1ccc(O)c(O)c1</source>
     </trans-unit>
     <trans-unit id="PEO_1163_definition">
       <source>A catecholamine in which C-1 of the aminoethyl side-chain is hydroxy-substituted.</source>
     </trans-unit>
     <trans-unit id="PEO_1163_synonyms_3">
       <source>InChIKey=SFLSHLFXELFNJZ-UHFFFAOYSA-N</source>
     </trans-unit>
     <trans-unit id="PEO_1163_synonyms_4">
       <source>InChI=1S/C8H11NO3/c9-4-8(12)5-1-2-6(10)7(11)3-5/h1-3,8,10-12H,4,9H2</source>
     </trans-unit>
     <trans-unit id="PEO_1163_synonyms_5">
       <source>4-(2-amino-1-hydroxyethyl)benzene-1,2-diol</source>
     </trans-unit>
     <trans-unit id="PEO_1163_synonyms_6">
       <source>noradrenalina</source>
     </trans-unit>
     <trans-unit id="PEO_1164_label">
       <source>older than marriageable age</source>
       <target>高齢
</target>
     </trans-unit>
     <trans-unit id="PEO_1164_synonyms">
       <source>increased maternal age</source>
     </trans-unit>
     <trans-unit id="PEO_1164_synonyms_1">
       <source>high maternal age</source>
     </trans-unit>
     <trans-unit id="PEO_1164_synonyms_2">
       <source>older than 35 years old</source>
     </trans-unit>
     <trans-unit id="PEO_1165_label">
       <source>open label study</source>
       <target>オープンラベル研究
</target>
     </trans-unit>
     <trans-unit id="PEO_1166_label">
       <source>outcome assessor</source>
       <target>治療成績評価者
</target>
     </trans-unit>
     <trans-unit id="PEO_1166_synonyms">
       <source>outcome assessors</source>
     </trans-unit>
     <trans-unit id="PEO_1167_label">
       <source>oxygen atom</source>
       <target>酸素原子
</target>
     </trans-unit>
     <trans-unit id="PEO_1167_synonyms">
       <source>[O]</source>
     </trans-unit>
     <trans-unit id="PEO_1167_synonyms_1">
       <source>O</source>
     </trans-unit>
     <trans-unit id="PEO_1167_synonyms_2">
       <source>8O</source>
     </trans-unit>
     <trans-unit id="PEO_1167_synonyms_3">
       <source>InChIKey=QVGXLLKOCUKJST-UHFFFAOYSA-N</source>
     </trans-unit>
     <trans-unit id="PEO_1167_synonyms_4">
       <source>oxygene</source>
     </trans-unit>
     <trans-unit id="PEO_1167_definition">
       <source>A chalcogen that has formula O.</source>
     </trans-unit>
     <trans-unit id="PEO_1167_synonyms_5">
       <source>oxygen</source>
     </trans-unit>
     <trans-unit id="PEO_1167_synonyms_6">
       <source>oxigeno</source>
     </trans-unit>
     <trans-unit id="PEO_1167_synonyms_7">
       <source>Sauerstoff</source>
     </trans-unit>
     <trans-unit id="PEO_1167_synonyms_8">
       <source>InChI=1S/O</source>
     </trans-unit>
     <trans-unit id="PEO_1168_label">
       <source>oxytocin</source>
       <target>オキシトシン
</target>
     </trans-unit>
     <trans-unit id="PEO_1168_synonyms">
       <source>L-Cysteinyl-L-tyrosyl-L-isoleucyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-leucylglycinamide cyclic(1-6)-disulfide</source>
     </trans-unit>
     <trans-unit id="PEO_1168_synonyms_1">
       <source>Endopituitrina</source>
     </trans-unit>
     <trans-unit id="PEO_1168_synonyms_2">
       <source>InChIKey=XNOPRXBHLZRZKH-DSZYJQQASA-N</source>
     </trans-unit>
     <trans-unit id="PEO_1168_synonyms_3">
       <source>(1-Hemicystine)oxytocin</source>
     </trans-unit>
     <trans-unit id="PEO_1168_synonyms_4">
       <source>3-Isoleucine-8-leucine vasopressin</source>
     </trans-unit>
     <trans-unit id="PEO_1168_synonyms_5">
       <source>InChI=1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35-/m0/s1</source>
     </trans-unit>
     <trans-unit id="PEO_1168_synonyms_6">
       <source>Pitocin</source>
     </trans-unit>
     <trans-unit id="PEO_1168_synonyms_7">
       <source>Ocytocin</source>
     </trans-unit>
     <trans-unit id="PEO_1168_synonyms_8">
       <source>Orasthin</source>
     </trans-unit>
     <trans-unit id="PEO_1168_synonyms_9">
       <source>1-({(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-(4-hydroxybenzyl)-13-[(1S)-1-methylpropyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl}carbonyl)-L-prolyl-L-leucylglycinamide</source>
     </trans-unit>
     <trans-unit id="PEO_1168_synonyms_10">
       <source>A cyclic nonapeptide hormone with amino acid sequence CYIQNCPLG that also acts as a neurotransmitter in the brain; the principal uterine-contracting and milk-ejecting hormone of the posterior pituitary. Together with the neuropeptide vasopressin, it is believed to influence social cognition and behaviour.</source>
     </trans-unit>
     <trans-unit id="PEO_1168_synonyms_11">
       <source>Oxytocin</source>
     </trans-unit>
     <trans-unit id="PEO_1168_synonyms_12">
       <source>oxitocina</source>
     </trans-unit>
     <trans-unit id="PEO_1168_synonyms_13">
       <source>oxytocin</source>
     </trans-unit>
     <trans-unit id="PEO_1168_synonyms_14">
       <source>oxytocine</source>
     </trans-unit>
     <trans-unit id="PEO_1168_synonyms_15">
       <source>C43H66N12O12S2</source>
     </trans-unit>
     <trans-unit id="PEO_1168_synonyms_16">
       <source>OXT</source>
     </trans-unit>
     <trans-unit id="PEO_1168_synonyms_17">
       <source>OT</source>
     </trans-unit>
     <trans-unit id="PEO_1168_synonyms_18">
       <source>Syntocinon</source>
     </trans-unit>
     <trans-unit id="PEO_1168_synonyms_19">
       <source>oxytocinum</source>
     </trans-unit>
     <trans-unit id="PEO_1168_synonyms_20">
       <source>Piton S</source>
     </trans-unit>
     <trans-unit id="PEO_1169_label">
       <source>perfluorodecanoic acid</source>
       <target>ペルフルオロデカン酸
</target>
     </trans-unit>
     <trans-unit id="PEO_1169_synonyms">
       <source>nonadecafluoro-n-decanoic acid</source>
     </trans-unit>
     <trans-unit id="PEO_1169_synonyms_1">
       <source>perfluorodecanoic acid</source>
     </trans-unit>
     <trans-unit id="PEO_1169_synonyms_2">
       <source>C10HF19O2</source>
     </trans-unit>
     <trans-unit id="PEO_1169_synonyms_3">
       <source>PFDA</source>
     </trans-unit>
     <trans-unit id="PEO_1169_synonyms_4">
       <source>perfluoro-n-decanoic acid</source>
     </trans-unit>
     <trans-unit id="PEO_1169_synonyms_5">
       <source>InChIKey=PCIUEQPBYFRTEM-UHFFFAOYSA-N</source>
     </trans-unit>
     <trans-unit id="PEO_1169_synonyms_6">
       <source>Ndfda</source>
     </trans-unit>
     <trans-unit id="PEO_1169_synonyms_7">
       <source>InChI=1S/C10HF19O2/c11-2(12,1(30)31)3(13,14)4(15,16)5(17,18)6(19,20)7(21,22)8(23,24)9(25,26)10(27,28)29/h(H,30,31)</source>
     </trans-unit>
     <trans-unit id="PEO_1169_definition">
       <source>A fluoroalkanoic acid that is perfluorinated decanoic acid.</source>
     </trans-unit>
     <trans-unit id="PEO_1169_synonyms_8">
       <source>nonadecafluorodecanoic acid</source>
     </trans-unit>
     <trans-unit id="PEO_1169_synonyms_9">
       <source>2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-nonadecafluorodecanoic acid</source>
     </trans-unit>
     <trans-unit id="PEO_1169_synonyms_10">
       <source>OC(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F</source>
     </trans-unit>
     <trans-unit id="PEO_1170_label">
       <source>perfluorononanoic acid</source>
       <target>ペルフルオロノナン酸
</target>
     </trans-unit>
     <trans-unit id="PEO_1170_synonyms">
       <source>PFNA</source>
     </trans-unit>
     <trans-unit id="PEO_1171_label">
       <source>perfluorooctane sulfonic acid</source>
       <target>ペルフルオロオクタンスルホン酸
</target>
     </trans-unit>
     <trans-unit id="PEO_1171_synonyms">
       <source>PFOSA</source>
     </trans-unit>
     <trans-unit id="PEO_1171_synonyms_1">
       <source>heptadecafluoro-1-octane sulfonic acid</source>
     </trans-unit>
     <trans-unit id="PEO_1171_synonyms_2">
       <source>perfluorooctane sulphonic acid</source>
     </trans-unit>
     <trans-unit id="PEO_1171_synonyms_3">
       <source>perfluorooctanyl sulfonate</source>
     </trans-unit>
     <trans-unit id="PEO_1171_synonyms_4">
       <source>http://purl.bioontology.org/ontology/MESH/C076994</source>
     </trans-unit>
     <trans-unit id="PEO_1171_synonyms_5">
       <source>heptadecafluorooctane sulfonic acid</source>
     </trans-unit>
     <trans-unit id="PEO_1171_synonyms_6">
       <source>1-Octanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-</source>
     </trans-unit>
     <trans-unit id="PEO_1171_synonyms_7">
       <source>perfluorooctane sulfonate</source>
     </trans-unit>
     <trans-unit id="PEO_1171_synonyms_8">
       <source>Perfluorooctanesulfonate</source>
     </trans-unit>
     <trans-unit id="PEO_1171_synonyms_9">
       <source>perfluorooctanesulfonic acid</source>
     </trans-unit>
     <trans-unit id="PEO_1171_synonyms_10">
       <source>PFOS compound</source>
     </trans-unit>
     <trans-unit id="PEO_1172_label">
       <source>perfluorooctanoic acid</source>
       <target>ペルフルオロオクタン酸
</target>
     </trans-unit>
     <trans-unit id="PEO_1172_synonyms">
       <source>pentadecafluorooctanoic acid</source>
     </trans-unit>
     <trans-unit id="PEO_1172_synonyms_1">
       <source>PFOA cpd</source>
     </trans-unit>
     <trans-unit id="PEO_1172_synonyms_2">
       <source>perfluorooctanoic acid, anhydride</source>
     </trans-unit>
     <trans-unit id="PEO_1172_synonyms_3">
       <source>perfluorooctanoic acid, chromium (3+) salt</source>
     </trans-unit>
     <trans-unit id="PEO_1172_synonyms_4">
       <source>perfluorooctanoic acid, monosodium salt</source>
     </trans-unit>
     <trans-unit id="PEO_1172_synonyms_5">
       <source>ammonium perfluorooctanoate</source>
     </trans-unit>
     <trans-unit id="PEO_1172_synonyms_6">
       <source>perfluorooctanoic acid, monosilver (1+) salt</source>
     </trans-unit>
     <trans-unit id="PEO_1172_synonyms_7">
       <source>perfluorooctanoate</source>
     </trans-unit>
     <trans-unit id="PEO_1172_synonyms_8">
       <source>APFO</source>
     </trans-unit>
     <trans-unit id="PEO_1172_synonyms_9">
       <source>perfluorooctanoic acid, monoammonium salt</source>
     </trans-unit>
     <trans-unit id="PEO_1172_synonyms_10">
       <source>perfluorooctanoic acid, lithium salt</source>
     </trans-unit>
     <trans-unit id="PEO_1172_synonyms_11">
       <source>perfluorooctanoic acid, cesium salt</source>
     </trans-unit>
     <trans-unit id="PEO_1172_synonyms_12">
       <source>perfluorooctanoic acid, cobalt (2+) salt</source>
     </trans-unit>
     <trans-unit id="PEO_1172_synonyms_13">
       <source>perfluorooctanoic acid, monopotassium salt</source>
     </trans-unit>
     <trans-unit id="PEO_1172_synonyms_14">
       <source>perfluorinated octanoic acid</source>
     </trans-unit>
     <trans-unit id="PEO_1172_synonyms_15">
       <source>sodium perfluorooctanoate</source>
     </trans-unit>
     <trans-unit id="PEO_1172_synonyms_16">
       <source>perfluorooctanoyl chloride</source>
     </trans-unit>
     <trans-unit id="PEO_1173_label">
       <source>perfluoroundecanoic acid</source>
       <target>ペルフルオロウンデカン酸
</target>
     </trans-unit>
     <trans-unit id="PEO_1173_synonyms">
       <source>PFUA compound</source>
     </trans-unit>
     <trans-unit id="PEO_1174_label">
       <source>performing physical activity</source>
       <target>身体活動
</target>
     </trans-unit>
     <trans-unit id="PEO_1174_synonyms">
       <source>physical activities</source>
     </trans-unit>
     <trans-unit id="PEO_1174_synonyms_1">
       <source>physical activity</source>
     </trans-unit>
     <trans-unit id="PEO_1174_synonyms_2">
       <source>high physical activity</source>
     </trans-unit>
     <trans-unit id="PEO_1175_label">
       <source>peroxynitrite</source>
       <target>亜硝酸過酸化物
</target>
     </trans-unit>
     <trans-unit id="PEO_1176_label">
       <source>phase 0</source>
       <target>第0相
</target>
     </trans-unit>
     <trans-unit id="PEO_1177_label">
       <source>phase 2A</source>
       <target>初期第II相
</target>
     </trans-unit>
     <trans-unit id="PEO_1178_label">
       <source>phase 2B</source>
       <target>後期第II相試験
</target>
     </trans-unit>
     <trans-unit id="PEO_1179_label">
       <source>phospatidylinositol signalling</source>
       <target>ホスファチジルイノシトールシグナリング
</target>
     </trans-unit>
     <trans-unit id="PEO_1180_label">
       <source>plumbum</source>
       <target>鉛
</target>
     </trans-unit>
     <trans-unit id="PEO_1180_synonyms">
       <source>Pb</source>
     </trans-unit>
     <trans-unit id="PEO_1181_label">
       <source>potassium(1+)</source>
       <target>カリウムイオン
</target>
     </trans-unit>
     <trans-unit id="PEO_1181_synonyms">
       <source>potassium(1+)</source>
     </trans-unit>
     <trans-unit id="PEO_1181_synonyms_1">
       <source>[K+]</source>
     </trans-unit>
     <trans-unit id="PEO_1181_synonyms_2">
       <source>potassium</source>
     </trans-unit>
     <trans-unit id="PEO_1181_synonyms_3">
       <source>K(+)</source>
     </trans-unit>
     <trans-unit id="PEO_1181_synonyms_4">
       <source>POTASSIUM ION</source>
     </trans-unit>
     <trans-unit id="PEO_1181_synonyms_5">
       <source>K+</source>
     </trans-unit>
     <trans-unit id="PEO_1181_synonyms_6">
       <source>InChI=1S/K/q+1</source>
     </trans-unit>
     <trans-unit id="PEO_1181_synonyms_7">
       <source>potassium(1+) ion</source>
     </trans-unit>
     <trans-unit id="PEO_1181_synonyms_8">
       <source>potassium(I) cation</source>
     </trans-unit>
     <trans-unit id="PEO_1181_synonyms_9">
       <source>potassium cation</source>
     </trans-unit>
     <trans-unit id="PEO_1181_synonyms_10">
       <source>InChIKey=NPYPAHLBTDXSSS-UHFFFAOYSA-N</source>
     </trans-unit>
     <trans-unit id="PEO_1181_definition">
       <source>A monoatomic monocation obtained from potassium.</source>
     </trans-unit>
     <trans-unit id="PEO_1181_synonyms_11">
       <source>K</source>
     </trans-unit>
     <trans-unit id="PEO_1182_label">
       <source>Prepregnancy body weight</source>
       <target>妊娠前体重
</target>
     </trans-unit>
     <trans-unit id="PEO_1183_label">
       <source>primary purpose design</source>
       <target>研究目的のデザイン
</target>
     </trans-unit>
     <trans-unit id="PEO_1183_synonyms">
       <source>primary purpose designs</source>
     </trans-unit>
     <trans-unit id="PEO_1184_label">
       <source>thing related to procedure using biomarkers</source>
       <target>バイオマーカーの利用に関連する概念
</target>
     </trans-unit>
     <trans-unit id="PEO_1184_synonyms">
       <source>biological marker</source>
     </trans-unit>
     <trans-unit id="PEO_1184_synonyms_1">
       <source>biomarker</source>
     </trans-unit>
     <trans-unit id="PEO_1185_label">
       <source>processes all cells</source>
       <target>全細胞処理
</target>
     </trans-unit>
     <trans-unit id="PEO_1186_label">
       <source>progesterone</source>
       <target>黄体ホルモン
</target>
     </trans-unit>
     <trans-unit id="PEO_1186_synonyms">
       <source>Agolutin</source>
     </trans-unit>
     <trans-unit id="PEO_1186_synonyms_1">
       <source>Gelbkoerperhormon</source>
     </trans-unit>
     <trans-unit id="PEO_1186_synonyms_2">
       <source>(S)-Progesterone</source>
     </trans-unit>
     <trans-unit id="PEO_1186_synonyms_3">
       <source>InChI=1S/C21H30O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h12,16-19H,4-11H2,1-3H3/t16-,17+,18-,19-,20-,21+/m0/s1</source>
     </trans-unit>
     <trans-unit id="PEO_1186_synonyms_4">
       <source>4-Pregnene-3,20-dione</source>
     </trans-unit>
     <trans-unit id="PEO_1186_synonyms_5">
       <source>InChIKey=RJKFOVLPORLFTN-LEKSSAKUSA-N</source>
     </trans-unit>
     <trans-unit id="PEO_1186_synonyms_6">
       <source>Progesterone</source>
     </trans-unit>
     <trans-unit id="PEO_1186_synonyms_7">
       <source>(S)-Pregn-4-en-3,20-dione</source>
     </trans-unit>
     <trans-unit id="PEO_1186_definition">
       <source>A C21-steroid hormone in which a pregnane skeleton carries oxo substituents at positions 3 and 20 and is unsaturated at C(4)-C(5). As a hormone, it is involved in the female menstrual cycle, pregnancy and embryogenesis of humans and other species.</source>
     </trans-unit>
     <trans-unit id="PEO_1186_synonyms_8">
       <source>Delta(4)-pregnene-3,20-dione</source>
     </trans-unit>
     <trans-unit id="PEO_1186_synonyms_9">
       <source>Progesteron</source>
     </trans-unit>
     <trans-unit id="PEO_1186_synonyms_10">
       <source>luteohormone</source>
     </trans-unit>
     <trans-unit id="PEO_1186_synonyms_11">
       <source>progesterone</source>
     </trans-unit>
     <trans-unit id="PEO_1186_synonyms_12">
       <source>Akrolutin</source>
     </trans-unit>
     <trans-unit id="PEO_1186_synonyms_13">
       <source>C21H30O2</source>
     </trans-unit>
     <trans-unit id="PEO_1186_synonyms_14">
       <source>pregn-4-ene-3,20-dione</source>
     </trans-unit>
     <trans-unit id="PEO_1186_synonyms_15">
       <source>corpus luteum hormone</source>
     </trans-unit>
     <trans-unit id="PEO_1186_synonyms_16">
       <source>Crinone</source>
     </trans-unit>
     <trans-unit id="PEO_1186_synonyms_17">
       <source>17alpha-progesterone</source>
     </trans-unit>
     <trans-unit id="PEO_1186_synonyms_18">
       <source>(S)-4-Pregnene-3,20-dione</source>
     </trans-unit>
     <trans-unit id="PEO_1186_synonyms_19">
       <source>PROGESTERONE</source>
     </trans-unit>
     <trans-unit id="PEO_1187_label">
       <source>protein synthesis</source>
       <target>タンパク質合成
</target>
     </trans-unit>
     <trans-unit id="PEO_1187_synonyms">
       <source>cerebral protein synthesis</source>
     </trans-unit>
     <trans-unit id="PEO_1187_synonyms_1">
       <source>rCPS</source>
     </trans-unit>
     <trans-unit id="PEO_1187_synonyms_2">
       <source>CPS</source>
     </trans-unit>
     <trans-unit id="PEO_1188_label">
       <source>randomized study</source>
       <target>無作為研究
</target>
     </trans-unit>
     <trans-unit id="PEO_1188_synonyms">
       <source>randomized studies</source>
     </trans-unit>
     <trans-unit id="PEO_1189_label">
       <source>regulation of cell adhesion</source>
       <target>細胞接着の制御
</target>
     </trans-unit>
     <trans-unit id="PEO_1189_definition">
       <source>Any process that modulates the frequency, rate or extent of attachment of a cell to another cell or to the extracellular matrix.</source>
     </trans-unit>
     <trans-unit id="PEO_1189_synonyms">
       <source>cell adhesion receptor regulator activity</source>
     </trans-unit>
     <trans-unit id="PEO_1190_label">
       <source>regulation of immune system process</source>
       <target>免疫システムの制御
</target>
     </trans-unit>
     <trans-unit id="PEO_1190_definition">
       <source>Any process that modulates the frequency, rate, or extent of an immune system process.</source>
     </trans-unit>
     <trans-unit id="PEO_1191_label">
       <source>sFlt1-PlGF ratio</source>
       <target>sFlt1-PlGF比
</target>
     </trans-unit>
     <trans-unit id="PEO_1192_label">
       <source>single blind study</source>
       <target>単盲検試験
</target>
     </trans-unit>
     <trans-unit id="PEO_1192_synonyms">
       <source>blinded</source>
     </trans-unit>
     <trans-unit id="PEO_1192_synonyms_1">
       <source>single blind studies</source>
     </trans-unit>
     <trans-unit id="PEO_1193_label">
       <source>single masked study</source>
       <target>単盲検試験
</target>
     </trans-unit>
     <trans-unit id="PEO_1193_synonyms">
       <source>single masked studies</source>
     </trans-unit>
     <trans-unit id="PEO_1194_label">
       <source>sleep disorder</source>
       <target>睡眠障害
</target>
     </trans-unit>
     <trans-unit id="PEO_1194_synonyms">
       <source>Sleep disorder (disorder)</source>
     </trans-unit>
     <trans-unit id="PEO_1195_label">
       <source>somatostatin</source>
       <target>ソマトスタチン
</target>
     </trans-unit>
     <trans-unit id="PEO_1195_synonyms">
       <source>somatostatinum</source>
     </trans-unit>
     <trans-unit id="PEO_1195_synonyms_1">
       <source>C76H104N18O19S2</source>
     </trans-unit>
     <trans-unit id="PEO_1195_synonyms_2">
       <source>somatostatina</source>
     </trans-unit>
     <trans-unit id="PEO_1195_synonyms_3">
       <source>L-alanylglycyl-L-cysteinyl-L-lysyl-L-asparaginyl-L-phenylalanyl-L-phenylalanyl-L-tryptophyl-L-lysyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-cysteine cyclic (3-14) disulfide</source>
     </trans-unit>
     <trans-unit id="PEO_1195_synonyms_4">
       <source>somatostatine</source>
     </trans-unit>
     <trans-unit id="PEO_1195_synonyms_5">
       <source>Somatostatin-14</source>
     </trans-unit>
     <trans-unit id="PEO_1195_definition">
       <source>A fourteen-membered heterodetic cyclic peptide comprising the sequence Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys cyclised by a disulfide bridge between the two Cys residues at positions 3 and 14.</source>
     </trans-unit>
     <trans-unit id="PEO_1195_synonyms_6">
       <source>Somatostatin-1</source>
     </trans-unit>
     <trans-unit id="PEO_1195_synonyms_7">
       <source>InChIKey=NHXLMOGPVYXJNR-ATOGVRKGSA-N</source>
     </trans-unit>
     <trans-unit id="PEO_1195_synonyms_8">
       <source>L-alanyl-N-[(4R,7S,10S,13S,16S,19S,22S,25S,28S,31S,34S,37R)-19,34-bis(4-aminobutyl)-31-(2-amino-2-oxoethyl)-13,25,28-tribenzyl-4-carboxy-10,16-bis[(1R)-1-hydroxyethyl]-7-(hydroxymethyl)-22-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecaazacyclooctatriacontan-37-yl]glycinamide</source>
     </trans-unit>
     <trans-unit id="PEO_1195_synonyms_9">
       <source>Synthetic growth hormone release-inhibiting hormone</source>
     </trans-unit>
     <trans-unit id="PEO_1195_synonyms_10">
       <source>InChI=1S/C76H104N18O19S2/c1-41(79)64(100)82-37-61(99)83-58-39-114-115-40-59(76(112)113)92-72(108)57(38-95)91-75(111)63(43(3)97)94-71(107)54(33-46-23-11-6-12-24-46)90-74(110)62(42(2)96)93-66(102)51(28-16-18-30-78)84-69(105)55(34-47-36-81-49-26-14-13-25-48(47)49)88-68(104)53(32-45-21-9-5-10-22-45)86-67(103)52(31-44-19-7-4-8-20-44)87-70(106)56(35-60(80)98)89-65(101)50(85-73(58)109)27-15-17-29-77/h4-14,19-26,36,41-43,50-59,62-63,81,95-97H,15-18,27-35,37-40,77-79H2,1-3H3,(H2,80,98)(H,82,100)(H,83,99)(H,84,105)(H,85,109)(H,86,103)(H,87,106)(H,88,104)(H,89,101)(H,90,110)(H,91,111)(H,92,108)(H,93,102)(H,94,107)(H,112,113)/t41-,42+,43+,50-,51-,52-,53-,54-,55-,56-,57-,58-,59-,62-,63-/m0/s1</source>
     </trans-unit>
     <trans-unit id="PEO_1195_synonyms_11">
       <source>somatostatin</source>
     </trans-unit>
     <trans-unit id="PEO_1195_synonyms_12">
       <source>Ala-Gly-cyclo-[Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys]</source>
     </trans-unit>
     <trans-unit id="PEO_1196_label">
       <source>steroid biosynthetic process</source>
       <target>ステロイド合成
</target>
     </trans-unit>
     <trans-unit id="PEO_1196_synonyms">
       <source>steroid biosynthesis</source>
     </trans-unit>
     <trans-unit id="PEO_1196_synonyms_1">
       <source>steroid anabolism</source>
     </trans-unit>
     <trans-unit id="PEO_1196_synonyms_2">
       <source>steroid formation</source>
     </trans-unit>
     <trans-unit id="PEO_1196_synonyms_3">
       <source>steroidogenesis</source>
     </trans-unit>
     <trans-unit id="PEO_1196_definition">
       <source>The chemical reactions and pathways resulting in the formation of steroids, compounds with a 1,2,cyclopentanoperhydrophenanthrene nucleus; includes de novo formation and steroid interconversion by modification.</source>
     </trans-unit>
     <trans-unit id="PEO_1196_synonyms_4">
       <source>steroid synthesis</source>
     </trans-unit>
     <trans-unit id="PEO_1197_label">
       <source>steroid hormone</source>
       <target>ステロイドホルモン
</target>
     </trans-unit>
     <trans-unit id="PEO_1197_synonyms">
       <source>hormona esteroide</source>
     </trans-unit>
     <trans-unit id="PEO_1197_synonyms_1">
       <source>steroid hormones</source>
     </trans-unit>
     <trans-unit id="PEO_1197_definition">
       <source>Any steroid that acts as hormone.</source>
     </trans-unit>
     <trans-unit id="PEO_1197_synonyms_2">
       <source>hormones steroides</source>
     </trans-unit>
     <trans-unit id="PEO_1197_synonyms_3">
       <source>hormonas esteroideas</source>
     </trans-unit>
     <trans-unit id="PEO_1197_synonyms_4">
       <source>hormone steroide</source>
     </trans-unit>
     <trans-unit id="PEO_1197_synonyms_5">
       <source>Steroidhormon</source>
     </trans-unit>
     <trans-unit id="PEO_1197_synonyms_6">
       <source>Steroidhormone</source>
     </trans-unit>
     <trans-unit id="PEO_1198_label">
       <source>stroke</source>
       <target>脳卒中
</target>
     </trans-unit>
     <trans-unit id="PEO_1198_synonyms">
       <source>strokes</source>
     </trans-unit>
     <trans-unit id="PEO_1199_label">
       <source>study caregiver</source>
       <target>介護者
</target>
     </trans-unit>
     <trans-unit id="PEO_1199_synonyms">
       <source>study caregivers</source>
     </trans-unit>
     <trans-unit id="PEO_1200_label">
       <source>study investigator</source>
       <target>研究者
</target>
     </trans-unit>
     <trans-unit id="PEO_1200_synonyms">
       <source>study investigators</source>
     </trans-unit>
     <trans-unit id="PEO_1201_label">
       <source>study nurse</source>
       <target>治験看護師
</target>
     </trans-unit>
     <trans-unit id="PEO_1202_label">
       <source>study subject</source>
       <target>研究対象者
</target>
     </trans-unit>
     <trans-unit id="PEO_1202_synonyms">
       <source>study subjects</source>
     </trans-unit>
     <trans-unit id="PEO_1203_label">
       <source>survivor</source>
       <target>生存者
</target>
     </trans-unit>
     <trans-unit id="PEO_1203_synonyms">
       <source>survivors</source>
     </trans-unit>
     <trans-unit id="PEO_1204_label">
       <source>syncytiotrophoblast cell</source>
       <target>合胞体栄養細胞
</target>
     </trans-unit>
     <trans-unit id="PEO_1204_synonyms">
       <source>plasmidotrophoblast</source>
     </trans-unit>
     <trans-unit id="PEO_1204_synonyms_1">
       <source>syntrophoblast</source>
     </trans-unit>
     <trans-unit id="PEO_1204_synonyms_2">
       <source>syncytial trophoblast</source>
     </trans-unit>
     <trans-unit id="PEO_1205_label">
       <source>thing related to biological functions</source>
       <target>生物学的機能に関連した概念
</target>
     </trans-unit>
     <trans-unit id="PEO_1206_label">
       <source>thing related to complication for child</source>
       <target>児の合併症に関連した概念
</target>
     </trans-unit>
     <trans-unit id="PEO_1207_label">
       <source>thing related to complications</source>
       <target>合併症に関する概念
</target>
     </trans-unit>
     <trans-unit id="PEO_1208_label">
       <source>thing related to complications for mother</source>
       <target>母親の合併症に関する概念
</target>
     </trans-unit>
     <trans-unit id="PEO_1209_label">
       <source>thing related to demographics</source>
       <target>人口統計学的背景に関する事象
</target>
     </trans-unit>
     <trans-unit id="PEO_1210_label">
       <source>thing related to early onset</source>
       <target>早期発症に関連した概念
</target>
     </trans-unit>
     <trans-unit id="PEO_1210_synonyms">
       <source>EO</source>
     </trans-unit>
     <trans-unit id="PEO_1210_synonyms_1">
       <source>Early onset</source>
     </trans-unit>
     <trans-unit id="PEO_1211_label">
       <source>thing related to economic status</source>
       <target>経済的状態に関連した概念
</target>
     </trans-unit>
     <trans-unit id="PEO_1212_label">
       <source>thing related to environmental exposure</source>
       <target>環境因子に関する概念
</target>
     </trans-unit>
     <trans-unit id="PEO_1213_label">
       <source>thing related to functional phenotypes</source>
       <target>機能的表現型
</target>
     </trans-unit>
     <trans-unit id="PEO_1214_label">
       <source>thing related to functional units</source>
       <target>機能単位に関連した概念
</target>
     </trans-unit>
     <trans-unit id="PEO_1215_label">
       <source>thing related to gene</source>
       <target>遺伝子に関連した概念
</target>
     </trans-unit>
     <trans-unit id="PEO_1215_synonyms">
       <source>genes</source>
     </trans-unit>
     <trans-unit id="PEO_1215_synonyms_1">
       <source>gene</source>
     </trans-unit>
     <trans-unit id="PEO_1216_label">
       <source>thing related to history of obestric complications</source>
       <target>過去の産科合併症に関連した概念
</target>
     </trans-unit>
     <trans-unit id="PEO_1217_label">
       <source>thing related to late onset</source>
       <target>晩期発症に関連した概念
</target>
     </trans-unit>
     <trans-unit id="PEO_1217_synonyms">
       <source>Late-onset</source>
     </trans-unit>
     <trans-unit id="PEO_1217_synonyms_1">
       <source>Late onset</source>
     </trans-unit>
     <trans-unit id="PEO_1217_synonyms_2">
       <source>LO</source>
     </trans-unit>
     <trans-unit id="PEO_1218_label">
       <source>thing related to lifestyle</source>
       <target>ライフスタイルに関する概念
</target>
     </trans-unit>
     <trans-unit id="PEO_1219_label">
       <source>thing related to main complaint</source>
       <target>主訴に関する概念
</target>
     </trans-unit>
     <trans-unit id="PEO_1220_label">
       <source>thing related to medical history</source>
       <target>病歴に関連する概念
</target>
     </trans-unit>
     <trans-unit id="PEO_1221_label">
       <source>thing related to medical resources</source>
       <target>医療リソースに関連した概念
</target>
     </trans-unit>
     <trans-unit id="PEO_1222_label">
       <source>thing related to medicational history</source>
       <target>治療歴に関係する概念
</target>
     </trans-unit>
     <trans-unit id="PEO_1223_label">
       <source>thing related to mild stage</source>
       <target>軽症に関連した概念
</target>
     </trans-unit>
     <trans-unit id="PEO_1224_label">
       <source>thing related to observations</source>
       <target>所見に関係する概念
</target>
     </trans-unit>
     <trans-unit id="PEO_1225_label">
       <source>thing related to outcome of child</source>
       <target>児のアウトカムに関連した概念
</target>
     </trans-unit>
     <trans-unit id="PEO_1226_label">
       <source>thing related to outcome of mother</source>
       <target>母親のアウトカムに関連した概念
</target>
     </trans-unit>
     <trans-unit id="PEO_1227_label">
       <source>thing related to outcomes</source>
       <target>アウトカムに関連した概念
</target>
     </trans-unit>
     <trans-unit id="PEO_1228_label">
       <source>thing related to past physical status</source>
       <target>過去の身体的な状態に関連した概念
</target>
     </trans-unit>
     <trans-unit id="PEO_1229_label">
       <source>thing related to past treatment</source>
       <target>治療歴に関連した概念
</target>
     </trans-unit>
     <trans-unit id="PEO_1230_label">
       <source>thing related to phenotypic features</source>
       <target>表現系に関連した概念
</target>
     </trans-unit>
     <trans-unit id="PEO_1231_label">
       <source>thing related to precursor</source>
       <target>前駆体に関連した概念
</target>
     </trans-unit>
     <trans-unit id="PEO_1232_label">
       <source>thing related to protein</source>
       <target>タンパク質に関連した概念
</target>
     </trans-unit>
     <trans-unit id="PEO_1233_label">
       <source>thing related to regional status</source>
       <target>地域内の役割に関連した概念
</target>
     </trans-unit>
     <trans-unit id="PEO_1234_label">
       <source>thing related to severe stage</source>
       <target>重症に関連した概念
</target>
     </trans-unit>
     <trans-unit id="PEO_1234_synonyms">
       <source>severe</source>
     </trans-unit>
     <trans-unit id="PEO_1235_label">
       <source>thing related to social factors</source>
       <target>社会的因子に関係する概念
</target>
     </trans-unit>
     <trans-unit id="PEO_1236_label">
       <source>thing related to social support</source>
       <target>社会的支援に関係する概念
</target>
     </trans-unit>
     <trans-unit id="PEO_1237_label">
       <source>thing related to stage</source>
       <target>ステージに関連する概念
</target>
     </trans-unit>
     <trans-unit id="PEO_1237_synonyms">
       <source>Stage</source>
     </trans-unit>
     <trans-unit id="PEO_1237_synonyms_1">
       <source>stages</source>
     </trans-unit>
     <trans-unit id="PEO_1238_label">
       <source>thing related to transcript</source>
       <target>転写に関連した概念
</target>
     </trans-unit>
     <trans-unit id="PEO_1239_label">
       <source>thing related to variants</source>
       <target>遺伝子変異に関連した概念
</target>
     </trans-unit>
     <trans-unit id="PEO_1239_synonyms">
       <source>genetic risk factor</source>
     </trans-unit>
     <trans-unit id="PEO_1239_synonyms_1">
       <source>genetic risk factors</source>
     </trans-unit>
     <trans-unit id="PEO_1240_label">
       <source>thing that acts as a genetic biomarker</source>
       <target>遺伝子バイオマーカーに関連した概念
</target>
     </trans-unit>
     <trans-unit id="PEO_1241_synonyms">
       <source>genetic biomarker</source>
     </trans-unit>
     <trans-unit id="PEO_1242_label">
       <source>thing that can increase the risk</source>
       <target>リスク因子に関連した概念
</target>
     </trans-unit>
     <trans-unit id="PEO_1243_label">
       <source>trans-Golgi Network</source>
       <target>トランスゴルジ網
</target>
     </trans-unit>
     <trans-unit id="PEO_1243_synonyms">
       <source>trans Golgi Network</source>
     </trans-unit>
     <trans-unit id="PEO_1243_synonyms_1">
       <source>Region, trans-Golgi</source>
     </trans-unit>
     <trans-unit id="PEO_1243_synonyms_2">
       <source>trans-Golgi Regions</source>
     </trans-unit>
     <trans-unit id="PEO_1243_synonyms_3">
       <source>Network, trans-Golgi</source>
     </trans-unit>
     <trans-unit id="PEO_1243_synonyms_4">
       <source>trans-Golgi Region</source>
     </trans-unit>
     <trans-unit id="PEO_1243_synonyms_5">
       <source>trans Golgi Region</source>
     </trans-unit>
     <trans-unit id="PEO_1243_definition">
       <source>A network of membrane compartments, located at the cytoplasmic side of the GOLGI APPARATUS, where proteins and lipids are sorted for transport to various locations in the cell or cell membrane.</source>
     </trans-unit>
     <trans-unit id="PEO_1243_synonyms_6">
       <source>Regions, trans-Golgi</source>
     </trans-unit>
     <trans-unit id="PEO_1244_label">
       <source>treatment at delivery</source>
       <target>分娩時の措置
</target>
     </trans-unit>
     <trans-unit id="PEO_1245_label">
       <source>treatment during pregnancy</source>
       <target>分娩中の措置
</target>
     </trans-unit>
     <trans-unit id="PEO_1246_label">
       <source>triglyceride</source>
       <target>トリグリセリド
</target>
     </trans-unit>
     <trans-unit id="PEO_1246_synonyms">
       <source>Triglyceride</source>
     </trans-unit>
     <trans-unit id="PEO_1246_synonyms_1">
       <source>C6H5O6R3</source>
     </trans-unit>
     <trans-unit id="PEO_1246_synonyms_2">
       <source>a triacylglycerol</source>
     </trans-unit>
     <trans-unit id="PEO_1246_synonyms_3">
       <source>triacylglycerols</source>
     </trans-unit>
     <trans-unit id="PEO_1246_synonyms_4">
       <source>Triglycerid</source>
     </trans-unit>
     <trans-unit id="PEO_1246_synonyms_5">
       <source>triglycerides</source>
     </trans-unit>
     <trans-unit id="PEO_1246_synonyms_6">
       <source>Triacylglycerol</source>
     </trans-unit>
     <trans-unit id="PEO_1246_synonyms_7">
       <source>[*]C(=O)OCC(COC([*])=O)OC([*])=O</source>
     </trans-unit>
     <trans-unit id="PEO_1246_synonyms_8">
       <source>Triglyzerid</source>
     </trans-unit>
     <trans-unit id="PEO_1247_label">
       <source>triglyceride-rich lipoprotein</source>
       <target>高トリグリセリドリポ蛋白質
</target>
     </trans-unit>
     <trans-unit id="PEO_1248_label">
       <source>type 2 immune response</source>
       <target>2型免疫応答
</target>
     </trans-unit>
     <trans-unit id="PEO_1248_synonyms">
       <source>Th2 immune response</source>
     </trans-unit>
     <trans-unit id="PEO_1248_definition">
       <source>An immune response which is associated with resistance to extracellular organisms such as helminths and pathological conditions such as allergy, which is orchestrated by the production of particular cytokines, most notably IL-4, IL-5, IL-10, and IL-13, by any of a variety of cell types including T-helper 2 cells, eosinophils, basophils, mast cells, and nuocytes, resulting in enhanced production of certain antibody isotypes and other effects.</source>
     </trans-unit>
     <trans-unit id="PEO_1248_synonyms_1">
       <source>T-helper 2 type immune response</source>
     </trans-unit>
     <trans-unit id="PEO_1249_label">
       <source>vascular inflammation</source>
       <target>血管炎
</target>
     </trans-unit>
     <trans-unit id="PEO_1249_synonyms">
       <source>inflammation of vessel</source>
     </trans-unit>
     <trans-unit id="PEO_1250_label">
       <source>very-low-density lipoprotein cholesterol</source>
       <target>超低密度リポタンパク質コレステロール
</target>
     </trans-unit>
     <trans-unit id="PEO_1250_definition">
       <source>Cholesterol esters and free cholesterol which are contained in or bound to very low density lipoproteins (VLDL).</source>
     </trans-unit>
     <trans-unit id="PEO_1250_synonyms">
       <source>VLDL-C</source>
     </trans-unit>
     <trans-unit id="PEO_1250_synonyms_1">
       <source>pre-beta-lipoprotein cholesterol</source>
     </trans-unit>
     <trans-unit id="PEO_1250_synonyms_2">
       <source>VLDL cholesterol</source>
     </trans-unit>
     <trans-unit id="PEO_1251_label">
       <source>vitamin</source>
       <target>ビタミン
</target>
     </trans-unit>
     <trans-unit id="PEO_1251_synonyms">
       <source>vitamins</source>
     </trans-unit>
     <trans-unit id="PEO_1252_label">
       <source>Vitamin C</source>
       <target>ビタミンC
</target>
     </trans-unit>
     <trans-unit id="PEO_1252_synonyms">
       <source>vitaminum C</source>
     </trans-unit>
     <trans-unit id="PEO_1252_synonyms_1">
       <source>vitamina C</source>
     </trans-unit>
     <trans-unit id="PEO_1252_synonyms_2">
       <source>vitamine C</source>
     </trans-unit>
     <trans-unit id="PEO_1252_synonyms_3">
       <source>Vitamin C</source>
     </trans-unit>
     <trans-unit id="PEO_1253_label">
       <source>vitamin D</source>
       <target>ビタミンD
</target>
     </trans-unit>
     <trans-unit id="PEO_1253_synonyms">
       <source>D vitamins</source>
     </trans-unit>
     <trans-unit id="PEO_1253_definition">
       <source>Vitamin D is a group of fat-soluble prohormones, which can be obtained from sun exposure, food and supplements. Vitamin D is biologically inactive and converted to the biologically active calcitriol via double hydroxylation in the body.</source>
     </trans-unit>
     <trans-unit id="PEO_1253_synonyms_1">
       <source>vitamin Ds</source>
     </trans-unit>
     <trans-unit id="PEO_1254_label">
       <source>16-20 wk</source>
       <target>妊娠週数16-20週
</target>
     </trans-unit>
     <trans-unit id="PEO_1255_label">
       <source>28 wk</source>
       <target>妊娠週数28週
</target>
     </trans-unit>
     <trans-unit id="PEO_1257_label">
       <source>8–10 wk</source>
     </trans-unit>
     <trans-unit id="PEO_1258_label">
       <source>wnt signalling</source>
       <target>WNTシグナリング
</target>
     </trans-unit>
     <trans-unit id="PEO_1258_synonyms">
       <source>wingless signalling</source>
     </trans-unit>
     <trans-unit id="PEO_1258_synonyms_1">
       <source>wnt-signalling</source>
     </trans-unit>
     <trans-unit id="PEO_1259_label">
       <source>younger than marriageable age</source>
       <target>18歳未満
</target>
     </trans-unit>
     <trans-unit id="PEO_1259_synonyms">
       <source>biological immature</source>
     </trans-unit>
     <trans-unit id="PEO_1259_synonyms_1">
       <source>adolescents of &lt;17 years old</source>
     </trans-unit>
     <trans-unit id="PEO_1260_synonyms">
       <source>Zn</source>
     </trans-unit>
     <trans-unit id="PEO_1261_label">
       <source>Gave up before pregnancy (Alcohol intake)</source>
       <target>妊娠前の飲酒中断
</target>
     </trans-unit>
     <trans-unit id="PEO_1262_label">
       <source>Gave up during pregnancy (Alcohol intake)</source>
       <target>妊娠中の飲酒中断
</target>
     </trans-unit>
     <trans-unit id="PEO_1263_label">
       <source>Total cholesterol:HDL ratio measurement</source>
       <target>LH比
</target>
     </trans-unit>
     <trans-unit id="PEO_1263_synonyms">
       <source>Total cholesterol:HDL ratio</source>
     </trans-unit>
     <trans-unit id="PEO_1263_synonyms_1">
       <source>Total cholesterol:high density lipoprotein ratio measurement</source>
     </trans-unit>
     <trans-unit id="PEO_1263_synonyms_2">
       <source>Total cholesterol:high density lipoprotein ratio measurement (procedure)</source>
     </trans-unit>
     <trans-unit id="PEO_1264_label">
       <source>Transporter</source>
     </trans-unit>
     <trans-unit id="PEO_1264_label_1">
       <source>Caffeine consumption</source>
     </trans-unit>
     <trans-unit id="PEO_1264_label_2">
       <source>neuronal damage</source>
     </trans-unit>
    </body>
  </file></xliff>
